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Abstract  
As   axons   from   the   raphe   nuclei   densely   innervate   the   somatosensory   cortex,   the  
modulation  of  transmitter  release  by  serotonin  (5-­HT)  was  investigated  in  pyramidal  cells  
in  layer  II  of  rat  barrel  cortex.  The  idea  was  that  5-­HT,  via  presynaptic  5-­HT2  receptors  
(5-­HT2R)   coupled   to   Gq   proteins,   activates   Ca2+   release   from   stores   to   increase  
spontaneous  transmitter  release.  
Addition  of  10  µM  5-­HT,   in   the  presence  of  TTX  and  gabazine,  caused  a  waxing  and  
waning   of   the   instantaneous   mEPSC   frequency.   Specifically,   5-­HT   increased   the  
frequency  by  28  ±  7%  within  5  minutes  (phase  1).  Later,  within  5  –  12  minutes,  it  dropped  
to  below  control  (-­15  ±  3%;;  phase  2).  Thereafter,  it  resurged  back  to  27  ±  7%  (phase  3).  
Concomitantly,  the  mEPSC  amplitude  remained  unaffected.  
These  changes  in  spontaneous  release  were  mediated  by  5-­HT2CR  and  5-­HT2AR,  with  
the   former  providing  a   larger  contribution.  The  downstream  signalling  was  verified  by  
blocking  PLCβ,  IP3R,  and  Ca2+  release  from  stores.  The  findings  were  consistent  with  
the   activation   of   a   classical   Gq   cascade.   Inhibiting   PKC   by   Gö   6983   rendered   the  
increase  sustained,  suggesting  that  a  phosphorylation  caused  the  reduction  in  frequency  
after  reaching  an  initial  peak.  
These   findings   were   restricted   to   a   subset   of   cells   (47%),   which   were   subsequently  
termed  responders.  No  change  occurred  in  non-­responders.  The  two  groups  differed  by  
the  size  of  the  reduction  in  input  resistance  (Rin)  and  the  change  in  holding  current.  For  
responders,  the  former  was  large,  but  the  latter  small.  In  contrast,  for  non-­responders,  
the  former  was  small,  but  the  latter  large.  
In  connected  pairs  of  pyramidal  cells  in  this  layer,  5-­HT  depressed  the  EPSC  amplitude  
by  49  ±  3%  without  significantly  altering  the  paired-­pulse  ratio.  This  depression  occurred  
downstream  of  5-­HT2R  activation.  It  was  caused  by  Gβγ,  because  it  was  blocked  by  Gβγ-­
binding  peptides  (mSIRK/ct-­SNAP-­25).  As  Gβγ  most  likely  inhibited  voltage-­dependent  
Ca2+  channels,  limited  influx  caused  the  EPSC  depression.  
Because  5-­HT  depressed  EPSCs  in  most  pairs,  specificity  in  the  connectivity  between  
responders   and   non-­responders  must   exist.   In   fact,   responders   were   typically   post-­,  
whereas  non-­responders  presynaptic.  Consistent  with  this  idea,  the  mEPSC  frequency  
only   increased   in   post-­,   but   not   presynaptic   cells.   Furthermore,   postsynaptic   cells  
showed   a   large   drop   in   Rin   associated   with   a   small   outward   current.   Conversely,  
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presynaptic   cells   showed   a   small   drop   in   Rin   together   with   a   considerable  
hyperpolarization.  
My   results   revealed   that,   in   contrast   to   the   classical   tenet   of   Katz’   hypothesis   of  
transmitter  release,  spontaneous  transmitter  release  increased,  whereas  evoked  release  
depressed  downstream  of  5-­HT2R  activation.  The  two  mechanisms  dissociated  at  the  Gq  
protein   level.  Spontaneous  release  was   increased  by  Ca2+   release   from  stores,  whilst  
evoked  release  was  depressed  most  likely  via  inhibition  of  VDCC  by  Gβγ.  Because  of  
their   restriction   to   responders,   these   mechanisms   would   differentially   affect   the  
neocortical  microcircuitry.     
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1.  Introduction  
This  research  project  started  with  the  question  whether  the  neuromodulator  serotonin  (5-­
HT)  is  capable  of  causing  calcium  (Ca2+)  release  from  presynaptic  stores  via  activation  
of   the   classical  Gq-­protein-­mediated   signalling   cascade,   and   consequently  modulates  
neurotransmitter   release.   This   question   was   tested   in   layer   II   pyramidal   cells   of   rat  
somatosensory   (S1)   cortex,   also   referred   to   as   barrel   cortex.   In   parts   3   and   4,   I   will  
provide  the  answer  to  this  question  for  both  spontaneous  and  evoked  glutamate  release,  
respectively.  
In   this   introduction,   I  will  start  by  presenting   important  concepts   related   to  my   field  of  
research.   First,   I   will   briefly   describe   some   anatomy   and   physiology   of   neocortex,  
specifically   of   barrel   cortex   from   the   perspective   of   the   whisker-­related   sensory  
pathways.   Second,   I   will   portray   how   information   transfer   between   neurons   in   the  
neocortex  occurs  via  synaptic  transmission.  As  my  research  was  focused  on  chemical  
transmission,  the  case  for  electrical  transmission  will  only  be  introduced  superficially.  For  
both  spontaneous  and  evoked  transmitter  release,  the  respective  dependency  on  Ca2+  
from  extra-­  and  intracellular  sources  will  be  reviewed.  Third,  I  will  introduce  aspects  of  5-­
HT  relating  to   its  synthesis,   innervation,  release  and  receptor  actions.  Additionally,  as  
some   of  my   results   will   be   compared  with   data  when   noradrenaline   (NA)  modulated  
transmitter  release  via  α1-­adrenoceptors  (α1-­AR),  which,  like  5-­HT2  receptors  (5-­HT2R),  
are  also  linked  to  a  Gq  cascade,  these  considerations  will  be  extended  to  also  include  
NA.  
1.1.  Neocortex  and  Primary  Somatosensory  Barrel  Cortex  
One  of  the  most  important  functions  of  the  brain,  and  specifically  neocortex,  is  to  process  
information   stemming   from   different   sensory   modalities.   Proper   processing   of   this  
information  is  critical  for  the  generation  of  an  appropriate  behavioural  output,  which  could  
manifest  itself  as  a  suitable  response  to  the  demands  of  the  environment.  
The  neocortex  consists  of  the  grey  matter  of  the  two  hemispheres  that  fill  out  most  of  the  
cranium,   specifically   its   antero-­lateral   and   dorsal   parts.   It   does   not   include   the  
hippocampus,  basal  ganglia  and  the  olfactory  bulb.  In  humans,  its  structure  is  gyrated,  
but  not  so   in   rodents,  where   the  surface   is   flat.  Based  on   the   information  processed,  
mouse  and  rat  neocortex  could  be  grossly  divided  into  four  primary  areas  (Rash  &  Grove,  
2006;;  Lodato  &  Arlotta,  2015).  In  rostral  to  caudal  order,  these  are:  1)  motor  (producing  
Introduction  
        22  
output  to  control  fine  motor  behaviours),  2)  somatosensory  (processing  input  from  the  
senses  like  touch  and  in  rodents  the  whiskers),  3)  auditory  (sound),  and  4)  visual  cortex  
(vision).  Although  these  areas  each  process  different  kinds  of  information,  the  neocortical  
structure  is  uniformly  composed  of  six  layers  (I  –  VI),  with  the  first  layer  superficial  and  
VI  deepest.  Based  on  the  development  of  the  different  layers,  layer  IV,  which  is  called  
the   granular   layer,   is   the   first   to   be   established.   Layers   II   and   III   are   also   called  
supragranular,  and  layers  V  and  VI  as  infragranular  layers;;  both  develop  afterwards.    
Whilst  different   layers  have  a  slightly  different  composition  of  excitatory  and   inhibitory  
neurons,  generally,  throughout  neocortex,  ~80%  of  cells  are  excitatory  neurons,  whilst  
the  rest  are  inhibitory  (GABAergic).  The  somata  of  excitatory  neurons  in  layers  II,  III,  V,  
and  VI  have  a  pyramidal  shape  and  are  referred  to  as  pyramidal  cells.  A  feature  of  all  
these  excitatory   cells   is   that   they   show  spines  along   their   dendrites   (Ramón  y  Cajal,  
1904)  and  they  release  the  neurotransmitter  glutamate  (glutamatergic).  In  layers  II  and  
III,  these  pyramidal  cells  can  be  classified  into  1)  associative  projection  neurons  and  2)  
commissural   projection   neurons.   The   former   send   their   axons   to   other   areas   in   the  
ipsilateral  hemisphere,  including  to  different  layers  of  the  same  area.  The  latter  project  
to  the  contralateral  hemisphere  via  the  corpus  callosum.   In   layers  V  and  VI,  there  are  
also  corticofugal  projection  neurons  that  extend  their  axons  to  distal  target(s)  outside  the  
cortex,  like  spinal  cord,  thalamus,  basal  ganglia  and  cerebellar  nuclei  (Molyneaux  et  al.,  
2007).   Besides   pyramidal   cells,   in   layer   IV,   there   are   two   other   excitatory   cell   types,  
namely  spiny  stellate  and  star  pyramidal  cells  (White,  1978).  
The   inhibitory   cells   are   often   referred   to   as   interneurons.   The   strict   definition   of   an  
interneuron  was   that   the   cell   only  makes   local   connections  within   the   same   layer   or  
(spinal)  segment.  However,  at  the  present  time,  it  was  realised  that  in  neocortex,  these  
connections  can  span  to  multiple  layers  (Kawaguchi  &  Kubota,  1996,  1997,  1998;;  Lodato  
et  al.,  2015).  They  are  exclusively  inhibitory  by  releasing  the  transmitter  γ-­aminobutyric  
acid   (GABAergic).   It   is   important   to   notice   that   the  GABAergic   interneurons   are   very  
diverse  (Gupta  et  al.,  2000),  and  each  neocortical  layer  has  a  different  composition  of  
interneurons  (Simons  &  Woolsey,  1984;;  Uematsu  et  al.,  2008).  A  morphological  feature  
of  most,  but  not  all  these  interneurons,  is  that  they  have  somata  that  are  not  pyramidal  
in  shape.  In  addition,  their  dendrites  are  sparsely  studded  with  spines,  and  often  beaded  
(Keller  &  White,  1987;;  Kubota  et  al.,  2011).  Large  variations  in  electrophysiological  and  
connection  properties  of  these  cells  present  an  immense  difficulty   in  creating  a  widely  
accepted  systematic  classification  (DeFelipe  et  al.,  2013).  However,  in  recent  years,  a  
simpler   classification   based   on   the   molecular   expression   of   certain   peptides,   like  
parvalbumin  and  somatostatin,  and  additionally  5-­HT3A  receptors,  was  used  to  include  
most  types  of  interneurons  (Lee  et  al.,  2010;;  Kepecs  &  Fishell,  2014).  
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The  study  of  neocortical  function  is  often  done  in  the  somatosensory  cortex  of  rodents,  
specifically   S1.   Its   cytoarchitechture   is   special   because   “barrel”-­like   structures   are  
formed  in  this  area.  These  barrels  were  initially  revealed  using  either  the  Nissl  or  Nissl-­
Golgi  staining  methods  (Woolsey  &  Van  der  Loos,  1970),  but   they  can  also  be  easily  
distinguished   in   unstained   tissue   (as   in   an   experiment  where   differential   interference  
contrast  optics  are  used  to  observe  brain  slices).  The  barrels  form  in  layer  IV,  and  are  
characterized  by  higher  density  of  cells  particularly  along  the  “walls”   in  contrast  to  the  
centre  parts.  The  beauty  of  this  S1  barrel  cortex  is  that  each  barrel  receives  the  input  
from  exactly  one  whisker   in   the  mystacial  part  of   the  rodent   face  (Welker  &  Woolsey,  
1974).  The  somatosensory  input  from  a  single  whisker  is  processed  in  the  neocortical  
column  associated  with  the  layer  IV  barrel  in  its  centre  (Petersen  &  Sakmann,  2001).  
The  afferent  pathway  from  whisker  to  barrel  cortex  is  as  follows.  The  stimulus-­induced  
whisker  motion  activates  the  sensory  receptor,  which  makes  contact  with  the  peripheral  
branch   of   trigeminal   ganglion   cell   (Birdwell   et   al.,   2007).   The   central   branch   of   the  
trigeminal  ganglion  cells  then  relays  the  information  as  a  sequence  of  action  potentials  
to  the  trigeminal  nucleus  in  the  brain  stem  (Torvik,  1956;;  Clarke  &  Bowsher,  1962).  This  
information   is   then   passed   to   the   thalamus   through   parallel   pathways,   namely   the  
lemniscal,  the  extralemniscal,  and  the  paralemniscal  pathways.  From  the  thalamus,  the  
information  is  relayed  to  the  barrel  cortex,  mostly  in  layer  IV  (Deschenes  et  al.,  2005).  
Specifically,  the  lemniscal  pathway  connects  the  dorsomedial  section  of  ventroposterior  
medial  nucleus  in  the  thalamus  to  the  corresponding  barrel  (layer  IV).  Whisker-­induced  
signals  are  then  relayed  from  layer  IV  to  II/III,  where  they  are  subject  to  local  recurrent  
excitation  or  amplification  (Douglas  &  Martin,  2004).  From  layer  II/III,  neurons  project  this  
information   to   layer  V  where   the  output   from   the  column   is  generated  and   relayed   to  
other  parts  of  the  brain  or  subcortical  structures  (Petersen  &  Sakmann,  2001).  From  layer  
V,  there  is  a  forward  connection  to  layer  VI,  from  which  cells  project  back  to  the  thalamus  
to  control  the  afferent   inputs.  The  intracortical  steps  are  often  referred  to  as  columnar  
processing  of  the  sensory  information.    
Note  that  my  thesis  focusses  on  how  information  flow  along  the  intralayer  (horizontal)  
connections  between  neighbouring  pyramidal  cells  in  layer  II  is  modulated  by  5-­HT.  As  
this   information   transfer   includes  synaptic   transmission  between  pyramidal  cells,   I  will  
proceed  to  give  a  short  background  of  the  physiology  of  chemical  transmission.  
1.2.  Physiology  of  Synaptic  Transmission  
The   transfer   of   information   or   “signal   relay”   from   one   neuron   to   another   occurs   at  
synapses   through   a   process   named   synaptic   transmission.   There   are   two   types   of  
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transmission,  electrical  and  chemical.  Both  essentially  involve  specific  presynaptic  and  
postsynaptic   elements,   but   fundamentally   differ   in   1)   the   physical   components   at   the  
synapse,  2)  the  speed  of  transmission,  3)  typically,  the  directionality  of  the  information  
transfer,  and  4)  ontogeny  or  prevalence  period.  Here,  I  will  briefly  describe  the  former  
(electrical)  before  proceeding  to  the  details  of  the  latter  (chemical  synaptic  transmission).          
1.2.1.  Electrical  Transmission  
An   electrical   synapse   takes   the   form   of   a   gap   junction,   which   is   an   intercellular   ion  
channel   connecting   the   cytoplasm   of   two   neurons.   This   channel   is   formed   by   two  
connexons,  specifically  one  each  in  the  pre-­  and  postsynaptic  neurons.  The  connexon  
itself  is  typically  made  up  of  six  subunits  called  connexins.  (Pereda  et  al.,  2013).    
Following  Ohm’s  law,  the  gap  junction  enables  current  to  flow  (ions)  through  its  channel  
in   a   manner   proportional   to   the   trans-­junctional   voltage.   In   this   case,   information   is  
transferred  from  one  neuron  to  another  neuron  almost  instantaneously,  i.e.  less  than  one  
third  of  a  millisecond.  Depending  on  how   the   trans-­junctional  voltage  changes  due   to  
neuronal  activity,  current  may  also  flow  in  the  reverse  direction,  creating  the  bidirectional  
and  graded  characteristics  of  electrical  transmission  (Furshpan  &  Potter,  1959;;  Connors,  
2017).  
Electrical  synaptic   transmission  does  not  only  depend  on   the  conductance  of   the  gap  
junction,  but  also  on  the  resistance  and  membrane  time  constant  of  the  postsynaptic  cell.  
Since  most  neurons   in  mammalian  brain  have   large  membrane   time  constants   in   the  
order   of   tens   of   milliseconds,   electrical   transmission   functions   as   a   low-­pass   filter  
(Connors  &  Long,  2004),  which  attenuates  high  frequency  signals  like  action  potentials  
(APs)  much  stronger   than   low   frequency  ones.  Therefore,  even   in   the  case  of  strong  
excitatory  activity  such  as  during  a  burst  of  APs  in  the  presynaptic  cell,  the  postsynaptic  
cell  could  hyperpolarize  if  there  is  a  large  afterhyperpolarization  (AHP)  following  a  single  
AP  (Galarreta  &  Hestrin,  2001).  Conversely,  if  the  AHP  is  small  and  short,  the  burst  of  
APs  in  the  presynaptic  cell  could  result  in  a  postsynaptic  depolarization  (Landisman  et  
al.,  2002).  These  examples  illustrate  that  the  electrical  synaptic  transmission  can  be  both  
excitatory  and  inhibitory.  Inhibition  of  the  postsynaptic  cell   through  electrical  synapses  
could   also   normally   occur   when   the   presynaptic   cell   undergoes   hyperpolarization  
(Apostolides  &  Trussell,  2013).  
The   functions   of   gap   junction   and   electrical   synaptic   transmission   include  
synchronization  and  phase-­locking,  generating  antiphase  firing  (Bennett  &  Zukin,  2004;;  
Gibson   et   al.,   2005;;   Merriam   et   al.,   2005;;   Hu   &   Agmon,   2015),   de-­synchronization  
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(Vervaeke   et   al.,   2010),   regulating   network   oscillations   (Buhl   et   al.,   2003),   reducing  
whole-­cell   noise   and   enhancing   signals   in   neuronal   circuits   (Medvedev,   2009),   and  
regulating  the  formation  and  tuning  of  microcircuits  (Yao  et  al.,  2016).  
Using  dyes  to  track  coupling  between  neurons,  Connors  et  al.  (1983)  and  Peinado  et  al.  
(1993)  showed  that  the  electrical  synapses  are  commonly  expressed  in  neocortex  during  
an  early  postnatal  period  (70%  of  neurons  during  P1  –  4).  Along  with  maturation,   this  
type  of  synapse  decreases  in  number,  with  less  than  20%  of  neurons  showing  coupling  
after  P18.  Neurons  expressing  such  synapses   in  adult  age  are   typically   interneurons,  
specifically  fast-­spiking  parvalbumin  (Galarreta  &  Hestrin,  1999,  2002),  irregular-­spiking  
(Galarreta   et   al.,   2004),   and   late-­spiking   (Chu   et   al.,   2003)   interneurons.   In   contrast,  
excitatory  cells   in   the  neocortex  are  known   to  only  express   these  electrical  synapses  
during   the   first   two   postnatal   weeks   (Sutor   &   Hagerty,   2005).   From   then   on,   these  
pyramidal   cells  utilize  chemical   synapses   for   information   transfer.  Because  my   thesis  
focusses  on  networks  made  up  of  excitatory  cells  at  the  age  of  P15  –  20  in  rat,  electrical  
synapses  will  not  be  discussed  any  further.  In  fact,  the  definition  of  synapses  or  synaptic  
transmission  will  solely  refer  to  chemical  synapses.    
1.2.2.  Chemical  Transmission  
In  comparison  with  electrical  synapses,  the  components  of  chemical  synapses  are  much  
more   complex.   Both,   the   presynaptic   and   postsynaptic   elements   are   very   different,  
including  their  morphology,  protein  biochemistry,  signal  generation  and  relay,  and  ionic  
dependency.  Here,  I  will  explain  these  properties  in  the  context  of  excitatory  chemical  
transmission  (glutamatergic  transmission)  in  the  neocortex,  and  then  address  specifically  
some  points  of  interest  for  my  PhD  research.  
Chemical  transmission  occurs  at  junctions  between  a  presynaptic  nerve  terminal,  also  
referred  classically  as  a  bouton,  and  a  postsynaptic  element,   in  neocortex   typically  a  
spine  head  on  a  piece  of  dendrite.  How  the  signal  is  generated  and  then  relayed  to  the  
postsynaptic  cell  using  these  elements  can  be  summarized  as  follows.  Upon  a  sufficiently  
large  physiological  stimulus  in  the  presynaptic  cell,  an  action  potential   is  generated  at  
the  end  of  the  axon  initial  segment  (Palmer  &  Stuart,  2006).  The  action  potential  then  
propagates   along   the   axon   down   to   its   nerve   terminals.   Due   to   the   large   change   in  
membrane  voltage  associated  with  the  AP,  the  terminal  membrane  is  depolarized  by  60  
–  100  mV.  This  depolarization  activates  high  voltage-­dependent  Ca2+  channels  (VDCC),  
which  then  open  causing  a  short  Ca2+  influx.  This  Ca2+,  through  an  interaction  with  the  
soluble   N-­ethylmaleimide-­sensitive   factor   attachment   protein   receptor   (SNARE)  
complex,  triggers  neurotransmitter-­containing  synaptic  vesicles  to  quickly  fuse  with  the  
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presynaptic  membrane  at  the  active  zone,  thus  releasing  the  neurotransmitter  into  the  
synaptic  cleft.  The  neurotransmitter  diffuses  across   the  synaptic  cleft  of  ~20  –  40  nm  
(Palay,   1956),   and   then   binds   to   specific   receptor(s)   on   the   spine   head   on   the  
postsynaptic  cell.  These  receptors,  majorly  ligand-­gated  ion  channels,  then  open  and  let  
ions  flow  into  the  postsynaptic  compartment.  The  activated  postsynaptic  receptor(s)  yield  
a  postsynaptic  voltage  change  that  then  propagates  along  the  dendrite  to  the  soma  to  
be  summed  and  integrated  with  other  inputs  to  the  dendrites  of  the  postsynaptic  cell.  
Neurotransmitter   release   at   chemical   synapses   is   dependent   on   SNARE   proteins   in  
concert  with  a  Ca2+  sensor  like  one  of  the  synaptotagmins  (reviewed  by  Sudhof  &  Rizo,  
2011;;  Sudhof,  2013).  The   latter  senses  the  Ca2+   influx  and  then  triggers   the  fusion  of  
synaptic  vesicles  with  the  presynaptic  membrane  (reviewed  by  Sudhof,  2012).  Different  
SNARE   proteins   have   been   recognised   and   classified   into   two   different   groups  
depending  on  which  subcellular  membrane  compartment   their  anchors   reside   to.  The  
first  group  comprises  the  v-­SNAREs  (vesicle).  The  anchor  here  is  within  the  vesicular  
membrane.  The  second  group  contains  the  t-­SNAREs  (target),  which  are  anchored  in  
the  terminal  (cytosolic)  membrane  (for  details  see  Wilhelm  et  al.,  2014).    
The  classic  conception  of  vesicle  fusion  states  that  three  different  SNARE  proteins  are  
essential  for  fusion  competency.  These  proteins  are  the  v-­SNARE  synaptobrevin  (either  
isotype  1  or  2)  also  called  vesicle-­associated  membrane  protein  1  or  2  (VAMP1/2),  and  
the  two  t-­SNAREs  syntaxin-­1,  and  SNAP-­25.  In  preparation  for  transmitter  release,  these  
SNARE   proteins   assemble   to   form   a   trans-­SNARE   complex,   in   which   four   α-­helix  
domains  (one  from  synaptobrevin,  one  from  syntaxin-­1,  and  two  from  SNAP-­25)  form  a  
coiled-­coil   interaction,   bringing   the   two   membranes   of   the   vesicle   and   of   the   nerve  
terminal  close  together  like  that  of  a  zipper  (Hayashi  et  al.,  1994;;  Hayashi  et  al.,  1995;;  
Sudhof  &  Rizo,  2011).  
When  the  intracellular  Ca2+  concentration  increases  via  influx  through  VDCCs,  another  
vesicle  associated  protein,  synaptotagmin  1,  acts  as  the  Ca2+  sensor,  by  binding  Ca2+  at  
its  two  C2  domains  (Davletov  &  Sudhof,  1993;;  Sutton  et  al.,  1995;;  Sugita  et  al.,  1996;;  
Ubach  et  al.,  2001;;  Fernandez-­Chacon  et  al.,  2002;;  Choi  et  al.,  2010;;  Chen  &  Jonas,  
2017).  The  binding  with  Ca2+  enables  synaptotagmin  1  to  remove  the  fusion  “lock”  by  
complexin  (another  SNARE  protein;;  Tang  et  al.,  2006)  and  interact  with  the  membrane  
phospholipid   (Zhang   et   al.,   1998;;   Arac   et   al.,   2006).   As   the   result,   a   conformational  
change  of   the  SNARE  complex  occurs   from  a   trans-­   to  cis-­configuration,  merging   the  
two   membrane   leaflets   together   with   subsequent   fusion   pore   opening   and  
neurotransmitter   release.   After   full   fusion   has   occurred,   the   cis-­SNARE   complex  
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dissociates   by   the   ATPase   N-­ethylmaleimide-­sensitive   factor   (NSF;;   Brunger,   2005;;  
Sudhof  &  Rizo,  2011).  
In  the  case  of  excitatory  neurotransmission  in  neocortex,  the  vesicle  contains  glutamate.  
This  transmitter  binds  to  two  different  types  of  glutamate  receptors  characterised  by  their  
postsynaptic   transduction   as   coined   by   Eccles   and   McGeer   (1979).   The   first   type  
consists  of   ionotropic   receptors.  The   feature  here   is   that  all   receptors  are   individually  
linked   to  a   ligand-­gated   ion  channel,   in   the  case  of  glutamate,  a  non-­selective  cation  
channel.  According   to   the  most  specific  agonist  at  each  of   these   receptors,   there  are  
three  ionotropic  groups,  namely  1)  α-­amino-­3-­hydroxy-­5-­methyl-­isoxazolepropionic  acid  
(AMPA)   receptors,   2)   N-­methyl-­D-­aspartate   (NMDA)   receptors,   and   3)   kainate   (KA)  
receptors.  All  three  ionotropic  glutamate  receptors  are  widely  and  abundantly  expressed  
in  the  neocortex.  The  second  type  consists  of  metabotropic  receptors.  The  feature  here  
is   that   these   receptors   are   individually   coupled   to   a   specific   type  of  G-­protein,  which  
produces  intracellular  signalling  cascade  that  may  target  or  affect  ion  channel(s).  In  case  
of  the  metabotropic  glutamate  receptors  (mGluRs),  they  have  eight  isotypes,  which  are  
grouped  into  three,  namely  group  I  –  III  (Niswender  &  Conn,  2010).  
The   three   ionotropic   receptors   have   a   tetrameric   structure.   Both,   homo-­   and  
heterotetramers  are  found  for  both  AMPA  and  KA  receptors,  but  only  heterotetramers  
for  NMDA  receptors.  In  the  case  of  AMPA  receptors,  these  homo-­/heterotetramers  are  
composed  of  subunits  from  four  different  genes,  namely  GluA1  –  4  (Keinanen  et  al.,  1990;;  
Monyer  et  al.,  1992;;  Greger  et  al.,  2017).  In  the  case  of  NMDA  receptors,  three  genes  
have  been  found,  namely  GluN1  –  3  (Monyer  et  al.,  1992;;  Regan  et  al.,  2015)  of  which  
GluN2  has   four  members.   In   the  case  of  KA  receptors,   five  genes  have  been  cloned,  
namely  GluK1  –  5   (Bettler  et  al.,  1990;;  Carta  et  al.,  2014).  Although   the   three   receptor  
groups  share  a  non-­specific  cation  conductance  (Na+,  K+,  and  in  some  cases  Ca2+),  their  
kinetics  and  sizes  of  the  respective  conductances  vary  in  many  aspects.  
AMPA   receptors   have   fast   kinetics   and   activate   in   the   range   of   few   hundreds   of  
microseconds.  They  are  responsible  for  the  fast  component  during  synaptic  transmission.  
NMDA   receptors   are   unique   because   their   activation   requires   the   coincidence   of   1)  
glutamate   binding   to   the   respective   receptor,   2)   a   depolarization   to   about   -­40  mV   to  
relieve  the  Mg+  block  of  the  channel  at  the  GluN2  subunits,  and  3)  the  presence  of  the  
co-­agonist  glycine  (or  alternatively  serine;;  Johnson  &  Ascher,  1987)  bound  to  either  the  
GluN1   or   GluN3   subunit.   Note   that,   under   normal   physiological   conditions,   the  
cerebrospinal   fluid   (CSF)   contains   sufficient   amount   of   glycine.   The   kinetics   of   these  
NMDA  receptors  is  typically  slow  in  the  range  of  tens  of  milliseconds.  In  contrast  to  the  
AMPA   receptors,   they   carry   the   slow   component   in   synaptic   transmission.   The   KA  
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receptors   share   similar   mechanisms   for   activation   and   desensitization   as   the   AMPA  
receptors  (Mayer,  2006;;  Perrais  et  al.,  2010).  However,  KA  receptors  need  extracellular  
Na+  for  activation,  unlike  the  AMPA  receptors  which  still  activate  normally  in  the  absence  
of   this   ion   (Plested   et   al.,   2008).   Furthermore,   the   rate   of   recovery   from   glutamate-­
induced   desensitization   is   much   longer   (~10   fold)   for   KA   than   the   AMPA   receptors  
(Bowie  &  Lange,  2002).  The  kinetics  of  the  EPSCs  mediated  by  KA  receptors,  in  contrast  
to  those  by  AMPA  receptors,  are  much  slower;;   i.e.  they  have  a  longer  rise  and  decay  
times  (Kidd  &  Isaac,  1999).  
As  indicated  above,  the  mGluRs  are  comprised  of  eight  different  isotypes  classified  into  
three  different  groups.  Group  I  consists  of  mGluR1  and  mGluR5,  which  are  coupled  to  
Gq-­protein.  Group  II  includes  mGluR2  and  mGluR3,  and  group  III  includes  mGluR4  and  
mGluR6-­8.  All  receptors  in  groups  II  and  III  are  coupled  to  Gi/o-­protein.  Because  mGluR1  
and  mGluR5  are   coupled   to   the  Gq-­protein,   their   activation   results   in   the   subsequent  
activation  of  phospholipase  Cβ  (PLCβ),  which  then  hydrolyses  phosphatidylinositol  4,5-­
bisphosphate   (PIP2)   to   produce   inositol   trisphosphate   (IP3)   and   diacylglycerol   (DAG).  
mGluR2  –  4  &  6  –  8  activate  the  Gi/o-­protein  to  inhibit  adenylyl  cyclase,  which  results  in  
the  drop  in  the  intracellular  concentration  of  cyclic  adenosine  monophosphate  (cAMP).  
The  three  groups  are  expressed  widely  in  neurons  and  glial  (astrocytic)  cells  in  the  brain,  
including  the  neocortex.  Group  I  mGluR  are  often  expressed  postsynaptically,  and  their  
activation  causes  a  depolarization  of  the  postsynaptic  cell  or,  more  generally,  causes  an  
increased   membrane   excitability   (Valenti   et   al.,   2002).   However,   when   expressed  
presynaptically,  they  are  able  to  increase  neurotransmitter  release  rate  (Park  et  al.,  2004;;  
Choy  et  al.,  2017a).  In  contrast,  group  II  and  III  mGluRs  are  predominantly  expressed  in  
presynaptic  nerve  terminals.  Their  activation  typically   inhibits  neurotransmitter  release  
(van  den  Pol  et  al.,  1998;;  Chen  et  al.,  2002;;  Doi  et  al.,  2002;;  Shen  &  Johnson,  2003;;  
Mateo  &  Porter,  2007).  
1.3.  Neurotransmitter  Release  
The  details  of  neurotransmitter  release  as  described  above,  are  based  on  widely  studied  
and  understood  synaptic  transmission  due  to  stimuli  that  evoked  AP(s).  This  process  is  
termed   evoked   neurotransmitter   release.   However,   there   is   also   neurotransmitter  
release   without   or   independent   of   a   stimulus.   This   release   is   termed   spontaneous  
neurotransmitter  release.  Many  aspects  of  the  spontaneous  release  are  still  a  matter  of  
debate  among  neuroscientists.  Some  contentious  examples  are  1)  whether  spontaneous  
and  evoked  releases  utilize  the  same  SNARE  proteins  and/or  synaptic  vesicles,  and  2)  
what  the  physiological  function  of  the  spontaneous  release  is.  Here,  I  will  expand  on  the  
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essential  aspects  of  spontaneous  glutamate   release  because  a   large  part  of   the  data  
presented  here  deals  with   its  modulation.  This  will  be  followed  by  discussing  the  Ca2+  
dependence  of  glutamate  release,  as  it  is  an  important  aspect  in  this  thesis.  
1.3.1.  Spontaneous  Neurotransmitter  release  
The  concept  of  spontaneous  neurotransmitter  release  was  initially  introduced  by  Fatt  and  
Katz  (1950).  At  the  frog  neuromuscular  junction,  they  observed  spontaneously  occurring  
miniature  end-­plate  potentials  (mEPPs;;  representative  of  acetylcholine  release  from  the  
presynaptic  terminal)  without  any  stimulus.  The  mEPPs  had  the  following  characteristics:  
1)  The  amplitudes  were  ~1  mV  (approximately  100  times  smaller  than  the  AP  evoked  by  
the  stimulus  of  the  muscle  nerve).  2)  The  frequency  was  0.1  –  100  Hz,  and  3)  the  mEPPs  
had  a  rapid  rise  of  1  –  2  ms  and  4)  a  slow  decay  time  (half-­decay  of  3  –  4  ms).  5)  The  
mEPP  amplitude  was  dependent  on  the  extracellular  Na+  concentration,  but  independent  
of  the  extracellular  Ca2+  concentration.  6)  The  frequency  was  independent  of  both  the  
extracellular  Na+  and  Ca2+  concentration,  but  7)  it  increased  as  the  temperature  or  the  
osmotic  pressure  of  the  superfusate  increased  (Fatt  &  Katz,  1952).  
Similarly,   spontaneous   synaptic   events   were   also   observed   in   many   regions   of   the  
central  nervous  system,  specifically   in  motoneurones  of   the  spinal   cord   (Brock   et  al.,  
1952;;  Katz  &  Miledi,  1963;;  Kuno,  1964;;  Colomo  &  Erulkar,  1968;;  Korn  et  al.,  1987)  and  
in  various  brain  regions,  such  as  hippocampus  (Brown  et  al.,  1979;;  Swann  et  al.,  1990;;  
Strowbridge   et   al.,   1992;;   Hosokawa   et   al.,   1994)   and   neocortex   (Watanabe   &  
Creutzfeldt,  1966;;  Pare  et  al.,  1998).  In  the  case  of  excitatory  synapses,  they  are  called  
spontaneous  excitatory  postsynaptic  potentials  or  currents  (sEPSPs  or  sEPSCs).  The  
application   of   the   fast   Na+   channel   blocker   tetrodotoxin   (TTX)   did   not   abolish   them,  
indicating  that   transmitter  release  is  not  caused  by  spontaneous  electrogenesis   in  the  
axon,  i.e.  locally  generated  AP(s).  To  differentiate  spontaneous  events  in  the  presence  
of   TTX   from   those   without,   the   former   are   termed   miniature   excitatory   postsynaptic  
potentials  or  currents  (mEPSPs  or  mEPSCs;;  Katz  &  Miledi,  1963).    
In  most  regions  of  the  brain,  sEPSP/Cs  and  mEPSP/Cs  are  typically  mediated  by  both  
AMPA  and  NMDA  receptors  (McBain  &  Dingledine,  1992;;  Myme  et  al.,  2003).  However,  
the  recording  conditions,  i.e.  the  presence  or  lack  of  extracellular  Mg2+  and  the  holding  
potential,  determine  whether  typical  NMDA-­mediated  sEPSP/Cs  or  mEPSP/Cs  can  be  
observed  or  not.  Hence,  the  kinetics  (average  time  course)  may  change  accordingly.  The  
frequency  and  amplitude  of  these  spontaneous  events  in  neocortex  differ  vastly  between  
cell  types  and  layers,  making  it  hard  to  capture  some  general  characteristics.  Therefore,  
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I   will   only   present   characteristics   of   mEPSCs   in   pyramidal   cells   of   layer   II   in   the  
somatosensory  cortex  (S1  barrel  cortex),  as  it  was  the  focus  of  my  studies.  
A  pyramidal  cell   in  layer  II  of  S1  barrel  cortex  receives  approximately  10,000  synaptic  
inputs,  ~70%  of  which  are  of   intracortical  origin   (Gruner  et  al.,  1974;;  Larkman,  1991;;  
DeFelipe  &  Farinas,  1992).  With  such  a   large  number  of   inputs,  Simkus  and  Stricker  
(2002b)  showed  that  in  these  cells,  obtained  from  Wistar  rats  at  the  age  of  12  –  17  days,  
the  average  sEPSC  frequency  in  vitro  was  33  ±  13  Hz  with  an  amplitude  of  -­9.9  ±  2.7  pA.  
These  sEPSCs  had  an  average  rise  time  of  0.7  ±  0.8  ms,  and  a  half-­width  of  2.1  ±  3.8  
ms.  In  the  presence  of  TTX,  the  mEPSCs  in  these  cells  had  an  average  frequency  of  28  
±  24  Hz  and  amplitude  of  -­10  ±  3  pA.  Neither  the  frequency,  amplitude,  rise  time,  nor  the  
half  width  of  sEPSCs  and  mEPSCs  were  significantly  different  from  each  other.  Note  that  
the  s/mEPSC  frequency  might  be  higher  in  vivo.  When  using  the  GABAA  receptor  blocker  
bicuculline   and   the   AMPA   receptor   antagonist   DNQX,   no   mEPSCs   were   observed  
indicating  that  these  mEPSCs  were  mediated  solely  by  AMPA  receptors.  The  presence  
of  Mg2+  in  artificial  cerebrospinal  fluid  (ACSF)  and  a  holding  potential  at  -­70  mV  further  
strengthened  their  conclusion.  With  such  a  high  frequency,  recordings  of  mEPSCs  are  
perfectly   suited   for   the   study   of   the   mechanism(s)   of   spontaneous   release   and   its  
modulation.  
As   indicated   above,   whether   the   spontaneous   glutamate   release   utilizes   the   same  
SNARE   proteins   as   the   evoked   release   remains   an   open   question.   In   cultured  
hippocampal  neurons  of  homozygous  knockout  mice  lacking  synaptobrevin/VAMP2,  the  
mEPSC  frequency  decreases  to  ~15%  of  control  (heterozygous)  without  any  change  to  
the  amplitude  and  rise  time,  whilst  evoked  release  is  absent  (Schoch  et  al.,  2001).  The  
complete   loss   of   syntaxin   1A  and  1B   in  mouse  hippocampal   neurons  abolishes  both  
mEPSCs  and  evoked  EPSCs  (Vardar  et  al.,  2016).  In  mature  hippocampal  cultures  from  
SNAP-­25  knockout  mice,  Ca2+-­evoked  release  is  abolished,  but  a  low  mEPSC  frequency  
of   ~10%   of   control   is   still   observed   (Bronk   et   al.,   2007).   These   studies   make   two  
important  points:  1)  A  large  proportion  of  the  spontaneous  glutamate  release  is  based  
on   utilising   synaptobrevin/VAMP2,   syntaxin   1,   and   SNAP-­25,   similar   to   the   evoked  
release.  2)  Other  SNARE  protein(s)  may  also  be  involved  in  the  spontaneous  release.  
The  first  candidate  tested  was  Vti1a,  because  it  is  robustly  trafficked  at  synapses  without  
AP  firing,  and  its  knockdown  reduced  the  frequency  of  mEPSCs  (Ramirez  et  al.,  2012).  
Another  candidate  is  VAMP7,  because  reelin  facilitates  spontaneous  transmitter  release  
by  specifically  mobilizing  VAMP7-­containing  synaptic  vesicles  (Bal  et  al.,  2013).  
Another   debated  matter   regarding   spontaneous   transmitter   release   is   the  nature   and  
number   of   different   vesicle   pools   involved.   Using   a   genetically-­encoded   probe   that  
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contains  biotinylated  VAMP2,  Fredj  and  Burrone  (2009)  and  Andreae  et  al.  (2012)  found  
that   synaptic   vesicles   for   spontaneous   release  belong   to   the   resting  pool,   vesicles  of  
which  are  not  or  poorly  mobilized  upon  neuronal  activity.  The   idea  of  a   “distinct”  pool  
involved  in  spontaneous  release  was  then  rebutted  by  Hua  et  al.  (2010).  Because  cross-­
depletion  of   recycled  vesicles  occurs   for  both  spontaneous  and  evoked   release,   they  
suggested   that   the   recycling   pool  was   involved   in   both   instances.   To   the   best   of  my  
knowledge,  there  is  still  no  decisive  answer  to  the  old  question  if  spontaneous  release  
utilises  a  different  pool  of  vesicles  than  evoked.  I  hope  that  some  of  my  results  may  shed  
some  light  on  some  of  these  ideas  (see  parts  3,  and  4).  
In  contrast   to  what  Fatt  and  Katz   (1952)   reported   for  sEPPs,  spontaneous  glutamate  
release   can   be   affected   by   extracellular   Ca2+   concentration   ([Ca2+]o).   Increasing   the  
[Ca2+]o  increases  the  rate  of  release  as  shown  by  Katz  and  Miledi  (1963).  This  may  occur  
via   activation   of   the   Ca2+-­sensing   receptor,   which   is   a   highly   expressed   G-­protein-­
coupled  receptor  in  nerve  terminals  (Ruat  et  al.,  1995).  Consequently,  the  increased  rate  
becomes  independent  of  Ca2+  influx  through  VDCC  (Vyleta  &  Smith,  2011;;  Tsintsadze  
et   al.,   2017).  Similarly,  Ca2+   from   intracellular   stores   (smooth  endoplasmic   reticulum)  
also  affects  the  rate  of  spontaneous  release.  Simkus  and  Stricker  (2002a)  have  shown  
that   either   emptying   or   blocking   Ca2+   efflux   from   the   presynaptic   stores   significantly  
decreased   the  mEPSC   frequency   in  neocortical   layer   II  pyramidal  cells.  Furthermore,  
increasing  Ca2+  efflux  by  activating  IP3  via  group  I  mGluR  or  ryanodine  receptors  led  to  
a  significant  increase  in  the  mEPSC  frequency.  
Such  findings  led  to  an  important  question,  i.e.  if  neuromodulatory  transmitters  other  than  
glutamate,  via  (presynaptic)  GqPCR,  might  also  be  capable  of  activating  presynaptic  Ca2+  
stores.  Such  transmitters  include  noradrenaline  (NA)  acting  via  α1-­adrenergic  receptors  
(AR)  and  serotonin  (5-­HT)  via  5-­HT2R.  This  idea  was  first  tested  for  α1-­AR  (Choy  et  al.,  
2017a).   Some   remaining   issues   will   also   be   presented   in   part   4   of   this   thesis.   In  
summary,  NA  indeed  activated  presynaptic  α1-­AR  and  caused  Ca2+  release  from  stores  
seen  as  a  sustained  increase  in  mEPSC  frequency.  In  this  context,  and  to  further  extend  
the  understanding  of  neuromodulatory  action  on  spontaneous  release  in  cortex,  I  studied  
if  5-­HT  also  modulated  the  mEPSC  frequency  through  the  same  or  similar  mechanism.  
Consequently,   access   to   store   release   may   be   a   universal   mechanism   of   altering  
spontaneous  transmitter  release  in  the  central  nervous  system.  
It  remains  a  debate  what  the  physiological  role  of  spontaneous  transmitter  release  is.  It  
has  been  suggested  that  it  may  assist  numerous  essential  functions.  First,  it  may  serve  
to   maintain   the   postsynaptic   ultrastructure   of   synapses   (spine   density   and   length)  
(McKinney  et  al.,  1999;;  Tyler  &  Pozzo-­Miller,  2003).  Second,  it  may  regulate  long-­term  
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synaptic   plasticity   by   activating   postsynaptic   mGluR   and   thereby   increase   the   Ca2+  
concentration   required   for   the   insertion  of  new  AMPA   receptors   into   the  postsynaptic  
density  (Jin  et  al.,  2012a;;  Jin  et  al.,  2012b).  Third,  it  may  regulate  neuronal  excitability  
and   AP   firing   by   directly   modulating   postsynaptic   conductances   in   the   dendritic  
membranes  (Pare  et  al.,  1998;;  Carter  &  Regehr,  2002).  
1.3.2.  Evoked  Neurotransmitter  Release  
In  this  section,  I  will  describe  how  evoked  transmitter  release  occurs  and  its  dependency  
on  Ca2+,  both  from  extracellular  and  intracellular  sources.  
Very  early  in  the  history  of  intracellular  recording,  it  was  recognised  that  Ca2+  played  a  
crucial  role  in  transmitter  release  (Del  Castillo  &  Katz,  1954a;;  for  review  see  Katz,  1962).  
In  short,  the  action  potential  depolarizes  the  nerve  terminal  membrane  and  in  doing  so  
activates  VDCC,  which   then  open   for  Ca2+   to   flow   into   the  presynaptic   terminal.  This  
event  then  triggers  vesicle  fusion  and  subsequent  neurotransmitter  release.  Specifically,  
in   presynaptic   nerve   terminals  of   pyramidal   cells   in   neocortex,   both  N-­  and  P/Q   type  
VDCCs  are  expressed  (Qian  &  Noebels,  2001;;  Yu  et  al.,  2010).  The  amount  of  release  
as   a   function   of   Ca2+   influx   is   best   described   via   a   cooperativity   around   4   –   5   (Hill  
coefficient  of  4;;  Dodge  &  Rahamimoff,  1967;;  Wu  &  Saggau,  1994;;  Borst  &  Sakmann,  
1996).   In   fact,   Dodge   and   Rahamimoff   (1967)   provided   an   interpretation   of   this  
cooperativity  as  indicating  that  4  –  5  Ca2+  ions  are  necessary  to  bind  to  the  Ca2+  sensor  
for  release  to  occur.  Because  of  this  power  relationship,  it  can  be  estimated  that  a  12.5%  
decrease  in  Ca2+  influx  for  example  depresses  the  EPSC/P  amplitude  by  ~50%.  
In  contrast  to  the  requirements  for  extracellular  Ca2+,  the  dependency  of  evoked  release  
on  Ca2+  from  intracellular  stores  like  the  smooth  endoplasmic  reticulum  (SER)  has  gained  
much   less   exposure.  Emptage   et   al.   (2001)   showed   that,   in   boutons   of   hippocampal  
pyramidal  cells  in  culture,  Ca2+-­induced  Ca2+  release  (CICR)  from  stores  augmented  the  
Ca2+  transients  and  paired-­pulse  facilitation.  Further,  Liang  et  al.  (2002)  found  that  Ca2+  
transients   in   mossy   fibre   terminals   in   response   to   a   brief   train   of   APs   were   also  
augmented  by  Ca2+  from  stores.  The  understanding  was  expanded  by  de  Juan-­Sanz  et  
al.  (2017)  in  their  recent  study,  showing  that  axonal  endoplasmic  reticulum  (ER)  acts  as  
a   Ca2+   buffer   during   neuronal   activity   and   creates   a   feedback   loop   controlling   the  
cytosolic  Ca2+  via  the  ER  Ca2+-­sensing  protein  STIM1.  
Clear  evidence  of  how  Ca2+  from  intracellular  stores  affects  evoked  glutamate  release  
raised  an  intriguing  question  if  neuromodulators  utilize  the  stores  in  modulating  EPSP/C.  
I  addressed  this  question  by  extending  my  research  to  the  modulation  of  EPSC  between  
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layer   II  pyramidal  pairs  by  NA  and  5-­HT,  and  elucidating   the  respective  mechanisms.  
The   results   were   rather   interesting   because   they   revealed   Gβγ   subunit-­dependent  
mechanisms  targeting  different  effectors  (for  details  see  part  4).  
1.4.  Neuromodulation  
Both   the   spontaneous   and   evoked   neurotransmitter   release   could   be   modulated   by  
different   type   of   neuromodulators,   hence,   signal   or   information   transferred   between  
neurons  is  altered  accordingly.  There  are  six  majorly  known  neuromodulators,  namely  
acetylcholine,  histamine,  neuropeptides  (e.g.  oxytocin/hypocretin),  dopamine,  NA,  and  
5-­HT.  Because  I  mainly  investigated  serotonergic  modulation  of  glutamate  release  in  S1  
barrel   cortex   layer   II   pyramidal   cells,   and   provided   comparisons   with   adrenergic  
modulation  in  the  same  region  and  layer  for  my  PhD  thesis,  I  focus  my  description  on  
NA  and  5-­HT  among  the  major  neuromodulators.  
With  the  order  of  NA  first,  then  followed  by  5-­HT,  I  explain  the  most  essential  aspects  of  
how  they  run  their  function  as  neuromodulators.  I  start  by  describing  their  biosynthesis  
and  degradation  processes   in   the  brain   respectively.  This  will  be   followed  by  detailed  
locations  of  the  nuclei  of  NA-­  and  5-­HT-­containing  neurons.  Subsequently,  I  will  explain  
to  which  brain   regions   the  axons  of   these  nuclei  project   to.  Receptors  which  bind  NA  
(adrenergic  receptor;;  AR)  and  5-­HT  (5-­HTR)  will  be  explained  from  the  perspectives  of  
signalling   mechanisms   and   their   expression   locations.   Note   that   the   abbreviation   of  
receptor(s)  with  R  refers  to  both  the  singular  and  the  plural.  Finally,  I  describe  in  general  
some  physiological  functions  related  to  the  adrenergic  and  serotonergic  modulations.  
1.4.1.  Noradrenaline  
Noradrenaline   (NA),   in   the   USA   also   called   norepinephrine,   belongs   to   the   group   of  
monoamines.  Its  structure  contains  1)  a  benzene  ring  with  two  attached  hydroxyl  groups  
(-­OH)  located  adjacently  and  2)  an  ethylamine  side  chain  with  one  amine  group  (-­NH2).  
NA   is   synthesized   in   the   brain   from   the   amino   acid   tyrosine.   The   first   step   of   its  
biosynthesis,  which  is  also  its  rate-­limiting  step  (Fitzpatrick,  1991),  converts  tyrosine  via  
tyrosine   hydroxylase   into   3,4-­dihydroxy-­l-­phenylalamine   (L-­DOPA).   L-­DOPA   is   then  
converted   in   the   presence   of   coenzyme   pyridoxal   phosphate   into   dopamine   by   the  
aromatic  amino  acid  decarboxylase  or  DOPA  decarboxylase.  In  noradrenergic  neurons  
(specifically   in   its   synaptic   vesicles),   dopamine   is   then   converted   further   into   NA   by  
dopamine-­β-­hydroxylase   (DBH),   also   called   dopamine-­β-­monooxygenase.   This   step  
involves  a  hydroxylation  and  requires  ascorbic  acid  as  electron  donor.  
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NA  is  released  from  synaptic  vesicles  via  exocytosis  from  specific  nerve  terminals  (see  
below),  the  axons  of  which  originate  in  the  locus  coeruleus.  Its  action  is  then  terminated  
primarily   by   reuptake   into   respective   nerve   terminals   via   the   Na+   and   Cl-­-­dependent  
norepinephrine  transporter  (NET;;  Blakely  et  al.,  1994;;  Bonisch  &  Bruss,  2006).    
NA  undergoes  degradation  by   two  enzymes,  namely  monoamine  oxidase   (MAO)  and  
cathecol-­O-­methyltransferase  (COMT).  MAO  has  two  different  isozymes  called  as  MAO  
A  and  B  (Shih,  1991).  MAO  A  is  found  concentrated  in  adrenergic  (noradrenaline)  cells  
in   the   locus   coeruleus   (Shih   et   al.,   1999a),   and   this   isozyme   catalyses  NA   oxidative  
deamination  to  yield  3,4-­dihydroxyphenylglicol  and  3,4-­dihydroxymandelic  acid.  COMT  
then  catalyses  the  chemical  reaction  in  which  the  methyl  group  of  S-­adenosylmethionine  
is  transferred  to  the  3-­position  hydroxyl  group  of  both  3,4-­dihydroxyphenylglicol  and  3,4-­
dihydroxymandelic   acid   to   yield   3-­methoxy-­4-­hydroxy-­phenylglycol   (MHPG)   and   3-­
methoxy-­4-­hydroxy-­mandelic   acid   (vanillylmandelic   acid;;   VMA)   respectively.   The  
degradation  by  these  two  enzymes  can  also  happen  in  the  reverse  order.  In  this  case,  
NA  is  initially  converted  into  normetanephrine  by  COMT,  which  then  undergoes  oxidative  
deamination  catalyzed  by  MAO  A  to  end  up  with  the  same  final  two  products  of  MHPG  
and  VMA.  
This  cycle  of  biosynthesis  and  degradation  primarily  occurs  in  noradrenergic  cells.  In  the  
mammalian  brain,  noradrenergic  cell  bodies  can  be  grouped  into  the   locus  coeruleus,  
the  dorsal  medullary  group  (located  close  to  the  dorsal  motor  nucleus  of  vagus  nerve  in  
the  medulla),  and  the  lateral  tegmental  system  (located  in  the  pontine  tegmentum  and  
reticular  formation  of  the  pons).  Among  these  three  groups  of  nuclei,  the  locus  coeruleus  
is  the  most  important  one  because  its  axons  widely  and  diffusely  innervate  brain.  The  
axons  project  rostrally  (dorsal  bundle)  to  innervate  thalamic  nuclei  and  different  regions  
of   cortex   including   the   neocortex,   hippocampus,   the   basolateral   amygdala,   and   the  
septum   (Loughlin   et   al.,   1986).   Other   axons   project   dorsally   to   innervate   cerebellum  
(Olson   &   Fuxe,   1971),   and   caudally   to   innervate   the   spinal   cord   (Hancock   &  
Fougerousse,  1976;;  Nygren  &  Olson,  1977).  
NA   signals   at   synapses   via   AR.   Based   on   their   pharmacological   profiles   and   the  
associated  signalling  pathways,  AR  are  classified  into  three  different  groups.  Note  that  
all  groups  are  G-­protein-­coupled  receptors  (GPCR).  The  first  group  consists  of  α1-­AR,  
which  are  coupled  to  the  Gq-­protein.  There  are  three  subtypes  of  α1-­AR:  α1A,  α1B,  and  
α1D-­AR  (Bylund  et  al.,  1994;;  Hieble  et  al.,  1995).  In  the  brain,  α1A-­AR  are  expressed  in  
the   cerebral   cortex   (Jones   et   al.,   1986;;   Parkinson   et   al.,   1988;;   Papay   et   al.,   2006;;  
Santana   et   al.,   2013),   hippocampus   (Zilles   et   al.,   1991;;   Papay   et   al.,   2006),   dorsal  
thalamus,  hypothalamus,  midbrain,  pontine  olivary  nuclei,  trigeminal  nuclei,  cerebellum  
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(Jones   et   al.,   1986;;  Papay   et   al.,   2006),   and   the  nucleus  accumbens   (Mitrano   et   al.,  
2012).  α1B-­AR  are  also  expressed   in  cerebral   cortex,   thalamus,  dorsal  and  medullary  
raphe   nuclei      (Nicholas   et   al.,   1991).   α1D-­AR   have   been   found   in   cerebral   cortex,  
hippocampus,  olfactory  bulb,  the  dorsal  geniculate  and  ventral  posterolateral  nuclei  of  
thalamus  (Sadalge  et  al.,  2003).  Binding  of  NA  to  α1-­AR  activates  the  Gq-­protein  to  cause  
the  activation  of  PLCβ,  which  then  hydrolyses  PIP2  to  produce  IP3  and  DAG.  The  former  
increases  Ca2+   release   from   intracellular   stores,  whilst   the   latter  may  activate  protein  
kinase  C  (PKC).    
The  second  group  consists  of  α2-­AR,  which  are  coupled   to   the  Gi/o-­protein  and   inhibit  
adenylyl  cyclase,  resulting  in  a  lowering  of  intracellular  cAMP.  Activated  Gβγ  subunits  of  
the  Gi/o-­trimer   are   also   capable   of   activating   K+   channels   (Williams   et   al.,   1985)   and  
inhibiting  voltage-­dependent  Ca2+  channels  (Boehm,  1999;;  Timmons  et  al.,  2004).  Three  
genes   have   been   found   to   code   for   α2-­AR,   namely   α2A,   α2B,   and   α2C.   In   brain,   the  
expression   of   these   three   subtypes   are   as   follows.   α2A-­AR   are   found   in   the   locus  
coeruleus,   cerebral   cortex,   hippocampus,   hypothalamus,   amygdala,   brain   stem   and  
septum,  α2B-­AR  in  the  thalamus  and  α2C-­AR  in  the  cerebral  cortex,  hippocampus,  basal  
ganglia,   olfactory   tubercle,   and   striatum   (Scheinin   et   al.,   1994;;   King   et   al.,   1995;;  
Holmberg  et  al.,  1999).    
The  third  and  last  group  contains  the  β-­AR,  which  are  coupled  to  the  Gs-­protein.  When  
NA  binds  to  β-­AR,  the  Gs-­protein  activates  adenylyl  cyclase,  causing  an  increase  in  the  
intracellular  cAMP  concentration.  There  are  three  different  subtypes:  β1,  β2,  and  β3.  In  
the  brain,  β1-­AR  are  highly  expressed  in  layer  I  and  II  of  cerebral  cortex,  cingulate  cortex,  
hippocampus,  ventral  striatum  (the  islands  of  Calleja),  and  the  mediodorsal  and  ventral  
nuclei  of  thalamus.  β2-­AR  are  highly  expressed  in  the  molecular  layer  of  cerebellum  and  
the  central,  paraventricular,  and  caudal  lateral  posterior  nuclei  of  thalamus.  Both  β1  and  
β2-­AR  are  co-­expressed  to  a  similar  extent  in  layer  IV  of  cerebral  cortex,  the  substantia  
nigra,  olfactory  tubercle,  medial  preoptic  nucleus,  and  the  nuclei  in  the  medulla  (Rainbow  
et  al.,  1984).  β3-­AR  are  expressed  in  cerebral  cortex  and  hypothalamus  (Evans  et  al.,  
1999)  and  the  subgranular  zone  of  hippocampus  (Jhaveri  et  al.,  2010).  
One   of   the   outcomes   of   AR   activation   is   a   change   in   neuronal   excitability   and   an  
associated   de-­   or   hyperpolarization.   As   all   AR   are   metabotropic   receptors,   these  
outcomes   are   generated   downstream   of   GPCR   activation,   mostly   with   specific  
channel(s)  as  targets  or  effectors.  For  example,  NA  can  activate  α1-­AR  to  suppress  a  
leak   K+   conductance,   and/or   β-­AR   to   enhance   the   hyperpolarization-­activated   cation  
current  (Ih),  resulting  in  a  switch  from  rhythmic  bursting  activity  to  sparse  spike  firing  in  
the   thalamus   (Pape   &   McCormick,   1989;;   McCormick   et   al.,   1991).   NA,   via   α2-­AR  
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activation  that  relieves  the  tonic  inhibition  of  TREK-­2  channels  by  protein  kinase  A  (PKA),  
can   also   cause   a   hyperpolarization   to   reduce   the   excitability   of   layer   II/III   pyramidal  
neurons  of  entorhinal  cortex  (Xiao  et  al.,  2009).  In  addition,  the  Gβγ  subunits  of  activated  
α2-­AR   can   open   a   G-­protein-­activated   inwardly   rectifying   K+   (GIRK)   conductance,  
inducing  a  hyperpolarization  in  locus  coeruleus  neurons  (Williams  et  al.,  1985).  In  cortical  
and  hippocampal  pyramidal  neurons,  NA  enhances  the  excitability  by  suppressing  a  slow  
Ca2+-­activated  K+  current  (IAHP)  downstream  of  β-­AR  activation  (Madison  &  Nicoll,  1982;;  
Haas  &  Konnerth,  1983;;  Foehring  et  al.,  1989;;  McCormick  et  al.,  1991;;  Satake  et  al.,  
2008).  
Another  outcome  of  noradrenergic  activity  is  the  modulation  in  transmitter  release.  There  
is   ample   of   evidence   in   the   literature   showing   that   NA  modulates   both   spontaneous  
(mEPSP/Cs)  and  evoked   transmitter   release   (EPSP/Cs).  Some  examples   include   the  
following:  In  layer  II/III  pyramidal  cells  of  the  medial  prefrontal  cortex  (mPFC),  NA  can  
increase  the  mEPSC  frequency  via  activation  of  presynaptic  α1-­AR  (Zhang  et  al.,  2013).  
However,   in   layer   II/III   and   V   pyramidal   cells   of   mPFC   and   temporal   cortex,   NA  
depresses  evoked  EPSCs  (Roychowdhury  et  al.,  2014)  via  α1-­AR  activation  (Salgado  et  
al.,  2016).  In  CA3  pyramidal  cells  of  organotypic  slice  cultures  from  rat,  NA  depresses  
the  evoked  EPSP  amplitude  via  presynaptic  α1-­AR  activation  (Scanziani  et  al.,  1993).  In  
addition,  a   recent  study   in   layer   II  of   rat  barrel  cortex   in   this   laboratory   found   that  NA  
increases  the  mEPSC  frequency  in  a  subset  of  pyramidal  cells  (Choy  et  al.,  2017a),  but  
depresses  the  EPSC  amplitude  in  all  pyramidal  pairs  recorded  from  (Choy  et  al.,  2017b;;  
for  details  see  part  4).  
By  modulating  neuronal  excitability  and/or  neurotransmitter  release  in  different  regions  
of   brain,   NA   plays   an   important   role   in   many   physiological   brain   functions,   such   as  
attention  and  arousal  (Mitchell  &  Weinshenker,  2010).  It  also  affects  the  consolidation  of  
long-­term  memory  in  the  amygdala  (Clem  &  Huganir,  2013)  and  hippocampus  (O'Dell  et  
al.,  2015;;  Walling  et  al.,  2016).  Furthermore,  α1-­AR  antagonists  are  widely  used  in  the  
treatment  of  psychotic  episodes  (Wadenberg  et  al.,  2000;;  Ma  et  al.,  2006;;  Lopez-­Gil  et  
al.,  2010).  
1.4.2.  Serotonin  
1.4.2.1.  Biosynthesis  and  Metabolism  of  Serotonin  
5-­HT   is   also  a  monoamine,   but   its   synthesis   derives   from  L-­tryptophan.  Following   its  
initial  identification  in  brain  by  Twarog  and  Page  (1953),  a  vast  set  of  studies  have  been  
done  to  further  understand  its  physiological  role.  
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Serotonin  is  synthesized  in  the  central  nervous  system  from  the  amino  acid  L-­tryptophan,  
which   is  acquired  primarily   from  dietary  protein  and  transported  to   the  brain  via  blood  
circulation.   Initially,   in   serotonergic   neurons,   tryptophan   is   converted   into   5-­
hydroxtryptophan   (5-­HTP)   by   tryptophan   hydroxylase   (Tph),   specifically   the   Tph2  
isoform  (Walther  et  al.,  2003).  5-­HTP  then  undergoes  decarboxylation,  catalysed  by  an  
enzyme  called  aromatic  L-­amino  acid  decarboxylase  (AADC),  to  yield  the  transmitter  5-­
HT.  During  this  biosynthetic  process  in  two  steps,  the  hydroxylation  by  Tph2  is  the  rate-­
limiting  step  (Cortes  et  al.,  1993).  
Freshly  synthesized  5-­HT   is   then  stored   in  synaptic  vesicles  by  vesicular  monoamine  
transporter   2   (VMAT2;;  Weihe   et   al.,   1994;;   Peter   et   al.,   1995;;   Erickson   et   al.,   1996)  
through  an  active  transport  process,  in  which  the  cytoplasmic  5-­HT  is  exchanged  with  
vesicular  protons.  5-­HT   is   released  via  exocytosis   into   the  extracellular  cerebrospinal  
fluid  where  it  can  bind  to  its  cognate  receptors.  
Upon  release,  the  mechanism  of  terminating  its  activity  is  via  re-­uptake  by  the  serotonin  
transporter  (SERT;;  Rudnick,  2006)  into  the  nerve  terminal  or  the  glial  cells,  again  as  with  
NA,  via  transport  along  the  Na+  gradient.  
Furthermore,  5-­HT  also  undergoes  breakdown  through  oxidative  reaction(s),  which  are  
also  catalysed  by  MAO,   to  yield  5-­hydroxy-­indoleacetaldehyde.  As  mentioned  earlier,  
there   are   two   isozymes  of  MAO,   namely  MAO  A  and  B   (Shih,   1991).  Whilst   5-­HT   is  
preferentially   oxidized   by   MAO   A,   interestingly   serotonergic   neurons   predominantly  
contain   MAO   B,   which   preferentially   oxidizes   both   phenylethylamine   (PEA)   and  
dopamine  (DA),  but  not  5-­HT  (Shih  &  Chen,  1999;;  Shih  et  al.,  1999b,  a).  The  product  of  
oxidation  by  MAO,   is  5-­hydroxy-­indoleacetaldehyde,  which   then   is  oxidized   further  by  
the   nicotinamide   adenine   dinucleotide+   (NAD+)-­dependent   aldehyde   dehydrogenase.  
The  final  product  is  5-­hydroxyindoleatic  acid  (5-­HIAA),  which  is  excreted  via  the  urine.  
1.4.2.2.  Serotonergic  Neurons  and  Axonal  Projections  
The  biosynthesis  process  of  5-­HT  in  mammalian  brain,  as  described  above,  occurs  in  
serotonergic   neurons   that   specifically   contain   the   necessary   enzymes.   Based   on  
cytoarchitectural   criteria,   their   cell   bodies   cluster   in   different   nuclei   in   the  
mesencephalon,   specifically   in   the   set   of   raphe   nuclei   (Taber   et   al.,   1960).   This   set  
contains  nine  groups,  numbered  B1  –  9  (Törk,  1990;;  Lesch  &  Waider,  2012).  Their  details  
are  as  the  followings:  1)  B1  –  raphe  pallidus  nucleus  in  the  caudal  ventrolateral  medulla.  
2)   B2  –   raphe   obscurus   nucleus.   3)   B3  –   raphe  magnus   nucleus,   rostral   ventrolateral  
medulla,   and   lateral   paragigantocellular   reticular   nucleus.   4)   B4   –   raphe   obscurus  
nucleus  (dorsolateral  part).  5)  B5  –  median  raphe  nucleus  (caudal  part).  6)  B6  –  dorsal  
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raphe  nucleus  (caudal  part).  7)  B7  –  principal  dorsal  raphe  nucleus  (rostral  part).  8)  B8  –  
principal  median  raphe  nucleus  (rostral  main  part),  caudal  linear  nucleus,  and  nucleus  
pontis  oralis.  9)  B9  –  Nucleus  pontis  oralis  in  the  supralemniscal  region  (Törk,  1990).  
The   serotonergic   projection   to   the   forebrain   originates   from   the   dorsal   (B6   and   B7),  
median  nuclei  (B5  and  B8),  and  the  B9  group.  The  median  raphe  nuclei  projects  mainly  to  
the  hypothalamus,  septum,  and  dorsal  hippocampus.  In  comparison,  the  dorsal  raphe  
nucleus   projects   to   the   striatum,   amygdala,   and   ventral   hippocampus.   Regarding  
cerebral  cortex,  more  specifically  neocortex,  both  the  median  and  dorsal  raphe  nuclei  
send  their  projections  in  an  overlapping  manner,  but  topographically  organized  to  target  
different  cortical  neurons.  One  important  point  to  notice  is  that  axon  fibres  and  terminals  
from  the  median  and  dorsal  raphe  nuclei  have  different  characteristics.  The  axons  that  
project  from  the  median  raphe  nuclei  (M  fibres)  are  made  up  of  thick  and  relatively  coarse  
fibres.  They  have  short  and  thin  branches,  with  large  and  round  boutons.  In  contrast,  the  
axons   from   the   dorsal   raphe   nuclei   (D   fibres)   contain   very   fine   fibres.   They   branch  
profusely  and  end  with  small  fusiform  boutons  (Törk,  1990;;  Hensler,  2006).  As  expected  
based   on   the   respective   properties,   these   serotonergic   neurons   also   differ   in   1)  
electrophysiological  characteristics,  i.e.  neurons  in  the  median  raphe  nuclei  have  shorter  
time   constants   and   a   larger   after-­hyperpolarization   after   an   AP,   and   2)   autoreceptor  
inhibition,  i.e.  neurons  in  the  dorsal  raphe  nuclei  have  a  higher  efficacy  of  reacting  to  5-­
HT1AR  activation  (Beck  et  al.,  2004).    
B1  to  B4  cell  groups,  which  are  distributed  between  the  mid-­pons  and  the  caudal  medulla,  
send  axonal  projections  to  the  brainstem  and  spinal  cord.  In  more  detail,  B1  projects  to  
Rexed  laminae  I  and  II  of  the  dorsal  horn  (Bowker  et  al.,  1982;;  Hylden  et  al.,  1986),  B2  
and  B4  to  lamina  IX  of  the  ventral  horn  (Bowker  et  al.,  1982;;  Bowker,  1986),  and  B3  to  
intermediolateral  cell  column  (Loewy  &  McKellar,  1981).    
The  nine  serotonergic  groups  are  interconnected.  Afferent  connections  link  the  median  
and  dorsal  raphe  nuclei,  and  also  the  three  cell  groups  of  B9  with  B1  and  B3.  
1.4.2.3.  Serotonin  Receptors  
5-­HT   signals   via   seven   different   groups   5-­HT   receptors   (5-­HTR),   namely   5-­HT1   –   7R.  
These   include   a   total   of   23   subtypes   of  metabotropic  GPCR,   and  an   ionotropic   non-­
specific  ligand-­gated  cation  channel,  which  is  comprised  of  5  different  subunits  (Hoyer  
et  al.,  1994;;  Fink  &  Göthert,  2007;;  Pytliak  et  al.,  2011).  In  addition,  recently  a  novel  type  
of  5-­HTR  called  Pr5-­HT8  has  been  discovered  in  the  larvae  of  the  small  white  butterfly,  
Pieris  rapae  (Qi  et  al.,  2014).  
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The  ligand-­gated  cation  channel  (5-­HT3R),  upon  5-­HT  binding,  allows  Na+,  K+,  and  Ca2+  
to  permeate  through  the  conducting  pore.  This  channel  has  a  heteropentamer  structure,  
which   is   formed   by   5-­HT3A-­E   receptor   subunits.   Different   genes   code   for   different  
subunits,  with  5-­HT3C-­E  specific  to  humans.  The  exact  heteropentameric  composition(s)  
between   different   subunits   likely   depend   on   the   brain   region   (Barnes   et   al.,   2009).  
Regarding  the   location  of  5-­HT3R  in  the  brain,  high  density  expression   is  found  in  the  
nucleus  of  solitary  tract,  dorsal  motor  nucleus  of  vagus,  area  postrema  (Gehlert  et  al.,  
1991),  amygdala,  hippocampus,  neocortex,  and  olfactory  bulb  where  they  are  typically  
found  on  GABAergic  interneurons  (Koyama  et  al.,  2017).  In  addition,  these  receptors  are  
also  expressed  in  the  superficial  layers  of  the  spinal  dorsal  horn  (Kia  et  al.,  1995).  
In  contrast,  the  metabotropic  receptors  can  be  summarized  as  follows.  The  5-­HT1R  and  
5-­HT5R  groups  are  coupled  to  the  Gi/o  protein,  which  lowers  cAMP.  In  contrast,  the  group  
of  5-­HT2R  are  coupled  to  the  Gq  protein.  The  groups  of  5-­HT4R,  5-­HT6R,  and  5-­HT7R  are  
coupled  to  the  Gs  protein.  Not  much  is  known  about  Pr5-­HT8,  except  that  it  increases  the  
intracellular  Ca2+  concentration  without  affecting  cAMP  levels.  The  5-­HT1R  and  5-­HT2R  
above   have   been   assigned   solely   to   their   respective   “classical”   signalling   cascades,  
actuated  typically  by  Gα.  Note,  however,  that  more  recent  researches  also  indicate  non-­
classical  coupling  to  a  different  adaptor  protein  (arrestin)  but  also  to  an  alternative  non-­
classical  G-­protein.  In  addition,  there  are  instances  where  the  signalling  may  be  carried  
not  by  Gα  but  by  Gβγ  (Choy  et  al.,  2017a;;  Choy  et  al.,  2017b;;  see  also  results).  
The  group  of  5-­HT1R  is  comprised  of  5-­HT1A,  5-­HT1B,  5-­HT1D,  5-­HT1E,  and  5-­HT1F.  Note  
because  5-­HT1CR  was   re-­classified  as  5-­HT2CR  based  on   its   structural  and  signalling  
mechanism,  5-­HT1CR  is  omitted  from  the  list  (Leonhardt  et  al.,  1992).  The  locations  of  
each   subtype,  mostly   based   on   binding   studies,   could   be   summarized   as   follows.   5-­
HT1AR  has  long  been  known  to  be  expressed  densely  on  serotonergic  neurons  in  median  
and   dorsal   raphe   nuclei   (Palacios   et   al.,   1983;;   Pazos   et   al.,   1987),   specifically   as  
somatodendritic  autoreceptors  that  receive  the  negative  feedback  (Pan  et  al.,  1993).  5-­
HT1AR  is  also  highly  expressed  in  prefrontal  and  frontal  (Hoyer  et  al.,  1985;;  Hoyer  et  al.,  
1986a),   entorhinal   cortex   (Cheetham   et   al.,   1989;;   Chalmers   &   Watson,   1991),  
hippocampus,  and  the  amygdala.  5-­HT1BR  (5-­HT1B  and  5-­HT1DβR  prior  to  nomenclature  
reassessment  by  Hartig  et  al.,  1996)  is  expressed  with  high  density  in  the  basal  ganglia  
(Middlemiss  &  Hutson,  1990),  more  specifically   in  the  substantia  nigra  and  the  globus  
pallidus  (Varnäs  et  al.,  2001),  both  on  the  presynaptic  terminals  of  serotonergic  boutons  
and   the  postsynaptic   targets.  A   recent   study  by  Kjaerby   et  al.   (2016)  shows   that   this  
receptor  is  also  expressed  on  presynaptic  terminals  in  the  ventral  hippocampus  and  the  
contralateral   inputs   to   the   medial   prefrontal   cortex.   5-­HT1DR   (5-­HT1DαR   prior   to  
nomenclature  reassessment  by  Hartig  et  al.,  1996)   is  not  only  expressed   in   the  basal  
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ganglia   (globus   pallidus,   ventral   pallidum,   caudate-­putamen,   and   substantia   nigra;;  
Bruinvels  et  al.,  1993),  but  also  in  the  hippocampus  and  the  entorhinal  cortex  (Lei,  2012).  
5-­HT1ER  is  likely  absent  from  mouse  and  rat  brains  as  the  respective  gene  has  not  been  
found  (Bai  et  al.,  2004).  However,  it  is  expressed  in  frontal  cortex  (Leonhardt  et  al.,  1989),  
caudate,  putamen,  hippocampus  (Lowther  et  al.,  1992),  and  olfactory  bulb  (Bai  et  al.,  
2004)   in   brains   of   humans   and   guinea   pigs.   The   5-­HT1FR   location   differs   in   different  
species  as  shown  by  Lucaites  et  al.  (2005).  In  rat,  (among  others)  it  is  expressed  in  layer  
IV/V   of   cortex,   the  CA3   region   of   the   hippocampus,   subiculum,  nucleus   accumbens,  
caudate-­putamen,   parafasicular   nucleus   of   thalamus,   several   amygdaloid   nuclei,   and  
olfactory  bulb.  In  human  brain,  the  receptor  is  expressed  in  neocortical  layers  4  and  5  
and  in  the  granule  cell  layer  of  the  cerebellum.  
5-­HT2R  were  classified  into  three  different  subtypes,  namely  5-­HT2A,  5-­HT2B,  and  5-­HT2C.  
5-­HT2AR  is  expressed  with  high  density  in  neocortex  (Watts  et  al.,  1994;;  Hamada  et  al.,  
1998;;  Hall   et   al.,   2000),   the   claustrum,   piriform   cortex,   olfactory   bulb,   pontine   nuclei,  
mammillary  bodies,  red  nucleus,  cranial  motor  nuclei  (Hamada  et  al.,  1998),  caudate-­
putamen,   nucleus   accumbens,   choroid   plexus   (Watts   et   al.,   1994),   hippocampus,  
thalamus  (Hall  et  al.,  2000),  and  spinal  cord  (both  on  motoneurons  in  ventral  horn,  and  
in  the  intermediolateral  nucleus  of  the  thoracic  cord;;  (Maeshima  et  al.,  1998).  5-­HT2BR  
in  the  brain,  based  on  an  immunohistochemistry  study  by  Duxon  et  al.  (1997),  is  found    
in   the   lateral   septum,   dorsal   hypothalamus,   medial   amygdala,   and   the   cerebellum.    
5-­HT2CR   (formerly   named   as   5-­HT1CR)   is   highly   expressed   in   ventromedial   hypotha-­
lamus,  globus  pallidus,  substantia  nigra,  and  choroid  plexus  (Hoyer  et  al.,  1986b;;  Pazos  
et  al.,  1987;;  Abramowski  et  al.,  1995),  with  low  to  moderate  expression  in  other  regions  
of   brain,   including   neocortex,   hippocampus  and   the   cerebellum   (Hoyer   et   al.,   1986b;;  
Abramowski   et   al.,   1995).   Further   details   of   the   expression   of   5-­HT1R   and   5-­HT2R,  
including  their  layer-­specific  and  subcellular  compartmentalisation,  will  be  described  later  
in  sections  3.1  and  4.1  in  relation  with  physiological  functions  in  neocortex.  
Using  specific  radioligands,  5-­HT4R  was  found  to  be  expressed  with  high  density  in  the  
olfactory   tubercle,   substantia   nigra,   striatum   (Grossman   et   al.,   1993),   as   well  
hippocampus   (Bonaventure   et   al.,   2000),   very   likely   on   the   postsynaptic   targets   of  
serotonergic  terminals.  
5-­HT5R   is   expressed   at   a   high   density   in   the   medial   habenula,   and   with   moderate  
densities  in  neocortex  and  the  olfactory  bulb  (Waeber  et  al.,  1998).  The  mRNA  of  5-­HT6R  
is  found  in  hippocampus,  striatum,  nucleus  accumbens,  and  olfactory  tubercle  (Ruat  et  
al.,  1993a).  Another  study  using  polyclonal  antibody  points  out  the  5-­HT6R  expression  in  
hippocampus  (CA1  and  dentate  gyrus),  striatum,  nucleus  accumbens,  olfactory  tubercle  
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(plexiform  layer),  in  the  frontal  and  enthorinal  cortices,  and  the  cerebellum  (Gérard  et  al.,  
1997).  5-­HT7R  is  found  to  be  expressed  (in  the  order  from  most  to  least  abundant)  in  the  
hypothalamus,  hippocampus  (pyramidal  cells),  cerebral  cortex,  olfactory  bulb,  and  the  
olfactory   tubercle   (Shen   et   al.,   1993;;   Mengod   et   al.,   1996).   Other   researchers   have  
pointed  out   that   this  receptor   is  also  expressed   in   the   taenia   tecta,  amygdaloid  nuclei  
(Ruat  et  al.,  1993b),  and  cerebellar  Purkinje  cells  (Geurts  et  al.,  2002).  
One   distinctive   characteristic   of   5-­HTR   is   high   ligand   binding   affinity   to   agonists.   In  
comparison  with  other  neuromodulator  receptors  that  generally  have  binding  affinities  or  
EC50  up  to  few  µM,  the  one  for  5-­HTR  (and  EC50)  is  within  a  range  from  a  few  to  tens  of  
nM  (Ki  for  displacement  of  [3H]  ligands  with  5-­HT  for  5-­HT1&2R  =  3.8-­17  nM;;  Peroutka  &  
Snyder,  1979;;  see  also  Barnes  &  Sharp,  1999;;  Ray,  2010).  Such  a  high  affinity,  up  to  a  
thousandfold,  suggests  a  potent  and  highly  sensitive  ability  for  neuromodulation.  
Describing  ascribed  physiological  role(s)  for  each  5-­HTR  subtype  is  very  difficult.  This  is  
because  of   the   following   reasons:   1)  The  same  5-­HTR  subtype  can  be  expressed   in  
many  different  brain  regions,  which  all  are  involved  in  different  physiological  roles.  2)  The  
receptors   are   often   expressed   in   an   overlapping   manner   throughout   different   brain  
regions.  This   fact  may  suggest   that,   in  producing  an  outcome,  different  5-­HTR  either  
work   in   tandem   or   competitively.   3)   Although   the   specific   layers   and   subcellular  
compartments,   where   the   5-­HTR   are   expressed,   determine   their   functional   impacts,  
unfortunately   the   picture   remains   incomplete.   4)   Compared   to   other   seven  
transmembrane  receptors  like  AR,  5-­HTR  are  involved  in  a  number  of  unusual  signalling  
combinations  like  mimicking  alternate  G-­protein  (Kaufman  et  al.,  1995)  action,  usage  of  
non-­classical  adaptor  proteins  (Gray  et  al.,  2003),  constitutive  receptor  activity  without  
ligand  binding  (for  review  see  Berg  et  al.,  2005),  receptor  transactivation  (Grewal  et  al.,  
2001),   and   the   activation   of   elements   of   mitogen-­activated   protein   kinase   (MAPK)  
signalling  pathways  (Watts,  1996).  Furthermore,   they  can  heterodimerize  with  various  
other  GPCR,  among  others  the  leptin  (Tecott  et  al.,  1995;;  Yadav  et  al.,  2009),  growth  
hormone  secretagogue  (Schellekens  et  al.,  2013),  D2  (Albizu  et  al.,  2011;;  Lukasiewicz  
et  al.,  2011),  melatonin  (Kamal  et  al.,  2015),  and  mGluR2  (Gonzalez-­Maeso  et  al.,  2008;;  
Moreno  et  al.,  2012).    Because  of  this  vast  complexity,  I  will  only  introduce  function(s)  of  
the  respective  5-­HTR  in  very  general  terms.  
5-­HT1AR  regulates  serotonergic  neurotransmission  by  functioning  as  a  somatodendritic  
autoreceptor   on   serotonergic   neurons   (Sharp   &   Hjorth,   1990).   As   expected   from   its  
expression  with  high  density  in  prefrontal  cortex,  agonism  of  5-­HT1AR  has  an  anxiolytic  
and  antidepressant  effect  (Charney  et  al.,  1990;;  Artigas,  2013).  5-­HT1BR  may  be  involved  
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in  diseases  related  to  function(s)  of  the  basal  ganglia,  for  example  Parkinson’s  disease  
(Riahi  et  al.,  2013).      
5-­HT2AR,  which   is  highly  expressed   in  neocortex,  has  been   linked   to  higher  cognitive  
functions.  Some  anti-­psychotic  drugs  are  antagonists  with  high  affinity  to  this  receptor  
(Leysen  et  al.,  1993;;  Artigas,  2013).  5-­HT2AR  is  also  involved  in  the  hallucinogenic  action  
of  some  drugs  (Gonzalez-­Maeso  et  al.,  2007).  Activation  of  5-­HT2CR  has  been  linked  to  
hypolocomotion,   hypophagia,   and   anxiety   (Koek   et   al.,   1992;;   Kennett   et   al.,   1994;;  
Kennett  et  al.,  1996).  
Because  of  a  high  5-­HT3R  expression  in  the  area  postrema,  antagonists  of  this  receptor  
have   been   developed   to   treat   nausea   and   vomiting   in   patients   undergoing  
chemotherapy.  5-­HT3R  has  also  been  linked  to  some  psychiatric  disorders  (Lucchelli  et  
al.,  1995;;  Eisensamer  et  al.,  2003),  including  states  of  anxiety  because  the  deletion  of  
this  receptor  in  mice  was  anxiolytic  (Kelley  et  al.,  2003).    
Agonists  at  5-­HT4R  have  been  shown   to   improve  cognitive  performance   (Letty   et  al.,  
1997;;  Marchetti-­Gauthier  et  al.,  1997).  They  also  mediate  a  rapid  antidepressant  action  
via  desensitization  of  5-­HT1A  autoreceptors  (Lucas  et  al.,  2007).  Antagonists  at  5-­HT6R  
are  also  involved  in  cognitive  enhancement  (Rosse  &  Schaffhauser,  2010),  but  agonists  
are   likely   involved   in   the   control   of   feeding   behaviour   (Heal   et   al.,   2008).   5-­HT7R  
regulates  circadian  rhythms  (Edgar  et  al.,  1993)  and  sleep  (Hedlund,  2009),  as  both  the  
agonist(s)  and  antagonist(s)  of  this  receptor  are  capable  to  alter  these  conditions.  Some  
studies  also  name  5-­HT7R  as  a  potential  target  of  anti-­depressant  action  (Wesolowska  
et  al.,  2006;;  Berman  et  al.,  2009).  
1.4.2.4.  Modulation  of  Membrane  Properties  
Similar   to   other   neuromodulators,   5-­HT   also   modulates   membrane   properties   and  
neuronal  excitability.  For  example,  5-­HT  causes  two  opposite  effects  on  the  polarization  
and  excitability  of  layer  V  pyramidal  cells  in  rat  mPFC  (Araneda  &  Andrade,  1991).  The  
first  response  is  a  hyperpolarization  by  3.3  ±  2.0  mV  via  5-­HT1AR  activation,  most  likely  
by   opening   of   G-­protein-­coupled   inwardly-­rectifying   potassium   channel   (Andrade   &  
Nicoll,   1987;;   Lüscher   et   al.,   1997).   The   second   response   is   an   enhancement   of   the  
membrane   excitability,   which   consisted   of   three   different   components,   namely   a  
membrane   depolarization   by   3.8   ±   2.1   mV,   a   switch   from   an   AHP   to   a   long-­lasting  
depolarizing  afterpotential   after   a  burst   of   spikes,   and  a  decrease   in   spike   frequency  
adaptation.  This  enhancement  of  excitability  is  mediated  by  5-­HT2(A)R  activation.  In  some  
cells,  the  depolarization  is  sufficiently  large  to  induce  tonic  AP  firing  at  a  frequency  of  2  
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–   5   Hz   (Zhang,   2003).   Later,   Beique   et   al.   (2007)   argued   that   such   an   increase   in  
excitability  most  likely  accounts  for  the  increase  of  spontaneous  glutamate  release.  
These  responses  were  investigated  further  by  Avesar  and  Gulledge  (2012),  who  found  
that  pyramidal  cells  which  show  a  5-­HT1AR-­mediated  hyperpolarization  and  inhibition  of  
firing  are  corticopontine-­projecting  neurons  (CPns).  In  contrast,  pyramidal  cells  with  a  5-­
HT2AR-­mediated  depolarization  and  an  AP  frequency  increase  are  callosal/commissural  
(COM)   neurons.   In   other   words,   the   projection   of   these   neurons   indicates   how   the  
excitability   changes   upon   exposure   to   5-­HT.   It   is   worth   noting   that   this   projection-­
dependent   specificity   is   not   solely   caused   by   the   difference   in   5-­HTR   expression,  
because  32%  of  CPns  exhibited  a  5-­HT2AR-­mediated  excitation  in  the  presence  of  a  5-­
HT1AR  blocker  (Stephens  et  al.,  2014).  
Similar   to  some  studies  above,  Foehring  et  al.   (2002)  also   found   that  5-­HT  produces  
opposite   responses   in   excitability   in   a   variety   of   cells   from   different   layers   of   rat  
sensorimotor  cortex.  In  layer  II,  about  50%  of  pyramidal  cells  depolarized  by  7  ±  1  mV  
upon   exposure   to   5-­HT,   but   the   remainder   hyperpolarized   by   5   ±   2  mV.   In   layer   III,  
however,  90%  of  pyramidal  cells  depolarized  by  4  ±  1  mV,  but  only  10%  hyperpolarized  
by   about   3  mV.   The   depolarization  was   found   to   be  mediated   by   5-­HT2R,  whilst   the  
hyperpolarization   by   5-­HT1AR.   However,   it   remained   unclear   if   the   projection   of   the  
pyramidal  cells  determined  the  direction  of  change  in  polarization.  In  this  thesis,  I  provide  
data   showing   that   a   specific   change   in   neuronal   membrane   property   (Rin)   actually  
signified   if   the   pyramidal   cell,   upon   superfusion   with   5-­HT,   would   show   a   significant  
change  in  the  spontaneous  rate  of  glutamate  release  or  not  at  all.  Further,  using  paired  
recordings,  I  show  that  there  is  a  specific  topology  within  small  networks  based  on  the  
cell’s  response  to  5-­HT.  
1.4.2.5.  Modulation  of  Neurotransmitter  Release  
Following   on   the   explanation   from  above,   5-­HTR  activation   can  modulate   transmitter  
release   of   both,   glutamate   and  GABA.   This   has   been   reported   in   numerous   studies  
undertaken   in   different   brain   regions.   For   example,   presynaptic   5-­HT3R   activation  
increases  mEPSC  frequency  in  42%  of  area  postrema  neurons  (Funahashi  et  al.,  2004).  
In  contrast,  presynaptic  5-­HT1BR  activation  induces  long-­term  depression  of  the  evoked  
EPSC   amplitude   in   medium   spiny   projection   neurons   at   the   corticostriatal   synapse  
(Mathur  et  al.,  2011).  Similarly,  5-­HT  decreases  the  mEPSC  frequency  and  depresses  
the  evoked  EPSC  amplitude  in   interneurons  and  projection  neurons  in  the  basolateral  
amygdala   of   rat   (Rainnie,   1999).   Moreover,   5-­HT   activates   presynaptic   5-­HT3R   to  
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transiently   increase   the  mIPSC   frequency   in   immature  CA3  pyramidal  cells  of   the   rat  
hippocampus  (Choi  et  al.,  2007).  
In  neocortex  results  from  several  studies  also  confirm  that  5-­HT  modulates  spontaneous  
release  (Aghajanian  &  Marek,  1997;;  Marek  &  Aghajanian,  1998;;  Aghajanian  &  Marek,  
1999;;  Marek   &   Aghajanian,   1999;;   Lambe   et   al.,   2000;;   Xiang   &   Prince,   2003).  More  
details   in   regard   to   this   observation  will   be   given   in   the   introduction   of  Part   3.  Other  
aspects,   including   the   relevant   receptors   and   knowledge   deficit   of   molecular  
mechanisms,  will  also  be  delineated,  followed  by  how  these  are  addressed  in  this  thesis  
(see  3.1).  
Likewise,  in  Part  4,  I  will  further  introduce  the  current  state  of  research  in  regard  to  the  
impact  of  5-­HT  on  evoked  transmitter  release  (Tanaka  &  North,  1993;;  Torres-­Escalante  
et  al.,  2004;;  Komlosi  et  al.,  2012;;  Barre  et  al.,  2016),  the  receptor(s)  involved,  what  is  
currently   unknown   about   the   molecular   mechanisms,   and   how   I   think   this   could   be  
addressed  in  this  thesis.  
1.5.  Scope  of  Thesis  
As  indicated  earlier,  this  thesis  was  designed  to  corroborate  if  5-­HT,  downstream  of  Gq  
activation,   modulates   transmitter   release   via   Ca2+   release   from   presynaptic   stores.   I  
started   by   investigating   if   and   how   5-­HT   modulates   spontaneous   glutamate   release  
(mEPSCs).  As  predicted,  I  found  that  5-­HT  did  increase  the  mEPSC  frequency,  however,  
only  transiently.  This  observation  was  linked  to  the  activation  of  5-­HT2R,  which  classically  
signals  via  Gq.  Consistent  with  this  type  of  signalling  cascade,  blocking  either  PLCβ,  IP3R  
and   chelating   intracellular  Ca2+  with  BAPTA-­AM  abolished   the   action   of   5-­HT   on   the  
mEPSC   frequency,   suggesting   that   presynaptic   stores   are   the   downstream   target   of    
5-­HT2R  in  causing  the  mEPSCs  frequency  increase.  
However,   this   frequency   increase  was   restricted   to  a  specific  population  of  pyramidal  
cells  in  layer  II,  which  were  termed  responders.  About  half  of  all  pyramidal  cells  recorded  
from  corresponded  to  this  group  (47%).  When  compared  to  cells   that  did  not  respond  
upon  5-­HT  exposure   (non-­responders),   the   former  showed  a   larger  decrease   in   input  
resistance  together  with  (on  average)  a  small  outward  current,  suggesting  that  the  action  
of  5-­HT  was  not  only  specific  to  a  particular  type  of  cells,  but  also  within  the  same  type.  
It   also   suggests   that   distinct   properties   other   than   the   mEPSC   frequency   were   also  
subject  to  modulation  by  5-­HT.  
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The  impact  of  5-­HT  on  evoked  glutamate  release  was  subsequently  assessed  in  pairs  of  
pyramidal  cells  obtained  in  the  same  layer.  I  found  that,  contrary  to  the  expectation  that  
evoked  transmitter  release  may  be  increased  after  exposure  to  5-­HT,  EPSCs  actually  
depressed   by   49%.   Even   though   subtle   changes   in   the   presynaptic   APs   and   the  
postsynaptic  properties  were  observed,  they  were  unlikely  responsible  for  the  depression  
observed.   I   discovered   that   the   depression   was   also   caused   by   5-­HT2R   activation.  
However,  in  this  case,  the  signaling  was  linked  to  Gβγ  as  peptides  that  bind  it  were  able  
to  block   the  depression.   In  contrast   to   the  depression  seen  with  noradrenaline   in   the  
same  cells,  there  was  no  increase  in  the  recovery  rate  from  depression  during  a  burst  of  
20  APs  at  50  Hz,  and  no  decrease  in  the  quantal  size  based  on  density  estimation.  These  
findings  suggest  that  the  target  of  Gβγ  was  unlikely  SNAP-­25,  as  with  noradrenaline,  but  
more  likely  the  VDCC  involved  in  transmitter  release.  
Given  that  the  depression  was  not  restricted  to  a  subset  of  cells,  but  was  seen  in  almost  
all  (97%)  pairs  recorded  from,  there  is  potentially  specificity  in  the  connectivity  and/or  the  
modulation  by  5-­HT.  In  fact,  responders  were  mostly  identical  with  postsynaptic,  whereas  
non-­responders  with  the  presynaptic  pyramidal  cells,  further  strengthening  the  idea  that  
5-­HT  modulates  specific  elements  in  the  neocortical  microcircuits.  
This  is  the  first  study  where,  at  the  level  of  single  cells,  the  serotonergic  modulation  of  
transmitter  release  together  with   the  corresponding  signalling  elements  have  carefully  
been  investigated  in  neocortical  tissue.  These  findings  may  have  important  physiological  
implications  for  future  work,  and  also  for  the  application  in  psychopharmacology  context.  
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2.  Methods  
2.1.  Slicing  of  Rat  Neocortex  
Male  Wistar  rats,  aged  15  –  19  days,  were  decapitated  using  a  small  animal  guillotine  
(model  802;;  NEMI  scientific,  Medway,  MA,  USA)  as  approved  by  the  ANU  animal  ethics  
clearances  No.  A2011/023  and  A2014/013.  The  head  was  rapidly  placed  into  icy  slush  
(0°C)   of   artificial   cerebrospinal   fluid   (ACSF;;   composition   see   below),   which   was  
continuously   gassed   with   95%   O2   and   5%   CO2   (CarbogenTM;;   BOC   Gases   Australia  
Limited,   North   Ryde,   NSW,   Australia)   to   maintain   a   pH   of   7.4.   The   head   was   then  
removed  from  the  beaker,  placed  on  blotting  paper  and  the  skin  opened  along  the  midline  
using   a   scalpel   (surgical   blade  No.   10;;   Swann-­Morton   Limited,   Sheffield,  UK).  Using  
repetitive  cutting  movements  along  the  midline  suture,  the  cranium  was  opened  up  and  
flipped  on  the  side  using  the  blade  of  a  bent  pair  of  anatomical  forceps  (4-­in-­full  curved,  
serrated  eye  dressing  forceps;;  Medical  Supplies  and  Equipment  Co.,  Katy,  Texas,  USA).  
Using  the  scalpel  blade,  two  cuts  of  the  brain  tissue  in  the  area  of  the  olfactory  bulbs  and  
one  right  before  the  cerebellum  were  done  to  block  the  neocortex  out.  Then  a  cut  along  
the   midline   was   performed   to   separate   the   left   and   right   hemispheres,   which   were  
immediately  put  into  fresh  ice-­cold  and  bubbled  ACSF.  
Each  hemisphere  was  then  taken  out  of  the  beaker  with  ice-­cold  ACSF,  the  midline  cut  
surface  was  blotted  dry  on  blotting  paper,  transferred  onto  weighing  spatula  to  be  placed  
and  glued  onto  a  stainless-­steel  stage  angled   forward  by  15°  using  cyanoacrylic  glue  
(Loctite™  406;;  Loctite  Australia  Pty.  Ltd,  Caringbah,  NSW,  Australia).  After   this  step,  
leftover  glue  around   the   tissue  was  carefully  blotted  dry  using   the  side  of   the  blotting  
paper.  This  stage  was  then  mounted  within  the  cutting  chamber  of  a  vibrating  microtome  
(Leica  VT  1200S;;   Leica  Biosystems  GmbH,  Nussloch,  Germany),   containing   ice-­cold  
ACSF   that   was   continuously   gassed  with  Carbogen.   The   cortex  was   set   to   face   the  
cutting  blade  that  was  angled  at  15°  to  the  horizontal  plane  (Fig.  2.1.1).  The  vibration  
movement  along  the  vertical  axis  of  the  blade  and  its  holding  unit  was  adjusted  every  
day  for  every  blade  to  be  ≤  100  nM  using  the  Vibrocheck  unit  as  part  of  the  VT  1200  S.  
Using  a  double-­edge  stainless  steel,  Teflon-­coated  0.004’’  thick  razor  blade  (Personna;;  
American  Safety  Razor  Company,  Verona,  VA,  USA),   the  height  of   the   lateral  pole  of  
each  hemisphere  was  determined  and  the  vertical  axis  on  the  slicer  zeroed.  The  blade  
was  then  retracted,  then  lowered  by  3.5  mm  to  reach  the  starting  point  of  slicing.  The  
slicing  process  was  conducted  by  advancing  the  blade  at  a  forward  sectioning  speed  of  
0.07  mm/s  and  a  horizontal  amplitude  of  1.5  mm.  The  tissues  associated  with  two  initial  
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Figure  2.1.1.  Mounting  of  hemispheres  on  the  metal  block.  
Both  hemispheres  of  rat  brain  were  glued  on  a  stainless-­steel  stage  and  mounted  in  the  slicing  
chamber   of   the   vibrating   microtome.   The   slicing   chamber   was   filled   with   ice-­cold   ACSF  
gassed  with  95%  O2  and  5%  CO2.  
parasagittal  orientation  cuts,  i.e.  an  initial  cut  at  3.5  mm  and  another  one  at  3.8  mm,  were  
discarded  to  expose  the  postero-­medial  lateral  barrel  subfield  (Woolsey  &  Van  der  Loos,  
1970;;  Elston  et  al.,  1997).  Subsequently,  6  –  7  slices,  each  having  a  thickness  of  300  
µM,   were   cut,   neocortex   and   hippocampus   separated   from   the   basal   ganglia   and  
thalamus   using   the   shaft   of   a   27G   fine   needle,   and   placed   in   a   holding   chamber  
containing  Carbogen-­gassed   ACSF   using   a   transfer   pipette   (Fig.   2.1.2).   The   holding  
chamber  was  made  from  a  platform  of  nylon  gauze  that  was  mounted  roughly  halfway  
up  of  250  ml  beaker.  
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Figure  2.1.2.  Layout  of  slices  for  incubation.  
Parasagittal  brain  slices  on  the  holding  chamber.  Six  slices  were  taken  from  each  hemisphere  
and   arranged   based   on   the   cutting   sequence   from   top   to   bottom.   The   tube   entering   the  
chamber  provided  95%  O2  and  5%  CO2  (CarbogenTM)  gases  for  buffering  while  moderately  
circulate  the  ACSF.  
The  holding  chamber  containing  all  slices  was  then  put  into  a  water  bath  set  up  at  34°C  
for  incubation  for  at  least  30  minutes.  After  that,  the  holding  chamber  was  removed  from  
the  water  bath  and  subsequently  maintained  at  room  temperature  until  the  experiment  
started.  
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2.2.  Extracellular  Solution  
The  ACSF  was  made  up  of  (in  mM):  NaCl,  125;;  KCl,  2.5;;  NaHCO3,  25:  NaH2PO4,  1.25;;  
CaCl2,  2;;  MgCl2,  1;;  glucose,  25  (experimental  solution)  or  10  (slicing  solution);;  gassed  
with  Carbogen  to  obtain  a  final  pH  of  7.4.  The  osmolality  of  this  ACSF  is  typically  315  
mOsm/kg  H2O.  ACSF  was  prepared  fresh  daily  and  kept  at  4°C  in  the  refrigerator  until  
the   experiment   was   conducted.   Small   volume   of   slicing   solution   ACSF   was   kept  
separately   at   -­20°C   in   the   freezer   to   produce   12   –   14   ice   cubes,   which   later   will   be  
blended  with  its  liquid  form  to  produce  ice  slush  for  brain  slicing.  
2.3.  Intracellular  Solution  
Most   electrophysiological   recordings   were   performed   in   the   whole-­cell   configuration  
using  a  K-­gluconate-­based  intracellular  solution.  This  intracellular  solution  contained  (in  
mM):  K-­gluconate,  115;;  KCl,  20;;  HEPES,  10;;  phosphocreatine,  10;;  Mg-­ATP,  4;;  Na-­GTP,  
0.3;;  and  biocytin  5.4  (0.2%  weight/volume).  In  some  experiments,  some  slightly  modified  
versions  of  this  solution  were  used.  These  will  be  presented  and  explained  in  the  relevant  
context.   The   intracellular   solution   was   aliquoted   and   kept   frozen   at   -­20°C   until   the  
experiment  was  conducted.        
2.4.  Drugs  Used  and  Their  Preparations  
All  solutions  containing  drugs  were  prepared  from  stock  freshly  every  day.  
Tetrodotoxin   (TTX;;   Latoxan   L8503,   citrate   free;;   MW   319.20),   a   specific   voltage-­
dependent  Na+  channel  blocker,  was  routinely  added  to  the  ACSF  used  in  all  recordings  
of  miniature  release.  A  1000x  stock  solution  (1  mM)  was  prepared  by  dissolving  1  mg  of  
TTX  in  3.132  ml  of  0.1  M  citric  acid  solution,  and  then  kept  in  the  refrigerator.  To  reach  
a  final  concentration  of  1  µM,  100  µl  of  stock  solution  were  added  to  99.9  ml  of  ACSF.    
Gabazine  (Tocris  Bioscience  1262  –  SR-­95531  hydrobromide;;  MW  368.23),  a  specific  
GABAA   receptor  blocker,  was   routinely  added   to   the  ACSF   in  all   experiments.  1000x  
stock  solution  (3  mM)  was  prepared  by  dissolving  50  mg  of  gabazine  in  45.3  ml  of  Milli-­
Q  water,  and  then  kept  in  the  refrigerator.  To  achieve  a  final  concentration  of  3  µM,  100  
µl  of  stock  solution  were  added  to  99.9  ml  of  ACSF.  
Serotonin  (5-­HT;;  Sigma-­Aldrich  H7752  –  creatinine  sulphate  complex;;  MW  387.41)  was  
prepared  into  aliquots  of  10  mM  stock  solution  by  dissolving  19.37  mg  of  5-­HT  in  5  ml  of  
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0.1  M  HCl  solution.  This  stock  solution  was  kept  in  the  -­20°C  freezer  for  a  maximum  time  
of  one  month  before  usage  (at  -­20°C,  5-­HT  degrades  through  oxidation  at  a  rate  of  3.33  
mM  per  year  as  shown  by  1H  NMR;;  recordings  were  performed  by  Dr  Laura  de  la  Cruz  
at  the  Australian  National  University  Research  School  of  Chemistry).  To  achieve  a  final  
concentration  of  10  µM,  100  µl  of  stock  solution  were  added  to  99.9  ml  of  ACSF.  The  
ACSF  containing  5-­HT  was  prepared  fresh  daily  in  order  to  prevent  oxidation  over  time.  
α-­Methyl-­5-­HT  (Tocris  Bioscience  0557  –  maleate;;  MW  310.82),  a  pan-­5-­HT2R  agonist,  
was  prepared  into  aliquots  of  2  mM  stock  solution  by  dissolving  6.22  mg  of  α-­methyl-­5-­
hydroxytryptamine  in  10  ml  of  Milli-­Q  water.  This  stock  solution  was  kept   in  the  -­20°C  
freezer  for  a  maximum  time  of  one  month  before  usage.  To  achieve  a  final  concentration  
of  20  µM,  1  ml  of  stock  solution  was  added  to  99  ml  of  ACSF.  This  experimental  solution  
was  prepared  fresh  daily  in  order  to  prevent  oxidation  of  α-­methyl-­5-­HT  over  time.  
Dimethoxybromoamphetamine   (DOB;;   Tocris   Bioscience   2863   –   hydrochloride;;   MW  
310.62),   a   selective   5-­HT2   receptor   agonist,   was   used   under   Prohibited   Substance  
Research  &  Education  Program  License  no.  0020/11  granted  by  the  Government  of  the  
Australian   Capital   Territory.   Aliquots   of   100   µM   stock   solution   were   prepared   by  
dissolving  0.62  mg  of  DOB  in  20  ml  of  Milli-­Q  water.  The  stock  solution  was  kept  in  the  -­
20°C  freezer  before  usage.  Two  different  concentrations  were  used  in  experiments.  One  
concentration  was  1  µM,  which  was  achieved  by  adding  1  ml  of  stock  solution  to  99  ml  
of  ACSF.  The  other  concentration  was  100  nM,  which  was  achieved  by  adding  100  µl  of  
stock  solution  to  99.9  ml  of  ACSF.  
(S)-­WAY  100135  (Tocris  Bioscience  1253  –  dihydrochloride;;  MW  477.48),  a  selective  5-­
HT1A  receptor  antagonist,  was  prepared  into  aliquots  of  1  mM  stock  solution  by  dissolving  
4.78  mg  of  (S)-­WAY  100135  in  10  ml  of  Milli-­Q  water.  Stock  solution  was  kept  in  -­20°C  
freezer  before  further  usage.  A  final  concentration  of  100  nM  was  achieved  by  adding  10  
µl  of  stock  solution  to  99.99  ml  of  ACSF.  
4F  4PP   (Santa  Cruz  Biotechnology  sc-­203782  –  oxalate;;  MW  429.49),  a  selective  5-­
HT2A   receptor   antagonist,   was   prepared   into   aliquots   of   200   µM   stock   solution   by  
dissolving  0.86  mg  of  4F  4PP  in  10  ml  of  dimethyl  sulfoxide  (DMSO).  Stock  solution  was  
kept  in  -­20°C  freezer  before  further  usage.  To  achieve  a  final  concentration  of  200  nM,  
100  µl  of  stock  solution  were  added  to  99.9  ml  of  ACSF.    
RS  102221   (Tocris  Bioscience   1050   –   hydrochloride;;  MW  667.1),   a   selective   5-­HT2C  
receptor  antagonist,  was  prepared  into  aliquots  of  100  µM  stock  solution  by  dissolving  
0.71  mg  of  RS  102221  in  10  ml  of  DMSO.  Stock  solution  was  kept  in  -­20°C  freezer  before  
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further  usage.  To  achieve  a  final  concentration  of  100  nM,  100  µl  of  stock  solution  were  
added  to  99.9  ml  of  ACSF.  
Gö  6983  (Selleck  Chemicals  S2911;;  MW  442.51),  a  pan-­PKC  inhibitor,  was  prepared  
into  aliquots  of  100  µm  stock  solution  by  dissolving  0.49  mg  of  Gö  6983  in  11.073  ml  of  
DMSO.   Stock   solution   was   kept   in   -­20°C   freezer   before   further   usage.   The   final  
experimental  concentration  was  100  nM.  This  concentration  was  achieved  by  adding  100  
µl  of  stock  solution  to  99.9  ml  of  ACSF.    
Edelfosine   (Tocris  Bioscience  3022;;  MW  523.73),  a  phospholipase  C   (PLC)   inhibitor,  
was  prepared  into  aliquots  of  3  mM  stock  solution  by  dissolving  10  mg  of  edelfosine  in  
6.3647  ml  of  Milli-­Q  water.  The  stock  solution  was  kept  in  -­20°C  freezer  until  experimental  
usage.  To  get  a  final  concentration  of  30  µM,  1  ml  of  stock  solution  was  added  to  99  ml  
of  ACSF.  
2-­Aminoethoxydiphenylborate  (2-­APB;;  Merck  Millipore  100065;;  MW  225.10),  an  inhibitor  
of   IP3-­induced   Ca2+   release,   was   prepared   into   aliquots   of   16  mM   stock   solution   by  
dissolving  36.02  mg  of  2-­APB  in  10  ml  of  DMSO.  The  stock  solution  was  kept  in  -­20°C  
freezer  until  experimental  usage.  To  get  a  final  concentration  of  16  µM,  100  µl  of  stock  
solution  were  added  to  99.9  ml  of  ACSF.  
1,2-­Bis(o-­aminophenoxy)ethane-­N,N,N′,N′-­tetraacetic  acid  tetrakis(acetoxymethyl  ester)  
(Tocris  Bioscience  2787  –  BAPTA-­AM;;  MW  764.68),  a  cell  permeable  Ca2+  chelator,  was  
prepared  into  stock  solution  by  dissolving  25  mg  of  BAPTA-­AM  in  0.981  ml  of  DMSO,  
then  kept  in  -­20  ºC  freezer.  For  experimental  usage,  150  µl  of  stock  solution  were  added  
to  850  µl  of  Milli-­Q  to  acquire  1  ml  of  5  mM  BAPTA-­AM  solution,  which  was  subsequently  
diluted  100  x  with  99  ml  of  ACSF  to  achieve  a  final  experimental  concentration  of  50  µM.  
Cyclodextrin  (Fluka  chemical  56332  –  2-­hydroxypropyl-­β-­cyclodextrin;;  MW  =  ~1380),  a  
stabilizer  of  the  AM  moiety  in  ACSF,  was  prepared  into  aliquots  of  70  mM  stock  solution  
by  dissolving  966  mg  of  2-­hydroxypropyl-­β-­cyclodextrin  in  10  ml  of  Milli-­Q  water.  Stock  
solution   was   kept   in   the   -­20°C   freezer   before   further   usage.   To   achieve   a   final  
concentration  of  0.7  mM,  1  ml  of  stock  solution  was  added  to  99  ml  of  ACSF.      
Probenecid  (Sigma-­Aldrich  P-­8761;;  MW  =  285.36),  a  facilitator  for  BAPTA  accumulation  
in  the  cytoplasm,  was  prepared  into  aliquots  of  50  mM  stock  solution  by  dissolving  142.68  
mg  of  probenecid  in  10  ml  of  1  M  NaOH  solution.  The  stock  solution  was  kept  in  -­20°C  
freezer  until  experimental  usage.  A  final  concentration  of  0.5  mM  was  achieved  by  adding  
1  ml  of  stock  solution  to  99  ml  of  ACSF.    
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mSIRK  (Merck  Millipore  371818;;  MW  1948.3),  a  Gβγ-­protein  selective  binding  peptide,  
was  used  as  a  solute  in  the  intracellular  solution.  To  achieve  a  final  concentration  of  100  
µM,  5  mg  of  mSIRK  was  firstly  dissolved  in  103  µl  of  DMSO  then  added  to  20.497  ml  of  
intracellular  solution  (described  above)  to  make  a  total  volume  of  20.6  ml.  This  100  µM  
mSIRK   intracellular   solution   in   0.5%  DMSO  was   kept   in   -­20°C   freezer   before   further  
usage.  Before  recordings  were  performed,  the  solution  was  thawed,  mixed  with  vortex,  
and  sonicated  for  a  minute  to  give  uniform  concentration.      
2.5.  Optical  Set-­Up  (IR-­DIC)  
Cells   were   visualized   using   infrared-­differential   interference   contrast   (IR-­DIC)   optics  
(Stuart  et  al.,  1993)  implemented  on  a  standard  Olympus  BX51WI  (Olympus,  Shinjuku,  
Tokyo,  Japan)  microscope.  The  infrared  filter  used  is  optimized  for  transmission  at  775  
nm  and  longer.  The  condenser  of  this  microscope  was  aligned  and  optimized  to  follow  
Köhler  illumination.  For  imaging,  all  apertures  were  fully  open.  The  DIC  phase  contrast  
on  the  microscope  was  set  by  a  half-­plate  at  the  bottom  of  the  condenser  such  that  the  
neurons  were  displayed  with  positive  phase;;  i.e.  the  shape  of  the  somata  appeared  as  
convex  bodies.  The  infrared  image  was  displayed  on  a  high-­resolution  black-­and-­white  
video   monitor   (PVM-­145E,   Sony,   Tokyo,   Japan)   after   being   acquired   via   a   camera  
(VX45;;  Optronics  GmbH,  Kehl,  Germany)  with  sensitivity  in  the  IR  range,  where  gain  and  
offset  were  set  on  the  respective  camera  controller  unit  to  ~85%  and  ~50%  of  full  range,  
respectively.  
2.6.  Patch  Pipettes  
Patch   electrodes   for   whole-­cell   recordings  were   pulled   from   borosilicate   glass   (outer  
diameter  2  mm,  inner  diameter  1  mm,  length  75  mm;;  Hilgenberg,  Malsfeld,  Germany,  
Art-­No.   1807502)   using   a   P-­97   type   Brown-­Flaming-­type   horizontal   puller   (Sutter  
Instruments  Co.,  Novato,  CA,  USA)  using  a  3  mm  square  box  platinum  filament.  The  
choice  of  electrode  glass   rested  upon   its  high  dielectric  constant  compared   to  similar  
glasses  and  wall  thickness.  
The  puller  was  set  up  to  produce  glass  electrodes  with  tip  resistances  in  the  range  of  3  
–  5  MΩ  when  filled  with  intracellular  solution.  This  corresponds  roughly  to  an  outside  tip  
diameter  of  2  –  3  µm  as  judged  on  the  monitor  in  DIC.  Patch  electrodes  were  produced  
by  utilising  a  pulling  procedure  in  five  steps  as  described  below  (table  2.6.1).  Electrodes  
were   neither   “sylgaarded”   nor   fire-­polished.   Typical   RAMP   values   (time   at   which   the  
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glass  reaches  a  minimum  fluidity  while  stepping  up  values  at  10  units/sec  from  zero;;  this  
value  is  “typical”  for  each  filament.)  of  this  electrode  glass  were  between  590  –  640.  
Table  2.6.1.  Program  used  to  pull  glass  electrode  for  whole-­cell  recording.  
Whole-­cell  electrode  program  (relative  to  RAMP)    
Step  No.   Heat   Pull   Velocity   Time  
1               Ramp    +  10   20   30   180  
2               Ramp      -­  10     15   20   200  
3               Ramp      -­  30   15   20   200  
4               Ramp      -­  60   15   20   200  
5               Ramp      -­  100   10   25   200  
  
Program  values  used  on  P-­97  Brown-­Flaming-­type  horizontal  puller.  Values  are  in  arbitrary  
units  set  by  Sutter.  The  air  pressure  was  set  to  500  units.  The  air  duration  at  the  beginning  
and  end  were  set   to  500  units  as  well.  Electrodes  were  pulled  at  a  minimum   interval  of  5  
minutes  between  pulls  to  minimise  the  impact  of  heating  up  on  the  electrode  tip.  
2.7.  Recording  Setup  
The  recording  chamber  was  designed  by  Dr.  Christian  Stricker  and  made   in   the   local  
workshop  from  Perspex™.  It  has  a  circular  surface,  with  two  small  inlets  at  its  edge  for  
ACSF  superfusion  pathway,  and  a  rectangular  opening  at  the  middle  for  placing  the  brain  
slice  (see  Fig.  2.7.1).  A  Mediglass  coverslip  (24  ×  50  mm)  was  glued  to  its  bottom  with  a  
silastic  compound  (732  RTV  Sealant;;  Dow  Corning,  Midland,  MI,  USA)   to   form  a   thin  
base  of  recording  chamber  and  let  light  pass  through  from  the  bottom.  
All   the   electrophysiological   recordings   were   performed   at   36   ±   1°C   unless   stated  
otherwise.  To  maintain  this  temperature,  ACSF  was  heated  before  being  supplied  to  the  
recording  chamber  using  a  water  jacket  around  the  inflow  pipe  fed  by  an  external  water  
heater  pump   (GD  120;;  Grant   Instruments  Ltd,  Shepreth,  Cambridgeshire,  UK),  which  
was   set   to   42   –   44°C.   The   temperature   within   the   central   part   of   the   chamber   was  
measured  before  each  experiment,  using  a  thermistor  connected  to  a  multimeter  (DMT  
1040;;  Monacor  UK  Ltd,  Buckinghamshire,  UK),  to  make  sure  that  the  recording  condition  
was  as  specified.  Otherwise,  the  temperature  in  the  water  jacket  was  adjusted.    
The  flow  rate  of  the  ACSF  was  maintained  at  3  –  4  ml  per  min  by  setting  the  drip  rate  to  
1-­1.2  Hz  with  an  adjustable  clamp  attached  to  the  initial  part  of  the  inflow  tube.  
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Figure  2.7.3.  Position  of  slices  in  the  recording  chamber.  
A  parasagittal  brain  slice  in  the  middle  compartment  of  the  recording  chamber,  A  harp,  made  
of  platinum  frame  and  dental  floss,   is  placed  on  the  slice  to  prevent  any  movement  due  to  
ACSF  flow.  
  
Mechanical  disturbances  caused  by  air  bubbles  emanating  from  the  water  jacket  were  
minimised   by   placing   a   small   roll   of   nylon   gauze   at   the   inflow   compartment   of   the  
chamber,  which  was  directly  in  contact  with  the  fluid  in  the  inflow  tube.  The  ACSF  entered  
the   recording   chamber   via   the   inflow   compartment,   superfused   the   brain   slice   at   the  
centre  in  a  rectangular  compartment  (see  Fig.  2.7.1),  and  was  sucked  off  in  the  outflow  
compartment.  The  slope  of  it  was  angled  at  ~30°  to  facilitate  the  control  of  the  fluid  level  
in  the  chamber.  Continuous  outflow  was  maintained  by  suction  on  the  angled  surface  via  
a  fine-­tipped,  fire-­polished  glass  pipette  connected  to  a  Tygon™  (R-­3603;;  Cole-­Parmer  
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Australia   New   Zealand,   Chatswood,   NSW,   Australia)   line   attached   to   the   waste  
reservoirs  exposed  to  a  vacuum  pump.  
The  slice  containing  the  barrel  cortex  was  held  in  place  on  the  bottom  of  the  recording  
chamber  by  a  platinum  ring  strung  with  three  threads  of  silk  on  top  of  it.  Individual  silk  
threads  were  untwisted   from  dental   floss  (Top  Care  unwaxed-­unflavored  dental   floss;;  
Topco  Associates  LLC,  Elk  Grove  Village,  IL,  USA)  and  glued  at  an  interval  of  ~3  mm  
each  using  cyanoacrylic  glue  (Loctite™  406;;  Loctite  Australia  Pty.  Ltd,  Caringbah,  NSW,  
Australia).    
Using  the  Olympus  BX51WI  microscope  with  the  5  times  magnifications  lens  (Olympus  
MPlan  5x;;  Olympus,  Shinjuku,  Tokyo,  Japan),  layer  II  of  the  barrel  cortex  in  the  slice  was  
firstly  identified.  The  criteria  used  are  the  following:  1)  An  area  of  slice  that  was  located  
roughly  above  the  hippocampus  and  extending  towards  the  rostral  part  of  the  brain.  2)  A  
layer  of  cells,  which  was  located  directly  above  the  thick  dark  band  making  up  the  barrel-­
like  structures  (layer  IV).  And  3)  the  outermost  layer  of  neocortex  with  high  cell  density  
(adjoining  to  layer  I).  In  order  to  choose  a  target  pyramidal  neuron,  the  upper  layer  II  was  
scanned  for  small  “clumps”  of  3  –  6  cells  in  roughly  the  same  optical  plane  which  were  
located  near  the  boundary  to  layer  I.  Pyramidal  cells  had  a  pyramidal-­like  shape  cell  body  
and  an  apical  dendrite  that  runs  towards  the  layer  I  in  a  slightly  oblique  direction  before  
forming   apical   tufts.   The   data   set   in   here   did   neither   contain   multipolar   nor   other  
interneuron  cell  types  (see  post-­hoc  histological  verification  below).  
Two   headstages   connected   to   a   MultiClamp   700A   amplifier   (Axon   instruments,  
Molecular  Devices,  Sunnyvale,  CA,  USA)  were  each  mounted  on  MP-­225  manipulators  
(Sutter  Instruments,  Novato,  CA,  USA)  at  an  angle  of  27°  from  the  horizontal  plane.  The  
manipulators   were   driven   with   step   length   size   of   zero   for   coarse   (visual   inspection  
before   making   a   choice   for   a   cell   to   be   recorded   from)   and   five   for   fine   movement  
(patching).  
2.8.  Whole-­Cell  Recordings  
Whole-­cell  recordings  were  obtained  in  the  following  way.  The  glass  electrode  was  filled  
with  intracellular  solution  at  its  tip,  attached  to  the  headstage,  and  exposed  to  a  constant  
positive  pressure  (~3.5  kPa)  through  a  small  diameter  plastic  hose  connected  to  25  ml  
syringe   and   manometer   (DM20;;   Sentinel   Systems   Gas   Detectors,   Sorrento,   WA,  
Australia).  Under  the  40  times  magnification  lens  (Olympus  LumPlanFLN  40x;;  Olympus,  
Shinjuku,  Tokyo,  Japan),  the  tip  of  the  patch  electrode  was  brought  down  close  to  the  
surface  of  the  slice  in  the  ACSF  using  the  micromanipulator.  At  that  stage,  the  pipette  
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offset  potential  was  set  to  zero.  Throughout  establishing  a  whole-­cell  configuration,  the  
electrode  tip  resistance  was  gauged  by  applying  a  brief  10  mV  command  potential.  
After  touching  the  surface  of  the  slice  with  the  electrode,  the  tip  was  lowered  down  to  
about  the  same  plane  as  that  of  the  targeted  soma  but  at  a  lateral  distance  of  ~40  µM  
from  it.    The  positive  pressure  caused  a  stream  of  intracellular  solution  to  flow  out  of  the  
electrode  tip,  preventing  soiling  and  accumulation  of  tissue  debris  at  the  tip  of  electrode  
during  the  movement  within  the  tissue  (Edwards  et  al.,  1989).  As  the  intracellular  solution  
was  high  in  K+  concentration  and,  therefore,  depolarized  cell,  the  approach  towards  the  
target  cell  was  done  swiftly.  For  one  last  time,  the  pipette  offset  was  compensated  and  
a  negative  pressure  around  -­1.5  kPa  was  pre-­set  before  the  pressure  valve  (type  74.001,  
Kuhnke,   Malente,   Germany).   In   close   succession,   the   electrode   tip   was   quickly  
horizontally   advanced   towards   the   targeted   cell.   If   sufficiently   close,   a   “halo”   formed  
between   the  electrode   tip  and   the  cell   surface.  At   this  stage,   the  pressure  valve  was  
flipped   to  apply   the  negative  pre-­set  pressure   to   the  electrode.  As   the   result,   the  cell  
membrane  sealed  to  the  electrode  tip  more  or  less  immediately.  To  help  the  formation  of  
a  GΩ  seal,  the  electrode  holding  potential  was  hyperpolarized  to  -­70  mV.  
When   the  holding  current  amplitude   reached  a  value  close   to  0  pA,   indicating  a  seal  
resistance  in  the  range  of  1  –  2  GΩ,  three  brief  suctions  by  mouth  were  applied  (around  
-­3,  -­6,  and  -­9  kPa)  to  break  the  membrane  inside  the  electrode  tip.  The  subsequent  small  
opening  provided  the  electrical  access  to  the  intracellular  compartment  in  the  whole-­cell  
configuration.  
2.9.  Measurement  of  Series  and  Input  Resistances  
One  criterion  for  the  quality  of  the  whole-­cell  recording  in  voltage-­clamp  is  that  the  series  
resistance  (Rs)  at  the  electrode  tip  should  not  exceed  20  MΩ  (≤  10%  of  the  value  of  the  
input   resistance   of   the   cell;;   see   part   3)   and   does   not   appreciably   change   during   the  
duration   of   the   recording   (maximum   change   allowed   is   ≤   20%   of   its   initial   value).  
Therefore,  Rs  was  monitored  in  voltage-­clamp  at  the  beginning,  in  between  sequences,  
and  at  the  end  of  each  recording  using  a  small  depolarizing  voltage  step  (Vs)  of  0.5  mV  
for  40  ms.  To  the  decaying  phase  of  the  resulting  current  response,  a  double  exponential  
transient  was  fit  and  extrapolated  to  the  time  of  onset  of  the  voltage  step  to  obtain  the  
peak   amplitude   of   the   capacitive   transient   without   significant   contamination   by   the  
electrode   capacitance.   In   other   words,   Rs   was   estimated   from   the   estimated   peak  
amplitude  of  the  capacitive  current  transient  (Ic)  at  the  onset  of  the  voltage  step  (t  =  0,  
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when  the  current  is  primarily  charging  the  capacitance  of  the  cell,  limited  by  Rs  itself)  by  
using  the  following  equation  Rs  =  Vs  /  Ic.  
For   recordings   in   current-­clamp,   the  quality  was  gauged  by   compensating   the  bridge  
circuit   using   the  procedure  available   in   the  MultiClamp  commander.   In   this   recording  
configuration,  an  uncompensated  Rs  causes  a  voltage  step  caused  by  the  current  flowing  
across  the  uncompensated  tip  resistor,  which  can  be  seen  as  a  voltage-­jump  at  the  start  
or  turn-­off  of  the  current  step.  
To  assess   the  quality  of   recording   throughout  an  entire  experiment,  monitoring  of   the  
input  resistance  (Rin)  is  also  necessary.  This  was  performed  in  voltage-­clamp  at  a  holding  
potential  of  -­70  mV  by  using  the  same  Vs  of  +0.5  mV  for  40  ms.  The  resulting  steady  
state  current  change  at  the  end  of  40  ms  served  to  estimate  total  resistance  (Rtot),  and  
Rin  was  calculated  as  the  difference  between  the  Rtot  and  the  Rs  (Rin  =  Rtot  ˗  Rs).  For  a  
recording   to  be  considered  sufficiently  stable,   the  Rin  might  only  change  by  ≤  25  MΩ  
(13%  from  pooled  average;;  see  part  3)  from  its  initial  value.  There  was  no  restriction  set  
for  pharmacologically  induced  changes  in  the  Rin  because  it  represented  physiological  
changes  through  opening  or  closing  of  certain  ion  channels.      
2.10.  Data  Acquisition  
All   data  was  acquired   from   layer   II   pyramidal   cells  of   rat  S1  barrel   cortex  patched   in  
whole-­cell   configuration,   with   a   sampling   frequency   of   5   kHz   (equals   to   a   sampling  
interval  of  0.2  ms).    
Miniature   excitatory   postsynaptic   currents   (mEPSCs)   were   measured   in   continuous  
voltage-­clamp  recordings,  with  holding  potential  being  set  to  -­70  mV  in  the  MultiClamp  
commander  on  a  G5  PowerPC  (Apple  Inc.,  Cupertino,  CA,  USA)  running  OS  X  10.4.  The  
typical  configuration  of  the  MultiClamp  Commander  was  as  follows:  1)  output  gain  was  
set  to  1,  2)  the  feedback  resistor  (Rf)  to  500  MΩ,  3)  the  8-­pole  built-­in  Bessel  filter  to  low  
pass  10  kHz,  and  4)  the  current  selection  to  direct  current  (DC).  Recorded  currents  or  
voltages   from   cells   were   initially   analogue-­filtered   by   a   sample-­and-­hold   unit   that  
contained   a   built-­in   10-­pole   Bessel   filter   (custom   made   at   JCSMR,   ANU,   Canberra,  
Australia).  For  mEPSC  and  evoked  EPSC,  the  low-­pass  cut-­off  frequency  chosen  on  this  
unit  was  typically  1  kHz,  whereas  for  AP  it  was  10  kHz.  The  signals  were  then  further  
amplified,  typically  by  200  times  after  removing  the  respective  offset  using  the  sample-­
and-­hold   unit.   Using   an   ITC-­18   analogue-­to   digital   converter   board   (Instrutech  
Corporation,  Port  Washington,  NY,  USA),  the  signals  were  then  converted  into  a  digital  
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format,  which  were  then  stored  on  the  hard  disk  of  the  computer  using  procedures  written  
in  IGOR  Pro  (written  by  Drs  Christian  Stricker  and  Anna  Cowan).  
During  recordings  from  synaptically  connected  pyramidal  pairs,  the  presynaptic  cell  was  
typically   kept   in   current-­clamp,  whilst   the  postsynaptic   cell  was   in   voltage-­clamp  at   a  
holding  potential  of  -­70  mV.  EPSCs  in  the  postsynaptic  cell  were  evoked  every  5  s  (0.2  
Hz)  by  injecting  a  current  step  into  the  presynaptic  neuron  which  elicited  an  AP.  Timings  
were  controlled  by  Master-­8  timer  (A.M.P.I,  Jerusalem,  Israel).  
2.11.  Analysis  
Analysis   for   the   modulation   of   spontaneous   release   (mEPSC)   was   performed   using  
Axograph  X  and  custom-­built  program  in  IGOR  pro  version  6,  whilst  for  the  modulation  
of  evoked  release  (EPSC)  was  performed  using  only  custom-­built  program  in  IGOR  pro  
version   6   (WaveMetrics   Inc.,   Portland,  OR,   USA).   Detailed   analysis  methods  will   be  
explained  further  in  the  later  chapters  of  3.3.2  –  3  for  mEPSC  analysis,  and  4.3.4  –  6  for  
EPSC  analysis  in  pyramidal  pairs.        
2.12.  Junction  Potential  and  Correction  
The  liquid  junction  potential  was  estimated  using  the  equations  provided  by  Barry  (1994).  
Since  all  experiments  were  performed  at  36  ±  1°C,  the  value  was  calculated  to  be  13.0  
mV.   The   membrane   potential   values   (Vm)   were   not   corrected   for   the   liquid   junction  
potential  throughout  this  thesis.  
2.13.  Histological  Processing  of  Slices  
Neurons  were   filled  with   0.2%  biocytin   (weight/volume;;   Toronto  Research  Chemicals  
Inc.,  Toronto,  ON,  Canada)  via  the  patch  solution  during  recording.  After  recording,  the  
brain  slice  containing  the  recorded  neurons  was  fixed  in  4%  paraformaldehyde  dissolved  
in  0.1  M  phosphate  buffer  solution  (200  mM  Na2HPO4  and  200  mM  NaH2PO4  were  mixed  
with  certain  volume  ratio  to  achieve  pH  7.4,  and  then  diluted  1:1  with  Milli-­Q  water),  lightly  
shaken   for   30   minutes   on   a   compact   rocker   (CR300;;   FINEPCR,   Gunpo,   Gyeonggi,  
Korea),   and   later   stored   in   the   refrigerator   until   further   processing.  Best   results  were  
obtained  when  processing  was  done  within  a  week’s  time;;  however,  in  some  instances,  
the  time  of  storage  was  up  to  a  month.    
Overall  methods  
        60  
For   histological   processing,   the   slices   were   firstly   washed   off   the   paraformaldehyde  
solution  with  0.1  M  phosphate  buffer  solution  several  times.  Unspecific  peroxidases  were  
blocked  with  hydrogen  peroxide  (Chem-­Supply,  Gillman,  SA,  Australia).  They  were  then  
incubated   in   Trizma®   solution   (pH   7.4,   Sigma-­Aldrich,   Castle-­Hill,   NSW,   Australia)  
containing   10%   volume/volume   normal   swine   serum   (Vector   Laboratories   Inc.,  
Burlingame,   CA,   USA)   in   0.5%   v/v   t-­octylhenoxypolyethoxyethanol   (triton   X-­100™;;  
Sigma-­Aldrich,  Castle-­Hill,  NSW,  Australia)  to  permeabilise  the  cell  membranes  for  about  
30  minutes.  Subsequently,   they  were   incubated   in  Trizma®  +  0.5%  v/v   triton  X-­100™  
solution   containing  avidin   and  biotin-­conjugated  horseradish  peroxidase   (Vectastain®  
ABC   Kit;;   Vector   Laboratories   Inc.,   Burlingame,   CA,   USA)   for   an   hour   at   room  
temperature  and  then  stored  overnight  for  at  least  12  hours  at  2°C  in  the  refrigerator.  
The  following  day,  the  slices  were  washed  with  Trizma®  solution  and  reacted  for  an  hour  
with   0.1%   catechol,   0.05%   phenylenediamine,   0.4%   di-­ammonium-­nickel-­sulphate-­6-­
hydrate,   and   0.6%   cobaltous   chloride   (Sigma  Aldrich,  Castle-­Hill,   NSW,  Australia)   to  
build-­up   the  redox  environment   for   the  next  step.  One  or   two  drops  of  30%  hydrogen  
peroxide  were   then  added   to   start   the  chemical   redox   reaction  until   staining   reached  
desired  level  (blackening).  The  reaction  was  stopped  by  repeatedly  (at  least  two  times)  
washing  with  phosphate  buffer  solution.  
The  slices  were  mounted  on  glass  slides  (76.2  ×  25.4  mm;;  Livingstone  International  Pty  
Ltd.,  NSW,  Australia),  embedded  in  a  watery  embedding  medium  (0.1%  Moviol®;;  Sigma-­
Aldrich,  Castle-­Hill,  NSW,  Australia),  covered  by  coverslips  (24  ×  24  ×  0.15  mm;;  Knittel  
Gläser,  Braunschweig,  Germany)  and  sealed  with  nail  varnish.  Subsequent  storage  was  
in  the  refrigerator.      
2.14.  Morphological  Identification  of  Cell  Types  
Cells  very  firstly  identified  using  a  standard  laboratory  microscope.  The  cells  “filled  with”  
metal  precipitates  (black)  were  then  imaged  on  a  Zeiss  Axioskop  2FS  MOT  (Carl  Zeiss  
Light   Microscope,   Göttingen,   Germany)   at   20x   magnification   using   a   Retiga   2000R  
camera  (QImaging,  Surrey,  BC,  Canada)  and  Neurolucida  version  10  (MBF  Bioscience,  
Williston,  VT,  USA)  image  acquisition  software.  
Excitatory  pyramidal  cells   in   layer   II  were   identified  according   to   the   following  criteria:  
pyramidal  or  close  to  cell  body  shape  of  about  10  –  25  µm  diameter;;  prominent  apical  
dendrite  which  elongates  via  apical  tufts  to  the  pial  surface  in  layer  I;;  spiny  apical  tufts;;  
skirt  of  basal  dendrites;;  thin  axon  (if  visible)  projecting  to  deeper  layers.  Cells  that  did  not  
conform  to   these  criteria  were   identified  as   interneurons.  Note   that  my  data  set  might  
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contain  a   few   layer   III  pyramidal  cells  as   in  some   instances,   the  boundaries  were  not  
clear.  
Such  a  layer  II  pyramidal  cell  is  shown  in  figure  2.14.1.  This  cell  is  identified  as  originating  
in  layer  II  because  the  cell  body  is  located  around  215  μm  from  pia.  The  shape  of  the  
cell  body  resembles  a  pyramid,  with  a  diameter  of  ~15  μm.  The  apical  dendrite  is  slightly  
oblique,  but  elongates  to  the  pial  surface,  via  some  spiny  apical   tufts   in   layer   I.  Basal  
dendrites   are   distributed  more   or   less   symmetrically   around   the   cell   body.   The   axon  
extends  vertically  towards  deeper  layer  IV/V.  
Most  of  the  layer  II  pyramidal  cells  in  my  data  set  had  apical  dendrites  at  slightly  oblique  
angle  to  the  pia  (~20°  from  vertical).  Few  cells  showed  a  ~45°  obliqueness,  but  none  of  
the   cell   showed   horizontal   or   even   inverted   apical   dendrites   as   described   by   van  
Brederode  et  al.  (2000).    
  
Figure  2.14.1.  Morphology  of  histologically  verified  layer  II  pyramidal  cell.  
A  layer  II  pyramidal  cell  after  post-­hoc  histological  processing,  showing  a  pyramidal  shaped  
cell  body,  apical  dendrite  and  tufts,  few  oblique,  basal  dendrites,  and  thin  axon.  White  scale  
bar  indicates  a  length  of  100  µM.
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3.  Modulation  of  Spontaneous  Release  
3.1.  Introduction  
In   previous   research   in   this   laboratory,   it   was   found   that   both   group   I   metabotropic  
glutamate  receptors  (mGluR;;  Simkus  &  Stricker,  2002a)  and  noradrenaline  (NA)  via  α1-­
AR  (Choy  et  al.,  2017a)  were  capable  of  causing  Ca2+  release  from  presynaptic  stores,  
which  resulted  in  an  increase  of  mEPSC  frequency  in  layer  II  pyramidal  cells  of  rat  barrel  
cortex.   The   common   feature   of   both   responses   is   that   in   each   case,   the   G-­protein-­
coupled  receptor  (GPCR)  was  linked  to  Gq/11  (Sternweis  &  Smrcka,  1992;;  Exton,  1994).    
In  the  case  of  NA,  it  was  found  that  the  respective  signalling  was  via  PLCβ,  as  blocking  
this  enzyme  with  edelfosine  prevented  the  increase  in  mEPSC  frequency.  The  classical  
tenet  of  the  associated  signalling  cascade  states  that  activation  of  PLCβ  results  in  the  
hydrolysis  of  PIP2  into  IP3  and  DAG  (Thompson  &  Dawson,  1964;;  Gonzales  &  Crews,  
1985;;  Litosch,  1987;;  Taylor  et  al.,  1991).  Whilst  there  was  no  significant  evidence  for  the  
action   of   DAG   on   the  mEPSCs   recorded,   experimental   data   solidly   showed   that   the  
signalling  molecule  IP3  bound  to  IP3  receptors  (IP3R)  on  stores,  which  then  caused  Ca2+  
release  that  increased  the  mEPSC  frequency.  
This  study  extends  this  research  effort  to  5-­HT2R,  as  this  group  of  receptors  also  utilises  
Gq/11  as  the  respective  adaptor  protein  (Baxter  et  al.,  1995;;  Barnes  &  Sharp,  1999).  The  
anticipation  was   that   like  with  NA,   the  addition  of  5-­HT   to   the  superfusate  would  also  
increase  the  mEPSC  frequency  due  to  the  activation  of  IP3R  on  Ca2+  stores.  In  keeping  
with  the  previous  studies  mentioned  above,  all  experiments  were  performed  in  the  same  
pyramidal  cells  in  layer  II  of  the  rat  S1  barrel  cortex.  Serotonergic  nerve  terminals  from  
the   raphe   nuclei   are   present   in   this   location   and   layer   of   cortex      (Steinbusch,   1981;;  
Kosofsky  &  Molliver,  1987;;  Törk,  1990;;  Vertes  et  al.,  1999),  and  5-­HT2R  are  also  well  
expressed   (Li  et  al.,  2004).  Because  5-­HT   regulates   rhythmic  whisking   (Hattox  et  al.,  
2003),  such  an  investigation  has  likely  physiological  relevance  at  least  for  rodents.    
In   this   context,   past   studies   (Aghajanian  &  Marek,   1997;;  Marek  &  Aghajanian,   1998;;  
Aghajanian  &  Marek,  1999;;  Marek  &  Aghajanian,  1999;;  Zhou  &  Hablitz,  1999;;  Lambe  et  
al.,  2000)  have  provided  evidence  that  5-­HT  modulates  spontaneous  glutamate  release  
in  rat  prefrontal  cortex  (PFC).  These  authors  observed  that  5-­HT  in  the  absence  of  Na+  
channel   blocker   TTX   significantly   increased   both   the   frequency   and   amplitude   of  
spontaneous  excitatory  postsynaptic  currents  (sEPSCs,  in  contrast  to  mEPSCs)  in  layer  
V  pyramidal  cells  via  the  activation  of  5-­HT2AR.    
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These   authors   also   surmised   that   the   increased   sEPSC   frequency  was   the   result   of  
enhanced  glutamate  release  from  axonal  terminals  that  most  likely  originated  from  the  
midline  and  intralaminar  nuclei  of  thalamus  (Berendse  &  Groenewegen,  1991;;  Lambe  et  
al.,  2000)  and  projected  to  the  apical  dendrites  of  layer  5  pyramidal  cells.  Beique  et  al.  
(2007),  however,  argued  that  the  sEPSC  frequency  increase  occurred  because  a  sub-­
population  of  PFC  pyramidal  cells  underwent  strong  excitation  after  5-­HT2AR  activation.  
In  both  cases,  the  authors  put  the  5-­HT2AR  at  the  core  of  their  explanations.  However,  in  
none  of  these  studies,  the  downstream  targets  of  the  respective  signalling  cascade  were  
identified.  
Because  5-­HT2AR  are  expressed  widely  throughout  layer  II,  III,  V,  and  VI  of  neocortex  
(Jakab   &   Goldman-­Rakic,   1998),   Lambe   et   al.   (2000)   investigated   the   serotonergic  
modulation  in  different  layers  of  PFC.  They  found  that  whilst  87%  of  layer  V  pyramidal  
cells  showed  a  significant  increase  in  sEPSC  frequency  when  5-­HT  was  applied,  in  layer  
II,   this   increase   was   restricted   to   only   25%   of   pyramidal   cells.   This   finding   strongly  
suggests   that   there   is   a   difference   in   regard   to   the   response   in   at   least   two   sub-­
populations  of  pyramidal  cells.  However,  these  authors  did  not  provide  any  further  data  
pertaining   to   the   differential   make-­up   of   these   two   populations.   Likewise,   Zhou   and  
Hablitz   (1999)   studied   the   modulation   of   both   sEPSCs   and   mEPSCs   in   frontal   and  
anterior   cingulate   cortex,   broadly   including   pyramidal   neurons   from   layer   II   to   VI.  
However,  they  only  presented  data  in  a  pooled  manner  without  differentiating  between  
different  layers.  Consequently,  their  data  was  similar  to  that  by  Aghajanian  and  Marek  
(1997).   Some   other   studies   in   different   regions   of   neocortex,   such   as   layer   II   of  
somatosensory   (S1)   cortex   (Foehring   et   al.,   2002;;   Torres-­Escalante   et   al.,   2004),  
focused  on  sIPSCs  or  evoked  transmitter  release.  
Because  most  studies  just  highlighted  were  done  outside  of  the  somatosensory  cortex,  
the  question  arouse  if  in  barrel  cortex  the  response  to  5-­HT  was  qualitatively  similar.  In  
addition,   the   nature   of   the   5-­HTR   involved   needs   characterising   together   with   the  
downstream  targets  of  this  signalling  cascade.  The  findings  will  be  contrasted  to  those  
obtained  with  NA.  
3.2.  Specific  Hypotheses  
In  analogy  to  the  observations  made  for  NA,  I  propose  to  test  the  following  hypotheses  
for  the  serotonergic  modulation  of  spontaneous  neurotransmitter  (glutamate)  release  in  
layer  II  of  rat  barrel  cortex:  
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1)   Serotonin   (5-­HT)   increases   the   frequency   of   spontaneous   glutamate   release,  
which  can  be  observed  as  increase  in  instantaneous  mEPSC  frequency,  but  not  
amplitude.  
2)   The   frequency   increase   is   only   observed   in   a   subset   of   pyramidal   cells  
(responders).  
3)   This  increase  is  caused  by  activation  of  presynaptic  5-­HT2A/CR  coupled  to  the  Gq-­
protein.  
4)   Activated  5-­HT2A/CR  produce  IP3  to  cause  Ca2+  release  from  presynaptic  stores,  
which  is  observed  as  an  increase  in  the  frequency  of  mEPSCs.  
In  this  part  of  my  thesis,  I  characterised  some  of  those  missing  points  mentioned  above  
by  concentrating  on  the  serotonergic  modulation  of  spontaneous  glutamate  release  onto  
pyramidal  cells   in  layer  II  of  young  (P15  –  20)  rats.  I  present  the  data  obtained  in  five  
sections.  First,  I  characterized  their  postsynaptic  membrane  properties  like  Rin,  passive  
membrane,  and  action  potential  properties  together  with  the  characteristics  of  sEPSCs  
and  mEPSCs  without  exposure  to  5-­HT  (3.4.1).  I  found  that  the  pyramidal  cells  in  this  
layer  had  properties  indistinguishable  from  those  found  in  an  earlier  study  (Choy  et  al.,  
2017a).   Second,   I   then   exposed   these   cells   to   5-­HT   and   observed   how   this  
neuromodulator   impacted   on   the   parameters   just   mentioned   and   specifically   on   the  
mEPSCs  (and  also  sEPSCs;;  3.4.2).  I  report  that  in  about  47%  of  cells  recorded  from,  I  
saw  a  transient  increase  in  mEPSC  frequency,  but  not  amplitude.  Third,  based  on  their  
responses  to  5-­HT,  I  was  able  to  differentiate  two  populations  of  pyramidal  cells  in  this  
layer,  subsequently  referred  to  as  responders  and  non-­responders  (3.4.3).  Responders  
showed   a   large   decrease   in   Rin,   whereas   non-­responders   a   large   hyperpolarizing  
current.  Fourth,  using  both  agonists  and  antagonists,  I  determined  the  subtype  of  5-­HTR  
involved  in  modulating  the  mEPSC  frequency  (3.4.4),  and  identified  that,  most  likely  it  is  
5-­HT2CR.  Fifth,  I  then  punctually  verified  the  signalling  pathway  downstream  of  5-­HT2R  
causing   the  observed   transient   increase   in  mEPSC  frequency.  As  predicted   for  a  Gq-­
mediated  signalling  cascade  and  consistent  with  the  hypothesis  above,  the  activation  of  
intracellular  Ca2+  stores  was  responsible  for  the  increase  in  mEPSC  frequency  (3.4.5).        
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3.3.  Methods  and  Analyses  
3.3.1.  mEPSC  Recordings  
mEPSCs  are  spontaneously  occurring  inward  currents  recorded  from  the  postsynaptic  
cell   in   the  presence  of  1  µM  TTX   (Na+  channel  blocker)  and  3  µM  gabazine   (GABAA  
channel  blocker).  Each  mEPSC  originates  from  the  spontaneous  release  of  a  glutamate-­
containing   vesicle   from   the   bouton   or   nerve   terminal   of   the   presynaptic   cell   (Katz   &  
Miledi,  1963).  
In   the  experiments   in   this   thesis,  mEPSCs  were   recorded   from  pyramidal  cells   in   the  
upper  part  of   layer   II  of  barrel  cortex,  which   received  spontaneous   intercortical   inputs  
from  many  other  pyramidal  cells  (Kisvarday  et  al.,  1986;;  Elhanany  &  White,  1990).  Once  
a  pyramidal  cell  was  patched  in  the  whole-­cell  configuration,  mEPSCs  were  recorded  in  
voltage-­clamp  mode  using  a  continuous  recording  protocol,  with  the  holding  potential  set  
to  -­70  mV.  During  the  first  five  minutes  of  recording  in  standard  ACSF,  the  stability  of  the  
patch  and  its  seal  around  the  electrode  and  cell  were  assessed  using  criteria  as  follows:  
1)  series  resistance  (Rs)  remained  ≤  20  MΩ,  2)  Rs  did  not  change  by  more  than  ±  20%  
throughout  the  recording,  3)  input  resistance  (Rin)  did  not  change  by  more  than  ±  25  MΩ  
(corresponding   to   ±   13%  of   the   pooled   average   as   shown   later   in   3.4.1),   and   4)   the  
properties  of  spontaneous  currents  including  the  instantaneous  frequencies,  amplitudes,  
and  time  courses  did  not  change  by  >  10%  over  a  period  of  five  minutes.  
Most   experiments   were   conducted   in   the   following   way.   The   first   5   minutes   of   the  
recording  served  as  control  period  (Fig.  3.4.3B;;  blue,  t  <  0).  Directly  following  this  period,  
I   measured   Rs   and   Rin   before   applying   5-­HT   or   its   agonists,   respectively.   These  
measurements  took  ~1  minute,  which  was  the  reason  of  a  blank  gap  between  the  control  
period  and  the  start  of  5-­HT  in  this  mEPSC  recording  (see  Fig.  3.4.3B).  At  t  =  0  (red),  the  
superfusion  of  5-­HT  was  commenced  and  the  recording  of  mEPSCs  resumed.  This  was  
conducted  for  at  least  another  15  minutes.  For  5-­HT,  it  took  less  than  a  minute  to  reach  
the  recording  chamber,  and  less  than  another  few  minutes  to  exert  its  full  effect.  
3.3.2.  Template-­Matching  Algorithm  to  Detect  mEPSCs  
Periods   of  mEPSC   recordings  were   analysed   using   the   template  matching   algorithm  
implemented   in   Axograph™  4.9   or   X   (Axograph.com)   as   described   in  Clements   and  
Bekkers  (1997).  This  program  estimates  for  each  mEPSC  its  amplitude,  the  time  of  the  
peak,  the  rise  time  (10  –  90%,  obtained  by  interpolation)  and  the  half-­width  (obtained  by  
interpolation)  from  the  fitted  scaled  template.  The  procedure  is  illustrated  in  Fig.  3.3.1.  
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Figure  3.3.1.  Detection  of  mEPSCs  using  template  matching  algorithm.  
A.  Two  seconds  of  a  continuous  recording  segmented  into  200  ms  periods,  each  separated  
vertically  from  top  to  bottom.  Red  dots  (●)  represent  mEPSCs  detected  by  algorithm.  Blue  
dots  (●)  represented  mEPSCs  identified  visually  but  not  by  the  algorithm.  The  total  number  
for  visually  identified  mEPSCs  is  the  sum  of  red  and  blue  circles.  B.  Time  course  of  the  
template  used  for  the  detection.  
  
A  template  was  chosen  from  the  mEPSC  time  courses  during  the  control  period  based  
on   the   following   criteria.   First,   the   respective   mEPSC   must   have   been   free   from  
contamination  by  other  mEPSCs  during  the  rising  and  early  decay  phase.  Second,  its  
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peak  amplitude  should  be  large  (as  large  as  possible,  typically  <-­50  pA)  to  ensure  a  
large  signal  to  noise  ratio;;  i.e.  the  time  course  is  not  dominated  by  the  randomness  of  
the  recording  noise  present.  Third,  the  rise  time  of  mEPSC  must  have  been  fast  (<  1  
ms)  with  the  decay  time  in  the  range  between  5  –  10  ms.  
Once  an  mEPSC  had  been  identified  to  serve  as  template  (B),  the  program  slid  it  along  
the   recording   to   pick   up   all  mEPSC   events   by   optimally   scaling   the   template   time  
course  and  amplitude  and  minimising  the  difference  between  the  scaled  template  and  
the  recorded  time  course.  When  the  template  fitted  the  time  course  well  and  the  criteria  
of  detection  were  fulfilled,  an  mEPSC  was  considered  detected.  
This   template   algorithm   detected   most   mEPSCs   accurately   despite   variation   in  
mEPSC   kinetics   and   holding   current.   However,   it   also   detected   false   positive  
mEPSCs,  typically  small  events,  which  were  unlikely  different   from  recording  noise.  
Therefore,   such   mEPSCs   needed   elimination   and,   consequently,   the   analysis   in  
Axograph™  4.9  or  X  was  subject  to  further  “thresholding”  based  on  the  noise  standard  
deviation  (σnoise).  The  latter  corresponded  to  the  point-­by-­point  standard  deviation  of  a  
chosen  stretch  of   the   recording  devoid  of  spontaneous  synaptic  currents.  The  data  
was   then   subject   to   a   routine   in   IGOR,   during   which   mEPSCs   with   amplitudes   <  
2.5·σnoise  were  removed.    
The  outcome  of  a  chosen  two  second  recording  sequence  was  then  compared  with  
what  was  identified  by  a  visual  detection  during  the  same  period  (A).  Specifically,  an  
mEPSC  detected   by   algorithm  and   identified   visually  was   considered   a  match.   An  
mEPSC   was   considered   false   negative,   if   it   was   detected   by   eye,   but   not   by   the  
algorithm.  In  analogy,  an  mEPSC  was  considered  false  positive  if  it  was  detected  by  
the  algorithm  but  not  visually.  Only  if  the  values  of  false  positives  and  negatives  was  
<  15%,   i.e.  >  85%  of  mEPSC  were  matched,  the  analysis  was  accepted.  If  this  was  
not  the  case,  the  analysis  was  repeated  with  a  new  template  until  the  above  criteria  
were  fulfilled.  
Using   the   template   in  B,   in   a   recording   sequence  of   two   seconds   shown   in  A,   the  
algorithm  successfully  detected  32  (red)  out  of  34  visually   identified  mEPSCs  (blue  
and   red).   Two  mEPSCs   that  were  not   detected  by   the  algorithm,   but   by   eye   (blue  
circles),  were  considered   false  negatives,  corresponding   to  a   fraction  of  6%  (2/34).  
Since   there   were   no  mEPSC   falsely   identified   by   the   algorithm,   the   false   positive  
fraction  was  0%  (0/34).  
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3.3.3.  Statistical  Analyses  
In  addition  to  the  thresholding  function,  the  custom-­made  IGOR  routine  also  extracted  
details   of   each   detected   mEPSC,   including   its   amplitude,   rise   time,   half-­width   and  
instantaneous   frequency   as   determined   by   the   time   between   the   preceding   and   the  
respective  mEPSC.  Furthermore,  the  routine  also  generated  histograms  and  cumulative  
probability  density  functions  (cPDFs)  of  the  instantaneous  mEPSC  frequencies  and  the  
amplitudes,  which  were  then  subject  to  further  statistical  analysis.    
The  cPDFs  between   the  control  and  periods  with  pharmacological  compounds  added  
(after   segmentation   into   subsets   of   five   minutes   each)   were   then   compared   and  
assessed  for  significance  using  the  Kolmogorov-­Smirnov  (KS)  statistic.  Significance  was  
reached  if  pKS  <  10-­21.  This  value  was  set  very  low  because  of  the  very  large  number  of  
mEPSCs  (~20,000  events).   It  also  corresponded   to   the  one  also  used   in  Simkus  and  
Stricker  (2002b,  2002a),  Choy  (2011),  and  Choy  et  al.  (2017a).  
Depending  on  the  respective  outcomes  after  5-­HT  or  agonist  superfusion,  which  were  
based   on   the   level   of   statistical   significance,   pyramidal   cells  were   classified   into   two  
groups:  Cells  with  a  significant  increase  in  mEPSC  frequency  were  named  responders,  
and   those   without   were   called   non-­responders;;   i.e.   the   frequency   change   was   not  
different  to  that  observed  during  the  control  period.  
The   probability   of   observing   a   certain   number   of   responders   and   non-­responders   in  
different  sets  of  experiments  was  compared  for  significance  using  a  chi-­squared  (χ2)  test.  
This  test  performs  best  with  sample  sizes  in  the  range  of  50  –  100.  However,  the  number  
of  observations  for  each  set  of  my  experiments  was  typically  much  smaller  (5  –  18).  The  
small   counts   per   category   in   this   case   causes   the χ2   value   to   become   small,   and  
correspondingly  make   the  p   value   bigger   and   less   reliable;;   i.e.   in   this   case,   the   null  
hypothesis  that  there  was  no  difference  between  the  two  outcomes  would  be  very  hard  
to  reject,  which  unnecessarily  penalises  the  alternative.  There  is  a  Yates’  correction  for  
small  data  values,  but  Haviland  (1990)  showed  that  this  method  is  not  necessarily  better.  
For  this  reason,  the  significance  level  was  set  at  <  0.10.  
Since   the   instantaneous  mEPSC   frequency  showed  a  characteristic   transient  change  
(see  part  3.4.2.1),  a  one-­way  repeated  measures  ANOVA  test  and  a  post-­hoc  t-­test  with  
Bonferroni  correction  (Abdi,  2007)  were  performed  to  assess  significance.  As  I  compared  
the  control  with  three  subsequent  phases,  an  ANOVA  of  one-­way  repeated  measures  
was  used  to  test   if   there  was  a  significant  difference  (pANOVA  <  0.05)  between  the  four  
different  data  subsets   in   the  same  experiment.  For   the  post-­hoc  t-­test  with  Bonferroni  
correction,  two  different  data  sets  in  the  same  experiment  were  considered  significantly  
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different,  if  pt-­Bon  <  0.05  /  n,  where  n  is  the  total  number  of  comparisons  in  the  respective  
experiment.  The  number  of  comparisons  was  a  combination  of  two  out  of  four  different  
data  sets,  which  was  n  =  4C2  =  6.  Therefore,   the  significance   level  was  set  at  pt-­Bon  ≤  
0.0083.  
For  comparing  pooled  mEPSC  amplitudes,  a  paired  t-­test  was  used  (ppt  ≤  0.05).    
Where  appropriate,  the  numerical  values  of  the  rise  times  and  half-­widths  were  used  to  
give  insight  into  the  changes  in  mEPSC  time  course  before  and  after  agonist  application.  
In  addition,  I  averaged  all  mEPSC  time  courses  from  the  control  and  subsequent  periods  
with  agonist/antagonist  exposure  and  compared  the  two  by  overlaying.  The  typical  length  
of  the  time  courses  was  ~5  ms,  including  a  very  short  baseline,  the  rising  phase,  its  peak,  
and  a  part  of  the  decay  phase.  
3.3.4.  Pharmacological  Compounds  
All  pharmacological  compounds  were  dissolved  in  ACSF  and  applied  to  the  slice  by  the  
addition  to  the  superfusing  solution.  All  blockers,  inhibitors,  or  antagonists  were  applied  
for  at  least  ten  minutes  prior  to  the  superfusion  with  5-­HT  or  agonist.  During  this  time,  
the   solution   in   the   superfusion   chamber   was   fully   exchanged   and   the   appropriate  
concentration   reached.   5-­HT   and   the   respective   agonists   were   directly   added   to   the  
superfusate,  mostly  exerting  their  full  effect  within  a  couple  of  minutes.    
3.3.5.  Characterising  Passive  Membrane  and  Action  Potential  Properties  
The   characterization   of   the   electrophysiological   properties   of   the   recorded   cells   was  
performed  prior   to  any  mEPSC   recording   (i.e.   in   the  presence  of   standard  ACSF)  by  
applying  multiple  current  steps  of  500  ms  duration  in  steps  of  50  pA  starting  from  -­200  
pA   and   ending   at   500   pA   (see   Fig.   3.4.1).   The   membrane   time   constant   (τc)   was  
determined  as  the  time  from  onset  to  63.2%  of  the  maximal  voltage  deflection  by  a  -­200  
pA  current  step.  The  procedure  is  illustrated  in  Fig.  3.3.2.  For  the  hyperpolarizing  current  
step   of   -­200   pA,   a   single   exponential   was   fitted   to   the   membrane   voltage   (A).   The  
threshold  voltage  of  the  action  potential  (Vthr)  was  determined  as  the  membrane  voltage,  
at  which  its  first  derivative  equalled  50  mV/ms  (Kole  &  Stuart,  2008).  The  action  potential  
amplitude  or  height  (H)  was  measured  as  the  difference  between  the  peak  and  Vthr.  The  
width  of  the  action  potential  (W)  was  measured  as  the  width  at  half  of  its  height  (0.5  H).  
The  relative  membrane  voltage  difference  (Vrel)  was  defined  as  the  difference  between  
Vthr  and  the  resting  membrane  potential  (Vrest;;  B  and  C).  
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Figure  3.3.2.  Estimation  of  electrophysiological  properties.  
A.  τc  was  determined  from  the  fit  of  a  single  exponential  (─)  to  the  membrane  voltage  after  
injection  of  a  square  current  pulse  of   -­200  pA.  B  and  C  show   the  determined  parameters  
related  to  the  action  potential,  including  Vrest,  Vthr,  Vrel,  H,  and  W.  
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3.4.  Results  
Results   in   this   part   are   presented   in   five   sections,   3.4.1   –   3.4.5.   First,   in   3.4.1,   I  will  
characterise   the   electrophysiological   properties,  which   include   the   passive   properties  
and   the   firing   pattern   of   upper   layer   II   pyramidal   cells.   I   will   also   include   the  
characteristics  of  mEPSCs  and  sEPSCs  recorded  in  these  pyramidal  cells.  Second,  in  
3.4.2,  I  will  provide  the  basic  observation  how  5-­HT  impacted  on  mEPSCs,  including  the  
concentration-­response  relationship  and  the  respective  changes  during  early  postnatal  
development.  Third,  in  3.4.3,  I  will  identify  some  characteristics  which  differentiate  cells  
with  a  significant  response  to  5-­HT  (responders),  from  the  rest  of  the  cells,  which  do  not  
show  a  noticeable  change  (non-­responders).  Fourth,  in  3.4.4,  I  will  present  experiments  
designed  to  determine  which  5-­HT  receptor  (5-­HTR)  caused  the  modulation  of  mEPSCs.  
Lastly,   in   3.4.5,   I   will   elucidate   some   of   the   molecular   targets   downstream   of   the  
respective  5-­HTR  activation.    
Note  that  all  numbers  are  presented  as  mean  ±  standard  error  of  the  mean  (SEM).  Note  
also  that  5-­HTR  relates  to  both  the  singular  but  also  the  plural  of  receptors.  The  same  
idea  applies  to  the  receptor  subtypes,  typically  indicated  by  a  subscript.  For  example,  5-­
HT2CR  refers  to  5-­HT  receptor(s)  of  the  subtype  2C.    
3.4.1  Electrophysiological  Properties  and  m/sEPSC  Characteristics  
3.4.1.1.  Electrophysiological  Properties  of  Pyramidal  Cells  
I  performed  recordings  from  198  pyramidal  cells  in  the  upper  layer  II  of  the  barrel  cortex.  
In  these  experiments,  I   isolated  miniature  EPSCs  by  using  tetrodotoxin  (TTX)  and  the  
GABAA  receptor  blocker  gabazine.   I  also  performed  recordings  from  19  other  cells,   in  
which  spontaneous  EPSCs  were  recovered   in   the  presence  of  gabazine  only,  without  
the  addition  of  TTX.  From  these  recordings,  the  electrical  properties  could  be  determined  
in   156   cells   (72%),   which   included  Vrest,   the   membrane   time   constant   (τc),   the   input  
resistance  (Rin),  the  action  potential  threshold  (Vthr),  its  amplitude  referred  to  as  its  height  
(H),  width  at  half-­amplitude  (W),  and  the  relative  voltage  difference  (Vrel)  between  Vrest  
and  Vthr.  
In  this  set  of  156  pyramidal  cells,  Vrest  was  on  average  -­76.6  ±  0.3  mV,  τc  12.7  ±  0.2  ms,  
Rin  187  ±  6  MΩ  at  a  series  resistance  (Rs)  of  12  ±  0  MΩ.  The  action  potential  properties  
were  as  follows.  Vthr  equalled  -­38.0  ±  0.3  mV,  H  74.0  ±  0.4  mV,  W  1.0  ±  0.0  ms,  and  Vrel  
38.6  ±  0.4  mV.  All  pyramidal  cells  showed  a  similar  firing  pattern.  In  response  to  a  500  
ms   long  current   step   larger   than   rheobase,   the  pyramidal   cells   fired  action  potentials  
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regularly  with  only  moderate  adaptation  (Fig.  3.4.1),  corresponding  to  the  regular  spiking  
classification  by  (Connors  et  al.,  1982)  and  Maravall  et  al.  (2004),  but  contrasting  it  with  
a   phasic   spiking   pattern   of   “immature”   layer   II   pyramidal   cells,  which   only   fire   action  
potentials  for  the  first  300  of  a  500  ms  long  stimulus  (Lorenzon  &  Foehring,  1993,  1995;;  
Maravall  et  al.,  2004).  
  
Figure  3.4.1.  Firing  pattern  due  to  current  steps.  
Injection  of  a  current  step  of   -­200  pA  caused  a  hyperpolarization  of  13.2  mV,  with  a  small  
voltage  sag  typical  of  pyramidal  cells  (bottom).  In  this  case,  rheobase  was  at  250  pA  (grey).  
A  current  step  of  500  pA  caused  regular  spiking  at  ~20  Hz.  
  
3.4.1.2.  Electrophysiological  Properties  of  Spontaneous  EPSCs  
In   the   presence   of   3   µM   gabazine   in   the   superfusate   to   block   GABAA   receptors,   I  
recorded  and  characterized  sEPSCs  in  9  pyramidal  cells.  The  point-­by-­point  standard  
deviation  of  the  noise  (σnoise)   in  these  recordings  ranged  from  1.7  to  2.5  pA,  giving  an  
average  value  of  2.1  ±  0.1  pA.  The  instantaneous  sEPSC  frequency  ranged  from  42  to  
82  Hz,  with  an  average  value  of  56  ±  5  Hz.  This  is  illustrated  in  Fig.  3.4.2.  The  average  
sEPSC  amplitude  was  -­11.0  ±  0.4  pA  (A),  with  individual  values  ranging  from  -­8.8  to  -­
12.7  pA.  The  average  rise  time  was  0.5  ms,  with  values  ranging  from  0.4  to  0.6  ms.  The  
average  half-­width  was  1.4  ms,  with  values  ranging  from  1.1  to  1.6  ms.  The  data  for  rise  
times  and  half-­widths  are  presented  without  SEM,  because  were  in  the  range  of  a  few  
µs,  much  smaller  than  the  A/D  time  used  in  these  recordings  (200  µs).  
In  the  presence  of  1  µM  TTX  to  block  voltage-­dependent  sodium  channels,  and  therefore  
sodium   electrogenesis,   together   with   3   µM   gabazine   (as   above),   I   recorded   and  
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characterized  mEPSCs  in  156  recordings  from  histologically  verified  pyramidal  cells  (B).  
σnoise  in  these  recordings  ranged  from  1.3  to  2.4  pA,  giving  an  average  value  of  1.8  ±  0.1  
pA.   This   value   was   slightly   smaller   than   the   value   obtained   for   sEPSCs   (pt   =   0.02),  
suggesting   that   blocking   sodium   channels   had   a   significant   impact   on   the   recording  
noise,  which  was  most   likely   dominated   by   perisomatic   channels.   The   instantaneous  
mEPSC  frequency  ranged  from  23  to  89  Hz,  with  an  average  value  of  59  ±  1  Hz,  not  
significantly   different   from   those   of   sEPSC   (pt   =   0.64).   The  mEPSC   peak   amplitude  
ranged  from  -­5.4  to  -­13.7  pA,  with  an  average  value  of  -­9.5  ±  0.1  pA.  This  value  was  
significantly  smaller  than  the  sEPSC  amplitude  (pt  =  0.007),  showing  that  the  amplitude  
was  also  affected  by   the  block  of  sodium  channels   (see  Fig.  3.4.2).  The  mEPSC  rise  
time   ranged   from  0.4   to   0.7  ms,   giving   an   average   value   of   0.5  ms,   not   significantly  
different  from  those  of  the  sEPSCs  (pt  =  0.058).  The  half-­widths  ranged  from  0.8  to  2.2  
ms,  with  an  average  value  of  1.6  ms,  not  significantly  different  either  from  those  of  the  
sEPSCs  (pt  =  0.08).  
  
  
Figure  3.4.2.  Time  courses  of  mEPSCs  and  sEPSCs.  
Typical  time  courses  of  sEPSC  (A)  and  mEPSC  (B)  from  individual  recordings.  
  
3.4.2.  5-­HT  Transiently  Increased  mEPSC  Frequency  But  Not  Amplitude    
In   this   section,   I  will   describe   the  effect   of   5-­HT  on  both,   the  mEPSC   frequency  and  
amplitude.  Specifically,  I  will  present  data  for  pyramidal  cells  which  showed  a  change  in  
mEPSC   frequency   to   5-­HT   (responders),   and   some   that   were   unresponsive   (non-­
responders).   In  addition,  several  control  experiments  were  done   to   further   investigate  
the   nature   of   this   increase   in  mEPSC   frequency.   Note   that   from   this   point   onwards,  
mEPSC  frequency  always  refers  to  the  instantaneous  mEPSC  frequency,  and  the  two  
words  are  used  interchangeably.    
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3.4.2.1.  5-­HT  Affects  Frequency  but  Not  Amplitude  in  Responders  
First,  I  checked  if  10  µM  5-­HT  affected  the  average  mEPSC  frequency,  amplitude,  and  
time  course  (i.e.   rise  time  and  half-­width).  After  a  control  period  of  at   least  5  minutes,  
upon   addition   of   10   µM  5-­HT   to   the   superfusate,   I   found   that   in   a   preliminary   set   of  
experiments,  7  out  15  (47%)  pyramidal  cells  showed  transient  increases  in  the  mEPSC  
frequency,  without  any  change  to  their  amplitudes  and  time  courses.  Pyramidal  cells  that  
showed  these  transient  increase(s)  were  referred  to  as  responders.  
A  typical  recording  from  such  a  responder  is  shown  in  Fig.  3.4.3.  Recording  sequences  
during  the  control  period  and  after  addition  of  5-­HT  are  presented  in  A0  –  3.  The  intervals  
between   two   subsequent   mEPSCs   served   to   calculate   the   respective   instantaneous  
frequencies,   which   were   then   plotted   against   time   (B).   For   frequencies   >   200   Hz,  
horizontal  “banding”  may  become  visible  in  the  respective  figures.  This  arises  because  
the  instantaneous  frequencies  were  calculated  based  on  the  A/D  conversion  rate,  which  
was  5  kHz  and  which  gives  a  time  resolution  for  the  intervals  of  200  µs.    
During  the  control  period  (A0)  with  σnoise  of  1.6  pA,  5473  mEPSCs  were  detected.  The  
average  instantaneous  mEPSC  frequency  was  47  ±  1  Hz,  the  amplitude  -­8.5  ±  0.1  pA,  
the   rise   time  and  half-­width   0.5   and  1.5  ms,   respectively.   This   control   recording  was  
considered  stable,  as  all  minute  averages  (blue  dots  in  D)  did  not  deviate  by  ≥  15%  from  
the  average  value  (dashed  line  in  D).  After  this  period,  the  recording  was  interrupted  for  
a  minute  (gap  before  0)  to  measure  the  series  (Rs)  and  input  resistances  (Rm;;  16  and  
148  MΩ,  respectively).  
Compared   to   the   control   period,   after   the   addition   of   10   µM   5-­HT   (t   ≥   0),   and   for   a  
continuous  recording  period  of  15  minutes,  I  recovered  23’007  mEPSCs.  The  average  
instantaneous  frequency  increased  transiently  from  47  ±  1  to  60  ±  2  Hz  (A1);;  i.e.  by  31  
±  7%  within  1  –  2  minutes.  This  increase  is  clearly  discernible  in  B,  with  more  dots  at  
higher  frequencies  preset.  In  D,  these  values  are  plotted  as  minute  averages  together  
with  the  respective  SEM.  In  F,  the  respective  cPDFs  for  the  mEPSC  frequencies  during  
the  control  and  after  5-­HT  are  illustrated.  There  was  a  right  shift  of  cPDF  around  the  time  
indicated  by  1  in  B  addition  of  5-­HT,  indicating  that  the  frequency  increased.  However,  
within  about  8  minutes  after  5-­HT  addition,  the  mEPSC  frequency  had  returned  to  control  
values   (number  2   in  B);;   i.e.  45  ±  2  Hz   (A2  and  D  dashed   line).  The  comparison  with  
control  was  insignificant.  
However,  the  mEPSC  frequency  did  not  remain  at  this  value,  but  subsequently  resurged  
to  74  ±  2  Hz  after  about  11  minutes  (A3,  number  3  in  B);;  i.e.  by  58  ±  5%  from  the  control    
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Figure  3.4.3.  mEPSCs  frequency  increase  by  10  µM  5-­HT.  
Colour  code  is  blue  for  the  data  acquired  during  the  control  period,  red  after  5-­HT  addition.  
A.  Representative  periods  (2  s)  during  control  (A0)  and  after  addition  of  5-­HT  at  different  
time  points  (A1  –  A3),  indicated  in  B  with  numbers  0  –  3.  B.  Time  course  of  all  instantaneous  
mEPSC  frequencies  during  the  recording.  C.  Same  as  in  B  but  for  mEPSC  amplitudes.  D.  
Minute  averages  of  the  instantaneous  mEPSC  frequency  during  the  recording.  Dashed  line  
indicates   the   average   frequency   during   control   extended   for   the   duration   of   the   whole  
experiment.  E.  Same  as   in  D  but   for  mEPSC  amplitude.  F.  cPDFs  of   the   instantaneous  
mEPSC  frequencies  during  control  (0,  blue)  and  the  first  increase  after  exposure  to  5-­HT  
(1,  red).  G.  Same  as  in  F,  except  that  in  this  case  the  comparison  was  between  control  and  
the  resurgence  (3,  red).  H.  cPDFs  of  the  mEPSC  amplitudes  during  control  and  after  5-­HT.  
I.  The  average  mEPSC  time  courses  during  control  (left),  after  the  initial  increase  (middle)  
and  peak-­scaled  and  overlaid  (right).  
  
value   (B   and   D).   The   comparison   of   the   respective   cPDFs   during   control   and   this  
resurgence  is  shown  in  G.  Similar  to  the  observation  in  F,  there  was  again  a  significant  
right  shift.  After  the  resurgence,  the  frequency  again  returned  back  to  control  values;;  i.e.  
45  ±  2  Hz,  which,  when  compared  to  control,  was  insignificant.  
Overall,   during   the  15  minutes  of   recording  with   5-­HT  added   to   the   superfusate,   two  
transient   increases   in  mEPSC  frequency  were  observed,  each   lasting   for  about  4  –  5  
minutes  before  returning  to  control  values.  
In   contrast   to   the   changes   in   frequency,   the   amplitude   did   not   show   any   significant  
change  upon  5-­HT  exposure  (E  and  H).  The  mEPSC  amplitude  during  the  control  period  
was  -­8.5  ±  0.1  pA,  and  remained  at  -­8.4  ±  0.1  pA  after  5-­HT  application.  In  addition  to  
the  comparison  of  mEPSC  amplitudes,  the  time  courses  of  the  two  average  mEPSCs  for  
the  control  period  and  after  5-­HT  are  presented  I  (left  control;;  middle  5-­HT;;  right  overlay).  
Note  that  the  baselines  of  the  average  mEPSCs  are  not  flat  due  to  the  fact  that  many  
mEPSCs  included  in  this  average  straddle  the  decay  phase  of  a  preceding  mEPSC.  The  
average  rise  time  during  the  control  period  was  0.5  and  the  half-­width  1.5  ms.  Likewise,  
there   is   flattening  of   the  average  mEPSC  decay  phase  after  about  2.5  ms  caused  by  
collisions/superpositions  of  mEPSCs.  For  comparison,   the   two   time  courses  are  peak  
scaled   and   overlaid   (I,   right).   The   graph   indicates   that   there   was   no   appreciable  
difference  between  the  two  time  courses.  Based  on  the  findings  so  far,  I  conclude  that  
the  increases  in  mEPSC  frequency  were  very  unlikely  caused  by  variations  in  mEPSC  
amplitude  seen  as  a  change   in   frequency,  but  were  most   likely  caused  by  a  genuine  
increase  in  mEPSC  frequency.  In  addition,  5-­HT  did  not  have  any  significant  effect  on  
either  the  amplitude  nor  the  time  courses.  
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Figure  3.4.4.  Average  mEPSC  frequency  and  amplitude  for  responders.  
Control  values  normalized  to  0%.  Same  colour  code  as  before.  A.  Minute  averages  of  the  
data  sets  after  all  7  recordings  were  pooled.  B.  &  C.  Instantaneous  mEPSC  frequencies  
for  two  simultaneous  recordings  in  the  same  slice  showing  that  5-­HT  affected  the  mEPSC  
frequency  with  identical  temporal  characteristics.  Arrows  with  numbers  indicate  when  the  
3  different  phases  occurred.  D.  The  average  peak  frequencies  when  plotted  for  the  three  
phases  relative  to  control.  E.  Minute  averages  of  the  average  mEPSC  amplitudes  with  the  
dashed  line  indicating  the  average  during  control.      
  
The  average  of  7  such  responders  is  illustrated  in  Fig.  3.4.4.  Each  point  in  A  represents  
the  average  during   the   respective  minute,  with   the  error  bar   indicating   the   respective  
SEM.  These  minute  averages  also  show  an  initial  increase  in  mEPSC  frequency  by  37  
±  10%  from  56  ±  5  to  75  ±  5  Hz  within  ~  3  minutes  after  5-­HT  addition.  Similar  to  the  
example   given   above,   the   mEPSC   frequency   had   returned   to   control   values   within  
another  4  –  5  minutes.  Note  that  in  this  average,  there  was  no  second  increase,  even  
though  in  all  7  cases  significant  changes  were  observed  at  the  individual  level.  This  is  
due  to  the  fact  that  the  timing  of  this  second  increase  was  variable.  This  observation  is  
supported  by  error  bars  becoming  larger  with  the  length  of  the  recording.  
Even  in  cases  when  data  was  acquired  simultaneously  from  two  cells  in  the  same  slice,  
5-­HT  still  caused   increases   in  mEPSC   frequencies  with  more  or   less   identical   timing.  
This   is   illustrated   in  Figs.  3.4.4B  and  C,  where  all   individual  mEPSC   frequencies  are  
shown  for  both  cells.  Note  that  the  initial  rise,  drop  and  resurgence  occurred  at  a  similar  
time  in  both  recordings  (arrows).  However,  in  cells  from  different  slices,  the  timings  were  
much   more   variable.   A   potential   explanation   may   be   that   5-­HT   caused   changes   in  
mEPSC  frequencies  that  depended  on  the  state  of  the  slice  and  its  superfusion.  Because  
of  this  reason,  pooling  of  the  minute  averages  might  have  been  inappropriate.  Therefore,  
I  measured  the  peaks  and  trough  individually  and  averaged  those  values.  Subsequently,  
the  first  mEPSC  frequency  increase  after  5-­HT  addition  is  referred  to  as  phase  1  but  also  
as   initial   increase.   The   respective   value   was   measured   just   before   the   frequency  
dropped  again.  Phase  2,  also  referred  to  as  drop,  captures  the  waning  of  the  frequency  
to  values  typically  below  those  during  control.  The  respective  value  was  measured  at  the  
minimum  during  the  time  course.  Phase  3,  also  referred  to  as  resurgence,  includes  the  
(subsequent)   second   frequency   increase.   Its   value   was   measured   as   the   maximum  
during  this  phase.  
Using  these  conventions,  the  respective  averages  of  all  7  responders  are  shown  in  D.  
The  average  mEPSC   frequency  during   the  control  period  was  56  ±  5  Hz,  which  was  
normalized  to  zero  for  this  plot.  Upon  superfusion  with  5-­HT,  the  frequency  increased  by    
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Figure  3.4.5.  Non-­responder.  
A.  Recording  periods  during  control  (A0),  and  after  the  addition  of  5-­HT  (A1  –  3).  B.  Plot  of  
the   instantaneous   mEPSC   frequencies   against   time   for   whole   recording   period.   The  
numbers  0  –  3  indicate  the  same  times  as  in  Fig.  3.4.3.  C.  Time  course  of  the  individual  
mEPSC  amplitudes  throughout  the  recording.  The  dashed  line  indicates  the  average  value  
during   control.  D.  Minute  averages  of   the  mEPSC   frequency  and  amplitude   (E)   for   the  
duration  of   the   recording.  F.  cPDFs  of  mEPSC  frequency  during  control  and  after  5-­HT  
taken  at  1  (B).  G.  Same  as  before,  but  for  the  period  indicated  by  3.  H.  cPDFs  of  mEPSC  
amplitude  during  control  (0)  and  after  5-­HT  during  3.  I.  Time  courses  of  average  mEPSCs  
during  control  (left),  after  5-­HT  (middle)  and  after  peak  scaling  and  overlaying  (right).  
  
39  ±  9%  during  the  initial  rise  within  a  time  window  between  1  and  5  minutes  (average  
of  2.7  ±  0.5  min;;  phase  1).  Thereafter,  it  dropped  to  -­11  ±  5%  during  phase  2  (5  –  12  min,  
around  an  average  of  8.3  ±  0.9  min).  Lastly,  the  mEPSC  frequency  resurged  back  to  35  
±  10%  during  phase  3  (9  –  15  min,  around  an  average  of  12.3  ±  0.9  min).  
The  average  mEPSC  amplitudes  for  all  7  responders  are  also  shown  in  E.  During  control,  
it  was  -­9.8  ±  0.5  pA,  and  remained  at  -­9.3  ±  0.4  pA  after  5-­HT  application.  This  change  
was  insignificant  after  the  pooling  of  these  7  recordings.  In  addition,  there  was  also  no  
change  in  either  rise  times  and  half-­widths.  
3.4.2.2.  Impact  on  Non-­Responders  
In  contrast  to  what  was  reported  above,  I  also  observed  that  in  the  other  8  cells,  there  
was  no  significant  increase  in  the  mEPSC  frequency  after  exposure  to  5-­HT.  These  cells  
will  subsequently  be  referred  to  as  non-­responders.  
In  analogy  to  the  presentation  above,  an  example  of  such  a  non-­responder  is  illustrated  
in  Fig.  3.4.5.  During  the  control  period,  with  noise  standard  deviation  of  2.0  pA,  an  input  
resistance  of  178  MΩ  and  a  series  resistance  of  17  MΩ,  I  recovered  4’019  mEPSCs.  The  
respective  average  instantaneous  mEPSC  frequency  was  45  ±  2  Hz  (A0),  the  amplitude  
-­9.5  ±  0.1  pA,  the  rise  time  and  half-­width  0.6  and  1.5  ms,  respectively.  
After   the   addition   of   5-­HT   to   the   superfusate,   the   mEPSC   frequency   in   this   case  
remained  at  45  ±  2  Hz  (A1);;  i.e.  it  was  no  different  to  that  observed  during  control.  This  
remained  so  throughout  the  remainder  of  the  recording  (A1  –  3)  as  shown  in  B  and  D,  
both   for   all   individual   frequencies   and   when   the   minute   averages   were   plotted.  
Comparisons  of  cPDFs  between  the  control  period  and  a  time  window  identical  to  phases  
1   and   3   above   (F   and   G,   respectively),   revealed   that   there   was   no   change   in   the  
frequencies   throughout.   Similar   to   the   case   for   the   responder   above,   the   mEPSC  
amplitude   did   not   show   any   significant   change   either   (C   and   E).   Specifically,   the  
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amplitude  during  control  period  was  -­9.5  ±  0.1  pA,  but  remained  unchanged  at  -­9.2  ±  0.1  
pA  after  exposure  to  5-­HT.  Neither  was  there  a  change  in  the  average  EPSC  time  course,  
rise  time  nor  the  half-­width  (I,  right).  
In   figure   3.4.6,   the   changes   in   the  minute   averages   for   both  mEPSC   frequency   and  
amplitude  are  shown  for  these  8  cells  after  normalising  the  respective  control  value  to  
0%.  For  the  15  minutes  of  superfusion  with  5-­HT,  neither  the  frequency  nor  the  amplitude  
changed.  Nor  were  there  any  alterations  to  the  average  mEPSC  time  course,  rise  time  
and  half-­width.  
  
3.4.2.3.  Pooling  of  Preliminary  Data  Sets  
Because  variations   in   the  mEPSC  frequency  are   typically   taken  as  a  sign  of  unstable  
recording  conditions,   I  wanted   to  apply  more   rigorous   testing  by   “diluting”   the  data   in  
responders  with   the  values  obtained  from  non-­responders;;   i.e.  by   introducing  a   larger  
amount  of  variability  at  the  price  of  gaining  a  larger  sample  size.  If  under  these  conditions,  
significance  remained,  I  would  be  re-­assured  that  the  changes  were  likely  genuine.    
  
Figure  3.4.6.  Average  time  courses  in  non-­responders.  
A.   Time   courses   of   the   minute   averages   of   the   instantaneous   mEPSC   frequency   and  
amplitude  (B)  after  normalising  the  control  value  to  0%.  
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Before  being  able  to  pool  these  two  data  sets,  I  checked  if  during  control,  there  were  any  
significant  differences  in  parameters  like  Rin,  Rs,  mEPSC  frequency,  amplitude,  rise  time,  
and   half-­width,  which  may   preclude   pooling.   I   found   that   there  were   no   significant  
differences  between  these  two  groups.  Specifically,  the  differences  in  Rin  (202  ±  39  vs.  
223  ±  31  MΩ;;  pt  =  0.67),  Rs  (13  ±  1  vs.  12  ±  1  MΩ;;  pt  =  0.60),  the  mEPSC  frequency  (56  
±  4  vs.  50  ±  3  Hz;;  pt  =  0.27),  amplitude  (-­9.8  ±  0.4  vs.  -­10.5  ±  0.6  pA;;  pt  =  0.43),  rise  time  
(0.5  vs.  0.5  ms;;  pt  =  0.69),  or  half-­width  (1.3  ±  0.1  vs.  1.5  ±  0.1  ms;;  pt  =  0.18)  were  all  
  
  
Figure  3.4.7.  Pooled  data  from  responders  and  non-­responders.  
A.  Minute  averages  of  the  instantaneous  mEPSC  frequencies  after  normalising  the  control  
value   to   0%.   B.   Average   relative   changes   in   the   mEPSC   frequencies   plotted   for   the  
different  phases.  The  dashed  line  indicates  no  change.  C.  Minute  averages  of  the  relative  
change  in  the  mEPSC  amplitude.  
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above  the  level  of  significance.  Therefore,   it  was  justifiable  to  pool  the  data  from  both  
preliminary  groups.  Note,  that  in  3.4.3,  I  will  later  present  an  analysis  of  the  much  larger  
set  of  recordings.  
After  pooling  the  data  from  all  15  cells,  the  respective  outcomes  are  presented  in  Fig.  
3.4.7.  In  A,  the  change  in  the  minute  averages  of  the  mEPSC  frequency  are  shown  after  
normalising  for  the  control  period.  As  in  Fig.  3.4.4A,  an  initial  increase  three  minutes  after  
the  addition  of  5-­HT  still  remained,  but  its  value  was  now  only  21  ±  8%  (53  ±  3  vs.  63  ±  
4  Hz).  But,  and  not  unlike  in  Fig.  3.4.4A  either,  there  was  no  resurgence  in  the  mEPSC  
frequency.  Consequently,  I  measured  the  respective  peak  values  during  the  previously  
defined  phases  and  averaged   those.   In   the  case  of  non-­responders,   the  values  were  
determined  during  the  third  (phase  1),  ninth  (phase  2)  and  thirteenth  minute  (phase  3),  
respectively.  
Table  3.4.1.  Peak  mEPSC  frequencies  during  different  phases.    
Phases  
Phase  1  
1  –  5  min  
Phase  2  
5  –  12  min  
Phase  3  
9  –  15  min  
(67  ±  4  Hz)   (45  ±  3  Hz)   (68  ±  6  Hz)  
Control   +28  ±  7%                  
(10-­4  **)  
-­15  ±  3%                        
(2·10-­4  **)  
+27  ±  7%                  
(0.002  *)  (53  ±  3  Hz)  
Phase  1  
1  –  5  min        -­32  ±  3%                          (1·10-­7  **)  
+1  ±  6%                      
(0.41)  (67  ±  4  Hz)  
Phase  2  
5  –  12  min             +51  ±  9%                  (9·10-­5  **)  (45  ±  3  Hz)  
  
Significance   level   reached   when   comparing   the   different   phases   within   the   same   group  
(pANOVA  =  8·10-­8  **;;  n  =  15).  Individual  comparisons  between  two  phases  were  further  subject  
to  a  t-­test  with  Bonferroni  correction  (*  pt-­Bon  <  0.008,  **  pt-­Bon  <  0.002).  Phase  1  refers  to  the  
initial  rise,  phase  2  to  the  intermediate  drop  and  phase  3  to  the  resurgence.  Note  that  there  
are  differences  between  all  phases  except  between  phases  1  and  3.  
  
This  way,  the  addition  of  5-­HT  still  caused  detectable  changes  in  the  mEPSC  frequency  
(pANOVA  =  8·10-­8).  After  normalising  the  value  during  control  for  0%,  the  average  mEPSC  
frequency  after  the  addition  of  5-­HT  increased  during  the  initial  rise  by  28  ±  7%  within  1  
–  5  minutes  (B;;  53  ±  3  vs.  67  ±  4  Hz;;  pt-­Bon  =  10-­4;;  phase  1).  The  frequency  waned  again  
after  5  –  12  minutes  by  -­15  ±  3%  when  compared  to  control  (45  ±  3  Hz;;  pt-­Bon  =  2·10-­4;;  
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phase  2),   to   then   resurge  back   to  27  ±  7%  (68  ±  6  Hz;;  pt-­Bon  =  0.002;;  phase  3).  The  
respective  details  are  given  in  Table  3.4.1.  
On  average,   the  mEPSC  amplitude  during   the  control  period  was  -­10.2  ±  0.4  pA  and  
remained  at  -­9.7  ±  0.3  pA  after  5-­HT.  When  the  relative  change  in  the  minute  average  
amplitudes  was  plotted  in  C,  there  was  no  significant  difference  either.  In  addition,  there  
was  no  change  either  the  mEPSC  time  course,  rise  time  or  half-­width.  
It  is  reassuring  that  the  differences  could  also  be  uncovered  with  ANOVA  in  conjunction  
with  a  post-­hoc  t-­test  with  Bonferroni  correction  even  when  the  data  sets  were  pooled.  
This  strengthens   the  argument   that  after   the  addition  of  5-­HT   to   the  superfusate,   the  
increases  in  mEPSC  frequency  are  genuine.  
With   no   changes   observed   for   the  mEPSC  amplitudes,   rise   times   or   half-­widths,   the  
increases   in   the   instantaneous   mEPSC   frequency   strongly   suggest   that   5-­HT  
predominantly  affects  presynaptic  targets.  
3.4.2.4.  Controls  for  the  Transient  Nature  of  the  Frequency  Increase  
Despite   the   conclusions   just   reached,   I   remained   concerned   whether   the   transient  
increases  in  mEPSC  frequency  were  an  artefact  of  recording  or  resulted  from  an  inability  
to  track  a  sustained  increase  accurately.    
I   subsequently   addressed   the   possibility   of   an   artefact   of   recording   in   3.4.2.4.1,   by  
performing  control  recordings  without  5-­HT  over  a  long  period.  If  in  such  recordings  there  
were  no  transient  increases,  the  notion  of  artefact  of  recording  was  unlikely  relevant.    
To  address  the  alternative   that   I  was  not  able   to   track  a  sustained   increase  reliably,   I  
performed  recordings  with  10  µM  noradrenaline  (NA)  in  the  same  way  as  with  5-­HT.  NA  
produced  a  sustained  increase  in  the  mEPSC  frequency  (Choy,  2011).  The  respected  
results  will  be  presented  in  3.4.2.4.2.  If  I  was  able  to  reliably  track  the  sustained  mEPSC  
frequency  increase  with  NA,  this  alternative  was  ruled  out.  
3.4.2.4.1.  Control  Recordings  Without  5-­HT  
To  present  further  evidence  that  the  transient  increases  in  mEPSC  frequency  by  5-­HT  
were   not   incurred   by   simply   switching   over   to   a   different   line   feeding   the   solution,  
recordings  of  equal  duration  were  performed,  containing  a  switch-­over  but  without  the  
addition  of  5-­HT.  
Such  a  recording  is  presented  in  Fig.  3.4.8.  During  a  period,  equivalent  to  that  of  control,  
the  mEPSC  frequency  was  63  ±  1  Hz  (A0,  B,  and  D).  This  frequency  was  not  different  to  
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Figure  3.4.8.  Control  recordings  without  5-­HT.  
A.  Periods  of  2  s  containing  mEPSCs  during  the  first  5  minutes  as  control  (A0)  and  at  the  
times  indicated  in  B  (A1  –  3).  B.  Instantaneous  mEPSC  frequencies  plotted  against  time.  
Zero  indicates  the  time  at  which  the  valve  was  switched  to  the  solution  without  5-­HT.  C.  
Same  as  in  B  but  for  the  mEPSC  amplitudes.  D.  Minute  Averages  of  the  mEPSC  frequency  
and  E.  amplitude.  Dashed  lines  show  the  average  values  during  the  control  period,  which  
was   extrapolated   to   the   whole   duration   of   the   recording.   F.   Values   of   Rin   and   G.   Rs  
measured  before,  in  between,  and  after  the  recording.  H.  Average  mEPSC  time  courses  
during  the  control  period  (left)  and  the  subsequent  recording  period  (middle).  The  two  time  
courses  are  shown  overlaid  on  the  right  after  peak  scaling.  
  
the  one  presented  above  (pt  =  0.67).  At  t  =  0,  the  perfusion  was  switched  over  to  another  
inlet  line,  but  only  containing  standard  ACSF.  Thereafter,  the  recording  was  resumed  for  
a  further  15  minutes.  After  switching  over,  the  frequency  remained  at  64  ±  1  Hz,  which  
was  not  significantly  different  from  control  at  times  equivalent  to  the  phases  1  –  3  (A1  –  
3,  B).  The  minute  averages  of  the  mEPSC  frequency  were  not  different  to  those  of  the  
control  period,  as  shown  in  D.  There  was  also  no  change  in  the  mEPSC  amplitude  (-­7.8  
±  0.1  vs.  -­7.5  ±  0.1  pA;;  C  and  E).  The  average  mEPSC  time  course  also  remained  the  
same  (H,  right),  as  was  the  rise  time  and  half-­width  (0.5  and  1.4  ms,  respectively).  
Changes  in  the  mEPSC  frequency  could  also  arise  if  Rs  and/or  Rin  changed  considerably  
during  the  recording.  To  exclude  this  possibility,  the  two  parameters  were  measured  at  
three  different  time  points  throughout  the  recording.  The  first  point  was  just  before  the  
control  period,  the  second  right  before  the  change-­over,  and  the  third  immediately  after  
the  final  recording  period.  The  respective  values  for  Rs  were  10,  10,  and  11  MΩ  (G)  and  
those  for  Rin  175,  152,  and  170  MΩ  (F).  The  values  for  Rs  and  Rin  changed  by  <  10%  
throughout   the  recording  and,  consequently,  would  unlikely  have  significantly  affected  
the  mEPSC  frequency.  
In  a  set  of  6  such  recordings,  illustrated  in  Fig.  3.4.9,  the  mEPSC  frequency  remained  at  
51  ±  3  Hz  (normalized  to  0%;;  A)  and  the  amplitude  at  -­9.4  ±  0.7  pA  (also  normalized  to  
0%;;  B)  without  any  significant  change  throughout  recordings.  The  mEPSC  time  course  
did  not  change  either,  with  the  rise  time  remained  at  0.6  and  the  half-­width  at  1.6  ms.  
The  average  values  for  Rs  in  these  recordings  were  13  ±  1  (before),  14  ±  1  (in  between),  
and  15  ±  1  MΩ  (after  recordings;;  D).  The  average  values  for  Rin  were  231  ±  32  (before),  
209  ±  39  (in  between),  and  252  ±  44  MΩ  (after  recordings;;  C).  
This  set  of  control  recordings  indicates  that  the  transient  increases  in  the  instantaneous  
mEPSC   frequency   after   5-­HT   superfusion   were   very   unlikely   recording   artefacts  
(stability)  or  caused  by  time  varying  changes  in  either  Rs  or  Rin.  
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Figure  3.4.9.  Minute  averages  of  mEPSC  frequency  and  amplitude.  
A.  Minute  averages  of  the  instantaneous  mEPSC  frequency  and  B.  amplitude  for  a  data  set  
of  6  recordings.  Dashed   lines   indicate   the  average  values  during  the  control  period,  which  
were  normalized  to  0%.  C.  Average  values  for  Rin  and  D.  RS  taken  before,  in  between  and  
after  the  recording.  
  
3.4.2.4.2.  Sustained  Increase  in  the  Presence  of  NA  
A  further  alternative  explanation  for  the  transient  nature  of  spontaneous  release  may  be  
that  with  the  recording  technique  used,  I  could  not  reliably  track  a  sustained  change  in  
the  mEPSC  frequency  over  the  duration  of  the  recording.  To  exclude  this  possibility,  I  
checked  if,  with  my  recording  set-­up  and  analysis  techniques  used,  I  was  able  to  track  a  
sustained  increase  in  mEPSC  frequency  by  NA.  From  a  previous  study  in  this  laboratory,  
I  knew  that  the  neuromodulator  NA  increased  the  mEPSC  frequency  in  a  sustained  way  
throughout  the  recording  period  (Choy,  2011;;  Choy  et  al.,  2017a).    
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Such   a   typical   recording   is   presented   in   Fig.   3.4.10.   During   the   control   period,   the  
mEPSC  frequency  was  53  ±  1  Hz  (A0,  B,  and  D).  Upon  addition  of  10  µM  NA  (t  =  0),  the  
frequency  increased  by  40  ±  5%  to  75  ±  2  Hz  in  a  sustained  manner  (A2  &  3,  B,  and  D).  
Even  during  the  last  minute  of  recording,  the  frequency  was  still  59  ±  1  Hz,  significantly  
above  control  value  (11  ±  3%).    
In  contrast  to  the  sustained  increase  in  frequency,  the  mEPSC  amplitude  did  not  show  a  
significant  change  (-­6.8  ±  0.1  vs.  -­6.2  ±  0.1  pA;;  E  and  H).  In  addition,  the  average  time  
courses  of  mEPSC  during  control  and  after  addition  of  NA  did  not  show  any  significant  
change  either  (I),  with  the  average  rise  time  remaining  at  0.7  and  the  half-­width  at  1.8  
ms.  
In  4  such  experiments,  the  average  frequency  during  control  was  not  different  to  the  one  
observed  for  the  data  set  with  5-­HT  (pt  =  0.97);;  in  fact,  it  was  the  same.  Of  these  4  cells,  
a  significant  increase  in  the  mEPSC  frequency  after  addition  of  NA  was  seen  in  2  cells.  
In  both  cases,  it  was  sustained  throughout.  The  fact  that  not  all  cells  showed  an  increase  
in  mEPSC  with  NA  has  been  observed  before  (Choy  et  al.,  2017a).  This  limited  set  of  
data  suggests   that   I  was  also  able   to   track  a  sustained  change   in  mEPSC   frequency  
reliably,  lending  further  support  to  the  argument  that  the  transient  changes  observed  with  
5-­HT  are  indeed  genuine.  
3.4.2.5.  Impact  of  Different  5-­HT  Concentrations  
An  explanation  for  the  existence  of  responders  and  non-­responders  in  the  preliminary  
data  set  could  be  that  10  µM  5-­HT  either  desensitized  the  respective  receptors  in  a  highly  
differential   manner,   or   it   was   not   a   saturating   concentration   at   these   receptors.   I  
addressed   these   two   alternatives   by   varying   the   5-­HT   concentration.   Specifically,   I  
decreased   the   concentration   to   1   µM   to   see   if   desensitisation  was   present,   but   also  
increased  it  to  100  µM  to  see  if  the  receptors  were  saturated.  
3.4.2.5.1.  1  µM  5-­HT    
The  case  for  1  µM  5-­HT  is  presented  in  Fig.  3.4.11.  During  the  control  period  (A0,  B  for  
t  <  0),  the  frequency  was  80  ±  3  Hz,  the  amplitude  -­9.9  ±  0.1  pA,  the  rise  time  0.5  ms  
and  the  half-­width  1.4  ms.  After  the  addition  of  1  µM  5-­HT  to  the  superfusate,  the  mEPSC  
frequency  and  amplitude  remained  71  ±  3  Hz  (A1  –  3,  B  and  D)  and  -­9.4  ±  0.1  pA  (C  and  
E),  respectively.  Both  changes  were  insignificant  (G  and  H).  In  addition,  the  time  courses  
of  the  average  mEPSC  during  the  control  period  (I,  left)  and  the  last  five  minutes  after  
addition  of  5-­HT  (I,  middle)  overlapped  with  each  other  (I,  right),  indicating  that  there  was  
no  change  in  time  course.  
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Figure  3.4.10.  mEPSC  frequency  increase  was  sustained  with  NA.  
This  figure  was  made  in  analogy  to  Fig.  3.4.3.  The  legend  there  also  applies  here  with  the  
exception  that  instead  of  5-­HT,  10  µM  NA  was  added  to  the  superfusate,  and  instead  of  
three,  only  two  recording  periods  are  presented  after  NA  addition.  
  
The  time  courses  of  the  pooled  data  for  10  such  experiments  are  presented  in  Fig.  3.4.12.  
After  exposure  to  1  µM  5-­HT,  no  cells  showed  any  increase  in  the  mEPSC  frequency.  
Specifically,   the  changes   in   frequency  and  amplitude   (pt   =  0.85)  were  minimal   (A,  B,  
respectively).  The  average  EPSC  time  courses  also  remained  the  same  as  did  rise  time  
and   half-­width.   These   values  were   also   not   different   to   those  with   10   µM  5-­HT.   The  
respective  comparisons  for  the  frequency  gave  a  value  for  pt  of  0.09,  0.85  for  amplitude,  
0.25  for  rise  time,  and  0.65  for  half-­width.  This  indicates  that  this  sample  was  not  biased.  
However,  the  outcome  in  this  sample  was  different  from  that  with  10  µM  5-­HT.  Based  on  
a  χ2-­test,  the  two  sets  were  not  the  same  ( =  0.011),  supporting  the  finding  that  1  µM  
was  an  insufficient  concentration  to  produce  the  increase  in  frequency.  
It  is  also  very  unlikely  that  all  10  cells  were  non-­responders.  Based  on  this  preliminary  
sample  where  8  out  of  15  were  non-­responders,  the  chance  of  having  only  such  cells  in  
the  sample  is  very  small;;  i.e.  0.5310  ≈  0.002,  strengthening  the  argument  that  1  µM  was  
not  high  enough.  
Compared   to   10   µM   5-­HT,   the   rate   of   desensitisation   by   1   µM   would   be   slowed.  
Therefore,   if   there  were  a  significant  contribution  by  desensitisation,  when  the  smaller  
concentration  of  1  µM  was  used,  more  cells  with  a  frequency  increase  should  have  been  
detected.  This  was  not  seen,  hence,  suggesting  that  differential  desensitisation  was  a  
very  unlikely  explanation  for  non-­responders.  This  then  leaves  me  to  conclude  that  1  µM  
was   an   insufficient   concentration.   This   conclusion   is   in   agreement   with   the   study   by  
Aghajanian  and  Marek  (1997),  which  showed  that  1  µM  5-­HT  was  insufficient  to  increase  
sEPSC  frequency   in   layer  V  pyramidal  cells  of  neocortex  and  transitional  cortex.  One  
possible  explanation  for  the  lack  of  effect  might  be  the  breakdown  of  5-­HT  by  MAO  A  in  
the  slice.  I  next  checked  if  100  µM  were  a  saturating  concentration.  
3.4.2.5.2.  100  µM  5-­HT    
To  address  the  issue  of  receptor  saturation,  an  individual  case  exposed  to  100  µM  5-­HT  
is  presented  in  Fig.  3.4.13.  Here,  the  mEPSC  frequency  was  66  ±  1  Hz  during  the  control  
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Figure  3.4.11.  No  mEPSC  frequency  increase  with  1  µM  5-­HT.  
This  figure  was  made  in  analogy  to  Fig.  3.4.5.  The  legend  there  also  applies  here  with  the  
exception  that  1  µM  5-­HT  was  used.  
  
  
Figure  3.4.12.  Outcomes  with  1  µM  5-­HT.  
This  figure  was  made  in  analogy  to  3.4.6.  The  same  legend  applies  here  as  well,  except  that  
1  µM  5-­HT  was  used.  
  
Hz  within  2  minutes  after  addition  (A1  and  F).  As  before,  the  initial  increase  was  followed  
by  a  drop  back  to  71  ±  2  Hz  after  6  minutes.  The  mEPSC  frequency  then  resurged  by  27  
±  4%  back  to  84  ±  2  Hz  after  12  minutes  (A3  and  G).  Towards  the  end  of  this  recording,  
the  frequency  dropped  back  to  71  ±  2  Hz  again,  i.e.  it  approached  the  value  during  control  
but  remained  significantly  different.  
However,  in  this  case,  there  was  a  decrease  in  mEPSC  amplitude  from  -­8.5  ±  0.1  to  -­7.8  
±  0.1  pA  (E,  and  H).  Despite  the  smaller  amplitude,  the  average  mEPSC  time  courses  
did  not  show  any  significant  change  (I,  right).  In  addition,  the  average  rise  time  and  half-­
width  also  remained  at  the  control  values  of  0.6  and  1.6  ms,  respectively.  
However,  I  only  observed  an  mEPSC  frequency  increase  in  1  out  of  the  10  cells  studied.  
In  the  other  9  cells  studied,  the  average  frequency  and  amplitude  together  with  the  rise  
time  and  half-­width  remained  at  the  control  value  of  66  ±  4  Hz,  -­10.0  ±  0.5  pA,  0.5  and  
1.5  ms,  respectively.  However,  this  case  illustrates  that  a  lack  of  receptor  saturation  was  
unlikely  the  cause  that  gave  rise  to  non-­responders.  
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Figure  3.4.13.  100  µM  5-­HT  increased  the  mEPSC  frequency.  
This  figure  was  made  in  analogy  to  Fig.  3.4.3.  The  legend  there  also  applies  to  this  figure  
except  that  in  this  case  the  exposure  was  to  100  µM  5-­HT.  
  
When  the  data  from  all  10  cells  was  pooled  (Fig.  3.4.14),  100  µM  5-­HT  failed  to  increase  
the  mEPSC  frequency;;  i.e.  there  were  minimal  variations  in  the  change  in  frequency  (A),  
amplitude  (B)  and  time  course  (not  shown).  
Based  on  a  χ2-­test,  the  outcome  for  this  sample  was  notably  different  to  that  seen  with  
10  µM  5-­HT  ( =  0.05).  This  could  have  been  the  case  if  I  obtained  a  biased  sample  
here.   I,   therefore,   checked   if   this   was   the   case.   I   found   that   the   average   values   for  
frequency,  amplitude,  rise  time,  and  half-­width  were  not  different  from  those  reported  for  
the   set  with  10  µM  5-­HT.  This   then  suggests   that   this   sample  was  not   biased  –  and  
therefore,  when   cells  were   exposed   to   100   µM  5-­HT,  mostly   no   increase   in  mEPSC  
frequency  was  seen.  This  finding  may  most  likely  be  explained  by  the  fact  that  in  contrast  
to  10,  100  µM  5-­HT  desensitized  presynaptic  receptors  much  more  powerfully.  
  
  
Figure  3.4.14.  Pooled  data  for  100  µM  5-­HT.  
A.  Minute  averages  of  the  instantaneous  mEPSC  frequency  and  B.  amplitude  for  a  data  set  
of   10   recordings  with   100  µM  5-­HT.  Dashed   lines   indicate   the   average   values   during   the  
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The   observations   just   made   suggest   the   following   scenario   in   regard   to   the   5-­HT  
concentration:  1  µM  was  insufficient  to  produce  any  increase  mEPSC  frequency.  10  µM  
showed  the   largest  change;;   i.e.   transient   increases   in  mEPSC  frequency  occurred  for  
responders.  100  µM,  on  average,  did  not  show  an  increase  in  mEPSC  frequency  either,  
but   it   did   result   in  an   increase   in   just  one  case.  Without  wanting   to  attribute   to  much  
weight  on  this  single  observation,  it  may  be  that  at  100  µM,  the  ratio  between  responders  
and  non-­responders  becomes  smaller.  
3.4.2.6.  Age-­Dependence  of  mEPSC  Frequency  Increases  
A  further  alternative  explanation  for  the  fact  that  5-­HT  affected  only  a  subset  of  cells  may  
be  that  at  the  age  of  the  animals  used  so  far  (P15  –  19),  there  is  a  rapid  change  in  the  
sensitivity   to   5-­HT   as   a   consequence   of   tissue   maturation   (development).   Previous  
research  has  shown  that   the  binding  affinity  of  5-­HT   to   its   receptor  changes  with  age  
(Beique  et  al.,  2004a).  Therefore,  I  checked  if  the  increase  in  mEPSC  frequency  changed  
with  age.  Specifically,  I  performed  mEPSC  recordings  in  the  tissue  of  animals  of  different  
ages:  P9  –  12  (young)  and  P34  –  38  (older).  These  values  were  then  compared  to  those  
of  the  standard  age  group  (P15  –  19).  
3.4.2.6.1.  Young  Animals  (P9  –  12)  
In  comparison  with  the  values  found  in  the  standard  age  bracket,  these  cells  (n  =  8)  had  
a  significantly  more  depolarized  Vrest  (-­63.1  ±  1.6  vs.  -­76.6  ±  0.3  mV;;  pt  =  10-­4),  larger  τc  
(20.0  ±  0.9  vs.  12.7  ±  0.2  ms;;  pt  =  2·10-­4),  and  higher  Rin  (344  ±  49  vs.  187  ±  6  mV;;  pt  =  
0.02),  but  no  difference  was  found  in  regard  to  Rs  (14  ±  2  vs.  12  ±  0  MΩ;;  pt  =  0.17).  For  
the  action  potential,  H  was  smaller  (66.4  ±  2.0  vs.  74.0  ±  0.4  mV;;  pt  =  0.009)  but  also  Vrel  
(25.8  ±  1.6  vs.  38.6  ±  0.4  mV;;  pt  =  10-­4).  No  significant  differences  were  observed  for  Vthr  
(-­37.3  ±  1.1  vs.   -­38.0  ±  0.3  mV;;  pt  =  0.55)  and  W   (1.1  ±  0.0  vs.  1.00  ±  0.01  ms;;  pt  =  
0.051).  
Regarding   the   mEPSC   properties,   the   average   instantaneous   frequency   was  
significantly  smaller  in  young  animals  (36  ±  2  vs.  59  ±  1  Hz;;  pt  =  4·10-­6).  However,  the  
average  amplitude  (-­10.7  ±  1.3  vs.  -­9.5  ±  0.1  Hz;;  pt  =  0.39),  rise  time  (0.5  vs.  0.5  ms;;  pt  
=  0.91),  and  half-­width  (1.5  vs.  1.6  ms;;  pt  =  0.72)  were  not.    
Despite  differences  in  their  electrophysiological  properties,  10  µM  5-­HT  caused  a  similar  
response  to  that  seen  in  the  standard  group.  In  Fig.  3.4.15,  a  typical  recording  from  a  
young  rat  is  presented.  Vrest  in  this  cell  was  -­63.6  mV,  Rin  158  MΩ,  and  Rs  17  MΩ.  During  
the  control  period  (A0),  the  mEPSC  frequency  was  42  ±  1  Hz.  After  the  addition  of  5-­HT,  
it  showed  an  initial  rise  by  51  ±  6%  within  the  first  minute  (A1)  to  63  ±  2  Hz  (B,  D,  and  F).  
Impact  on  spontaneous  transmitter  release  
         97  
After  7  minutes,  the  frequency  had  dropped  back  to  42  ±  2  Hz;;  i.e.  to  the  average  during  
control  condition  (A2  and  D).  The  frequency  then  resurged  back  to  157  ±  8%  (107  ±  2  
Hz,  A3),  to  then  drop  again  to  33  ±  2  Hz  after  15  minutes,  which  was  no  different  than  
the  control  value.  This  result  shows  that  like  in  the  “standard”  tissue  (P15  –  19),  during  
the  15-­minute  recording  period  with  5-­HT  application,  there  were  two  cycles  in  which  the  
mEPSC  frequency  waxed  and  waned,  each  lasting  for  about  3  –  4  minutes.  
In   this   example,   the   addition   of   5-­HT   also   caused   mEPSC   amplitude   to   decrease  
significantly  by  25  ±  1%  from  -­8.9  ±  0.1  pA  during  control  to  -­6.7  ±  0.1  pA  after  5-­HT  (C,  
E,   and   H).   The   decrease   occurred   gradually   within   the   first   five   minutes,   and   then  
persisted  until  the  end  of  the  recording.    
The  rise  time  and  half-­width  of  mEPSCs  during  the  control  period  were  0.7  and  2.1  ms  
respectively.  These  values  were  not  affected  by  addition  of  5-­HT,  as  the  time  course  of  
the  average  mEPSC  remained  the  same  (I,  right)  throughout  recording.  
Out   of   a   sample  of   8   pyramidal   cells   studied   in   young   rats,   4   cells   showed   transient  
increases  after  5-­HT  application;;  i.e.  were  responders.  Compared  to  the  “standard”  age  
group,  this  ratio  was  not  significantly  different  (
  
=  0.88).  
As  done   in  3.4.2.3,   I  averaged   the  cells  of   this  age  group  (Fig.  3.4.16,  Table  3.4.2).   I  
found  that  10  µM  5-­HT  caused  transient  increases  in  the  mEPSC  frequency  (pANOVA  =  
2·10-­5;;  A).  Specifically,  during  the  control  period,  the  mEPSC  frequency  was  36  ±  2  Hz.  
Upon  5-­HT  exposure,   there  was  an   initial   rise  by  51  ±  9%   to  54  ±  5  Hz  within  1  –  6  
minutes  (phase  1;;  pt-­Bon  =  0.001).  It  then  dropped  back  to  33  ±  3  Hz  after  7  –  11  minutes,  
which  was  not  significantly  different  from  control  (phase  2;;  pt-­Bon  =  0.21),  different  to  what  
was   presented   for   the   standard   age   group,   in  which   the   frequency  was   smaller   than  
control.  Subsequently,  the  frequency  resurged  back  to  86  ±  19%  after  8  –  14  minutes  
(66  ±  8  Hz;;  phase  3;;  pt-­Bon  =  0.002).  This  value  was  no  different  to  that  during  phase  1  
(pt-­Bon  =  0.053).  
In  contrast   to  the  frequency,   the  mEPSC  amplitude  significantly  decreased  after  5-­HT  
exposure  in  6  out  of  8  cells.  These  6  cells  comprised  3  responders  and  non-­responders.  
This   indicates   that   the   decrease   in   amplitude  occurred   in   both,   responders   and  non-­
responders.  Since  this  significant  decrease  was  only  observed  in  young  animals,  but  not  
in  the  “standard”  group,  a  χ2-­test  resulted  in  a  highly  significant  difference  (   =  0.003).  
On  average,  in  all  8  cells  studied,  10  µM  5-­HT  caused  a  significant  decrease  in  mEPSC  
amplitude  by  18  ±  5%  from  -­10.7  ±  1.3  pA  to  -­8.8  ±  1.2  pA  (ppt  =  0.001;;  B).  This  decrease  
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Figure  3.4.15.  In  young  animals,  the  mEPSC  frequency  increased.  
This  figure  was  made  in  analogy  to  Fig.  3.4.3.  The  legend  there  also  applies  to  this  figure  
except  that  in  this  case  this  cell  was  from  the  group  of  young  animals  after  exposure  to  10  
µM  5-­HT.  
sustained   for   the   remainder   of   the   recording.   When   checked   in   the   individual   cells,  
however,   the   average   time   courses   of  mEPSCs  before   and   after   5-­HT   remained   the  
same.  The  average  rise  time  and  half-­width  remained  at  the  control  values  of  0.5  and  
1.5  ms,  respectively.  
  
  
Figure  3.4.16.  Pooled  data  from  young  animals.  
Dashed  lines  indicate  the  average  values  during  control  period,  which  were  normalized  to  
0%.  A.  Average  relative  changes  of  peak  mEPSC  frequencies  during  the  different  phases.  
B.  Time  course  of  the  minute  averages  of  the  mEPSC  amplitude  throughout  the  recording.  
  
I  conclude  that  in  the  set  with  young  animals,  and  similar  to  the  “standard”  age  group,  10  
µM   5-­HT   caused   the   observed   increases   in   mEPSC   frequency,   but   in   addition,   the  
amplitude  became  smaller.  
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Significance   level   reached   when   comparing   the   different   phases   within   the   same   group  
(pANOVA  =  2·10-­5  **;;  n  =  8).  Individual  comparisons  between  two  phases  were  further  subject  
to  a  t-­test  with  Bonferroni  correction  (*  pt-­Bon  <  0.008,  **  pt-­Bon  <  0.002).  Phase  1  refers  to  the  
initial  rise,  phase  2  to  the  intermediate  drop  and  phase  3  to  the  resurgence.  Note  that  there  
are  differences  between  all  phases  except  between  phases  1  and  3.  Most  comparisons  were  
significant.  There  were  no  differences  between  control  and  phase  2,  and  likewise,  between  
phases  1  and  3.    
  
3.4.2.6.2.  Older  Animals  (P34  –  38)  
A  typical  recording  is  presented  in  Fig.  3.4.17,  obtained  from  a  cell  of  a  34  day-­old  rat.  
During  the  control  period,  the  mEPSC  frequency  was  54  ±  1  Hz,  amplitude  -­6.4  ±  0.1  pA,  
rise  time  0.5  and  half-­width  1.3  ms.  After  the  addition  of  5-­HT,  both  the  frequency  and  
the  amplitude  remained  at  52  ±  1  Hz  (B,  D,  F,  and  G)  and  -­6.0  ±  0.1  pA  (C,  E,  and  H),  
respectively.  The   time  courses  of   the  average  mEPSC   in   control   and  during   last   five  
minutes  of  5-­HT  overlapped  with  each  other  (I,  right)  indicating  no  change.  
Overall,  in  a  set  of  6  pyramidal  cells  from  older  rats  (Fig.  3.4.18),  no  significant  mEPSC  
frequency  increases  were  detected  after  addition  of  5-­HT  (A).  The  change  in  the  average  
frequency  varied  around  control  after  normalising  to  0%  (A).   In  fact,  as  there  were  no  
responders,   this  make-­up  of   this  set  was  markedly  different   from   that   in   the  standard  






1  –  6  min  
Phase  2  
7  –  11  min  
Phase  3  
8  –  14  min  
(54  ±  5  Hz)   (33  ±  3  Hz)   (66  ±  8  Hz)  
Control   +51  ±  9%                  
(0.001  **)  
-­5  ±  9%                        
(0.21)  
+86  ±  19%                  
(0.002  *)  (36  ±  2  Hz)  
Phase  1  
1  –  6  min        -­36  ±  7%                          (0.002  *)  
+23  ±  12%                      
(0.053)  (54  ±  5  Hz)  
Phase  2  
7  –  11  min             +99  ±  17%                  (8·10-­4  **)  (33  ±  3  Hz)  
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At  this  age,  the  average  pooled  amplitude  also  remained  at  control  -­6.7  ±  0.3  pA.  The  
values   after   normalising   the   control   value   to   0%   are   presented   in   B   showing   that   in  
relative   terms,   they  varied   little  around  the  control  value.  Likewise,   the   time  course  of  
average  mEPSCs  also  remained  unchanged,  with  an  average  rise  time  and  half-­width  of  
0.6  and  1.4  ms,  respectively.  
Comparing  the  results  from  the  three  different  age  groups,  I  found  that  the  increases  in  
the  mEPSC  frequency  by  5-­HT  were  most  prominent  in  young  animals  (phase  1:  51  ±  9  
vs.  28  ±  7%  at  standard  age;;  pt  =  0.03;;  phase  3:  86  ±  19  vs.  27  ±  7%;;  pt  =  0.009),  still  
pronounced  in  the  standard  age  group,  but  absent  in  older  animals.  The  make-­up  of  the  
sets  in  regard  to  responders  vs.  non-­responders  in  the  young  vs.  standard  sets  were  not  
different   (
  
=   0.88),   suggesting   that   the   two   groups   very   unlikely   arose   as   a  
consequence  of  a  differential  effect  on  5-­HTR  affinity  during  development.  
In  addition,  in  5-­HT  the  mEPSC  amplitude  became  smaller  in  young  animals,  but  did  not  
change  in  the  other  two  age  groups.  This  may  suggest  that  the  impact  of  5-­HT  on  (the  
dendritic)  Rin  in  young  animals  is  larger  and  therefore  more  current  is  lost  between  the  
synapse  and  the  somatic  recording  electrode,  making  the  mEPSC  smaller.  
3.4.2.7.  sEPSC  Frequency  Not  Affected  by  TTX  
Aghajanian  and  Marek  (1997)  reported  that  there  was  an  increase  in  sEPSC  frequency  
in   layer   V   pyramidal   cells   of   rat   prefrontal   cortex   only   if   TTX   was   omitted   from   the  
superfusate.  This  suggests  that  sodium  electrogenesis  was  involved  in  the  generation  of  
sEPSCs.  I,  therefore,  checked  if  the  frequency  increase  by  5-­HT  in  my  preparation  was  
sensitive  to  TTX.  Therefore,  in  these  recordings,  TTX  was  omitted  but  gabazine  retained  
in   the   superfusate.   I   wondered   if   this   could   change   the   ratio   of   responders   vs.   non-­
responders,  and  if  the  increase  in  sEPSC  frequency  would  become  sustained?  
Recordings   of   sEPSCs   were   not   without   challenges,   as   each   slice   underwent  
epileptiform  discharges  numerous   times.  This  was   to  due  gabazine  blocking  GABAA-­
mediated   inhibition.  As  a  consequence,   the  networks  became  disinhibited.   In  voltage-­
clamp,  these  epileptic  activities  were  associated  with  massive  inward  currents  (>  -­200  
pA)  that  lasted  for  ~15  seconds.  Such  periods  were  easily  recognised  and  excluded  from  
the  analysis  (small  gaps  in  Fig.  3.4.19).  However,  such  epileptic  discharges  did  not  much  
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Figure  3.4.17.  No  frequency  increases  in  older  animals.  
This  figure  was  made  in  analogy  to  Fig.  3.4.3.  The  legend  there  also  applies  to  this  figure  





Figure  3.4.18.  Pooled  data  from  older  animals.  
This   figure   was   made   in   analogy   to   Fig.   3.4.19.   That   legend   also   applies   here   with   the  
difference  that  these  recordings  were  obtained  in  cells  from  older  animals.  
  
In  Fig.  3.4.19,  data  from  the  only  responder  is  presented.  During  the  control  period,  the  
instantaneous  sEPSC  frequency  was  49  ±  2  Hz  (A0).  After  addition  of  5-­HT,  there  was  
an  initial  rise  by  28  ±  8%  to  63  ±  3  Hz  within  6  minutes  (A1,  B,  D,  and  F).  Compared  to  
control,  the  frequency  then  dropped  back  by  13  ±  11%  to  43  ±  5  Hz  after  8  minutes  (A2).  
Subsequently,  it  resurged  back  by  38  ±  10%  from  control  around  9  minutes  (68  ±  4  Hz;;  
A3,  B,  D,  and  I).  After  15  minutes,  the  frequency  had  dropped  back  to  55  ±  4  Hz.  This  
time  course,  was  very  similar  to  that  seen  for  the  mEPSC  frequency.  
However,  the  absence  of  TTX  affected  the  sEPSC  amplitude  differently  than  what  has  
been   reported   (Aghajanian  &  Marek,   1997).  During   the   control   period,   the   sEPSC  
amplitude  was  -­9.6  ±  0.1  pA.  After  5-­HT,  the  sEPSC  amplitude  increased  by  110  ±  6%  
to  -­20.2  ±  0.5  pA  within  6  minutes  (A1,  C,  E,  and  G).  The  amplitude  then  decreased  back  
to  a  value  of  -­9.5  ±  0.2  pA  after  8  minutes  (A2),  which  was  not  different   from  control.  
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Figure   3.4.19.   In   the   absence   of   TTX,   both   sEPSC   frequency   and   amplitude  
increased  in  5-­HT.  
A  –  E.  This  part  of  the  figure  was  done  in  analogy  to  Fig.  Fig.  3.4.3.  The  legend  there  also  
applies   to   this   part   of   the   figure   except   that   in   this   case   TTX   was   omitted   from   the  
superfusate   to   obtain   sEPSCs.   cPDFs   of   the   instantaneous   sEPSC   frequency   (F)   and  
amplitude  (G)  during  control  (0)  and  the  first  increase  (1).  H.  Time  courses  of  the  average  
sEPSC  during  control  (0)  and  the  first  rise  (1).  The  respective  amplitudes  were  peak  scaled  
for  the  control  amplitude  and  overlaid  for  comparison.  I  –  K.  Same  as  in  F  –  H,  except  that  
in  this  case,  the  control  (0)  was  contrasted  to  the  second  increase  (3).  
  
Thereafter,  the  amplitude  rose  again  by  101  ±  6%  to  -­19.3  ±  0.5  pA  after  9  minutes  (A3,  
C,  E,  and  J).  After  15  minutes,  the  amplitude  was  still  -­13.2  ±  0.3  pA.  Note  that  these  
increases  in  sEPSC  amplitude  were  much  larger  than  those  reported  for  the  frequency.  
Despite   significant   increases   in   both   sEPSC   frequency   and   amplitude,   5-­HT   did   not  
cause   any   significant   change   in   the   average   sEPSC   time   course   throughout   the  
recording.  This  is  indicated  in  both  H  and  K  (right)  by  the  perfect  overlay.  
Of  all  5  pyramidal  cells  studied,  only  1  cell  (Fig.  3.4.19)  showed  increase(s)  in  the  sEPSC  
frequency  after  exposure  to  5-­HT.  The  ratio  of  responders  vs.  non-­responders  was  not  
significantly   different   from   that   seen   in   mEPSC   recordings   (   =   0.29).   Not  
unexpectedly,   the   omission   of   TTX   from   superfusate   did   not   influence   the   ratio   of  
responders  and  non-­responders.  The  large  increases  in  sEPSC  amplitude  suggest  that  
there   is   likely   considerable   local   sodium  electrogenesis   in   the   respective   presynaptic  
cells/axons,   which  may   have   resulted   in   synchronised   transmitter   release.   However,  
neither  APs  nor  spikelets  were  seen  in  the  somatic  (postsynaptic)  recordings.  
3.4.3.  Differences  between  Responders  and  Non-­Responders  
Several  lines  of  experiment  (see  3.4.2.5  –  7)  were  designed  to  establish  what  gave  rise  
to  the  groupings  into  responders  and  non-­responders.  To  get  further  insight  and  increase  
the  statistical  power  to  the  analyses,  the  data  from  the  different  lines  of  experiment  were  
pooled.  Data  were  pooled  from  all  those  experiments  in  which  either  5-­HT  or  a  respective  
agonist  was  used.  However,  data  from  experiments,  in  which  the  downstream  signalling  
was  pharmacologically  blocked,  were  excluded.  
In  3.4.3.1,  I  will  compare  the  synaptic  parameters  in  both  groups.  This  will  be  followed  
by  comparisons  of   the  properties  of   the  postsynaptic  membrane,   the  action  potential,  
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defined  responders  and  non-­responders.  These  characteristics  will  later  be  used  in  the  
context  of  evoked  transmitter  release  (see  4.4.5).  
3.4.3.1.  No  Difference  in  mEPSCs  Properties  
The  pooling  resulted   in  a  data  set  comprising  36  responders  and  68  non-­responders.  
During   the  control  period,   for  each  cell,   the  noise  standard  deviation   (σnoise),   average  
instantaneous   mEPSC   frequency,   its   amplitude,   rise   time,   and   half-­width   were  
determined.  Averages  of   these  parameters  were   then  compared  between  responders  
and  non-­responders  to  see  if  these  could  serve  as  predictor(s)  of  the  subsequent  change  
in  mEPSC  frequency  (Table  3.4.3).  
There  were  no  significant  differences  in  any  of  the  synaptic  parameters  determined.  This  
outcome  indicates  that  both,  responders  and  non-­responders,  received  a  similar  amount  
of  spontaneous  mEPSCs,  and  that  there  was  no  detectable  difference  in  the  make-­up  of  
the  AMPA  receptors  (AMPAR)  involved.  As  σnoise  and  Rs  were  also  not  different  suggests  
that  this  grouping  did  not  artefactually  arise  as  a  consequence  of  a  systematic  bias  during  
the  recordings.  This  lends  further  support  that  the  respective  grouping  is  genuine.  
Table  3.4.3.  Synaptic  parameters  during  control.  
  
3.4.3.2.  No  Difference  in  Postsynaptic  Properties  
Given  that  there  were  no  differences  in  the  synaptic  parameters  investigated,  I  wondered  
if   some  postsynaptic   parameters   defined   these   groups.   To   evaluate   this   possibility,   I  
determined   the   electrophysiological   postsynaptic   properties   in   this   pooled   set.   These  
included  Vrest,   τc,  Rin,  Vthr   of   the   AP,   its  H,  W,   and  Vrel   (see   3.3.5   for   definition).   The  
average  values   for  both  groups  are  presented   in  Table  3.4.4   including   the   respective  
     Responders   Non-­Responders  
pt  
     (n  =  36)   (n  =  68)  
      Rs  [MΩ]   13  ±  1   13  ±  1   0.65  
      σnoise  [pA]   1.9  ±  0.1   1.9  ±  0.1   1.00  
      mEPSC  frequency  [Hz]   58  ±  2   60  ±  2   0.47  
      mEPSC  amplitude  [pA]   -­9.3  ±  0.2   -­9.8  ±  0.2   0.13  
      Rise  time  [ms]   0.5   0.5   0.14  
      Half-­width  [ms]   1.5   1.5   0.91  
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significance   levels.   Interestingly,   there   were   no   differences   between   responders   and  
non-­responders  in  any  of  the  properties  analysed.    
Table  3.4.4.  Passive  and  AP  properties  of  responders  &  non-­responders.  
     Responders   Non-­Responders  
pt  
     (n  =  28)   (n  =  61)  
                            Vrest  [mV]   -­76.6  ±  0.6   -­77.4  ±  0.4   0.29  
                            τc  [ms]   12.5  ±  0.4   12.8  ±  0.3   0.61  
                            Rin  [MΩ]   184  ±  14   183  ±  9   0.96  
                            Vthr  [mV]   -­38.4  ±  1.1   -­38.2  ±  0.6   0.85  
                            H  [mV]   75.5  ±  1.1   73.7  ±  0.8   0.17  
                            W  [ms]   1.0   1.0   0.60  
                            Vrel  [mV]   38.2  ±  1.1   39.2  ±  0.7   0.43  
  
In  addition,   there  was  no  difference   in   the   firing  pattern  either   (Fig.  3.4.20),  with  cells  
belonging   to   both   groups   spiking   regularly   upon   a   sufficiently   large   current   step   as  
described  in  3.4.1.1.  
3.4.3.3.  Rin  Decreased  in  Both  Responders  and  Non-­Responders  
Because  1  µM  TTX  was  added  to  the  superfusate  to  isolate  mEPSCs,  I  was  not  able  to  
characterize   changes   in   the   properties   of   the   action   potential   and   the   resulting   firing  
  
Figure  3.4.20.  Firing  patterns  in  responders  (A)  and  non-­responders  (B).  
Responses  to  a  hyper-­  and  two  depolarizing  current  steps.  The  grey  step  and  respective  
voltage  change  is  for  rheobase.  
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pattern  after   the  addition  of  5-­HT.  However,   I  was  able   to  monitor  Rin   throughout   the  
recording.  The  comparisons  of  Rin  and  its  change  after  the  addition  of  5-­HT  between  the  
two  groups  are  given  in  Table  3.4.5.  
Table  3.4.5.  Rin  in  responders  vs.  non-­responders.  
     Rin  -­  Control   Rin  -­  5-­HT   ΔRin  
ppt  
   [MΩ]   [MΩ]   [MΩ]  
Responders  
197  ±  15   141  ±  8   -­56  ±  13   10-­4  **  
(n  =  36)  
Non-­Responders  
191  ±  10   161  ±  7   -­30  ±  11   0.004  **  
(n  =  67)  
  
In  the  pooled  data  set,  5-­HT  caused  a  significant  drop  in  Rin  in  both  groups  (see  also  Fig.  
3.4.21A  later).  Specifically,   in  responders,  Rin  decreased  by  56  ±  13  from  197  ±  15  to  
141  ±  8  MΩ  (ppt  =  10-­4).  As  indicated,  in  non-­responders,  5-­HT  also  caused  a  drop  in  Rin  
by  30  ±  11  from  191  ±  10  to  161  ±  7  MΩ  (ppt  =  0.004).  However,  in  this  case,  the  changes  
between  the  two  groups  were  not,  but  close  to  significant  (pt  =  0.068).  
A  reduction   in  Rin   indicates   that  5-­HT  caused  the  opening  of   ion  channel(s).  Previous  
research  has  indeed  shown  that  5-­HT  can  open  ion  channel(s)  which  may  result  either  
in   a   de-­   or   hyperpolarization   (Andrade   &   Nicoll,   1987;;   Araneda   &   Andrade,   1991;;  
Foehring  et  al.,  2002;;  Goodfellow  et  al.,  2009).  
Because  my  recordings  were  made  in  voltage-­clamp  at  a  holding  potential  of  -­70  mV,  
this  change  in  postsynaptic  polarisation  can  be  tracked  by  monitoring  the  holding  current  
(Ihold).  A  decrease  in  holding  current  is  caused  by  a  net  inward  current,  whilst  an  increase  
corresponds  to  a  net  outward  current.  I,  therefore,  checked  the  change  in  Ihold  for  both  
responders  and  non-­responders.  
Such  changes   in  Rin  and   Ihold  are   illustrated   in  Fig.  3.4.21.   In  A,  Rin   is  plotted   for  both  
responders   (black)   and   non-­responders   (grey).   The   values   before   and   after   5-­HT  
application   are   joined   by   a   dashed   line.   In   B,   the   change   in   Ihold   is   presented   for   a  
responder.  It  corresponded  to  a  net  inward  current  of  -­36.1  pA,  which  started  shortly  after  
5-­HT  addition  and  peaked  around  9  minutes.  However,   not   all   responders   showed  a  
decrease  in  Ihold.  Such  an  example  is  shown  in  C,  where  a  small  outward  current  of  18.4  
pA  is  evident,  which  started  3  minutes  after  the  addition  of  5-­HT  and  peaked  around  5  
minutes.  Note  that   in  both   instances,   the  direction  of   the  net   in-­  and  outward  currents  
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persisted   for   the   duration   after   exposure   to   5-­HT.   For   responders   (n   =   25),   10   cells  
showed  a  net  inward  current,  whilst  the  remaining  cells  were  associated  with  a  small  net  
outward  current  (E).  On  average,  the  change  in  Ihold  was  outward,  with  an  amplitude  of  
6.3  ±  7.8  pA  (F,  right).  
In  contrast,  non-­responders  (n  =  51)  typically  showed  a  large  outward  current  as  shown  
in  D.  In  this  case,  an  outward  current  of  45.7  pA  started  2  minutes  after  the  addition  of  
5-­HT,  and  peaked  around  4  minutes  later.  Subsequently,  the  current  gradually  became  
smaller.  Again,  as  above,   the  direction  of   the  current  remained  for  as   long  as  the  cell  
was  exposed  to  5-­HT.  In  contrast,  there  were  only  3  that  were  associated  with  a  small  
net   inward   current.   The   remaining   48   cells   showed   a   net   outward   current   (E).   On  
average,  the  change  in  Ihold  was  34.4  ±  4.2  pA.  The  change  in  Ihold  for  non-­responders  
was  significantly  larger  than  that  for  responders  (pt  =  0.002;;  F,  right).  In  addition,  when  
the  respective  samples  were  compared  using  a  χ2-­test,  the  two  sets  were  different  (
=  2·10-­4),  lending  further  support  that  the  separation  into  two  groups  was  justified.  
To   summarise,   I   found   that   responders  and  non-­responders  differed  by   the   following  
characteristics.  1)  Responders  showed  larger  decrease  in  Rin  than  non-­responders.  2)  
responders   showed   a   much   smaller   net   outward   current,   however,   there   was  
considerable  variability  in  the  current  direction.  3)  The  number  of  responders  showing  a  
net   inward   current   was   significantly   larger   than   that   for   non-­responders.   These  
differences  will  be  discussed  in  more  detail   in  the  discussion.  Further,   in  part  4,  these  
characteristics  will  be  further  refined  in  the  context  of  paired  recordings  to  characterise  
the  impact  on  evoked  transmitter  release.  
3.4.4.  5-­HTR  Involvement  
In   this  section,   I  will  describe  which   type  of  5-­HTR  caused  the   increase(s)   in  mEPSC  
frequency.  For   this  purpose,   I  will  present  data   from  experiments  using  both  agonists  
and  antagonists.  In  addition,  I  will  provide  evidence  that  the  transient  increase  in  mEPSC  
frequency  was  a  consequence  of  PKC  activation,  which  most  likely  phosphorylated  5-­
HT2A/CR.  Note  that  the  focus  here  is  on  the  increases  in  mEPSC  frequency,  without  much  
addressing  the  postsynaptic  changes  reported  earlier.  
3.4.4.1  5-­HT2R  Activation  Caused  mEPSC  Frequency  Increase  
I  hypothesized  that  the  significant  transient  increases  in  mEPSC  frequency  were  caused  
by  the  activation  of  5-­HT2R.  I  tested  this  hypothesis  by  using  the  pan-­5-­HT2R  agonist  α-­




Impact  on  spontaneous  transmitter  release  






Impact  on  spontaneous  transmitter  release  
        111  
Figure  3.4.21.  Changes  in  Rin  and  Ihold  in  both  groups.  
Data   from   responders  are   in  black,  non-­responders   in  grey.  A.  Values  of  Rin  measured  
before  5-­HT  exposure  and  after   the  recording  period  plotted  against   time.  Dashed   lines  
join  the  respective  values.  B.  Time  course  of  the  change  in  Ihold.  0  indicates  the  baseline  
value,  and  1  the  peak  of  the  current.  C.  Time  course  of  Ihold   in  a  responder  with  a  small  
outward  current.  D.  Time  course  of  Ihold  in  a  non-­responder  with  a  large  outward  current.  E.  
Make-­up  of  the  data  set  in  regard  to  responders  and  non-­responders  showing  either  a  net  
inward  or  outward  current.  F.  Box  and  whisker  plot  showing   the  distribution  of   the  peak  
holding   currents   for   both   groups   (left),   with   the   average   respective   current   amplitudes  
(right).      
  
at  submicromolar  concentrations  (Baxter  et  al.,  1995).  This  agonist  has  been  used  in  this  
context  before  (Zhou  &  Hablitz,  1999;;  Beique  et  al.,  2007).  In  accordance  with  the  study  
by  Zhou  and  Hablitz  (1999),  I  chose  a  concentration  of  20  µM.  
The   addition   of   20   µM   α-­methyl-­5-­HT   caused   transient   increases   in   the   mEPSC  
frequency  in  a  subset  of  cells.  Fig.  3.4.22  shows  an  example  of  a  responder.  During  the  
control  period  (A0),  the  frequency  was  52  ±  1  Hz.  After  α-­methyl-­5-­HT  addition,  within  2  
minutes   it   increased  by   67   ±   5%   to   87   ±   2  Hz   (A1,  B,  D,   and  F).   Like   for   5-­HT,   the  
frequency  then  dropped  back  to  48  ±  1  Hz  after  8  minutes  (A2),  which  was  not  different  
to  the  control  value.  Thereafter,  it  resurged  by  108  ±  7%  to  108  ±  3  Hz  (A3,  B,  D,  and  G).  
This  pattern  was  very  similar  to  what  was  observed  with  10  µM  5-­HT.  
The  average  mEPSC  amplitude  was  -­7.9  ±  0.1  pA  during  the  control  period.  With  the  
addition  of  α-­methyl-­5-­HT,  the  amplitude  gradually  decreased  by  13  ±  2%  to  -­6.9  ±  0.1  
pA  (C  and  E)  towards  the  end  of  recording.  Although  this  decrease  was  significant  (H),  
this  was  not  commonly  observed.  In  only  4  (2  responders  and  2  non-­responders)  out  of  
18   cells   was   such   a   significant   decrease   observed.   The   average   time   course   of   the  
mEPSC   did   not   change   with   this   agonist   either   (I,   right),   as   the   average   rise   time  
remained  0.6  and  the  half-­width  1.8  ms.  
In  a  set  of  18  such  experiments,  the  addition  of  α-­methyl-­5-­HT  caused  increases  in  the  
mEPSC   frequency   in   6   pyramidal   cells.   Comparing   this   result   with   that   using   the  
physiological  agonist  5-­HT  revealed  that  this  set  was  not  significantly  different  in  regard  
to  the  number  of  responders  and  non-­responders  (   =  0.44).    
The  average  values  from  all  18  cells  are  presented  in  Fig.  3.4.23.  In  A,  the  respective  
values   are   shown   for   the   different   phases.   I   found   that   α-­methyl-­5-­HT   still   caused  
transient  increases  in  the  mEPSC  frequency  (pANOVA  =  10-­12).  During  the  control  period,  
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Figure  3.4.22.  α-­Methyl-­5-­HT  mimicked  the  action  of  5-­HT.  
This  figure  was  made  in  analogy  to  Fig.  3.4.3.  The  legend  there  also  applies  to  this  figure  
except  that  in  this  case  this  cell  exposed  to  20  µM  α-­methyl-­5-­HT.  
  
normalisation.  Upon  addition  of  α-­methyl-­5-­HT,  the  frequency  increased  by  21  ±  4%  to  
68  ±  3  Hz  within  1  –  4  minutes  (phase  1;;  pt-­Bon  =  10-­5).  It  then  dropped  back  by  -­21  ±  4%  
to  45  ±  3  Hz  after  7  –  11  minutes  (phase  2;;  pt-­Bon  =  2·10-­5).  Thereafter,   the  frequency  
resurged  back  to  23  ±  7%  (68  ±  4  Hz;;  phase  3;;  pt-­Bon  =  0.003).  Details  of  the  respective  
comparisons  are  given  in  Table  3.4.6.  
  
  
Figure  3.4.23.  Pooled  data  set  with  α-­methyl-­5-­HT.  
This  figure  was  made  in  analogy  to  Fig.  3.4.16.  The  legend  there  also  applies  to  this  figure  
except  that  in  this  case  the  cells  were  exposed  to  20  µM  α-­methyl-­5-­HT.  
  
On  average,  α-­methyl-­5-­HT  did  not  cause  any  significant  change  in  the  average  mEPSC  
amplitude,  as  it  remained  close  to  the  control  value  of  -­9.4  ±  0.3  pA  (B).  In  addition,  the  
respective  average  mEPSC  time  courses  of  did  not  show  any  significant  changes  from  
control  either,  with  both  the  rise  times  and  half-­widths  remaining  at  control  values.  Again,  
this  is  very  much  as  that  observed  with  5-­HT.  
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To  check  if  the  changes  in  frequency  were  quantitatively  not  different  from  those  seen  
with  5-­HT  (see  3.4.2.3),  I  performed  comparisons  of  the  respective  phases  from  the  two  
data  sets.  I  found  no  significant  differences  (control  pt  =  0.33,  phase  1  pt  =  0.36,  phase  
2  pt  =  0.25,  and  phase  3  pt  =  0.67).  This  data,  showing  mimicry  of  5-­HT’s  effects  by  a  5-­
HT2R  agonist,  is  consistent  with  the  increases  in  the  instantaneous  mEPSC  frequency  
being  due  to  5-­HT2R  activation.  
Table  3.4.6.  mEPSC  frequency  increase  by  α-­methyl-­5-­HT.  
Phases  
Phase  1  
1  –  4  min  
Phase  2  
7  –  11  min  
Phase  3  
9  –  15  min  
(68  ±  3  Hz)   (45  ±  3  Hz)   (68  ±  4  Hz)  
Control   +21  ±  4%                  
(10-­5  **)  
-­21  ±  4%                        
(2·10-­5  **)  
+23  ±  7%                  
(0.003*)  (57  ±  3  Hz)  
Phase  1  
1  –  4  min        -­34  ±  3  %                          (5·10-­9  **)  
+1  ±  4%                      
(0.49)  (68  ±  3  Hz)  
Phase  2  
7  –  11  min             +58  ±  9%                  (3·10-­7  **)  (45  ±  3  Hz)  
  
Significance   level   reached   when   comparing   the   different   phases   within   the   same   group  
(pANOVA  =  10-­12  **;;  n  =  18).  Individual  comparisons  between  two  phases  were  further  subject  
to  a  t-­test  with  Bonferroni  correction  (*  pt-­Bon  <  0.008,  **  pt-­Bon  <  0.002).  Phase  1  refers  to  the  
initial  rise,  phase  2  to  the  intermediate  drop  and  phase  3  to  the  resurgence.  Note  that  there  
are  significant  differences  between  all  phases  except  between  phases  1  and  3.  
  
To  strengthen  this  argument   further,   I  also  used  another  pan-­5-­HT2R  agonist,  namely  
DOB.  Although  DOB  is  classically  considered  a  partial  agonist  at  5-­HT2AR  and  5-­HT2CR  
(Arvanov  et  al.,  1999),  a  more  recent  study  shows  that  DOB  is  actually  an  agonist  for  all  
5-­HT2AR,  5-­HT2BR  and  for  5-­HT2CR  with  Kd  values  of  23.1,  3.9,  and  41.5  nM,  respectively  
(Ray,  2010).  Because  DOB  has  Kd  values  of  2550,  940.7,  635.5,  and  1427  nM  for  5-­
HT1AR,   5-­HT1BR,   5-­HT1DR,   and   5-­HT1ER,   respectively   (Ray,   2010),   I   chose   a  
concentration  of  1  µM  to  sufficiently  activate  5-­HT2R  whilst  minimizing  and/or  avoiding  
activation  of  5-­HT1R.  
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Figure  3.4.24.  DOB,  another  5-­HT2  agonist,  increased  mEPSC  frequency.  
This  figure  was  made  in  analogy  to  Fig.  3.4.3.  except  that  here  the  cell  was  exposed  to  
DOB.  In  addition,  all  aspects  in  regard  to  mEPSC  amplitudes  were  dropped  here  (C  and  E  
in  that  figure),  and  only  one  set  of  cPDFs  is  shown  in  D.  E  here  corresponds  to  I  in  that  
figure.  
  
In  Fig.  3.4.24,  the  data  of  a  responder  exposed  to  1  µM  DOB  is  presented.  The  mEPSC  
frequency   during   control   period   was   45   ±   2   Hz   (A0).   After   DOB   was   added   to   the  
superfusate,  the  frequency  started  to  rise  with  a  delay  of  7  minutes  (A1)  and  increased  
by  65  ±  12%  to  74  ±  4  Hz  (B,  C,  and  D).  The  frequency  then  gradually  decreased  back  
to   45   ±   8   Hz   within   11   minutes,   which   was   not   different   to   the   control   period   (A3).  
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Consequently,  in  this  case,  the  frequency  only  increased  once,  in  contrast  to  what  was  
seen  with  5-­HT  and  α-­methyl-­5-­HT.  
There  was  no  significant  change  to  the  mEPSC  amplitude  which  remained  at  the  control  
value  (11.1  ±  0.1  vs.  -­11.2  ±  0.2  pA).  Likewise,  the  average  mEPSC  time  course  did  not  
change  either  (E,  right),  with  the  average  rise  time  and  half-­width  also  remaining  at  the  
control  values  (0.5  and  1.6  ms,  respectively).  
Of  the  6  cells  exposed  to  DOB,  there  were  2  cells,  for  which  an  increase  in  the  mEPSC  
frequency   was   observed.   Again,   the   outcomes   in   regard   to   responders   and   non-­
responders  were  not  different   to   that  with  5-­HT   (   =  0.58)  or  α-­methyl-­5-­HT   (   =  
1.00).  
The  two  data  sets  for  α-­methyl-­5-­HT  and  DOB  showed  that  both  agonists  increased  the  
instantaneous   mEPSC   frequency.   This   observation   then   is   consistent   with   an  
involvement   of   5-­HT2R.   Furthermore,   as   there   was   no   difference   between  what   was  
observed  with  5-­HT  and  α-­methyl-­5-­HT,  the  latter   is  a  full  agonist  at  5-­HT2R.  Notably,  
though,   the   outcomes   with   DOB   were   slightly   different   from   those   with   5-­HT.   The  
respective  frequency  increase  was  delayed  and  observed  only  once  during  the  length  of  
the  recordings.  This  may  suggest  that  DOB  might  not  cause  the  same  signalling  as  5-­
HT  downstream  of  5-­HT2R  activation.  
3.4.4.2.  Block  of  5-­HT2AR  with  4F  4PP  
As  5-­HT2R  activation  caused  the  increases  in  the  mEPSC  frequency,  the  question  arises  
as  to  which  subtype(s)  is/are  involved.  Several  studies  have  identified  5-­HT2AR  as  the  
subtype   that   causes   the   sEPSC   frequency   increase   in   layer   V   pyramidal   cell   of   rat  
prefrontal  cortex  (Aghajanian  &  Marek,  1999;;  Marek  &  Aghajanian,  1999;;  Zhou  &  Hablitz,  
1999;;  Beique  et  al.,  2007).   In  addition,   there   is  evidence   that  5-­HT2AR  are  expressed  
presynaptically  in  the  neocortex  (Jakab  &  Goldman-­Rakic,  1998),  including  in  layer  II  of  
the  somatosensory  cortex  (Lidow  et  al.,  1989).  I  therefore  tested  if  the  mEPSC  frequency  
increases  in  my  preparation  were  caused  by  the  activation  of  the  5-­HT2AR.  
I  aimed  to  selectively  block  the  5-­HT2AR  without  affecting  other  5-­HT2R  subtypes.  For  
this  purpose,  4F  4PP  was  added  to  the  superfusate  before  5-­HT.  4F  4PP  is  an  antagonist  
with  high  affinity  for  the  5-­HT2AR  (Ki  =  5.3  nM),  but  much  lower  affinity  for  the  5-­HT2CR  
(Ki  =  620  nM;;  Herndon  et  al.,  1992).  In  electrophysiological  recordings,  the  IC50  for  4F  
4PP  at  the  5-­HT2AR  was  84  nM,  but  17.14  µM  at  5-­HT2CR  (Acuna-­Castillo  et  al.,  2002).  
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In  Fig.  3.4.25,  a  typical  recording  is  presented.  4F  4PP  was  added  to  the  superfusate  
more  than  10  minutes  before  and  remained  so  even  when  5-­HT  was  added  at  t  =  0  s.  
During   the  control  period   (i.e.  with  TTX,  gabazine,  and  4F  4PP  present),   the  mEPSC  
frequency   was   53   ±   2   Hz   (A0).   After   the   addition   of   5-­HT,   the   frequency   increased  
transiently  by  51  ±  13%  to  80  ±  6  Hz  within  the  first  minute  (A1,  B,  D,  and  F).  After  11  
minutes,  the  frequency  had  dropped  back  to  control  values  (51  ±  3  Hz).  Thereafter.  No  
significant  increases  were  seen  (A2  and  G).  
The  mEPSC  amplitude  did  not  show  any  significant  change  throughout  recording,  with  it  
remained  at  -­7.4  ±  0.1  pA  (C,  E,  and  H).  In  addition,  there  was  no  change  in  the  time  
course  of  the  average  mEPSC  (I),  and  the  average  rise  time  and  half-­width  of  mEPSC  
remained  at  0.6  and  1.6  ms,  respectively.  
Out  of  a  set  of  13  cells,  despite  the  presence  of  4F  4PP,  6  cells  still  showed  a  significant  
increase  after  5-­HT  addition.   In  comparison  with  the  data  set  for  5-­HT,  the  number  of  
responders/non-­responders  was  not  different  (
  
=  0.98).  Note  that  only  one  transient  
increase  was  observed.  
Pooling  of  data  from  all  13  cells  is  presented  in  Fig.  3.4.26.  I  found  that  4F  4PP  did  not  
have   significant   effect   on   the   frequency  during   control   (60  ±   3  vs.   53   ±   3;;  pt   =   0.12)  
suggesting  that  it  did  not  have  an  unwanted  effect  on  the  mEPSC  frequency.  Upon  5-­HT  
exposure  and  in  the  presence  of  4F  4PP  (A),  the  average  frequency  increased  by  25  ±  
4%  to  75  ±  4  Hz  within  1  –  4  minutes  (ppt  =  2·10-­6).  This  transient  increase,  which  lasted  
for  5  –  6  minutes,  was  the  only  significant  increase  observed  throughout  the  15  minutes  
of  exposure  to  5-­HT.  
In  keeping  with  previous  observations,  the  average  mEPSC  amplitude  did  not  show  any  
significant  change;;  it  remained  at  the  control  value  of  -­9.8  ±  0.4  pA  (normalized  in  B).  For  
each   cell,   the   average   time   course   of   the  mEPSC   remained   the   same.  The  average  
changes  for  Rin  and  Ihold  were  -­62  ±  18  MΩ  (ppt  =  0.006)  and  49.4  ±  9.8  pA  (ppt  =  3·10-­4)  
respectively,   providing   further   support   that   5-­HT   could   still   activate   the   respective  
conductance  to  cause  a  hyperpolarisation.  
I   found  that  blocking  5-­HT2AR  with  4F  4PP  neither  altered  the  ratio  of  responders  and  
non-­responders  nor  did  it  affect  the  peak  of  the  frequency  change  (28  ±  7  vs.  25  ±  4%;;  
pt  =  0.70).  I  note  that  only  one  increase  was  seen  compared  to  that  with  5-­HT.  Therefore,  
I   conclude   that   5-­HT2AR   have   a   negligible   effect   on   the   initial   increase   in   mEPSC  
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Figure  3.4.25.  4F  4PP  failed  to  block  the  mEPSC  frequency  increase.  
This  figure  was  made  in  analogy  to  Fig.  3.4.3.  The  legend  there  also  applies  to  this  figure  
except  that  in  this  case  this  cell  exposed  to  200  nM  4F  4PP  before  and  when  5-­HT  was  
added  at  t  =  0.  
  
  
Figure  3.4.26.  Pooled  data  when  5-­HT2AR  were  blocked  with  4F  4PP.  
This  figure  was  made  in  analogy  to  Fig.  3.4.16.  The  legend  there  also  applies  to  this  figure  
except  that  in  this  case  the  cells  were  exposed  to  200  nM  4F  4PP  throughout.  At  t  =  0,  10  µM  
5-­HT  was  added.  Note  that  there  was  only  one  significant  increase.  
  
3.4.4.3.  Block  of  5-­HT2CR  with  RS  102221  
Regarding   the   expression   of   5-­HT2BR,   its   presence   in   rat   brain   remains   a   matter   of  
debate.   Although   Kursar   et   al.   (1994)   showed   that   mRNA   of   the   5-­HT2BR   was   not  
significantly  expressed   in  rat  brain,  Duxon  et  al.   (1997)  showed  immunohistochemical  
evidence  of  5-­HT2BR  expression  in  the  rat  cerebellum,  medial  amygdala,  lateral  septum,  
and   the   dorsal   hypothalamus.   However,   to   this   date,   not   much   evidence   has   been  
presented   in   regard   to   the   expression   of   5-­HT2BR   in   rat   neocortex,   especially   in   the  
somatosensory   cortex.   Faint   expression   may   be   found   on   glial   cells   (Sandén   et   al.,  
2000).  
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Figure  3.4.27.  RS  102221  blocked  the  mEPSC  frequency  increase.  
A  –  C  for  a  non-­responder;;  D  –  G  for  a  responder.  A.  Representative  traces  of  mEPSCs  
during  the  control  period  (A0)  and  after  addition  of  5-­HT  (A1  –  3)  at  different  time  points  
indicated  in  B  with  numbers  0  –  3.  B.  Time  course  of  all  instantaneous  mEPSC  frequencies.  
C.  Minute  averages  of  the  mEPSC  frequency.  Dashed  line  indicates  the  average  frequency  
during   the  control  period.  D  –   I  were  made   in  analogy   to  parts  A   -­  C.  F.   cPDFs  of   the  
mEPSC   frequencies   during   control   (0)   and   at   point   1.   G,   H.   Same   as   F,   except   for  
comparison  with  3  and  the  last  five  minutes.  
  
In  contrast,  the  5-­HT2CR  (formerly  known  as  5-­HT1CR)  is  not  only  highly  expressed  in  the  
choroid  plexus,  but  also  in  human  and  rat  cerebral  neocortex  (Hoyer  et  al.,  1986b;;  Pazos  
et  al.,  1987;;  Mengod  et  al.,  1990;;  Abramowski  et  al.,  1995;;  Nocjar  et  al.,  2015).  Hence,  
the  5-­HT2CR  is  another  likely  candidate  to  be  tested  with  an  antagonist.  
I  tested  the  involvement  of  the  5-­HT2CR  using  RS  102221,  an  antagonist  having  a  ~50-­
fold   increased  selectivity  over  5-­HT2AR  (Bonhaus  et  al.,  1997).   In  electrophysiological  
recordings,  the  IC50  at  5-­HT2CR  was  32  nM,  but  3.01  µM  for  the  5-­HT2AR  (Acuna-­Castillo  
et   al.,   2002).   Hence,   by   choosing   a   concentration   of   100   nM,   5-­HT2CR   are   blocked  
without  much  affecting  other  5-­HT2R.  
In  analogy  to  the  experiments  presented  above  (see  3.4.4.2),  RS  102221  was  added  to  
the  superfusate  for  the  duration  of  the  whole  experiment,  while  5-­HT  was  added  at  t  =  0  
s.  Out  of  9  pyramidal  cells  studied,  I  found  that  8  failed  to  show  any  significant  increase  
in   the   mEPSC   frequency   after   5-­HT   application.   In   only   one,   a   small   but   significant  
transient   increase   remained   (see   below).   In   contrast   to   the   data   set   with   5-­HT,   the  
outcomes  in  this  set  of  cells  was  very  different  (
  
=  0.07),  suggesting  that  the  increases  
in  mEPSC  frequency  were  caused  by  5-­HT2CR  activation.  
In  Fig.  3.4.27,  a   typical   recording  from  a  cell  without  a  significant   increase   in  mEPSC  
frequency  is  presented.  During  the  control  period  and  in  the  presence  of  TTX,  gabazine,  
and  RS  102221,  the  mEPSC  frequency  was  82  ±  3  Hz  (A0).  The  exposure  to  5-­HT  did  
not  change  the  mEPSC  frequency  (A1  –  3,  B,  and  C).  Not  unexpectedly,  the  average  
amplitude,  time  course,  rise  time,  and  half-­width  did  not  change  either.  
For   comparison,   in   D   –   I,   the   data   from   the   only   cell   with   a   significant   increase   is  
illustrated.  The  mEPSC  frequency  of   the  control  period  was  72  ±  3  Hz  (D0).  After   the  
addition  of  5-­HT,  a  transient  increase  by  25  ±  10%,  to  89  ±  6  Hz  was  observed  within  2  
minutes  (D1,  E,  F,  and  G).  The  frequency  then  dropped  back  to  60  ±  5  Hz  after  6  minutes  
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The  mEPSC  amplitude  during  the  control  period  was  -­10.2  ±  0.1  pA.  After  addition  of  5-­
HT,  however,   there  was  a  significant  decrease   to  9.0  ±  0.1  pA   (I).  The  average   time  
courses  of  mEPSCs  during  the  control  period  and  after  5-­HT  remained  the  same.  
  
  
Figure  3.4.28.  Pooled  data  for  the  experiments  with  RS  102221.  
This  figure  was  made  in  analogy  to  Fig.  3.4.16.  The  legend  there  also  applies  to  this  figure  
except  that  here  the  data  were  obtained  in  the  continual  presence  of  100  nM  RS  102221  and  
5-­HT  was  added  at  t  =  0.  
  
When  all  data  from  this  type  of  experiment  were  pooled  (9  cells,  Fig.  3.4.28),  I  found  that  
10  µM  5-­HT  failed  to  cause  significant  increase  in  mEPSC  frequency  when  100  nM  RS  
102221  was  present.  This  is  expected  because  the  majority  of  the  cells  did  not  show  any  
significant  change  in  frequency,  and  the  only  increase  would  hardly  render  the  overall  
average  significant.  Specifically,  after  5-­HT,  the  average  frequency  remained  unchanged  
from  the  control  value  of  70  ±  4  Hz  (A).  Note  that  the  average  instantaneous  mEPSC  
frequency  in  the  presence  of  this  5-­HT2CR  antagonist  was  significantly  higher  compared  
to  the  condition  without  the  antagonist  (70  ±  4  vs.  53  ±  3  Hz;;  pt  =  0.007).  However,  it  did  
not   limit   the  magnitude   of   the   increase   by   5-­HT   in   the   sole   responder.   The   average  
amplitude  also  remained  the  same  throughout  (-­9.6  ±  0.5  pA;;  B).  The  same  statement  
also  applies  for  the  average  time  course  of  mEPSC.  The  average  changes  for  Rin  and  
Ihold  were  -­42  ±  16  MΩ  (ppt  =  0.03)  and  35.3  ±  16.3  pA  (ppt  =  0.06),  respectively.    
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This  data  set  with  RS  102221  shows  that  blocking  5-­HT2CR  abolishes   the   increase   in  
mEPSC   frequency   in  most   cells.   The   small   number   of   cells,   in  which   an   increase   in  
frequency   remained,  however,   suggests   that   there  may  be  a  small   contribution  by  5-­
HT2AR.  In  addition,  it  suggests  that  waxing  and  waning  of  the  mEPSC  frequency  may  be  
caused  by  an  interaction  between  these  two  receptors.  
3.4.4.4.  Block  of  Both  5-­HT2AR  and  5-­HT2CR  
If  both  receptors  were  involved  in  increasing  the  mEPSC  frequency,  then  their  joint  block  
should  completely  abolish  the  increase(s)  in  the  mEPSC  frequency.  I  tested  this  idea  by  
adding  both  4F  4PP  (200  nM)  and  RS  102221  (100  nM)  to  the  standard  ACSF  throughout  
the  recording,  and  adding  5-­HT  at  t  =  0.  
A  typical  such  recording  is  given  in  Fig.  3.4.29.  During  control,  the  instantaneous  mEPSC  
frequency  was  55  ±  2  Hz  (A0),  the  amplitude  -­10.7  ±  0.1  pA,  the  rise  time  0.5  ms,  and  
the  half-­width  1.5  ms.  After  the  addition  of  5-­HT,  there  was  no  significant  change  in  either  
the  frequency  (A1  –  3,  B,  D,  F,  and  G),  amplitude  (C,  E,  and  H)  or  average  mEPSC  time  
courses.  
The  same  observation  was  made   for  another   four  cells.  However,   interestingly,   three  
other  cells  showed  a  significant  depression  of  the  mEPSC  frequency,  on  average  by  39  
±  8  %  from  73  ±  2  to  44  ±  6  Hz.  This  depression  occurred  around  4  –  5  minutes  after  5-­
HT  application  and  persisted  until  the  end  of  recording.  
Because  a  non-­responder  was  defined  as  a  cell  without  a  significant  mEPSC  frequency  
increase  upon  exposure  to  5-­HT,  all  cells  in  this  set  of  8  were  non-­responders.  Hence,  
the  outcome  in  this  set  compared  to  5-­HT  was  very  different  (
  
=  0.02)  indicating  that  
the   block   of   both   receptors   was   responsible   for   the   lack   of   increase(s)   in   mEPSC  
frequency.  
The   pooled   data   are   presented   in   Fig.   3.4.30.   During   the   control   period,   the  
instantaneous  mEPSC   frequency  was  65  ±  5  Hz   (A).  Note   that   this   value  again  was  
significantly  higher  than  the  average  frequency  without  both  antagonists  (65  ±  5  vs.  53  ±  
3;;  pt  =  0.04).  After  the  addition  of  5-­HT,  the  frequency  dropped  by  17  ±  2%  to  53  ±  4  Hz  
(ppt  =  2·10-­4).  This  drop  started  after  4  minutes,  and  persisted  for  the  remainder  of  the  
recording.   The   mechanism(s)   causing   this   drop   in   mEPSC   frequency   are   not   fully  
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Figure  3.4.29.  mEPSC  increase  was  blocked  with  both  4F  4PP  and  RS  102221.  
This   figure   follows  the  same  logic  as   the  one  presented   in  Fig.  3.4.3.  The  same  legend  
applies  here  as  well.  However,  note  that  both  5-­HT2AR  antagonist  4F  4PP  and  5-­HT2CR  
antagonist   RS   102221   were   continuously   present   throughout   the   recording.   5-­HT   was  
added  at  t  =  0.  
  
The  average  mEPSC  amplitude  was  -­10.8  ±  0.7  pA  during  the  control  period  and  -­9.9  ±  
0.6  pA  after  5-­HT  addition.  In  B,  the  time  course  of  the  relative  amplitude  change  before  
and  after  5-­HT  addition  is  shown.  The  change  was  insignificant.  The  time  courses  of  the  
average  mEPSCs  remained   the  same  after  5-­HT  addition;;   the  rise   time  remained  0.5  
and  the  half-­width  1.5  ms.  The  average  changes  for  Rin  and  Ihold  as  a  consequence  of  5-­
HT  addition  were  -­19  ±  26  MΩ  (ppt  =  0.47)  and  32.6  ±  9.1  pA  (ppt  =  0.009),  respectively.  
  
  
Figure  3.4.30.  Pooled  data  for  experiments  with  4F  4PP  and  RS  102221.  
This  figure  was  made  in  analogy  to  Fig.  3.4.16.  The  legend  there  also  applies  to  this  figure  
except  that  here  the  data  were  obtained  in  the  continual  presence  of  both  200  nM  4F  4PP  
and  100  nM  RS  102221  and  5-­HT  was  added  at  t  =  0.  
  
These  results  strengthen  the  conclusion  made  earlier  that  5-­HT  activated  both  5-­HT2AR  
and  5-­HT2CR,  which  resulted   in  the  observed  transient   increases   in  the   instantaneous    
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Figure  3.4.31.  mEPSC  frequency  persisted  when  5-­HT1AR  were  blocked.  
This   figure   follows  the  same  logic  as   the  one  presented   in  Fig.  3.4.3.  The  same  legend  
applies  here  as  well.  However,  note  that  in  this  case,  (S)-­WAY  100135  was  continuously  
present  throughout  the  recording.  5-­HT  was  added  at  t  =  0.  
  
mEPSC   frequency.   This   data   further   indicates   that   activation   of   5-­HT2CR   contributes  
much  more  strongly  to  the  frequency  increase  than  that  of  5-­HT2AR.  
3.4.4.5.  No  Involvement  of  5-­HT1AR  
So  far,  the  data  are  consistent  with  the  idea  that  both  5-­HT2AR  and  5-­HT2CR  cause  the  
increases  in  mEPSC  frequency.  However,  5-­HT1AR  are  also  expressed  in  the  axon  initial  
segment  of  pyramidal  cells  (Azmitia  et  al.,  1996;;  Czyrak  et  al.,  2003),  where  they  may  
indirectly  affect  glutamate  release  by  modulating  the  shape  of  the  AP.  To  directly  test  if  
5-­HT1AR  were  involved,  I  performed  a  set  of  experiments  using  the  specific  antagonist  
(S)-­WAY  100135,  which  has  a  high  affinity  at  5-­HT1AR  (IC50  =  15.5  nM)  and  is  a  partial  
agonist  at  5-­HT1BR  (EC50  =  520  nM)  and  5-­HT1DR  (EC50  =  25  nM;;  Davidson  et  al.,  1997).  
Using   a   concentration   of   100   nM,   all   5-­HT1AR   are   expected   to   be   blocked  while   the  
activation   of   5-­HT1BR   and   5-­HT1DR   is   minimised,   but   5-­HT2AR   and   5-­HT2CR   are   not  
affected.  Therefore,  I  checked  if  in  the  presence  of  (S)-­WAY  100135,  5-­HT  still  caused  
the  observed  increases  in  the  mEPSC  frequency.  
Note  that   these  experiments  were  conducted   in   the  presence  of   the  PKC  inhibitor  Gö  
6983  (100  nM).  As  will  be  demonstrated  in  3.4.5.1,  this  PKC  inhibitor  caused  a  sustained  
increase   in   the  mEPSC   frequency,   but   did   not   have   any   other   observable   unwanted  
effects.   The   block   of   PKC   should   make   the   outcome   of   5-­HT1AR   activation   better  
discernible  if  involved  in  increasing  the  mEPSC  frequency.  Consequently,  both  (S)-­WAY  
100135   and   Gö   6983   were   added   to   the   superfusate   for   the   whole   duration   of   the  
experiment,  and  5-­HT  was  added  at  t  =  0.  
The  outcomes  of  such  a  typical  recording  are  presented  in  Fig.  3.4.31.  During  the  control  
period,   the  mEPSC   frequency  was  48  ±   1  Hz   (A0).  After   the  addition  of   5-­HT   to   the  
superfusate,  the  frequency  increased  by  40  ±  4%  to  67  ±  1  Hz  (A2,  B,  D,  and  F).  This  
increase   remained   for   at   least   another   10   minutes   (A3,   B,   D,   and   G).   The   mEPSC  
amplitude  did  not  change  significantly  (-­10.0  ±  0.1  vs.  -­9.2  ±  0.1  pA  after  5-­HT;;  C,  E,  H),  
nor  were  there  any  changes  to  the  time  courses  of  the  respective  mEPSCs  (I,  right).  
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Figure  3.4.32.  With  PKC  blocked,  the  frequency  increase  was  sustained.  
This   figure  follows  the  same  logic  as   the  one  presented   in  Fig.  3.4.3.  The  same  legend  
applies  here  as  well.  However,  note  that  in  this  case  PKC  was  blocked  by  100  nM  Gö  6983  
throughout  the  recording  and  5-­HT  was  added  at  t  =  0.  
  
In  a  set  of  5  such  experiments,  2  cells  showed  a  sustained  significant   increase  in  the  
mEPSC  frequency  after  5-­HT  addition.  This  percentage  of  responders  was  not  different  
from  that  observed  with  5-­HT  application  only  (40%  vs.  47%;;   =  0.80).  The  average  
changes  for  Rin  was  4  ±  20  MΩ  (ppt  =  0.50).  
These  results  support  the  idea  that  with  5-­HT1AR  blocked,  5-­HT  still  caused  increase(s)  
in  the  mEPSC  frequency.  The  data  also  suggest  that  the  mEPSC  frequency  increase  is  
independent  of  5-­HT1AR  signalling.  
3.4.4.6.  Sustained  mEPSC  Increase  with  PKC  Blocked  
Previous  studies  in  HEK  cells  showed  that  after  prolonged  exposure  to  5-­HT,  5-­HT2AR  
undergo   internalization   in  a  protein  kinase  C  (PKC)-­dependent  way  (Bhattacharyya  et  
al.,   2002;;   Raote   et   al.,   2013).   If   this   observation   applied   here,   inhibiting   PKC  would  
prevent  the  internalisation  of  5-­HT2A  and  5-­HT2CR,  and  render  the  increases  in  mEPSC  
frequency  from  transient  into  sustained.  
For  this  purpose,  PKC  was  inhibited  with  Gö  6983  throughout  the  recording  before  10  
µM  5-­HT  was  then  applied.  Gö  6983  is  a  broad  spectrum  PKC  inhibitor  with  IC50  values  
of  7,  7,  6,  10,  60,  20000  nM  for  PKCα,  β,  γ,  δ,  ζ,  and  μ,  respectively  (Gschwendt  et  al.,  
1996).  Therefore,  by  choosing  a  concentration  of  100  nM,  most  of   the  PKC   isoforms  
were  blocked.  
In  Fig.  3.4.32,  data  from  such  a  typical  recording  are  presented.  During  the  control  period  
and   in   the  presence  of  100  nM  Gö  6983,   the  mEPSC  frequency  was  65  ±  3  Hz  (A0).  
After  the  addition  of  5-­HT  at  time  zero,  the  frequency  increased  by  18  ±  6%  to  an  average  
value  of  77  ±  2  Hz  after  7  minutes  (A2,  B,  D,  and  F).  This  increase  was  sustained  for  the  
remainder  of  the  recording;;  i.e.  the  average  increase  was  51  ±  8%  to  98  ±  2  Hz  (A3,  B,  
D,  and  G).  
In   this  example,   the  mEPSC  amplitude  during   control   period  was   -­8.3  ±  0.1  pA.  The  
addition  of  5-­HT  caused  a  small,  but  in  this  case,  significant  decrease  by  10  ±  2%  to  -­7.5  
±  0.1  pA   (C,  E,  and  H)  by   the  end  of   the   recording.  Significant  decreases  were  only  
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was   observed   in   some   cell,   it   remained   insignificant   (see   below).   The   mEPSC   time  




Figure  3.4.33.  Pooled  data  for  experiments  with  PKC  block.  
A.  Time  course  of  the  minute  averages  of  the  relative  change  in  frequency  (normalised  for  a  
control  value  of  0%).  B.  Average  change  in  mEPSC  frequency  after  aligning  for  the  respective  
peak  values.  C.  Same  as  in  A  but  for  the  changes  in  mEPSC  amplitude.  
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In   a   data   set   of   14   cells,   illustrated   in  Fig.   3.4.33,   7   showed  a   sustained   increase   in  
mEPSC   frequency   after   5-­HT.   In   comparison   to   the   data   set  without  PKC  block,   the  
number  of  responders/non-­responders  in  this  data  set  was  not  different  (
  
=  0.86).  
The  minute  averages  of  the  change  in  the  mEPSC  frequency  after  pooling  all  14  cells  
rose  by  16  ±  6%   from  61  ±  3   to  72  ±  6  Hz   (A).  However,   this   increase  was   likely  an  
underestimate  because  in  each  responder,  the  rise  started  at  different  times.  Therefore,  
I  averaged  the  values  after  the  increase  was  fully  established.  For  non-­responders,  the  
respective  value  was   taken  during   the  seventh  minute.  During   the  control  period,   the  
average   frequency   was   61   ±   3   Hz,   significantly   higher   than   the   value   without   PKC  
inhibition  (61  ±  3  vs.  53  ±  3;;  pt  =  0.045).  After  the  addition  of  5-­HT,  it  increased  by  34  ±  
5%  to  82  ±  6  Hz  (ppt  =  6·10-­5;;  B).  
The  average  mEPSC  amplitude  during  control  period  was  -­9.4  ±  0.4  pA.  This  was  then  
used   to  normalise   the  amplitude  after  5-­HT  against   (C).  There  was  no  change   in   the  
amplitude.  In  addition,  both  the  average  time  course,  rise  time  and  half-­width  also  did  
not  change.  
This  set  of  data  revealed  three  important  points.  First,  inhibiting  PKC  rendered  transient  
increases   into   a   single   sustained   increase.   But   it   did   not   change   the   number   of  
responders/non-­responders,  nor  the  extent  of  the  increase  in  the  instantaneous  mEPSC  
frequency  (pt  =  0.51).  Second,  the  block  of  PKC  increased  the  frequency  during  control,  
indicating  that  there  was  tonic  PKC  activity,  which  reduced  the  mEPSC  frequency.  These  
data  are  consistent  with  the  idea  above  that  internalization  of  5-­HT2AR  and/or  5-­HT2CR  
may   take   place.   Third,   since   both   5-­HT2R   and   PKC   block   increased   the   mEPSC  
frequency  in  control  by  the  same  amount,  suggests  that  PKC  activation  is  downstream  
of  5-­HT2R  stimulation.  
3.4.5.  Verifying  the  Signalling  Cascade  Downstream  of  5-­HT2R  Activation  
In  the  following  sections  3.4.5.1-­3,  I  will  test  the  involvement  of  important  signalling  steps  
downstream   of   5-­HT2AR   and   5-­HT2CR,   which   caused   the   increases   in   the   mEPSC  
frequency.  Since  both  5-­HT2AR  and  5-­HT2CR  are  coupled  to  Gq  proteins  that  classically  
signal  via  phospholipase  Cβ  (PLCβ),  I  will  present  data  from  experiments  when  PLC  was  
blocked  in  3.4.5.1.  Further  downstream  of  the  signalling  cascade,  PLC  hydrolyses  PIP2  
to  produce  DAG  and  IP3.  In  3.4.5.2,  I  will  focus  on  blocking  IP3  receptors  (IP3R).  Finally,  
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Figure  3.4.34.  Inhibiting  PLC  with  edelfosine.  
This   figure   follows  the  same  logic  as  the  one  presented   in  Fig.  3.4.3.  The  same  legend  
applies  here  as  well.  However,  note  that  in  this  case,  PLC  and  PKC  were  blocked  by  30  
µM  edelfosine  and  100  nM  Gö  6983  throughout  and  5-­HT  was  added  at  t  =  0.  
  
transmitter   release,   I  performed  experiments  using  BAPTA-­AM  to  chelate   intracellular  
Ca2+  in  3.4.5.3.  Note  that,  except  for  the  experiments  with  BAPTA-­AM,  in  all  subsequent  
experiments,  PKC  was  blocked  by  Gö  6983  to  make  the  subsequent  changes  by  5-­HT  
more  prominent.  
3.4.5.1.  Inhibition  of  Phospholipase  C  
Agonist  binding  to  5-­HT2AR  and  5-­HT2CR  results  in  the  downstream  activation  of  PLCβ  
(Shimohama   et   al.,   1998;;  Watanabe   et   al.,   1998),   which   marks   the   first   step   in   the  
signalling  cascade.  I  tested  if  inhibiting  PLCβ  would  prevent  the  observed  5-­HT-­mediated  
frequency  increases.  
For  this  purpose,  PLCβ  was  inhibited  with  30  µM  edelfosine  (Powis  et  al.,  1992)  for  at  
least  10  min  prior  to  the  addition  of  5-­HT.  This  concentration  was  chosen  in  accordance  
with  studies  by  Horowitz  et  al.  (2005)  and  Choy  (2011).  Note  again  that  edelfosine  was  
present  together  with  Gö  6983  throughout  the  experiment  (see  3.4.4.6).  
A   typical   recording   is   shown   in   Fig.   3.4.34.   In   this   cell,   the   presence   of   edelfosine  
prevented   5-­HT   from   causing   any   significant   increase   in   the   instantaneous   mEPSC  
frequency  (B,  D,  F,  and  G),  as  it  remained  at  the  control  value  of  60  ±  1  Hz  throughout  
(A1  –  4).  The  mEPSC  amplitude  did  not  significantly  change  either  (-­8.6  ±  0.1  vs.  7.9  ±  
0.1   pA;;   C,   E   and   H).   In   addition,   the  mEPSC   time   course   during   the   control   period  
overlapped  with  that  after  addition  of  5-­HT  (I,  right).  
Out  of  6  such  experiments,  I  found  that  5  cells  failed  to  show  an  increase  in  the  mEPSC  
frequency.  The  remaining  cell  showed  a  small  increase  by  21  ±  3%  from  72  ±  1  to  87  ±  
2  Hz,  which  only  lasted  for  four  minutes.  In  comparison  to  the  increase  when  only  Gö  
6983  was  present  (see  3.4.4.6),  this  increase  was  much  smaller  and  not  sustained,  which  
may  indicate  an  incomplete  inhibition  of  PLC  by  edelfosine.  
It  was  very  unlikely  that  the  5  cells  were  all  non-­responders  for  the  following  reasons.  1)  
The  probability  of  getting  5  non-­responders  out  of  6  cells  equals  0.019  (0.535  ·  (1  -­  0.53)),  
which  unlikely  occurred,  but  cannot  be  ruled  out.  2)  In  this  set  of  5,  I  observed  2  cells  
with   characteristics   consistent   with   those   of   responders.   One   cell   showed   a   large  
decrease  in  Rin  by  121  MΩ,  accompanied  with  a  small  outward  current  of  16  pA  after  5-­
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HT  addition.  The  other  cell  showed  a  decrease  in  Rin  by  19  MΩ,  which  was  accompanied  
by  a   large   inward  current  of   -­140  pA.  3)  When   the  properties  of   these   two  cells  were  
plotted  on  the  respective  distributions  of  responders,  they  were  in  the  tail  which  did  not  
overlap  with   that   for  non-­responders.  Altogether,   these  considerations   indicate   that  at  
least  two  responders  were  contained  in  the  data  set.  Consequently,  edelfosine  prevented  
the  increase  in  mEPSC  frequency.  
The  pooled  data   for   this  set  are   illustrated   in  Fig.  3.4.35.  The   relative  changes   in   the  
average  mEPSC  frequency  (A)  and  amplitude  (B)  were  minimal  throughout.  
  
  
Figure  3.4.35.  Pooled  data  for  experiments  with  edelfosine.  
This  figure  was  made  in  analogy  to  Fig.  3.4.16.  The  legend  there  also  applies  to  this  figure  
except  that  the  data  were  obtained  under  the  conditions  described  in  the  legend  above.  
  
This  set  of  data  shows  that  inhibiting  PLC  with  edelfosine  prevented  5-­HT  from  causing  
an   increase   in   the   mEPSC   frequency   downstream   of   the   5-­HT2AR   and   5-­HT2CR  
activation.  This  is  consistent  with  a  classical  Gq  signalling  cascade  downstream  of  these  
receptors.  
A  further  conclusion  may  be  drawn  by  comparing  the  outcomes  of  this  experiment  with  
those  when  the  5-­HT2R  were  blocked  (Fig.  3.4.30A).  As  indicated  above,  there  was  no  
change   in  mEPSC   frequency,  whereas,  when   the  5-­HT2R  were  blocked,   there  was  a  
decrease  in  mEPSC  frequency.  This  suggests  that  the  decrease  in  mEPSC  frequency  
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observed   in   Fig.   3.4.30A   most   likely   occurred   as   a   consequence   of   a   PKC  
phosphorylation  downstream  of  the  respective  receptor  activation.  
3.4.5.2.  Block  of  IP3R  
Activation  of  PLCβ  results  in  the  hydrolysis  of  PIP2  to  produce  DAG  and  IP3.  As  stated  
in  3.2,  I  hypothesized  that  IP3  binds  to  its  receptor  on  presynaptic  stores,  causing  Ca2+  
release   to   increase   the  mEPSC   frequency.  To   test   this  hypothesis,   I   added   the   IP3R  
blocker  2-­APB  to  the  superfusate.  In  accordance  with  the  previous  study  by  Simkus  and  
Stricker  (2002a),  I  chose  a  concentration  of  16  µM.  Be  reminded  that  the  PKC  inhibitor  
Gö  6983  (100  nM)  was  also  present  throughout  the  recording.  
A  typical  such  recording  is  shown  in  Fig.  3.4.36.  During  the  control  period,  the  mEPSC  
frequency  was  54  ±  1  Hz  (A0).  After  exposure  to  5-­HT,  the  frequency  remained  at  54  ±  
1  Hz  (A1  –  3,  B,  D,  F,  and  G).  There  were  no  significant  changes  in  either  the  mEPSC  
amplitude  (-­7.6  ±  0.1  vs.  -­7.1  ±  0.1  pA;;  C,  E,  and  H)  or  its  time  course  (I,  right),  with  the  
rise  time  and  half-­width  remaining  at  0.6  and  1.9  ms,  respectively.    
In   the   presence   of   16   µM   2-­APB,   for   all   7   cells   studied,   5-­HT   failed   to   cause   any  
significant  increase  in  the  mEPSC  frequency.  This  outcome  was  significantly  different  to  
the  one  observed  for  the  set  with  5-­HT  (
  
=  0.03).  
Pooling   the   data   from   all   7   cells   (Fig.   3.4.37),   the   changes   in   the   relative   mEPSC  
frequency  (A)  or  amplitude  (B)  varied  minimally  throughout  the  recording.  In  addition,  in  
the  presence  of   2-­APB,  5-­HT  did  not   have  any  effect   on   the   time  course  of   average  
mEPSC,  rise  time  and  half-­width.  
I   surmised   that  people  may  say   that   this   set  was  drawn   from  7  non-­responders,  and  
hence,   there   is  no  evidence  that  2-­APB  blocked  the  5-­HT-­induced  mEPSC  frequency  
increase.   However,   this   was   very   unlikely   to   be   the   case   because   of   the   following  
reasons.  1)  The  probability  of  just  having  7  non-­responders  is  small  (0.537  =  0.011)  and  
therefore  unlikely.  2)  One  cell  exhibited  the  characteristics  of  a  responder  (ΔRin  of  -­31  
MΩ   and   an   inward   current   change   of   -­28   pA).   In   addition,   two   more   showed   large  
decreases  in  Rin  (-­94  and  -­97  MΩ)  with  small  outward  currents  with  5-­HT.  3)  When  the  
properties   of   these   3   cells   were   plotted,   their   values   fell   into   the   respective   tails   of  
responders.  These  considerations  suggest  that  there  were  at  least  3  responders  in  this  
set.     Consequently,   these  data  do  provide  evidence   that   2-­APB  blocked   the  mEPSC  
frequency   increase.   In  addition,   they  are  also  consistent  with   the   idea  that  a  classical  
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Figure  3.4.36.  IP3R  block  prevented  frequency  increase.  
This   figure   follows  the  same  logic  as   the  one  presented   in  Fig.  3.4.3.  The  same  legend  
applies  here  as  well.  However,  note  that  in  this  case,  IP3R  and  PKC  were  blocked  by  16  
µM  2-­APB  and  100  nM  Gö  6983  throughout  the  recording  and  5-­HT  was  added  at  t  =  0.  
  
  
Figure  3.4.37.  Pooled  data  for  experiments  in  which  IP3R  were  blocked.  
This  figure  was  made  in  analogy  to  Fig.  3.4.16.  The  legend  there  also  applies  to  this  figure  
except  that  here  the  data  was  obtained  under  the  conditions  described  in  the  legend  above.  
  
3.4.5.3.  Chelation  of  Ca2+  Released  from  Presynaptic  Stores    
Ca2+  released  from  presynaptic  stores  may  trigger  the  release  of  vesicles  from  the  nerve  
terminal,  and  may  act  as  the  final  step  in  the  signalling  pathway.  I  tested  this  possibility  
by  chelating  Ca2+  in  presynaptic  terminals  using  BAPTA-­AM.  
BAPTA-­AM,   at   a   concentration   of   50   µM,  was   loaded   into   cells   as   described   by  
Ouanounou  et  al.  (1996).  Specifically,  this  procedure  was  performed  at  least  20  minutes  
prior   to   the  start  of   the  recording.  BAPTA-­AM  was  applied   in   the  presence  of  0.7  mM  
cyclodextrin,  which   stabilized  BAPTA-­AM   in   the   extracellular   solution,   and   0.5  mM  
probenecid,  which  prevented  the  transport  of  BAPTA  out  of  the  nerve  terminal  via  organic  
acid   transporters.   These   three   compounds  were   superfused   continuously   throughout    
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Figure  3.4.38.  Chelation  of  intracellular  Ca2+  with  BAPTA-­AM.  
This   figure   follows  the  same  logic  as   the  one  presented   in  Fig.  3.4.3.  The  same  legend  
applies  here  as  well.  However,  note  that  in  this  case,  Ca2+  was  chelated  after  loading  50  
µM  BAPTA-­AM  into  the  nerve  terminals.  5-­HT  was  added  at  t  =  0.  
  
recordings.   However,   because   additional   3   compounds   were   already   present   in   the  
ACSF,  PKC  was  not  blocked  in  these  cases.  
Such   a   recording   is   shown   in   Fig.   3.4.38.   During   the   control   period,   the   mEPSC  
frequency  was  65  ±  4  Hz.  The  subsequent  addition  of  5-­HT  did  not  cause  any  significant  
increase   in   the  mEPSC  frequency   throughout;;   i.e.  at   the  end  of   the  15-­min   recording  
period,  the  frequency  was  54  ±  8  Hz,  not  significantly  different  from  control  (B,  D,  F,  and  
G).  There  was  also  no  significant  change  in  either  the  mEPSC  amplitude  (-­7.8  ±  0.1  vs.  
-­7.8  ±  0.1  pA;;  C,  E,  and  H),  time  course  (I,  right),  rise  time  or  half-­width.  
Out  of  set  of  6  such  recordings,  none  showed  any  significant   increase   in   the  mEPSC  
frequency  after  5-­HT  application.  The  outcomes  of  this  set  when  compared  to  that  with  





Figure  3.4.39.  Pooled  data  for  experiments  with  BAPTA-­AM.  
This  figure  was  made  in  analogy  to  Fig.  3.4.16.  The  legend  there  also  applies  to  this  figure  
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Again,  I  considered  evidence  for  the  presence  of  responders  in  this  set.  The  probability  
of  having  6  non-­responders  in  this  data  set  was  very  low  (0.022)  and,  hence,  unlikely.  
Furthermore,  3  cells  showed  the  characteristics  of  responders.  Specifically,  one  had  an  
ΔRin  of  -­60  MΩ  and  a  ΔIhold  -­5  pA,  another  a  ΔRin  of  -­47  MΩ  and  a  ΔIhold  3  pA,  and  the  
third  a  ΔRin  of  -­37  MΩ  and  a  ΔIhold  7  pA.  These  values  were  again  in  the  respective  tails  
for   responders.   Hence,   there   were   at   least   3   responders   in   this   set,   yet   BAPTA-­AM  
prevented  the  mEPSC  frequency  increase.  
The  data   for   the  pooled  set   is  presented   in  Fig.  3.4.39.  After   it  was  normalised   for  a  
control  value  of  0%,  the  change  in  both  mEPSC  frequency  (A)  and  amplitude  (B)  after  
exposure  to  5-­HT  was  abolished.  BAPTA-­AM  also  had  no  effect  on  the  time  course  of  
the  mEPSCs,  the  average  rise  time  and  half-­width.  
From  this  set  of  data,  I  conclude  that  the  increase  in  mEPSC  frequency  was  most  likely  
caused   by  Ca2+   release   from  presynaptic   stores.   In   addition,   this   observation   is   also  
consistent  with  that  of  a  classical  signalling  cascade  downstream  of  5-­HT2R  activation,  
congruent  with  my  hypothesis  above.  
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3.5.  Discussion  
In  Part  3  of  my  thesis,  I  have  investigated  how  5-­HT  modulates  spontaneous  glutamate  
release  in  pyramidal  neurons  of  layer  II  of  rat  barrel  cortex.  I  found  that  in  a  subset  of  
pyramidal   cells   (47%)   referred   to   as   responders,   addition   of   10   µM   5-­HT   to   the  
superfusate  increased  the  mEPSC  frequency  transiently  within  the  first  5  minutes.  It  then  
decreased  below  control  values,  but  later  surged  again.  The  mEPSC  frequency  increase  
was   not   accompanied   by   a   concomitant   change   in   amplitude.   Since   there   was   no  
significant  change  in  either  mEPSC  amplitude  or  its  time  course,  the  frequency  increase  
by  5-­HT  is  most   likely  presynaptic.  Cells  without  such  a  change   in  mEPSC  frequency  
were  subsequently  named  non-­responders.  After  addition  of  5-­HT,  the  most  significant  
difference  between  these  two  groups  was  a  much  larger  decrease  of  Rin  in  responders  
than   non-­responders,   suggestive   of   the   opening   of   (a)   larger   postsynaptic  
conductance(s).  
The  mEPSC  frequency  increase  was  predominantly  caused  by  activation  of  5-­HT2R,  with  
a   larger   contribution  made   by   5-­HT2CR   than   5-­HT2AR.   I   further   verified   the   signalling  
pathway   downstream   of   5-­HT2R   activation,   and   found   that   inhibiting   PLCβ,   blocking  
IP3R,  and  chelating   intracellular  Ca2+  all  successfully  blocked   the   increase   in  mEPSC  
frequency.  These   results   fully  support  a   “classical”   signalling  cascade  whereby  PLCβ  
activation  downstream  of  Gq/11  hydrolysed  PIP2  to  yield  DAG  and  IP3,  the  latter  of  which  
then  bound  to  IP3R  causing  Ca2+release  from  presynaptic  stores  seen  as  an  increase  in  
mEPSC   frequency.   In   addition,   I   found   that   blocking   PKC,   which   might   have   been  
activated  downstream  of  DAG,  rendered  the  transient  nature  of  the  mEPSC  frequency  
increase  into  a  sustained  one.  
3.5.1.  Electrophysiological  Properties  of  Pyramidal  Cells  
Based  on  a  considerable  number  of  pyramidal  cells  recorded  from  in  layer  II,  I  have  been  
able  to  characterise  some  basic  electrophysiological  properties.  Because  all  cells  were  
histologically   verified   post   hoc,   I   am   very   confident   that   this   sample   consists   of   a  
homogeneous   population   of   pyramidal   cells,   mostly   in   the   upper   part   of   layer   II.   In  
agreement  with   earlier   studies   in   this   laboratory   (Simkus  &  Stricker,   2002b,   a;;  Choy,  
2011;;   Choy   et   al.,   2017a;;   Choy   et   al.,   2017b)   and   another   report   in   the   literature  
(Feldmeyer  et  al.,  2006),  Vrest  in  these  cells  was  quite  hyperpolarized.  I  note  that  these  
values  were  not  corrected  for  a  liquid  junction  potential  of  13.0  mV  (Barry,  1994)  and,  
therefore,  are  even  more  negative.  Also  in  agreement  with  these  studies  is  the  fact  that  
upon  a  sufficiently  large  currents  step,  these  cells  fire  more  or  less  regularly,  with  the  AP  
threshold  typically  set  at  -­38  mV.    
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The  characteristics  of  mEPSCs  in  these  cells  are  also  consistent  with  earlier  studies  from  
this  laboratory  (Simkus  &  Stricker,  2002b;;  Choy  et  al.,  2017a).  The  mEPSC  frequency  
was  typically  high,  with  an  average  value  of  59  ±  1  Hz.  Given  that  this  frequency  was  
indifferent   from   that  of  sEPSC,   i.e.  was  not  affected  by  TTX,   it  was  not  generated  by  
spontaneous  sodium  electrogenesis.  However,  TTX  did  have  a  significant  effect  on  σnoise,  
which  became  smaller.  This  is  most   likely  due  to  the  high  density  of  sodium  channels  
around  the  soma  which  may  generate  a  small  persistent  current  at  rest.  In  addition,  the  
mEPSC  amplitude  became  smaller.  This  is  harder  to  interpret,  but  a  likely  explanation  is  
that   when   the   persistent   current   is   removed,   electrogenesis   by   Ca2+   and/or   NMDA  
receptors,   that   may   also   be   present   in   these   axons   and   cause   multivesicular  
(synchronised)  release,  is  abolished.  This  would  result  in  a  smaller  mEPSC  amplitude.  
3.5.2.  Transient  Increases  in  mEPSC  Frequency  but  Not  Amplitude  
Throughout  the  different  sets  of  experiments  in  this  part,  I  have  mostly  used  an  agonist  
concentration  of  10  µM  in  agreement  with  what  Singer  et  al.  (1996)  have  used.  I  note  
that  in  different  studies,  diverse  concentrations  were  used;;  in  some  much  less  (Lee  et  
al.,  2008;;  Hosford  et  al.,  2014;;  Nishijo  &  Momiyama,  2016)  and   in  others  much  more  
(Aghajanian  &  Marek,  1999;;  Marek  &  Aghajanian,  1999).  However,  because  the  relevant  
EC50  was  measured  to  be  ≤  1  µM  (Xu  &  Chuang,  1987;;  Singer  et  al.,  1996),  the  chosen  
concentration  was  very  likely  sufficiently  high  for  receptor  activation.  
The  main  finding  in  this  part  is  that  10  µM  5-­HT  caused  transient  increases  in  mEPSC  
frequency  in  a  subset  of  layer  II  pyramidal  cells  in  the  age  bracket  between  P15  and  P20,  
consistent  with  the  hypothesis  that  downstream  of  a  Gq-­mediated  signalling  cascade,  the  
release  of  Ca2+   from  presynaptic  stores  generates  an   increased  number  of  mEPSCs.  
This  study  shows  for  the  first  time  that  5-­HT  causes  a  specific  pattern  in  the  modulation  
of  spontaneous  release.  Specifically,  upon  5-­HT  activation,  and  for  the  typical  recording  
period  of  15  minutes,  there  was  a  transient   increase  by  28  ±  7%  within  the  first  4  –  5  
minutes,  which   decayed   back   to   a   value   below   the   control   level   (-­15   ±   3%),   to   then  
resurge  towards  the  end  of  the  recording  (27  ±  7%;;  see  Table  3.4.1).  
I  provided  three  lines  of  evidence  that  this  pattern  of  mEPSC  frequency  increase  was  
very   unlikely   a   recording  artefact.   First,  when   I   instead  used  10  µM  NA,   a   sustained  
increase   could   be   reliably   tracked   throughout   the   remainder   of   the   recording   period.  
Second,  I  also  demonstrated  that  I  could  reliably  track  the  mEPSC  frequency  in  ACSF  
over   the   whole   duration   of   such   an   experiment   without   any   significant   change   in  
frequency,   indicating   that   random   variability   during   the   recording   is   an   unlikely  
explanation  for  the  transient  nature  of  the  increase.  Third,  when  PKC  was  blocked  with  
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Gö   6983,   the   frequency   increase   was   sustained   for   the   duration   of   the   experiment,  
suggesting  that  a  PKC-­mediated  phosphorylation  downstream  of  receptor  activation  is  
likely  causing  the  drop  in  mEPSC  frequency  (see  3.5.7  below).  
In  contrast  to  the  mEPSC  frequency  increase  observed  with  NA  (64  ±  7%;;  n  =  42;;  Choy  
et  al.,  2017a),   the  increase  for  5-­HT  in  phase  1  was  28  ±  7%,  which  was  significantly  
smaller  (pt  =  0.001).  Despite  the  involvement  of  a  Gq–linked  signalling  cascade  in  both  
cases   (see  also  below),   the   smaller   response   to   5-­HT   likely   reflects   the   fact   that   the  
increase  observed  was  due  to  an  interaction  between  two  processes,  one  that  increased  
the  mEPSC  frequency  as  in  the  case  for  NA,  and  another  slower  process,  which  curtailed  
this  increase.  In  addition,  either  the  relevant  5-­HTR  or  the  associated  signalling  cascade  
was  likely  desensitised  (see  below),  also  contributing  to  the  smaller  increase  observed  
(Roth  et  al.,  1995;;  Stout  et  al.,  2002).    
It  is  important  to  point  out  that  the  increase  observed  with  5-­HT  was  not  that  far  above  
what  can  reliably  be  detected  with  the  analysis  technique  used.  The  transient  nature  of  
the  response,  and  the  fact  that  the  frequency  increase  was  only  observed  in  a  subset  of  
cells,  may  have  prevented  other  researchers  from  observing  it.  See  below  for  more  on  
the  transient  nature  of  this  frequency  increase.  
I  found  that  all  throughout  the  different  phases,  the  mEPSC  amplitude  did  not  significantly  
change.  This  conclusion  was  based  on  the  lack  of  significance  between  the  respective  
densities  (KS  statistic),  but  also  from  the  overall  average  time  courses  of  mEPSCs  as  
illustrated  for  example  in  Fig.  3.4.3I.  The  lack  of  change  in  mEPSC  amplitude  is  similar  
to   that   observed   for   NA   (Choy   et   al.,   2017a),   but   different   from   the   reported   small  
changes   by   5-­HT1BR   or   5-­HT2R   (Aghajanian   &   Marek,   1997;;   Austgen   et   al.,   2012).  
However,   I   note   that   I   cannot   rule   out   small   changes   to   the   amplitude   that,   with   the  
methods  used,  remained  undetectable.  
In  a  limited  number  of  experiments,  I  observed  that  the  response  to  5-­HT  was  develop-­
mentally  regulated.  In  contrast  to  young  (P9  –  12)  and  standard  juvenile  (P15  –  20),  there  
was   no   significant   increase   in   the   mEPSC   frequency   in   older   animals   (P34   –   38).  
However,  it  needs  to  be  stressed  that  a  small,  but  undetectable  increase  may  have  been  
present.   This   observation  most   likely   reflects   the   postnatal   expression   of   5-­HT2R,   in  
agreement   with   a   study   by   Morilak   and   Ciaranello   (1993).   They   found   that   the  
immunoreactivity  for  5-­HT2R  is  high  around  birth,  increases  up  to  P14,  but  then  settles  
on  a  smaller  adult  pattern  around  P28,  indicating  that  5-­HT2R  remain  expressed  in  the  
tissue.  Despite  this  observation,  it  remains  unclear  why  the  frequency  increase  became  
insignificant  in  older  (P34  –  38)  animals.  Potential  explanations  may  include  a  change  in  
receptor  heterodimerization   (Herrick-­Davis  et  al.,  2005;;  Moutkine  et  al.,  2017),  and/or  
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signal  transduction  downstream  of  receptor  activation  (Knauer  et  al.,  2009;;  Zhang  et  al.,  
2017).  As  will  be  discussed  below,  it  is  unlikely  that  this  change  occurred  at  the  effector  
level  (presynaptic  Ca2+  stores),  but  rather  at  the  level  of  the  signalling  cascade.  
This  discussion  so  far  implied  that  the  source  of  the  increased  glutamate  release  was  of  
synaptic   (neuronal)   origin.  However,   this   tenet   is   far   from  established.  An   alternative  
explanation  may  be  that  the  increased  glutamate  release  is  of  glial,  specifically  astrocytic  
origin.  In  fact,  neocortical  astrocytes  express  5-­HT2R,  both  the  2A  and  2B  isoforms  (Hirst  
et  al.,  1998;;  Sandén  et  al.,  2000;;  Xu  &  Pandey,  2000).  In  addition,  astrocytes  are  indeed  
capable  of  releasing  glutamate  downstream  of  Ca2+  store  activation  (Parpura  et  al.,  1994;;  
Pasti  et  al.,  1997;;  Araque  et  al.,  1998).  At  this  stage,  because  the  experimental  proof  for  
an  astrocytic   involvement   is   not   easy   to  achieve,   this   possibility   cannot   be   ruled  out.  
Perhaps,  in  the  near  future,  via  astrocytic  expression  of  designer  receptors  exclusively  
activated  by  designer  drugs  (DREADD)  in  neocortex  (Urban  &  Roth,  2015),   it  may  be  
possible   to   functionally   silence   5-­HT2R   on   astrocytes   and   abolish   their   potential  
contribution  to  spontaneous  glutamate  release.  
3.5.3.  Impact  of  5-­HT  on  Responders  vs.  Non-­Responders  
Ever  since  early  cellular  studies  on  the  function  of  5-­HT  in  the  central  nervous  system,  it  
was   realised   that   not   all   cells   uniformly   responded   to   this   neuromodulator   (North   &  
Uchimura,  1989;;  Araneda  &  Andrade,  1991;;  Larkman  &  Kelly,  1992;;  Tanaka  &  North,  
1993;;  Schmitz  et  al.,  1998;;  Foehring  et  al.,  2002).  It  is  worth  pointing  out  that  in  my  data  
set,   prior   to   5-­HT   exposure,   there   were   no   differences   between   the   two   groups   of  
postsynaptic   cells,   neither   in   regard   to   the   mEPSC   frequency   nor   the   postsynaptic  
properties   (like  Rin).   The   groupings   into   responders   and   non-­responders   was   simply  
based  on  the  fact  that  there  was  either  a  significant  or  no  mEPSC  frequency  increase,  
respectively.  However,  when  further  comparing  the  data  based  on  this  ad  hoc  grouping,  
also   differences   in   some   postsynaptic   changes   became   apparent.   Particularly,   non-­
responders  showed  an  insignificant  change  in  mEPSC  frequency,  typically  together  with  
a  large  outward  current  associated  with  a  small  decrease  in  Rin.  Responders,  in  contrast,  
showed  significant   increases   in  mEPSC   frequency,   together  with,  on  average,  a  very  
small  outward  current,  but  in  a  good  number  of  these  cells,  an  inward  current  associated  
with  a  large  reduction  in  Rin.  
It  is  important  to  point  out  that  this  grouping  was  defined  based  on  the  significance  level  
based   on   the   Kolmogorov-­Smirnov   statistic,   the   cut-­off   value   of   which   was   notably  
chosen   ad   hoc.   In   hindsight,   this   cut-­off   was   most   likely   appropriately   set,   as   it  
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decomposed   the   data   set   into   two   groups,   which   also   showed   distinct   postsynaptic  
properties.  
It   is   very   unlikely   that   inadequante   space-­clamp   (Spruston   et   al.,   1993;;   Williams   &  
Mitchell,  2008)  differentially  affecting  responders  and  non-­responders  gave  rise  to  this  
distinction.  First,  I  could  not  find  that  there  were  systematic  differences  in  the  extent  of  
the   dendritic   tree   between   the   two   groups.  Second,   the   fact   that   in   both   groups,   the  
mEPSC  amplitude  and   time  course  remained   the  same  during  control  and  after  5-­HT  
suggests  that  both  groups  were  similarly  affected  by  space-­clamp  issues.  Third,  as  both  
the  change  in  Rin  and  Ihold  after  5-­HT  occurred  over  several  minutes  (i.e.  they  were  slow),  
the   impact   of   inadequante   space-­clamp   is   much   smaller   than   on   AMPA   mediated  
mEPSCs.  Based  on  these  considerations,  I  judge  the  impact  to  be  minimal.  
The  nature  of   this  distinction   is   likely  associated  with   the   functional  expression  of   the  
respective  5-­HTR  on  nerve   terminals   impinging  on  dendrites   of   pyramidal   cells,   from  
which  the  recordings  were  made  (see  Fig.  3.5.1).  A  similar  distinction  was  recently  made  
in  prefrontal  cortex  by  two  different  groups  (Dembrow  et  al.,  2010;;  Avesar  &  Gulledge,  
2012),  where  the  expression  of  the  5-­HTR  was  target  specific.  In  addition,  we  found  a  
similar  grouping  when   looking  at  how  NA  modulated   transmitter   release   (Choy  et  al.,  
2017a),  although,  in  this  case,  the  attribution  to  two  groups  was  less  strict.  
I   reiterate   that   there  was   no   difference   between   responders   and   non-­responders   in  
regard   to   the  control  mEPSC  frequency  (58  ±  2  vs.  60  ±  2  Hz;;  pt  =  0.47).  Because  a  
large  number  of  nerve  terminals  onto  dendrites  in  this  layer  stems  from  local  collaterals  
(Lübke  et  al.,  2003),  a  likely  scenario  could  be  that  the  target  cells  also  express  5-­HT2R  
on   their   axon   terminals,   potentially  making   recurrent   contacts   back   onto   themselves  
(autoreceptors).  This  could  be  an  explanation  for  the  fact  that  the  increase  in  mEPSC  
frequency  remained  restricted  to  responders.  This  possibility   is   illustrated  in  Fig.  3.5.1  
(scheme  1).  An  alternative  could  be  that  most  nerve  terminals  onto  dendrites  of  layer  II  
pyramidal   cells   express   5-­HT2R,  which   in   the   case   of   responders   are   active,   but  
functionally   silenced   in   the   case   of   non-­responders   (Fig.   3.5.1,   scheme   2).   This  
explanation,  however,  would  require  some  form  of  “retrograde”  message  to  be  delivered  
to  silence  the  respective  nerve  terminals.  Target  cell  specific  modulation  of  transmitter  
release  has  been  described  at  the  crayfish  neuromuscular  junction  (Krause  et  al.,  1998),  
chick  sympathetic  ganglion  cells   (Devay  et  al.,  1999),  hippocampus   (Scanziani  et  al.,  
1996;;  Scanziani  et  al.,  1998;;  Toth  &  McBain,  2000;;  Koester  &  Johnston,  2005;;  Buchanan  
et  al.,  2012;;  Glickfeld  et  al.,  2013),  and  neocortex  (Reyes  et  al.,  1998;;  Reyes  &  Sakmann,  
1999;;  Cowan  &  Stricker,  2004).  Admittedly,  the  difference  between  the  cell  types  could  
also  lie  with  the  effectors  (channels,  signalling  molecules,  etc.).  However,  based  on  the  
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Figure  3.5.1.  Schemes  generating  responders  and  non-­responders.  
Two  possible  schemes  depicting  the  differences  between  responders  and  non-­responders.  
In  scheme  1,  non-­responders,  which  show  a  large  outward  current  due  to  the  activation  of  
postsynaptic   5-­HT1AR,   receive   synapses,   which   do   not   express   presynaptic   5-­HT2R.  
Therefore,  5-­HT  does  not  increase  the  mEPSC  frequency.  Conversely,  responders,  which  
show  either  a  small  outward  or  inward  current  due  to  the  activation  of  both  postsynaptic  5-­
HT1AR  and  5-­HT2R,  receive  synapses  with  functional  presynaptic  5-­HT2R.  In  this  case,  5-­
HT   increases   the   mEPSC   frequency.   Alternatively,   in   scheme   2,   the   postsynaptic  
properties  are  the  same  as  in  scheme  1.  However,  in  this  case,  the  synapses  that  project  
to  both  groups  uniformly  express  presynaptic  5-­HT2R.  But  in  non-­responders,  retrograde  
signalling  renders  the  respective  5-­HT2R  non-­functional  and  therefore,  there  is  no  mEPSC  
frequency  increase.  
  
available  literature,  there  is  little  evidence  for  it.  This  possibility  has  therefore  not  been  
included  in  the  Fig.  3.5.1.  Whilst  it  is  conceivable  that  the  target  could  functionally  curtail  
transmitter  release  from  nerve  terminals,  at  this  stage,  I  am  unable  to  identify  which  of  
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the  two  illustrated  possibilities  is  at  work  here.  Further  points  of  discussion  in  regard  to  
this  classification  will  be  raised  in  4.5.3.  
3.5.4.  5-­HT  Also  Affects  Postsynaptic  Properties  
Because  5-­HT  as  the  physiological  agonist  was  used   in   this  study,  potentially  several  
different  5-­HTR  could  have  been  activated.  Some  of  the  effects  showed  themselves  in  
the   hyperpolarization   of   the   postsynaptic   cells   upon   addition   of   5-­HT.   Specifically,   in  
voltage-­clamp  (held  at   -­70  mV),   responders   typically  showed  a  small  outward  current  
(hyperpolarizing),  with  some  cells  exhibiting  a  net  inward  current  (depolarizing),  but  non-­  
responders   mostly   showed   a   large   outward   current   (see   Figs.   3.4.21   and   3.5.1).   In  
addition,  it   is  worth  noting  that  the  reduction  in  Rin  was  about  twice  that  in  responders  
than  non-­responders  (-­56  ±  13  vs.  -­30  ±  11  MΩ,  respectively;;  see  Table  3.4.5),  indicating  
that   downstream   of   receptor   activation,   a   much   larger   conductance   was   opened   in  
responders.  
The  fact  that  in  both  groups,  there  were  considerable  deviations  from  the  typical  result,  
indicates  that  the  underlying  conductance  change  most  likely  consisted  of  a  mixture  of  
at   least   two   currents,   one   depolarizing   and   one   hyperpolarizing,   with   the   mixture   in  
responders  dominated  by  an  inward  and  in  non-­responders  by  an  outward  current.  The  
inward  current  most  likely  resulted  from  the  activation  of  postsynaptic  5-­HT2R  (Foehring  
et  al.,  2002),  whilst  the  outward  current  from  5-­HT1AR  (Goodfellow  et  al.,  2009).  Given  
that  the  outward  current  for  non-­responders  was  larger  despite  a  smaller  conductance  
change,  suggests  that  the  driving  force  on  the  respective  current  was  larger.  With  GIRK  
channels  (Lüscher  et  al.,  1997)  being  the  most  likely  target  in  this  case  (as  inferred  from  
the  lack  of  hyperpolarization  when  either  of  the  two  Gβγ-­binding  peptides  was  present  in  
the  presynaptic  cells;;  see  also  4.4.4.2  and  3),  and  given  Vrest  of  ~  -­78  mV  in  these  cells,  
a  driving  force  of  about  15  mV  was  behind  this  current.  In  contrast,  as  the  conductance  
change  for  responders  was  larger,  but  the  magnitude  of  the  current  smaller,  suggests  
that  the  driving  force  for  the  inward  current  must  be  significantly  smaller  than  the  15  mV  
for  GIRK  channels.  
This  observation  also  rules  out  the  possibility  that  most  of  this  net   inward  current  was  
caused  by  the  closure  of  a  K+  conductance  as  that  would  have  increased  Rin,  which  was  
not  observed.  This   consideration  places   the  apparent   reversal  potential   for   this/these  
conductance/s  more  positive   than   -­78  mV,   likely   in   the   range  of  about   -­70  mV.   If   the  
depolarizing  current  were  made  up  of  a  single  type  of  ion  channel,  likely  candidates  could  
be   two   pore   potassium   (K2P)   channels   (Mathie,   2007;;   Enyedi   &   Czirjak,   2010)   or  
voltage-­  or  Ca2+-­dependent  Cl-­  channels   like  ClC-­0  or  TMEM16,  respectively  (Chen  &  
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Hwang,  2008;;  Zhang  et  al.,  2015).  Given  that   in  most   instances,  the  activation  of  Gαq  
typically  resulted  in  the  inhibition  of  K2P  conductances  (Enyedi  &  Czirjak,  2010),  these  
channels   were   unlikely   involved   as   an   increase   in  Rin   should   have   been   observed,  
inconsistent   with  my   findings.   In   addition,   the   two   types   of   Cl-­   channels   are   unlikely  
involved   either,   as   according   to   my   incomplete   knowledge,   no   link   between   5-­HT2R  
activation   and   these  Cl-­   channels   has   been   documented.   However,   if   the   underlying  
current  were  indeed  a  mixture  of  at  least  two  channels  with  one  of  them  being  GIRK,  the  
associated   reversal  potential   for   the   inward  current  could   likely  be  considerably  more  
positive  than  -­70  mV,  consistent  with  a  current  like  Ih  or  another  unspecific  cation  current.  
In  fact,  there  is  evidence  that  depolarizations  can  arise  downstream  of  5-­HT1AR  activation  
by  shifting   the  activation  curve  of   Ih   to  more  positive  values   in  motoneurons,   thalamic  
relay  neurons  and  CA1  pyramidal  cells  (Pape  &  McCormick,  1989;;  McCormick  &  Pape,  
1990;;   Takahashi   &   Berger,   1990;;   Larkman  &  Kelly,   1992;;  Gasparini   &  DiFrancesco,  
1999).  Conversely,  in  rat  prefrontal  cortex,  a  depolarization  was  reported  downstream  of  
5-­HT2R,  while  the  subtype  of  this  receptor  remained  undetermined  (Araneda  &  Andrade,  
1991),   as   was   the   ionic   nature   of   the   conductance   involved.   In   the   amygdala,   a  
depolarization   was   observed   because   of   the   activation   of   a   TRPC-­like   current  
downstream  of  5-­HT2CR  (Yamamoto  et  al.,  2014).  From  my  data  set,   it   is  also  evident  
that  the  depolarization  in  responders  was  also  downstream  of  5-­HT2R,  and  might  have  
involved  both  5-­HT2AR  and  5-­HT2CR,  but  very  unlikely  5-­HT1AR.  The  ionic  nature  of  this  
depolarizing  conductance  remains  to  be  elucidated.  
3.5.5.  5-­HT2R  Activation  Causes  mEPSC  Frequency  Increase  
I  further  investigated  which  5-­HTR  caused  the  mEPSC  frequency  increase,  using  both  
agonists  and  antagonists.  I   found  that  the  pan-­5-­HT2R  agonist  α-­methyl-­5-­HT  (20  µM;;  
for  review  see  Baxter  et  al.,  1995)  mimicked  the  action  of  5-­HT,  consistent  with  earlier  
observations  in  neocortex  (Aghajanian  &  Marek,  1999;;  Zhou  &  Hablitz,  1999;;  Lambe  et  
al.,  2000;;  Beique  et  al.,  2007)  and  other  locations  in  the  brain  (Hori  et  al.,  1996;;  Rainnie,  
1999;;  Hasuo  et  al.,  2002;;  Austgen  et  al.,  2012;;  Sangare  et  al.,  2016).  In  addition,  DOB,  
another  pan-­5-­HT2R  agonist,  also  increased  the  mEPSC  frequency,  but  the  pattern  of  
the   increase   was   different   from   that   of   5-­HT   and   α-­methyl-­5-­HT   (see   below).   These  
observations  were  further  supported  by  the  fact  that  after  5-­HT1AR  were  blocked  with  (S)-­
WAY  100135,  I  did  not  find  any  evidence  that  these  were  significantly  involved.  However,  
in  other  preparations,  the  respective  change  was  attributed  to  these  receptors  (Singer  et  
al.,  1996;;  Schmitz  et  al.,  1998;;  Ding  et  al.,  2013;;  Hosford  et  al.,  2014).  
The  involvement  of  5-­HT2R  was  further  supported  when  working  with  sub-­type  specific  
antagonists   at   5-­HT2AR   (4F   4PP)   and   5-­HT2CR   (RS   102221).   In   fact,   with   5-­HT2AR  
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blocked,  I  observed  that  there  was  only  one  frequency  increase.  This  suggests  that  5-­
HT2CR  likely  contributed  to  the  initial  increase  in  mEPSC  frequency.  In  contrast,  when  5-­
HT2CR  were  blocked,  the  frequency  increase(s)  were  absent  in  most  cells,  but  in  about  
11%  of  them,  an  early  small   increase  remained  detectable;;   i.e.  5-­HT2AR  contributed  a  
small  amount.  Given  that  the  increase  in  mEPSC  frequency  was  fully  prevented  when  
both  5-­HT2R  were  blocked  suggests  that  other  5-­HTR  like  5-­HT7R  are  unlikely  involved  
in  the  modulation  of  spontaneous  release  (Beique  et  al.,  2004b;;  Celada  et  al.,  2013).  
The  fact  that  during  phase  2,  the  frequency  significantly  dropped  below  that  during  the  
control  period  (-­15  ±  3%;;  see  Table  3.4.1),  may  indicate  that  there  is  constitutive  5-­HT2R  
activation  in  the  absence  of  5-­HT,  which  during  phase  2  was  abolished,  most  likely  due  
to  phosphorylation  either  of  the  receptor,  the  associated  G  protein  subunits  or  an  element  
in   the   signalling   cascade.   In  addition,   the  observation   that  when  both  5-­HT2R  and  5-­
HT2CR  were  blocked,  the  control  frequency  also  increased  further  supports  the  idea  of  
constitutive  receptor  activity  (see  also  3.5.7  below).    In  fact,  there  is  evidence  for  such  
constitutive   activity   of   5-­HT2R   (Harvey,   2003;;   Berg   et   al.,   2005;;   Di   Giovanni   &   De  
Deurwaerdere,  2016),  specifically   for  5-­HT2CR  under  both   in  vivo  and   vitro   conditions  
(Barker  et  al.,  1994;;  De  Deurwaerdere  et  al.,  2004),  but  also  for  5-­HT2AR  in  vivo  (Egan  
et  al.,  1998).  The  molecular  mechanism  for  this  constitutive  activity,  i.e.  activity  without  
agonist  binding,   is  most   likely  structurally   linked   to   the  coupling  site  of   the   trimeric  G  
protein  to  the  receptor  in  the  region  of  the  second  intracellular  loop.  If  in  human  5-­HT2CR,  
via  mRNA  editing  at  amino  acid  positions  156,  158,  and  160,  the  sequence  is  changed  
from   isoleucine-­asparagine-­isoleucine   (INI)   to   valine-­serine-­valine   (VSV),   the  
constitutive  activity  is  lost    (Niswender  et  al.,  1999).  It  is  unclear,  which  5-­HT2CR  isoform  
is  expressed  in  my  preparation,  but  a  likely  candidate  is  one  which  shows  a  high  agonist  
potency   for   5-­HT,   akin   to   the   INI   isoform.   The   extent   of   constitutive   activity   (~15%)  
corresponds   roughly   to   the   one   reported   earlier   by   Barker   et   al.   (1994)   and   lends  
credence  to  the  involvement  of  this  potential  mechanism.  
The  transient  nature  of  the  mEPSC  frequency  increases  is  very  unlikely  due  to  a  slowly  
evolving  receptor  desensitisation  (Roth  et  al.,  1995;;  Stout  et  al.,  2002)  because  when  
PKC  was  blocked,  the   increase  was  sustained.  However,   it   is  very   likely,   though,  that  
due  to  the  slow  solution  exchange  during  the  experiment,  which  typically  took  a  couple  
of  minutes,  the  relevant  receptors  may  already  have  been  desensitised  at  the  start  of  the  
frequency  increase,  as  5-­HT2R  can  do  so  within  this  time  frame  (Stout  et  al.,  2002).  
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3.5.6.  Involvement  of  5-­HT2AR  and  5-­HT2CR  
It  is  important  to  point  out  that  the  functional  involvement  of  5-­HT2BR  in  my  preparation  
is   absent   or   at   least   insignificant.  This   is   in   agreement  with  an   immunohistochemical  
study  in  neocortex  by  Choi  and  Maroteaux  (1996).  However,  most  likely  both  5-­HT2AR  
and  5-­HT2CR  are  functionally  expressed  on  presynaptic  nerve  terminals,  with  5-­HT2CR  
making  likely  a  larger  contribution  to  the  mEPSC  increase  than  5-­HT2AR.  
The   two   data   sets   with   5-­HT2AR   and   5-­HT2CR   antagonists   are   best   reconciled   if   the  
transient  nature  of  the  mEPSC  frequency  increases  reflected  an  interaction  downstream  
of  receptor  activation  (see  below).  These  findings  rest  upon  the  co-­expression  of  both  
receptors   either   as   co-­localised   homodimers,   or   potentially   as   heterodimers,   or   a  
combination  between  homo-­  and  heterodimers.  Indeed,  there  is   immunohistochemical  
evidence  that  both  receptors  are  co-­expressed  in  neocortex  (Pompeiano  et  al.,  1994;;  Li  
et  al.,  2004;;  Nocjar  et  al.,  2015).  Moreover,  a  recent  study  in  a  heterologous  expression  
system  suggests  that  heterodimers  between  the  two  receptors  can  be  formed  (Moutkine  
et   al.,   2017).   It   was   found   that   under   these   expression   conditions,   the   downstream  
signalling  remained  unaltered.  Consequently,   I  am  unable  to  distinguish  which  dimers  
are  present  in  my  preparation.  
Downstream   of   5-­HT2AR   signalling,   bi-­   and   triphasic   signalling   responses   have   been  
seen  before  (Qvigstad  et  al.,  2005;;  Zhang  et  al.,  2017).  These  resulted  from  the  fact  that  
the  signalling  was  not  only  comprised  of  the  well-­known  signalling  arm,  which  involves  
PLCβ  activation  by  Gq/11  and  results   in  Ca2+  release  from  IP3R  on  stores  (Streb  et  al.,  
1983;;  Berridge,  1987),  but  also  of  alternate  signalling.  It  is  well  known  that  5-­HT  via  5-­
HT2AR  can  also  activate  the  mitogen-­activated  protein  kinase  (MAPK),  specifically  either  
a  member  of   the  extracellular-­regulated  kinase   (ERK)  and/or   the  p38  MAPK  pathway  
(Watts,  1996;;  Quinn  et  al.,  2002;;  Kurrasch-­Orbaugh  et  al.,  2003;;  Franklin  &  Carrasco,  
2015;;  Zhang  et  al.,  2017).  The   latter   typically  antagonises  the  action  of   the  former.   In  
their   recent   paper,   Zhang   et   al.   (2017)   point   out   in   neurons   of   Aplysia   that   as   a  
consequence   of   this   interaction   between   the  ERK  and   p38  MAPK  pathways,   both   of  
which  are  activated  downstream  of   the  5-­HT2AR  activation,  multiphasic  responses  are  
expected  to  arise.  
In   other   instances,   receptor   activation   can   result   in   non-­classical   signalling   which,  
independently  of  Gq,  is  transduced  via  Gi/o  to  activate  phospholipase  A2  (PLA2)  to  yield  
arachidonic  acid,  which  then  inhibits  store  release  (Berg  et  al.,  1998).  Consistent  with  
my   observations   and   extrapolating   from   such   reports,   it   is   likely   that   the   classical  
signalling   downstream   of   5-­HT2R   is   responsible   for   the   initial   increase   in   mEPSC  
frequency.  However,  5-­HT2AR  with  a  time  delay,  either  via  Gi/o  or  via  activation  of  one  
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arm  of  the  MAPK  pathway  (Kurrasch-­Orbaugh  et  al.,  2003),  inhibited  store  release  and  
consequently   the   frequency   dropped   below   the   control   value.  After   that,   the  mEPSC  
resurged  as  the  inhibition  was  likely  relieved  by  the  other  arm  of  the  MAPK  pathway.  In  
the  future,  this  idea  could  be  directly  tested  by  using  specific  MAPK  blockers  (Zhang  et  
al.,  2017).    
Because  the  signalling  was  independent  of  Gq  and  PLCβ  in  the  studies  mentioned  above,  
suggests  that  in  the  reported  context,  some  5-­HT2AR  are  likely  linked  to  a  non-­classical  
G  protein  and  downstream  signalling.  If  the  increase  in  mEPSC  frequency  involved  the  
activation  of  presynaptic  Ca2+  stores,  consistent  with  Gq  signalling,  a   likely  conclusion  
could   be   that   both   classically   and   non-­classically   linked   5-­HT2AR   are   present   on   the  
respective  nerve  terminals.  
I  note  that  there  are  potentially  other  alternative  explanations  for  the  different  phases.  
The  first  considers  the  surface  expression  of  5-­HT2AR.  It  has  indeed  been  reported  that  
5-­HT2AR  can  be  internalised  in  a  PKC-­dependent  way  (Bhattacharyya  et  al.,  2002;;  Gray  
et  al.,  2003).  Such  a  scenario  is  plausible  as  with  PIP2  hydrolysis  by  PLCβ,  both  IP3  and  
DAG  are  produced,  the   latter  of  which  can  result   in  the  activation  of  PKC  (Berridge  &  
Irvine,  1984).  The  idea  then  is  that  after  PKC  activation  (which  may  take  longer  as  it  is  
further   downstream   of   receptor   activation),   5-­HT2AR   phosphorylation   gives   rise   to  
internalisation   limiting   transduction   and   reducing   the   mEPSC   frequency.   These  
receptors  can  later  be  re-­inserted  into  the  membrane,  but  the  time  taken  for  this  to  occur  
is  of  the  order  of  2.5  hours  (Gray  et  al.,  2003),  much  longer  than  what  is  reported  here  
for  phase  3.  Because  this  resurgence  may  likely  be  caused  by  5-­HT2CR  activation,  it  is  
possible  that  5-­HT2AR  internalisation  during  phase  2  may  be  involved  in  the  decrease  in  
mEPSC  frequency.  
The  second  alternate  explanation  considers   receptor  desensitisation.   It   is   known   that  
PKC  activation  can  result  in  5-­HT2AR  and  5-­HT2CR  desensitisation  (Boddeke  et  al.,  1993;;  
Berg  et  al.,  2001).   I  note   that   in   this  context,   there  are  other   forms  of  desensitisation  
associated  with  the  signalling  cascade  (see  below).  Nevertheless,  it  is  conceivable  that  
receptor   desensitisation   may   play   a   role   in   the   second   phase,   where   the   mEPSC  
frequency  decreases.  However,  given   that   the  EPSC  depression   (see  Part  4)  did  not  
show  a  relief  with  a  similar  time  course  to  that  seen  for  mEPSCs,  the  first  two  possibilities  
are  likely  ruled  out.  
The   third  alternative   rests  upon   the   finding   that  desensitisation  of   the  5-­HT-­mediated  
response  may  depend  on  the  downregulation  of  the  G  protein  transduction.  It  is  known  
that  phosphorylation  of   the  Gαq  can  downregulate   the  signalling   response   (Shi  et  al.,  
2007).  Functionally,   this  desensitisation  of   the  signal   transduction   is   indistinguishable  
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from  that  of  the  receptor  itself.  Because  the  effect  is  quite  small  (~20%)  at  least  in  the  
expression  system  used,  I  don’t  think  that  this  mechanism  is  significantly  at  work  here.  
The  fourth  alternative  is  based  upon  the  observation  that  in  a  heterologous  expression  
system,  the  signalling  which  results   in  store  release   is  significantly  slowed  down  (~60  
seconds)  when  5-­HT2CR  had  been  subjected  to  mRNA  editing  (Price  &  Sanders-­Bush,  
2000).   A   similar   slowing   has   been   demonstrated   for   5-­HT2AR   in   platelets   as   a  
consequence  of  a  receptor  polymorphism,  where  the  delay  is  about  40  seconds  (Ozaki  
et  al.,  1997).  It  may  well  be  that  in  my  preparation,  most  likely  downstream  of  5-­HT2CR,  
the  signalling  causing  store  release  is  even  further  delayed,  for  example  via  an  ancillary  
protein  somewhere  in  the  cascade.  This  may  give  rise  to  a  further  delay  in  store  release  
as   seen   in   phase   3.  However,   given   that   the   delay   in  my   preparation   is   an   order   of  
magnitude  longer,  I  think  that  such  a  mechanism  was  unlikely  responsible,  as  there  is  
no  evidence  in  the  literature  that  such  a  long  delay  could  have  been  generated.  
The  reason  why  DOB  only  caused  a  single  transient  frequency  increase,  rather  than  the  
two  seen  with  5-­HT,  may  stem  from  its  biased  agonism  (Berg  et  al.,  1998),  a  property  
commonly  shared  between  different  hallucinogens  (Gonzalez-­Maeso  et  al.,  2007).  The  
concept  behind  this  idea  is  that  depending  on  which  kind  of  agonist  binds  to  a  receptor,  
downstream  signalling  can  be  differentially  affected.  Since  both  5-­HT2AR  and  5-­HT2CR  
can  signal  in  either  a  classical  or  non-­classical  way,  any  agonist  could  show  a  preference  
for  both  ways.    
3.5.7.  Role  of  PKC  in  the  mEPSC  Frequency  Increase  
As  indicated  above,  PKC  may  have  played  a  central  role  in  patterning  the  5-­HT-­mediated  
mEPSC   frequency   increases.   When   PKC   was   inhibited   with   100   nM   Gö   6983,   the  
mEPSC  frequency  increase  became  sustained  for  the  whole  duration  of  the  recording.  
This  observation  implies  that  a  critical  phosphorylation  took  place  before  or  during  phase  
2.  I  offer  two  explanations  as  to  how  this  could  arise.  
First,  as  indicated  above,  PKC  itself  may  be  directly  involved  in  the  phosphorylation  of  
both  5-­HT2AR  and  5-­HT2CR.  In  fact,   it   is  known  that  phosphorylation  can  result   in  both  
receptor   internalisation   and   desensitisation   (Boddeke   et   al.,   1993;;   Berg   et   al.,   2001;;  
Bhattacharyya  et  al.,  2002;;  Shi  et  al.,  2007).  As  indicated  above,  I  don’t  think  that  there  
is   much   evidence   for   evolving   receptor   desensitisation   during   the   time   of   agonist  
exposure   in   my   preparation.   However,   it   is   also   known   that   the   MAPK   pathway,  
specifically  the  ERK  pathway,  is  very  sensitive  to  PKC  block  (Knauer  et  al.,  2009),  as  a  
number  of  kinases  are  involved  in  generating  the  output  from  this  signalling  cascade  (for  
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review   see   Adams   &   Sweatt,   2002).   I   prefer   this   explanation   over   receptor  
desensitisation  as  it  remains  consistent  with  the  observations  that  will  be  presented  in  
Part  4,  specifically  the  fact  that  for  evoked  transmitter  release,  there  is  no  evidence  of  
receptor  desensitisation  causing  a  relief  from  depression.  
In  this  context,   it   is  important  to  point  out  that  constitutive  5-­HT2R  activity  (see  above)  
also   has   implications   for   downstream   signalling.   In   fact,   it   is   known   that   this   type   of  
activity  leads  to  increased  receptor  phosphorylation  and  consequently  a  higher  degree  
of  desensitisation  (Westphal  et  al.,  1995).  This  may  well  explain  the  finding  that  when  5-­
HT2CR  alone  or  in  combination  with  5-­HT2AR  were  blocked,  the  mEPSC  frequency  during  
control   rose,   suggesting   that   when   the   antagonist   was   bound   to   the   receptor,   the  
constitutive  activity  was   relieved  and  with   it,   the  downstream  signalling   that  may  well  
have  resulted  in  the  phosphorylation  of  either  the  receptor  or  the  associated  signalling  
proteins.  
Second,  an  alternative  explanation  for  the  pattern  in  the  frequency  increases  rests  upon  
reports  showing  that  several   isoforms  of  PLCβ  are  also  subject   to  phosphorylation  by  
PKC  (Ryu  et  al.,  1990;;  Strassheim  et  al.,  1998;;  Strassheim  &  Williams,  2000;;  Yue  et  al.,  
2000;;   Xu   et   al.,   2001).   In   doing   so,   the   downstream   signalling   by   5-­HT2R   may   be  
curtailed.  This  explanation  would  functionally  be  no  different  to  receptor  desensitisation,  
except   that   in   this   case   the   mechanism   of   “desensitisation”   is   at   the   level   of   the  
downstream  signalling  cascade.  Such  a  mechanism  has  so  far  not  been  identified  for  5-­
HT2R,  and,  as  a  consequence,  it  is  unlikely  responsible  for  the  observations  made  here.  
Because  it  is  known  that  G-­protein-­coupled  receptor  kinases  (GRKs)  are  also  involved  
in  5-­HT2R  phosphorylation  and  desensitisation  (Sallese  et  al.,  2000),  the  question  arises  
if  Gö  6983  specifically  blocked  PKC  without  having  an  effect  on  GRKs.  However,  I  have  
not  been  able  to  find  any  evidence  that  GRKs  could  be  blocked  by  this  compound.  This  
inhibitor  seems  to  be  quite  specific  for  most  isoforms  of  PKC  and,  consequently,  rules  
phosphorylation  by  GRK  most  likely  out.  
An  interesting  point,  that  came  to  light  after  all  experiments  were  done,  is  the  fact  that  
both  5-­HT2CR  and  PKC  block  resulted  in  the  same  increase  in  mEPSC  frequency  during  
control,   but   no   such   increase   was   seen   when   5-­HT2AR   were   blocked.   This   is   highly  
suggestive  of  PKC  activation  downstream  of  5-­HT2CR.  Future  experiments  could   look  
into  this  more  specifically.  
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3.5.8.  Verification  of  Downstream  Signalling  
The  discussion  here  is  intended  to  punctually  verify  which  signalling  cascade  is  activated  
by  5-­HT2R  to  the  increase  the  mEPSC  frequency.  I  note  that  I  did  not  extensively,  but  
only  tested  for  some  crucial  steps  in  the  signalling  cascade.  
Most  of  the  experiments  presented  in  this  context  were  performed  with  PKC  inhibited,  
just  to  make  sure  that  the  changes  associated  with  receptor  activation  stood  out  more  
and  for   longer.  The  classical  signalling  cascade  would   involve  the  activation  of  PLCβ,  
the  subsequent  production  of   IP3  and  DAG,  the  activation  of   IP3  receptors,  and  finally  
Ca2+  release  from  stores.  
I  note  that  there  was  a  potential  confound  in  several  experiments  with  blockers  of  steps  
in  the  signaling  cascade  relating  to  the  complication  of  responders  and  nonresponders  
and   possible   sampling   bias.   As   for   the   latter,   such   experiments   cannot   provide   any  
insight,  the  question  arises  if  a  sufficient  number  of  responders  were  in  each  data  set.  In  
most  sets  of  experiment,  there  were  at  least  6  –  8  cells.  Given  that  in  a  randomly  obtained  
set  of  cells,  about  half  of  the  cells  correspond  to  responders  and  non-­responders  (as  in  
3.4.2.1),  the  probability  of  all  cells  being  of  one  group  only  is  very  small,  namely  (0.47)6  
=  0.01  and  (1  -­  0.47)6  =  0.02,  respectively;;  or  in  other  words,  it  was  very  unlikely  that  in  
any  of  the  relevant  experiments,  there  were  only  non-­responders  or  responders;;   i.e.   it  
was  very  likely  that  cells  of  both  groups  were  contained  in  the  data  sets.  Nevertheless,  
this  possibility  cannot  be   ruled  out.  Because  of   this,   I  attempted   to  provide  additional  
evidence  by  checking  if  alternative  properties  like  the  typical  inward  current  and  the  size  
of  the  change  in  Rin  were  indicative  of  responders.  Based  on  these  criteria,  I  found  that  
in  each  set  of  experiments,  there  were  at  least  two  to  three  responders.    
3.5.8.1.  Involvement  of  PLCβ  
As  5-­HT2R  are  linked  to  Gq,  signalling  downstream  of  G-­protein  activation  is  most  likely  
via  one  of  the  four  isoforms  of  PLCβ,  namely  PLCβ1  –  4.  Most  of  them  are  expressed  in  
neocortex   (Yamada   et   al.,   1991;;   Shimohama   et   al.,   1998;;   Watanabe   et   al.,   1998).  
Certainly,  the  isoforms  PLCβ1  -­  3  can  be  activated  by  Gαq.  I  note  that  the  same  isoforms  
can  also  be  activated  by  Gβγ  (Exton,  1994;;  Rhee  &  Bae,  1997;;  Rhee,  2001).  However,  
the  concentrations  required  for  activation  by  Gβγ  are  much  higher   than  for  Gα.  PLCβ  
was   blocked   using   30   µM   edelfosine,   an   ether   lipid   analogue   (Powis   et   al.,   1992;;  
Horowitz  et  al.,  2005).  I  chose  this  compound  over  others  like  U73122  because  the  latter  
showed  an  unspecific  effect  on  Ca2+-­activated  cation  channels  as  shown  in  pancreatic  
acinar  cells  (Mogami  et  al.,  1997;;  Horowitz  et  al.,  2005).  
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My  main  finding  was  that  with  PLCβ  blocked  (and  in  the  presence  of  Gö  6983),  in  most  
cells,  the  mEPSC  frequency  increase  was  prevented.  I  note  that  in  these  experiments,  I  
did  not  test  for  the  effect  of  edelfosine  on  its  own,  as  this  was  tested  in  a  previous  study,  
which  reported  that  there  is  tonic  PLCβ  activation  in  this  part  of  the  cortex  (Choy,  2011;;  
Choy   et   al.,   2017a).  With   PLCβ   blocked,   5-­HT   was   unable   to   increase   the   mEPSC  
frequency.   This   finding   is   consistent  with   the   involvement   of   a   classical  Gq-­mediated  
transduction  in  that  PLCβ  activation  leads  to  PIP2  hydrolysis  and  the  production  of  IP3  
and  DAG.  
3.5.8.2.  IP3R  Activation  
In   the  classical  cascade,   the  production  of   IP3  activates   IP3R,   leading   to  Ca2+  release  
from   stores.   To   test   this   idea,   I   blocked   IP3R   with   16   µM   2-­APB.   I   note   that   at   this  
concentration,   the  action  of   2-­APB  was   found   to  be  quite   specific   to   IP3R   (Simkus  &  
Stricker,  2002a;;  Hirst  et  al.,  2008).  However,  I  note  that  at  higher  concentrations,  which  
are  typically  used  to  block  TRP  channels  (Chinopoulos  et  al.,  2004),  the  plasmalemmal  
Ca2+-­ATPase  (Maruyama  et  al.,  1997),   the  SERCA  pump  (Bilmen  et  al.,  2002),  store-­
operated  Ca2+  channels   (Dobrydneva  &  Blackmore,  2001),  and  connexins   (Bai  et  al.,  
2006),  2-­APB   is  unspecific.  Consistent  with   this  hypothesis,  when   the   receptors  were  
blocked,   again   no   increase   in   mEPSC   frequency   was   observed.   This   outcome   is  
internally  consistent  with  that  seen  with  edelfosine  and  further  supports  the  idea  that  2-­
APB  blocked  IP3R.    In  accordance  with  this  observation,  IP3R  are  likely  involved  in  the  
generation  of  mEPSCs,  consistent  with  Ca2+  store  release.  
3.5.8.3.  Ca2+  Release  from  Stores  
Given  that   in  this  preparation  the  generation  of  mEPSCs  is  not  dependent  on  random  
openings  of  VDCC,  but   requires   intracellular  Ca2+   release   (Simkus  &  Stricker,  2002a;;  
Choy  et  al.,  2017a),  presynaptic  chelation  by  BAPTA-­AM  should  abolish  the  frequency  
increase.  This  was  indeed  the  case  as  in  none  of  the  relevant  experiments,  an  increase  
in  mEPSC  frequency  was  observed.  This  is  again  consistent  with  the  idea  that  5-­HT2R  
activation   results   in   the   stimulation   of   the   classical   Gq-­mediated   signalling   cascade.  
However,  it  needs  to  be  stressed  that  even  though  this  cascade  is  most  likely  involved,  
it  does  not  preclude  that  DAG  may  also  activate  PKC  and/or  MAPK.  
3.5.9.  Functional  Consequences  
5-­HT   is   functionally   involved   in  many  different  brain  states  and  behaviours   like  mood,  
perception,  memory,   anger,   aggression,   fear,   stress   responses,   appetite,   and   sexual  
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behaviour   (Berger   et   al.,   2009).   It   is   also   critically   implicated   in   the   development   of  
neocortex,  and,  specifically,  in  the  patterning  of  barrel  cortex  (Erzurumlu  &  Kind,  2001).  
Furthermore,   5-­HTR   have   been   linked   to   several   neuropsychiatric   syndromes   like  
depression,   schizophrenia,   Parkinson’s   disease,   and   abnormal   mental   states   like  
delirium,  addiction,  psychosis,  anxiety  and  obsessive-­compulsive  disorders  (for  review  
see  Chagraoui  et  al.,  2016;;  Di  Giovanni  &  De  Deurwaerdere,  2016).  In  addition,  it  has  
long   been   known   that   several   antipsychotic   drugs   like   haloperidol   and   clozapine  
(neuroleptics)   have   a   pronounced   blocking   effect   on   5-­HT2AR   with   the   respective  Ki  
values   in   the   range  of  53  and  5.4  nM,   respectively   (Kroeze  et  al.,  2003).  However,   it  
needs   to  be  stressed   that  such  drugs  are  highly  unspecific  and  are   reported   to  block  
other  receptors  as  well.  
As  explained  in  the  introduction,  there  are  seven  5-­HTR  groups  in  mammals  (Hoyer  et  
al.,  1994;;  Pytliak  et  al.,  2011),  with  six  of  them  giving  rise  to  some  twenty-­three  G-­protein-­
coupled  receptor  subtypes.  In  addition,  there  is  one  ionotropic  group  (5-­HT3R)  with  five  
different  subunits   (5-­HT3A  –  E),  not   including   their  alternatively  spliced  or  mRNA  edited  
isoforms.   This   complexity   in   5-­HTR  expression,   in   combination  with   the   possibility   of  
receptor   heterodimerization   or   multimerization,   and   the   diverse   coupling   to   various  
signalling  cascades  opens  up  a  vast  possibility  for  differential  cellular  responses.  It  is  not  
surprising   that  under  such  conditions,  specific   functions  and  dysfunctions  are  hard   to  
specifically  attribute  to  specific  receptor  subtypes.  
In  this  part  of  my  thesis,  I  have  largely  concentrated  on  the  effect  of  5-­HT  on  spontaneous  
transmitter   release   and   essentially   found   that   within   this   context,   the   significant  
contributors   are   predominantly   5-­HT2CR   with   a   smaller   contribution   by   5-­HT2AR.  
Admittedly,   whilst   both   receptors   are   critically   involved   in   shaping   the   properties   of  
thalamocortical  afferents   in   layer  IV  of  barrel  cortex  during  development  (Erzurumlu  &  
Kind,  2001),  their  functional  role  in  layer  II  is  much  less  clear.  Given  that  the  impact  on  
mEPSC  frequency  is  not  above  detectability  beyond  P28,  5-­HT  may  likely  be  involved  in  
the  developmental  fine  tuning  of  specific  networks,  which  certainly  contain  responders.  
However,  as  Rin  is  reduced  and  GIRK  channels  are  activated  in  non-­responders  as  well,  
5-­HT  is  also  involved  in  tuning  of  the  networks  made  up  of  non-­responders,  but  not  of  
their  synapses.  
Whilst  a  considerable  body  of  evidence  exists  for  a  role  of  5-­HT  in  synaptic  plasticity  in  
Aplysia   (Eliot   et   al.,   1993;;   Alberini   et   al.,   1994;;   Martin   et   al.,   1997),   the   situation   in  
mammals   is  much   less  clear.  At   the  cellular   level,  5-­HT  has  been  documented   to  be  
involved  in  some  forms  of  synaptic  plasticity,  specifically  in  LTP  and  LTD  in  visual  cortex,  
both  in  vivo  and  in  vitro  (Kojic  et  al.,  2000).  Interestingly,  both  forms  of  plasticity  depend  
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on  the  expression  of  5-­HT2CR.  Whilst  LTP  is  typically  observed  in  areas  of  high  receptor  
expression  (blobs  in  V1),  LTD  is  observed  in  areas  with  low  expression.  As  5-­HT2CR  are  
capable  of  inducing  Ca2+  release  from  intracellular  stores,  it  is  conceivable  that  the  locally  
increased  Ca2+  from  stores  may  serve  to  lower  the  threshold  for  induction  of  LTP  or  LTD  
(Bienenstock  et  al.,  1982).  In  this  context,  the  triphasic  nature  of  the  mEPSC  frequency  
increase  may  serve  as  the  relevant  “patterning”  that  may  ensure  efficient  induction  and  
expression   of   the   respective   long-­term   plasticity.   The   issue   here   is   that   desensitised  
receptors/signalling  cascade(s)  (as   in  phase  2)  may  not  be  able  to  sufficiently  elevate  
the  local  Ca2+  above  the  induction  threshold  for  long  enough,  but  upon  the  resurgence  
during  phase  3,  this  may  become  possible.  
The  outcome  of  long-­term  synaptic  plasticity  is  often  growth  of  dendrites  and  spines  (for  
review   see   Yuste   &   Bonhoeffer,   2001).   There   is   evidence   that   one   of   the   roles   of  
spontaneous   transmitter   release   is   that   it   serves   to  maintain  spines   (McKinney  et  al.,  
1999).  As  a  consequence,  5-­HT  could  facilitate  the  formation  and  maintenance  of  spines,  
which  has  been  observed  in  tissue  cultures  (Pfister  &  Goworek,  1978;;  Chubakov  et  al.,  
1986;;  Yoshida  et  al.,  2011).  In  addition,  5-­HT  may  exert  a  trophic  effect  on  neurons  in  
neocortex,  potentially  similar  to  that  caused  by  brain-­derived  neurotropic  factor  (BDNF)  
or  some  other  growth  factors,  which  typically  signal  via  receptor  tyrosine  kinases  (RTK).  
In  fact,  5-­HT2R  are  reported  to  be  able  to  cause  transactivation  of  RTK,  for  example  of  
glia-­derived  neurotrophic  factor  (Tsuchioka  et  al.,  2008),  but  also  of  BDNF  (Vaidya  et  al.,  
1997).  Because  constitutive  activity  is  likely  involved  in  vivo  and  a  considerable  extent  of  
receptor  desensitisation  (see  above)  exists  with  these  receptors,  the  functional  outcome  
of   receptor   activation   may   likely   be   small.   However,   when   5-­HT2R   are   blocked   by  
antagonists,   the   constitutive   activity  may   cease   and   desensitisation  may   be   relieved.  
This  could  result  in  the  functional  “re-­sensitisation”  of  these  receptors.  This  is  most  likely  
the  mechanism  at  work  that  may  explain  the  rapid  antidepressant  effects  seen  with  some  
5-­HT2R  antagonists  (Opal  et  al.,  2014).  
A  full  appreciation  of  the  functional  impact  of  5-­HT  on  transmitter  release  is  likely  linked  
to  a  detailed  understanding  of  its  impact  on  evoked  release.  This  will  be  investigated  in  
the  next  part,  with  the  idea  that  if  there  is  a  transient  increase  in  spontaneous  release,  
evoked  release  would  be  affected  in  a  similar  way.
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4.  Modulation  of  Evoked  Release  
4.1.  Introduction  
In   contrast   to   the   considerable   number   of   studies   on   the   serotonergic  modulation   of  
spontaneous   glutamate   release   in   neocortex,   only   few   studies   have   investigated   the  
modulation   of   evoked   release   in   this   area   of   brain   (Tanaka   &   North,   1993;;   Torres-­
Escalante  et  al.,  2004;;  Komlosi  et  al.,  2012;;  Barre  et  al.,  2016).  
Specifically,  Tanaka  and  North  (1993)  showed  that  in  layer  V  pyramidal  cells  of  the  rat  
cingulate   cortex,   5-­HT   depressed   the   EPSP   amplitude   evoked   by   extracellular  
stimulation   of   either   the   subcortical   white   matter   or   layer   V   itself.   In   this   study,   the  
receptor  causing  the  depression  was  identified  as  5-­HT1BR.  Barre  et  al.  (2016)  showed  
that  at  thalamocortical  synapses  onto  layer  V  pyramidal  neurons  in  the  mPFC,  activation  
of   presynaptic   5-­HT2AR   potentiated   NMDA   receptor-­mediated   EPSCs.   In   contrast   to  
these   two   studies,   which   focussed   largely   on   synapses   formed   by   extracortical  
projections,   Torres-­Escalante   et   al.   (2004)   stimulated   layer   V   neurons   of   the   rat  
somatosensory  cortex  with  a  bipolar  electrode  and  demonstrated  that  5-­HT  via  activation  
of  both  5-­HT1R  and  5-­HT2R,  altered  the  release  probability  at  glutamatergic  synapses  
made  onto  layer  II  pyramidal  cells.  
These   three   studies   mentioned   remained   incomplete   because,   first,   their   research  
method   (extracellular   stimulation)   activated   an   inhomogeneous   set   of   synapses,   and  
second,  whilst  the  authors  determined  which  5-­HTR  were  activated,  they  did  not  address  
the  downstream  molecular  targets  of  modulation.    
The  use  of  extracellular  stimulation  might  have  resulted  in  an  unspecific  stimulation  of  
presynaptic  fibres  of  various  origins.  The  lack  of  stimulus  specificity  was  partially  solved  
by  Komlosi  et  al.  (2012),  who  recorded  a  limited  set  of  cell  pairs  in  human  tissue  obtained  
during  surgery.  This  study  provided  extremely  valuable  insights  by  finding  that,  in  pairs  
of  layer  II  pyramidal  cells,  activation  of  5-­HT2R  caused  a  depression  of  unitary  EPSPs  
by  more  than  50%.  Unfortunately,  again,  they  only  specified  the  involvement  of  5-­HT2R  
without  elucidating  the  signalling  cascade  downstream  of  its  activation.  
In  analogy  with  this  finding,  a  previous  line  of  research  in  this  laboratory  unveiled  that  in  
connected  pairs  of   layer   II   pyramidal  neurons,  activation  of  presynaptic  α1-­AR  by  NA  
depressed  the  EPSC  amplitude  by  about  two  thirds  (Choy  et  al.,  2017b).  Because  there  
was  a  dissociation  between  a  concomitant  increase  in  the  mEPSC  frequency,  but  a  large  
depression  in  evoked  transmitter  release,  the  mechanism  employed  by  NA  was  found  to  
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rest   upon   a   Gβγ-­mediated   inhibition   of   the   release  machinery,   most   likely   SNAP-­25  
(Gerachshenko  et  al.,  2005;;  Yoon  et  al.,  2007).  This  mechanism  was  different  from  the  
“classical”   signalling   cascade   downstream   of   α1-­AR   activation   which   involved  
spontaneous  presynaptic  Ca2+  store  release.    
In  a  further  effort  to  check  if  similar  or  different  mechanisms  were  also  employed  when  
activating  5-­HT2R,  which  are  also  linked  to  Gq  signalling,  I  examined  the  impact  of  5-­HT  
on  evoked  glutamate  release.  In  this  part  of  my  thesis,  I  will  present  data  how  both  NA  
and  5-­HT  affected  EPSCs  recorded  in  pairs  of  layer  II  pyramidal  cells  in  barrel  cortex.  
Subsequently,   I   will   discuss   how,   downstream   of   5-­HT2R   activation,   an   increase   in  
spontaneous  release  can  be  reconciled  with  a  large  depression  of  evoked  EPSCs.  
4.2.  Specific  Hypotheses  
Analogous   to   the   modulation   of   evoked   EPSCs   by   NA,   I   propose   the   following  
hypotheses  for  the  5-­HT-­mediated  modulation  of  evoked  EPSCs:  
1)   5-­HT  depresses  evoked  glutamate  release  in  pairs  of  pyramidal  cells.  
2)   This  depression  is  caused  by  activation  of  presynaptic  5-­HT2R,  which  are  coupled  
to  a  Gq  signalling  cascade.    
3)   As  with  NA,  downstream  of  5-­HT2R  activation,  the  EPSC  depression  is  caused  
by  Gβγ,  most  likely  resulting  in  the  direct  inhibition  of  the  SNARE  complex.  
  
Consequently,  in  connected  pairs,  I  first  characterized  the  electrophysiological  properties  
of   both   pre-­   and   postsynaptic   pyramidal   cells   in   layer   II   of   rat   barrel   cortex.   I   then  
assessed  the  monosynaptic  EPSCs  between  them,  including  their  responses  to  a  paired-­
pulse  stimulus  (4.4.1).  I  found  that  the  electrophysiological  and  synaptic  properties  of  the  
pairs  of  pyramidal  cells  presented  in  this  thesis  were  not  different  to  those  in  the  data  set  
with  NA,  allowing  a  direct  comparison  of  the  two  sets.  Second,  I  provide  data  quantifying  
the  5-­HT  mediated  changes   in  both   the  presynaptic  APs  and  postsynaptic  properties,  
including  characterising  the  respective  EPSCs.  Furthermore,  I  performed  experiments  to  
determine  which  5-­HTR  were  activated  to  cause  this  depression  (4.4.2).  Besides  some  
subtle  changes  to  the  APs,  I  discovered  that  5-­HT  depressed  unitary  EPSCs  by  49  ±  3%.  
Concomitantly,  the  presynaptic  cells  typically  hyperpolarized  and  showed  a  small  drop  
in  Rin,  whereas   the  postsynaptic  cells  showed  a  variable  but  small   change   in  holding  
current,  together  with  a  large  drop  in  Rin.  The  depression  was  mimicked  by  the  5-­HT2R  
agonist  α-­methyl-­5-­HT.  Third,  I  also  present  data  for  the  depression  caused  by  NA,  and  
make  comparisons  between  the  depression  caused  by  5-­HT  and  that  by  NA  (Choy  et  al.,  
2017a;;  Choy  et  al.,  2017b;;  sub-­part  4.4.3).  I  observed  that  the  depression  caused  by  5-­
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HT  was  smaller  than  that  by  NA.  In  addition,  the  depression  by  NA  was  caused  by  Gβγ  
as  a  peptide  that  “chelates”  the  dimer  subunit  was  able  to  prevent  the  depression.  Fourth,  
I  elucidated   the  signalling  downstream  of  5-­HT2R  activation   (4.4.4)  and   found   that  as  
with  NA,  the  depression  was  also  caused  by  Gβγ.  However,  in  the  case  of  5-­HT  but  in  
contrast  to  NA,  there  was  neither  a  speed-­up  in  the  recovery  from  the  depression  (R50)  
nor  a  decrease  in  quantal  size.  These  findings  suggest  that  in  contrast  to  the  depression  
by  NA,  where  Gβγ  directly  inhibited  the  SNARE  complex,  the  targets  of  Gβγ  downstream  
of  5-­HT2R  activation  were  most   likely  Ca2+  channels.   In  4.4.5,   I   then  brought   together  
different  aspects  to  reveal  that  there  was  specificity  in  the  5-­HT-­mediated  modulation  of  
transmitter   release.  Specifically,   I   found   that   in  my  paired  recordings,  non-­responders  
were   typically   pre-­,   but   responders   postsynaptic.   To   directly   test   this   specificity,   I  
performed   experiments   where   I   was   able   to   confirm   this   arrangement   within   the  
microcircuit  in  layer  II.      
4.3.  Methods  and  Analyses  
Most  aspects  in  regard  to  solution  and  slicing  have  already  been  described  earlier.  Only  
specific  aspects  not  covered  previously  will  be  presented  in  this  part.  
4.3.1.  Obtaining  Paired  Recordings  
Modulation  of  evoked  release  was  investigated  in  paired  recordings  of  layer  II  pyramidal  
cells  in  the  somatosensory  cortex  in  rats  aged  P15  –  19.  These  cell  pairs  were  connected  
through  glutamatergic  synapses  made  up  of  predominantly  AMPA  receptors  (Tsumoto  
et  al.,  1990).  In  this  section,  I  will  describe  in  detail  how  to  find  connected  cell  pairs  and  
perform  the  recordings.  
One  of  the  most  important  aspects  in  obtaining  a  successful  paired  recording  is  choosing  
the   “optimal”   slice   in   which   the   connectivity   between   layer   II   pyramidal   cells   is   well  
preserved.  With  parasagittal  slices  obtained  at  a  cutting  angle  of  15°  from  the  midline,  
the  “optimal”  slice  was  typically  the  5th  slice  in  brains  of  these  rats;;  i.e.  5.0  –  5.3  mm  down  
from  the  lateral  poles  towards  the  midline  cut.  In  some  instances,  the  4th  slice  could  also  
contain  connected  cell  pairs.  Once   the  slice  with   the  best  conserved  connectivity  had  
been  selected  and  placed  into  the  recording  chamber,  the  temperature  of  the  superfusing  
ACSF  was  strictly  maintained  at  36  ±  1°C,  which  is  within  the  physiological  temperature  
range.   A   lower   temperature   was   found   to   result   in   a   significantly   smaller   rate   of  
connectivity;;  i.e.  connected  cell  pairs  were  much  harder  to  find,  consistent  with  an  earlier  
report  (Hardingham  &  Larkman,  1998).  
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In  order  to  successfully  obtain  cell  pairs,  I  adhered  to  the  following  five  criteria.  1)  The  
connectivity  between  pyramidal  cells  was  best  in  an  area  of  tissue  in  which  4  –  5  cells  
grouped  together  in  very  close  proximity.  I  refer  to  this  aggregation  as  a  “nest”  of  cells.  
2)   The   distance   between   somata  was   typically   less   than   25   µm.   2)   Connected   cells  
usually  had  their  somata  more  or  less  in  the  same  optical  plane  as  judged  with  the  40x  
lens.  4)  Both,  the  apical  dendrites  and  the  axon  initial  segments  remained  parallel  to  the  
optical  plane.  5)  If  two  somata  were  vertically  aligned  with  the  top  one  slightly  offset  from  
the   bottom   one   (see   also   Fig.   4.3.1),   the   connectivity   was   greater   than   if   they   were  
horizontally  aligned.  
If   two   neurons   fulfilled   these   criteria,   both   of   them   were   patched   in   the   whole-­cell  
configuration  using  the  same  intracellular  solution  as  specified  in  Part  2,  unless  stated  
otherwise.  
4.3.2.  Recording  Conditions  
For  connected  pairs,  recordings  were  performed  as  follows.  Using  a  MultiClamp  700A,  
the   presynaptic   cell   was   kept   in   current-­clamp  with   the   bridge   balance   automatically  
compensated  using  the  MultiClamp  Commander.  The  resting  membrane  potential  (Vrest)  
was  then  measured  and  allowed  to  float  freely,  except  in  some  cases  when  it  was  >  -­60  
mV.  In  these  instances,  a  constant  hyperpolarizing  bias  current  of  ~200  pA  was  delivered  
to  restore  a  normal  Vrest.  A  paired-­pulse  protocol  was  employed  to  elicit  two  APs  at  an  
interval  of  50  ms  which  were  evoked  by  short  current  steps  of  5  ms  duration  and  an  
amplitude  of  ~1.8  nA.  Such  a  trial  was  repeated  every  5  s  (0.2  Hz)  for  a  minimum  of  10  
times.  The  low  frequency  repetitions  were  chosen  to  minimise  the  induction  of  long-­term  
depression   as   described   by   Feldmeyer   et   al.   (2006).   The   presynaptic   membrane  
potential  was  sampled  at  5  kHz  after  filtering  at  10  kHz  using  the  same  sample-­and-­hold  
amplifier.  
The   respective   recording   arrangements   are   shown   in   Fig   4.3.1.   The   DIC   image   is  
presented  in  A  with  the  two  somata  of  the  pyramidal  cells  patched  with  two  electrodes.    
The  postsynaptic  cell  was  kept   in  voltage-­clamp  at  a  holding  potential  of  -­70  mV.  The  
two   evoked   unitary   EPSCs,   used   to   gauge   short-­term   plasticity   like   depression   or  
facilitation  (B),  were  also  sampled  at  5  kHz  after  filtering  at  1  kHz.  Series  resistance  (Rs)  
was  monitored  continuously  by  recording  the  current  response  to  a  voltage  step  of  0.5  
mV  for  40  ms  at  the  end  of  every  trial.  Rs  was  not  compensated  as  it  introduced  additional  
electronic   feedback   noise   into   the   recording,   which   negatively   affected   the   signal-­to-­
noise  ratio  of  unitary  EPSCs.  
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Connectivity  existed  if,  after  on-­line  averaging  of  10  stimulus  trials,   two  EPSCs  above  
baseline  noise  and  with  a  delay  of  <  3  ms  to  the  presynaptic  APs  were  evident  (A).  The  
connectivity  between  two  cells  was  checked  in  both  directions  to  establish  whether  it  was  
unidirectional  or  reciprocal.  In  cases  of  the  latter,  the  direction  that  produced  the  larger  
EPSC  amplitude  was  chosen  for  the  subsequent  experiment.  The  control  period  typically  
consisted   of   300   trials,   after   which   10   µM   5-­HT   was   added   to   the   superfusate.  
Subsequently,  the  recordings  were  resumed  for  at  least  another  300  trials.  
To   monitor   synaptic   dynamics,   I   evoked   20   APs   at   a   frequency   of   50   Hz   in   the  
presynaptic  cell  to  induce  a  steady-­state  EPSC  depression.  Thereafter,  with  an  interval  
of  500  ms,  I  evoked  another  AP  to  measure  the  recovery  from  steady-­state  depression  
(Fuhrmann  et  al.,  2004).  
The  data  were  stored  on  a  computer  disk  using  custom-­made  IGOR  Pro  procedures.  
  
Figure  4.3.1.  Paired  recordings.  
A.  DIC   image  of   the   two   recorded   cells   in   layer   II  with   the   tips   of   the   respective   patch  
electrodes  visible.  Superimposed  are   the   traces  of   the  AP   (black)  and   the  postsynaptic  
EPSC  (blue).  B.  Time  courses  of  the  of  two  elicited  APs  (50  ms  interval;;  black)  and  the  
evoked   average  EPSCs   (blue).   C.  Overlay   of   the   time   courses   of   the   first   AP   and   the  
respective  EPSC  indicating  the  synaptic  delay.  The  two  pairs  of  cursors  indicate  where  and  
how  the  amplitude  of  the  EPSC  was  measured.  
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4.3.3.  Intracellular  Solution  
In  most  experiments,  the  standard  intracellular  solution  as  in  Part  3  was  used.  In  addition,  
in  some  experiments,  100  µM  of  the  commercially  available  myristoylated  Gβγ-­binding  
peptide  mSIRK  (Goubaeva  et  al.,  2003)  was  added  to   the  presynaptic  patch  solution.  
The  addition  of  this  peptide  increased  the  osmolality  of  the  patch  solution  from  303  to  
~310   mOsm/kg   H2O.   However,   since   this   value   remained   lower   than   the   standard  
osmolality  of  the  ACSF,  which  was  around  320  mOsm,  no  further  dilution  was  performed.  
Likewise,   the   synthesized   C-­terminal   peptide   of   SNAP-­25   (ct-­SNAP-­25),   which   also  
scavenges  Gβγ,  was  added  to  the  presynaptic  patch  solution  in  a  few  experiments.  The  
final   concentration   of   this   ct-­SNAP-­25   was   set   to   8   mg/ml   (=   5.41   mM).   Again,   no  
adjustments  needed  to  be  made  to  the  patch  solution  when  this  peptide  was  added.  
4.3.4.  Analysis  of  EPSCs  
Analysis  was  performed  by  displaying  the  AP  together  with  the  corresponding  EPSC.  In  
order  to  avoid  any  contamination  by  spontaneous  EPSCs,  each  EPSC  amplitude  was  
manually  examined  and  measured  as  the  difference  between  the  averages  of  two  time  
windows,  one  at  the  peak  (1  ms)  and  the  another  before  the  onset  of  the  EPSC  (2  ms  
baseline;;  Fig.  4.3.1C).  If  the  baseline  or  rise-­time  was  contaminated  by  a  spontaneous  
EPSC,  the  trial  was  discarded  without  replacement.  The  membrane  current  noise  (σn)  
was  then  estimated  from  the  population  of  the  differences  between  the  averages  of  two  
equivalent  time  windows  along  the  baseline  of  the  EPSC.  These  two  windows  were  also  
chosen  such  that  they  did  not  contain  any  spontaneous  EPSCs  either.  Note,  however,  
that   the  whole-­cell  noise   (σwn)  as  used   in  4.4.5.2  was  different   to  σnoise   (as  defined   in  
3.3.2)   and  σn.  σwn   represents   the   point-­by-­point   standard   deviation   of   the  membrane  
current  over  a  large  time  window  (48  ms)  and  intentionally  did  not  exclude  spontaneous  
EPSCs.  It  was  introduced  to  capture  the  impact  of  spontaneous  release.  It  was  measured  
after   the   evoked   EPSCs   had   decayed   back   to   baseline,   not   to   be   contaminated   by  
asynchronous  release  (see  Fig.  4.4.24).  I  note  that  a  comparison  between  σnoise  and  σwn  
could  be  justified,  with  the  latter  always  being  larger  than  the  former.  But  this  cannot  be  
done  with  σn  as  the  latter  was  typically  about  half  of  either  σnoise  or  σwn.  
The   latency   from   the  peak  of   the  AP   to   that  of   the  EPSC  (peak-­to-­peak   latency)  was  
measured   during   the   last  minute   of   the   control   recording   period  and  during   the   sixth  
minute   after   5-­HT   addition,   after   which   5-­HT   had   certainly   reached   a   constant  
concentration.  The  properties  of  APs  were  measured  as  described  earlier  in  3.3.5.  The  
EPSCs  were  characterised  as  follows.  The  rise  time  was  determined  as  the  time  between  
10  and  90%  of  the  average  peak  EPSC  amplitude.  The  half-­width  was  measured  as  the  
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width  of  the  EPSC  at  half  of  its  peak  amplitude.  The  stationarity  of  EPSCs  between  two  
periods  (a  minute  each)  was  judged  by  a  Student’s  t-­test,  and  considered  stationary  if  pt  
>  0.05.  
4.3.5.  Quantification  of  Synaptic  Dynamics  







where  R50  is  the  recovery  at  50  Hz,   ERec   the  average  amplitude  of  the  recovery  EPSC,    
 E1   the  average  amplitude  of  the  first  EPSC,  and   ESS   the  average  amplitude  in  steady-­
state  depression.     was  calculated  as  the  average  of  the  last  four  EPSC  amplitudes  
during   the  50  Hz   train.  Note   that   after   a  burst   of   20  APs,   short-­term  depression  was  
always  observed  at  these  synapses;;  i.e.   ESS <   E1 .  As  a  consequence,  the  denominator  
was  always  positive,  and  hence,  R50  was  positive  if   ERec   >   E1 .  The  values  of  R50  during  
control  and  5-­HT  were  then  statistically  compared  using  a  paired  t-­test.  During  control  
condition,  the  value  was  typically  negative.  
4.3.6.  Quantal  Analysis  
Density  based  quantal  analyses  of  EPSCs  were  done  as  described  earlier  (Stricker  et  
al.,  1996a,  b;;  Cowan  &  Stricker,  2004).  In  short,  after  each  recording  fulfilled  the  quality  
criterion  of  stationarity  (i.e.  having  at  least  100  –  300  stationary  EPSCs  evoked  during  
the  control  period,  and  approximately  an  equal  number  after  NA  or  5-­HT  addition),  the  
respective  probability  density  function  (PDF)  was  formed  using  an  optimised  Gaussian  
kernel.  To   these  PDFs,  models  were   first   fitted   to   the  null   hypothesis   (H0)   that   these  
densities   could   have   resulted   from   a   unimodal   process   (gamma,   Weibull,   double  
Gaussian  and  cubic  transform  of  a  Gaussian  variable)  and,  hence,  were  not  created  by  
a  multi-­modal  process.  If  this  H0  could  be  rejected,  multimodal  models  of  transmission  
with  an  increasing  number  of  constraints  (complexity)  were  systematically  tested  against  
less  complex  models.  These  were  a)  a  quantal  model  where  the  normal  distributions  in  
the  mixture  model   are   separated  by  a   constant   increment   (i.e.   quantal   size,  Q);;   b)   a  
quantal  model  as  in  a)  but  with  quantal  variance  added  to  the  noise  variance;;  c)  a  quantal  
model  with  uniform  release  probabilities  (binomial),  with  or  without  quantal  variance;;  and  
 ESS
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d)  a  quantal  model  with  non-­uniform  release  probabilities  (compound  binomial),  with  or  
without  quantal  variance.  
Each  of   these  models  of   transmission  had   their  parameters  adjusted   to  maximise   the  
likelihood  of  the  fit   to  the  PDF.  Once  the  most  appropriate  model  of  transmission  was  
determined,  Q,  the  coefficient  of  variation  of  Q  (CVQ)  where  appropriate,  and  the  quantal  
content   (m  =  n   *   p  =  average  EPSC   /  Q)  were   calculated.  Confidence   limits   of   each  
parameter  were  estimated  using  a  balanced  bootstrap  scheme.  
4.3.7.  Statistical  Analyses  
Linear  correlations  were  evaluated  using  Pearson’s  correlation  test,  with  r  the  correlation  
coefficient,  and  pPr  the  probability  under  the  null  hypothesis  that  there  is  no  correlation.  
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4.4.  Results  
The   results   are   presented   in   five   sections,   4.4.1   –   4.4.5.   In   4.4.1,   I   will   describe   the  
electrophysiological  properties  of  both  the  pre-­  and  postsynaptic  cells  in  pyramidal  pairs.  
These   include   their  passive  membrane  properties,   the  properties  of  presynaptic  APs,  
and   those   of   the   postsynaptic   EPSCs.   In   4.4.2,   I   will   describe   how   5-­HT  modulated  
evoked   EPSCs,   accompanied   with   results   from   experiments   that   pharmacologically  
determined   which   5-­HTR   were   activated.   To   get   further   insight   into   the   molecular  
mechanism(s),  in  4.4.3,  I  will  compare  the  modulation  of  the  EPSC  by  5-­HT  with  that  by  
NA.  In  4.4.4,  I  will  present  data  from  experiments  designed  to  determine  the  signalling  
pathway  downstream  of  5-­HTR,  which  caused  the  EPSC  modulation.  In  addition,  I  will  
detail   the   results   of   quantal   analyses   based   on   density   estimation,   to   unravel   the  
downstream  target(s).  Finally,   in  4.4.5,   I  will  describe  how  5-­HT  affected  the  “network  
specificity”,  and  link  together  the  results  from  Part  3  on  spontaneous  and  from  this  Part  
on  evoked  release.  
4.4.1.  Properties  of  Pyramidal  Cell  Pairs  in  Layer  II  
4.4.1.1.  Slow  Depression  Seen  in  Most  Cell  Pairs  
I  obtained  recordings   from  56  pyramidal  cell  pairs   in   layer   II  of   the  barrel  cortex.  The  
paired-­pulse   protocol   (as   described   in   4.3.2)  was   employed   in   38   pairs,  whilst   in   the  
remaining   18   pairs,   trains   of   APs  were   applied.   The   characteristics   presented   in   the  
following  two  sections  4.4.1.1  and  4.4.1.2  are  based  solely  on  the  data  obtained  from  the  
38  cell  pairs  studied  with  the  paired-­pulse  protocol.  
A  typical  result  of  a  paired  recording  between  two  pyramidal  cells  is  shown  in  Fig.  4.4.1.  
In  this  pair,  the  presynaptic  cell  had  an  input  resistance  (Rin)  of  157  MΩ  at  Vrest  of  -­69.1  
mV,  and  Rs  of  19  MΩ.  When  two  square  current  pulses  of  1.2  nA  were  injected  at  an  
interval  of  50  ms,  two  presynaptic  APs  were  elicited  (A,  top  trace).  The  time  delay  from  
the  starting  point  of  first  current  injection  to  the  threshold  of  the  first  AP  (time  to  Vthr)  was  
3.1  ms.  The  threshold  of  the  first  AP  (Vthr)  was  -­43.7  mV.  The  difference  between  Vthr  
and  Vrest,  called  relative  membrane  voltage  difference  (Vrel),  was  25.4  mV  in  this  case.  
The  height  of  the  first  AP  (H),  measured  from  Vthr   to   its  peak,  was  70.3  mV.  The  time  
taken  from  Vthr  to  the  peak  of  AP  is  called  action  potential  rise  time  (RT),  which  in  this  
case  was  0.6  ms.  The  width  of  this  AP  at  half  amplitude  (W)  was  0.9  ms.  
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Figure  4.4.1.  Typical  recording  using  a  paired-­pulse  protocol.  
A.  Time  courses  of  the  presynaptic  membrane  potential  with  two  APs  (upper  trace)  and  the  
postsynaptic  currents  including  the  average  EPSCs  (lower  trace).  B.  Individual  peak  EPSC  
amplitudes  evoked  by  the  1st  AP  plotted  against  time  during  the  experiment.  C.  Same  as  
in   B,   but   for   the   2nd   EPSC.   D.   Minute   averages   of   the   postsynaptic  Rs   for   the   entire  
recording  period.  The  average  value  is  indicated  by  the  open  circle  and  the  value  is  plotted  
for  the  duration  of  recording  period  as  the  dashed  line.  E.  Same  as  in  D,  but  for  Rin,  pooled  
for  blocks  of  5  min.  
  
The  second  AP,  which  was  elicited  50  ms  after  the  first  one,  had  the  following  properties:  
time  to  Vthr  2.7  ms,  Vthr  -­42.7  mV,  Vrel  26.4  mV,  H  68.9  mV,  RT  0.6  ms,  and  W  was  0.9  
ms.  
For  each  AP  elicited  in  the  presynaptic  cell,  the  membrane  current  for  a  holding  potential  
of  -­70  mV  in  the  postsynaptic  cell  was  recorded.  The  postsynaptic  cell  in  this  pair  had  a  
Rin  of  135  MΩ  and  Rs  of  11  MΩ.  The  recording  noise  in  the  baseline  (σn)  was  0.7  pA.  
Each   EPSC   amplitude   was   measured   and   the   respective   average   time   course   was  
formed  from  300  trials  recorded  over  a  period  of  25  min.  It  is  shown  as  the  bottom  trace  
in  A  with  the  corresponding  AP  above.  The  average  EPSC  amplitude  was  -­41.6  ±  1.3  
pA.  The  latency  from  the  first  AP  peak  to  the  EPSC  peak  (peak  latency)  was  2.3  ms.  The  
EPSC  rise  time  was  1.7  ms  and  the  half-­width  4.1  ms.  
The  average  second  EPSC  had  the  following  properties:  average  amplitude  of  -­30.2  ±  
0.9  pA,  peak  latency  of  2.2  ms,  rise  time  of  1.6  ms,  and  half-­width  of  3.9  ms.  The  paired-­
pulse  ratio  (PPR)  for  this  pair  was  0.73  ±  0.03;;  i.e.  there  was  a  small  depression  at  this  
junction.  
The  individual  peak  EPSC  amplitudes  of  each  of  the  300  trials  are  plotted  in  B.  Note,  that  
the  EPSC  amplitude  was  not  stationary  throughout  this  recording  period.  The  average  
peak  EPSC  amplitude  for  the  first  minute  was  -­72.4  ±  9.5  pA.  The  peak  EPSC  amplitudes  
showed  a  slight  facilitation  reaching  an  average  amplitude  of  -­84.1  ±  6.0  pA  during  the  
fifth  minute.  This  was  followed  by  a  slow  depression  in  a  single  exponential  manner  (τ  =  
8.2  min),  which   finally   reached  stationarity   for   the   last  eight  minutes  of   the   recording.  
During  this  final  stationary  period,  the  average  peak  amplitudes  of  the  first  and  the  last  
minutes  were  not  significantly  different  (-­34.3  ±  4.8  vs.  34.4  ±  2.2  pA;;  pt  =  0.99),  giving  
an  average  peak  amplitude  of  -­28.3  ±  1.2  pA  for  the  whole  stationary  period.  In  this  case  
and  compared   to   its   initial  value,   there  was  a  significant  depression  by  61  ±  5%  (pt  =  
7·10-­4).  
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A  similar  pattern  was  observed  for  the  peak  amplitudes  of  the  second  EPSC,  which  also  
reached   a   stationary   period   for   the   last   8   minutes   of   recording   (C).   Specifically,   the  
average  peak  amplitudes  were  -­44.0  ±  5.7  pA  in  the  first  minute,  -­46.1  ±  4.6  pA  after  the  
initial  facilitation  (the  fifth  minute),  and  -­23.5  ±  1.2  pA  during  the  stationary  period  (the  
last  eight  minutes).  These  values  indicated  that  a  significant  slow  depression  (τ  =  11.0  
min)  by  47  ±  7%  (pt  =  5·10-­3)  occurred  for  the  second  EPSC.  Note  that  when  the  extents  
of  the  slow  depression  of  the  first  and  second  EPSCs  were  tested  with  a  Student’s  t-­test,  
no  significant  difference  was  found  (pt  =  0.14).  
In  D,  the  values  of  Rs  in  the  postsynaptic  cell,  after  pooling  for  every  minute,  are  given  
(solid  circles).  The  open  circle,  extrapolated  with  the  dashed  line,  indicates  the  average  
value  during  this  recording  period;;  i.e.  11  MΩ  throughout.  This  figure  suggests  that  the  
slow  depression  observed  in  this  case  was  not  the  result  of  a  change  in  Rs.  Likewise,  in  
E,  the  values  of  Rin  in  the  postsynaptic  cell  are  presented  after  pooling  for  five  minutes  
each  (solid  circles).  The  open  circle,  and  indicated  with  the  dashed  line  for  the  duration  
of  the  recording,  represents  the  average  value  of  135  MΩ  obtained  from  the  total  sample.  
Again,  no  significant  changes  were  seen  during  the  recording  period,  suggesting  that  a  
systematic  change  in  Rin  could  not  account  for  the  slow  depression  either.  
I  also  checked  if  this  slow  depression  affected  the  kinetics  of  the  EPSCs  (Fig.  4.4.2).  For  
this   purpose,   I   compared   the   time   courses   of   average   first   EPSC   from   1)   all   300  
repetitions  during  the  recording  (B,  black),  2)  60  repetitions  during  the  first  5  min  (A  and  
C,  dark  grey),  and  3)  60   repetitions  of   last  5  min   (A  and  D,   light  grey).  Despite  clear  
differences  in  amplitude,  i.e.  -­41.6  ±  1.3  vs.  -­72.4  ±  3.4  vs.  -­29.3  ±  1.5  pA,  respectively  
(E),   there  was   no   difference   in   the   time   courses,  when   all   the   average  EPSCs  were  
overlaid  and  peak-­scaled  to  the  same  amplitude  (F).    
Out  of  38  pyramidal  pairs  studied  in  this  manner,  32  (84%)  showed  a  slow  depression  in  
the  EPSC  amplitudes.  On  average,  the  presynaptic  cells  had  Rin  of  175  ±  15  MΩ  and  
Vrest  of  -­76.2  ±  0.8  mV.  
The  characteristics  of  the  first  AP  in  the  presynaptic  cell  were  as  follows:  time  to  Vthr  was  
3.8  ±  0.1  ms,  Vthr  -­44.1  ±  0.9  mV,  Vrel  32.1  ±  0.9  mV,  H  75.0  ±  1.5  mV,  RT  0.6  ms,  and  W  
0.9  ms.  For  the  second  AP,  the  characteristics  were:  time  to  Vthr  was  3.2  ±  0.1  ms,  Vthr    
-­43.9  ±  0.9  mV,  Vrel  32.3  ±  0.9  mV,  H  74.4  ±  1.5  mV,  RT  0.6  ms,  and  W  0.9  ms.  
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Figure  4.4.2.  EPSC  time  course  not  affected  by  slow  depression.  
A.  Individual  peak  amplitudes  of  the  first  EPSCs  plotted  vs.  recording  time  (same  data  as  
in  Fig.  4.4.1B).  The  time  course  of  the  average  EPSC  during  the  whole  period  is  presented  
in  B  (black),  that  bounded  by  the  dashed  box  to  the  left  is  shown  in  C  (dark  grey),  and  D  
for  the  box  to  the  right  (light  grey).  E.  Superposition  of  the  time  courses  presented  in  B  –  
D.  F.  Same  as  in  E,  except  that  EPSCs  are  peak-­scaled  to  the  same  value.  
  
On  average,  the  postsynaptic  cells  had  a  Rin  of  212  ±  20  MΩ  and  σn  of  0.9  ±  0.0  pA  at  a  
Rs  of  15  ±  1  MΩ.  The  average  amplitude  of  the  first  EPSC  was  -­28.4  ±  3.7  pA  during  the  
first  minute  of  recording.  The  slow  depression  occurred  at  a  single  exponential  rate  with  
an   average   time   constant   (τ)   of   10.8   ±   2.0   minutes.   Consequently,   the   first   EPSC  
amplitude   depressed   by   67   ±   2%   to   -­9.4   ±   1.3   pA   over   the   first   15   –   20  minutes   of  
recordings.  Thereafter,  in  most  cells,  the  EPSC  did  not  depress  significantly  any  further;;  
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i.e.  it  had  reached  a  stationary  period  for  at  least  5  minutes,  which  fulfilled  the  criterion  
of   stationarity.   As   the   depression   had   steadied,   such   periods   were   accepted   for  
comparisons   with   subsequent   parts   of   the   experiment.   The   average   peak-­to-­peak  
latency  for  the  first  EPSC  was  2.9  ±  0.1  ms,  the  rise  time  1.8  ±  0.1  ms,  and  half-­width  
4.5  ±  0.2  ms.  There  was  no  relationship  between  the  rate  of  the  depression  and  Rs  as  
one  might  have  expected  (ppt  =  0.18).  
Similar  to  the  first  EPSC,  the  amplitude  of  the  second  also  exhibited  a  slow  depression  
at  an  exponential  rate.  At  the  start,  the  amplitude  was  -­22.1  ±  3.6  and  at  the  end  -­6.9  ±  
1.3   pA,   which   corresponded   to   a   depression   of   68   ±   3%.   This   depression   was   not  
different  from  that  of  the  first  EPSC  (ppt  =  0.59).  The  average  value  of  τ  was  9.5  ±  1.4  
min,  again  no  different  from  that  of  the  first  EPSC  (ppt  =  0.56).  The  other  properties  of  
the  second  EPSC  were  as  follows:  peak-­to-­peak  latency  2.7  ±  0.2  ms,  rise  time  1.7  ±  0.0  
ms,  and  half-­width  4.3  ±  0.2  ms.  
From   this  set  of  data,   the   following  conclusions  could  be  drawn:  1)   In   the  majority  of  
pairs,  a  significant  depression  was  observed  within  the  first  15  –  20  min  of  recording.  2)  
In  most  cells,  the  depression  had  reached  a  stationary  amplitude  after  about  20  min.  3)  
The  time  course  of  the  EPSC  was  not  affected  by  this  depression.  
4.4.1.2.  Pairs  without  EPSC  Depression  
In   contrast   to   the   32   pyramidal   pairs   with   this   slow   depression,   6   pyramidal   pairs  
maintained  a  stationary  EPSC  amplitude  throughout  the  recording  period.  The  data  from  
such  a  pair  are  shown  in  Fig.  4.4.3.  
In  this  case,  the  presynaptic  cell  had  a  Rin  of  344  MΩ  and  a  Vrest  of  -­74.7  mV.  Two  square  
current  pulses  of  1.2  nA  amplitude,  injected  at  an  interval  of  50  ms,  elicited  two  APs  in  
this   cell   (A,   top   trace).   The   time   to   Vthr   for   the   first   AP   was   3.7   ms.   Vthr   was    
-­44.7  mV,  and  hence  Vrel  30.0  mV.  The  other  properties  of  this  first  AP  were:  H  74.8  mV,  
RT  0.5  ms,  and  W  0.6  ms.  The  second  AP  had  the  following  properties:  time  to  Vthr  2.8  
ms,  Vthr  -­44.1  mV,  Vrel  30.6  mV,  H  72.9  mV,  RT  0.5  ms,  and  W  was  0.6  ms.  
The  bottom  trace  in  A  shows  the  average  time  courses  of  EPSCs  from  the  300  repetitions  
recorded  over  25  minutes.  The  postsynaptic  cell  had  a  Rin  of  308  MΩ  and  a  σn  of  1.0  pA  
at   a  Rs   of   11  MΩ.  The   respective   individual   peak   amplitudes   of   the   first  EPSC  were  
stationary,   as   shown   in   B,   in   which   the   average   value   for   the   first   12   points  
(corresponding  to  one  minute)   is  not  significantly  different   to   that  of   the   last  12  points    
(-­9.7  ±  3.1  vs.  -­9.3  ±  2.0;;  pt  =  0.92).  
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The  average  value  throughout  the  25  minutes  recording  period  was  -­12.4  ±  0.5  pA.  Other  
properties  of  the  average  first  EPSC  were  as  follows:  peak-­to-­peak  latency  2.4  ms,  rise  
time  1.4  ms,  and  half-­width  3.7  ms.  
The  second  EPSC  is  shown  in  C  and  had  an  average  amplitude  of  -­9.4  ±  0.5  pA.  Similar  
to  the  first,  the  second  EPSC  was  also  stationary  as  there  was  no  significant  difference  
in  the  average  peak  amplitude  between  the  first  12  points  and  the  last  12  points  (-­8.9  ±  
3.2  vs.  -­6.2  ±  1.8;;  pt  =  0.46).  The  value  of  PPR  was  0.76  ±  0.05,  again  indicating  a  small  
short-­term  depression.  The  other  properties  of   this  second  EPSC  were:  peak-­to-­peak  
latency  2.2  ms,   rise   time  1.6  ms,  and  half-­width  3.6  ms.   In  D,   the  values  of  Rs   in   the  
postsynaptic  cell  for  every  minute  are  shown  (solid  circles).  The  open  circle  represents  
the  average  value  in  this  recording.  This  average  value  is  indicated  by  the  dashed  line  
throughout.  The  values  of  the  postsynaptic  Rin  for  every  5  minutes  are  shown  in  E  (solid  
circles),   with   both   the   open   circle   and   the   dashed   line   indicating   the   average   value  
throughout  the  recording.  
In  this  set  of  6  pairs,  the  presynaptic  cells  had  a  Rin  of  157  ±  43  MΩ  and  a  Vrest  of  -­74.8  
±  1.1  mV.  The  average  values  of  the  first  AP  were:  time  to  Vthr  3.8  ±  0.2  ms,  Vthr  -­38.5  ±  
4.1  mV,  Vrel  37.6  ±  4.9  mV,  H  70.7  ±  2.6  mV,  RT  0.6  ms,  and  W  1.0  ±  0.2  ms.  The  average  
values  for  the  second  AP  were:  time  to  Vthr  3.2  ±  0.2  ms,  Vthr  -­38.3  ±  4.1  mV,  Vrel  37.9  ±  
4.9  mV,  H  70.2  ±  2.2  mV,  RT  0.6  ±  0.1  ms,  and  W  1.1  ±  0.2  ms.  The  postsynaptic  cells  
had  a  Rin  of  163  ±  28  MΩ  and  σn  of  0.9  ±  0.0  pA  at  a  Rs  of  16  ±  4  MΩ.  
The  average  amplitude  for  the  first  EPSC  during  the  first  minute  of  recording  (initial  EPSC  
amplitude)  was  -­14.2  ±  3.4  pA,  and  during  the  last  minute  was  -­16.9  ±  5.2  pA,  whilst  the  
average   amplitude   for  whole   25  minute-­recording   period  was   -­14.3   ±   3.9   pA,   clearly  
showing  that  a  slow  depression  did  not  occur  in  these  pairs  (pANOVA  =  0.51).  The  average  
peak-­to-­peak  latency  for  the  first  EPSCs  was  2.3  ±  0.3  ms,  rise  time  1.5  ±  0.0  ms,  and  
half-­width  4.0  ±  0.4  ms.  The  average  amplitude  for  the  second  EPSC  was  slightly  smaller  
than  the  first  one  (-­12.1  ±  3.1),  giving  an  average  PPR  of  0.94  ±  0.11.  Other  properties  
of  the  second  EPSC  were:  peak  latency  2.5  ±  0.4  ms,  rise  time  1.5  ±  0.1  ms,  and  half-­
width  3.9  ±  0.3  ms.  
Comparing  this  set  of  values  with  those  for  the  pairs  with  depression  revealed  that  there  
was   no   significant   difference   in   the   passive   membrane   and   AP   properties   of   the  
presynaptic   cells   (pt   ≥   0.16).   Likewise,   the   passive   membrane   properties   of   the  
postsynaptic  cells  did  not  show  any  significant  differences  either  (pt  ≥  0.19).  
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Figure  4.4.3.  Paired  recording  with  maintained  EPSC  amplitudes.    
A.  Time  courses  of  the  membrane  potential  with  two  APs  (upper  trace)  and  the  average  
EPSCs  (lower  trace).  B.   Individual  peak  EPSC  amplitudes  evoked  by  the  1st  AP  plotted  
against   time  during   the  experiment.  C.  Same  as   in  B,  except   for   the  2nd  AP.  D.  Minute  
averages   of   the   postsynaptic  Rs   for   the   entire   recording   period.   The   average   value   is  
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indicated  by  the  open  circle  and  a  dashed  line  drawn  for  the  duration  of  the  experiment.  E.  
Same  as  in  D,  except  for  Rin  after  pooling  for  5  min.  
  
However,   I  observed  an  obvious  difference   in   the   initial  EPSC  amplitude.   Its  average  
value   in   pairs   with   a   stationary   amplitude   was   only   half   of   that   in   pairs   with   a   slow  
depression   (-­14.2   ±   3.4   vs.   -­28.4   ±   3.7   pA;;   pt   =   0.01).   Interestingly,   after   the   slow  
depression  had  become  stationary,  no  significant  difference  could  be  observed  between  
the  two  groups  (-­14.3  ±  3.9  vs.  -­10.3  ±  1.3  pA;;  pt  =  0.38).  In  addition,  the  first  AP  peak  to  
the  EPSC  peak  latency  in  pairs  with  a  stationary  amplitude  was  significantly  faster  than  
that  that  of  pairs  with  a  slow  depression  (2.3  ±  0.3  vs.  2.9  ±  0.1  ms;;  pt  =  0.007).  This  was  
also  close  to  significant  for  the  latency  from  the  second  AP  peak  to  the  second  EPSC  
peak  (2.5  ±  0.4  vs.  2.7  ±  0.2  ms,  respectively;;  pt  =  0.076).  This  difference  was  partially  
accounted  for  by  a  significantly  faster  rise  time  of  the  first  (1.5  ±  0.0  vs.1.8  ±  0.1;;  pt  =  
3·10-­4)   and   second   EPSCs   (1.5   ±   0.1   vs.1.7   ±   0.0   ms;;   pt   =   0.017).   No   significant  
differences  were  observed  for  the  half-­widths  of  EPSC  (pt  >  0.30)  and  PPR  (pt  >  0.29).  
The  observed  differences  in  the  peak-­to-­peak  latency  and  EPSC  rise  time  were  unlikely  
caused  by  different  AMPA  subunit  combinations   in  these  pyramidal  cells   (Conti  et  al.,  
1994).  These  findings  rather  indicate  a  difference  in  the  position  of  synapses  along  the  
axon   (latency)   and   their   location   on   imperfectly   space-­clamped   dendrites   (rise   time).  
Specifically,  synapses  in  pairs  with  a  slow  depression  might  be  located  further  away  on  
the  axon,  and  also  on  more  remote  dendritic  compartments  (from  the  soma).  
4.4.1.3.  Properties  of  Presynaptic  Cells  
As  there  was  no  difference  between  the  two  groups  of  pairs  in  regard  to  the  presynaptic  
properties  (pt  >  0.52),  I  pooled  the  respective  data.  In  addition,  because  the  first  AP  in  a  
50   Hz   train   of   20   APs   was   not   different   either   (pt   >   0.069),   data   from   the   other   18  
pyramidal  pairs  were  also  included  to  give  a  total  of  56  pairs.  The  data  of  these  properties  
are  presented  in  Fig.  4.4.4.  in  the  form  of  histograms.  
Vrest   ranged   from   -­82.5   to   -­66.5   mV   with   an   average   value   of   -­75.4   ±   0.5   mV.   The  
respective  histogram  is  presented  in  A,  formed  using  a  bin  width  of  4  mV.  The  distribution  
was  more  or  less  symmetric  around  the  mean.  Likewise,  Rin  ranged  from  of  38  to  417  
MΩ,  having  an  average  value  of  162  ±  10  MΩ.  The  distribution  for  Rin  is  shown  in  B,  with  
a  bin  width  of  45  MΩ.  It  had  a  slightly  positive  skew  (skew  =  1.03),  with  a  tail  towards  
larger  values  of  Rin.  
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Figure  4.4.4.  Properties  of  the  presynaptic  cells  and  APs.  
Histograms  formed  from  the  passive  membrane  properties  Vrest  (A),  and  Rin  (B).  Also  shown  
are  the  respective  probability  densities  of  the  time  to  Vthr  (C),  Vthr  (D),  Vrel  (E),  H  (F),  RT  
(G),  and  W  (H).  
  
In  regard  to  the  AP,  the  average  time  to  Vthr  was  3.6  ±  0.1  ms  (range  2.1  to  4.9  ms;;  C;;  
bin  width  0.5  ms).  The  average  Vthr  was  -­43.2  ±  0.8  mV  (range  -­52.1  to  -­23.7  mV;;  D;;  bin  
width  4  mV).  Vrel  had  an  average  value  of  32.3  ±  0.9  mV  (range  21.1  to  51.3  mV;;  E;;  bin  
width  4  mV).  On  average,  H  of  the  first  AP  was  73.8  ±  1.2  mV  (range  54.7  to  89.7  mV;;  
F;;  bin  width  5  mV),  while  RT  was  0.6  ±  0.0  ms  (range  0.4  to  1.6  ms;;  G;;  bin  width  0.04  
ms),  and  W  was  0.9  ±  0.0  ms  (range  0.6  to  1.4  ms;;  H;;  bin  width  0.075  ms).  The  densities  
of  the  time  to  Vthr,  and  H,  RT,  and  W  of  the  first  AP  were  more  or  less  symmetrical.  In  
comparison,  the  histograms  of  Vthr  and  Vrel  had  a  distribution  with  a  short  tail.  
To  further  characterize  the  presynaptic  cells,  I  also  compared  the  properties  of  the  two  
APs  elicited  at  the  short   interval  of  50  ms  (Fig.  4.4.5).   In  this  set,   the  number  of  pairs  
corresponded  to  38.    
In  A,  the  comparison  between  the  time  to  Vthr  of  the  second  against  that  of  the  first  AP  
for  each  pair  is  presented,  with  the  line  of  identity  dashed.  The  data  in  almost  all  cases  
showed  that,  for  the  second  AP,  the  time  to  Vthr  was  systematically  shorter  than  that  for  
the  first.  In  fact,  a  significant  linear  correlation  was  uncovered  by  a  Pearson’s  correlation  
test   (r38  =  0.91;;  pPr  =  1·10-­14;;  solid   line).  Further,   I   tested   if   this   linear  correlation  was  
statistically  different  from  the  line  of  equality  by  rotating  the  data  points  by  -­45°  and  then  
checking  if  the  deviations  around  zero  were  random;;  i.e.  if  the  data  points  in  this  situation  
were  still  correlated  with  the  time  to  Vthr.  This  was  not  the  case  (pPr  =  0.92);;  i.e.  the  best  
linear   fit   to   the   data   points  was   not   significantly   different   from   the   line   of   identity   (A,  
dashed   and   superpositioned   solid   line).   Note   that   this   outcome   most   likely   resulted  
because,  as  compared  to  D  and  E  for  example,  the  variance  around  the  line  of  identity  
was  much  larger.  
Similar  comparisons  were  performed  for  the  other  properties.  Specifically,  Vthr  (B),  Vrel  
(C),  H  (D),  RT  (E),  and  W  (F)  of  the  second  AP  were  all  linearly  correlated  to  those  of  
the  first  AP  (all  pPr  <  10-­13).  Except  for  the  two  cases  in  D  and  E,  the  correlations  were  
not  different  from  the  line  of  identity  (pPr  >  0.29  in  all  cases).  
The  linear  correlation  between  H  of  the  second  (y)  and  first  (x)  AP  could  be  described  by  
y  =  0.99  x.  The  slope  of  this  linear  relationship  indicates  that  the  second  H  was  slightly  
(1%)  smaller  than  the  first  one.  Regarding  RT,  the  linear  correlation  was  y  =  1.04  x,  with  
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y  RT  of  the  second  and  x  that  of  the  first  AP.  The  slope  indicates  that  RT  of  the  second  
was  slower  by  4%  compared  to  that  of  the  first  AP.  This  data  suggests  that  there  were  
minimal  changes  to  the  presynaptic  APs.  
  
Figure  4.4.5.  Comparison  of  presynaptic  properties.  
Plots  of  the  second  vs.  first  time  to  Vthr  (A),  Vthr  (B),  Vrel  (C),  H  (D),  RT  (E),  and  W  (F).  Solid  
line  represents  the  best  linear  fit  to  the  data.  Line  of  identity  dashed.  
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4.4.1.4.  Properties  of  Postsynaptic  Cells  and  EPSCs  
Based  on  56  pairs,  the  respective  distributions  for  the  passive  membrane  properties  (Rin,  
Ihold,  and  σn)  and  the  first  EPSC  (initial  peak  amplitude,  amplitude  during  the  stationary  
period,  rise  time,  and  half-­width)  are  presented  in  Fig.  4.4.6.    
Rin  had  an  average  value  of  207  ±  16  MΩ  and  ranged  from  64  to  628  MΩ.  The  distribution  
of  Rin,  formed  with  a  bin  width  of  45  MΩ,  is  shown  in  A.  This  density  had  a  positive  skew  
(1.55),   i.e.   it   had   a   long   tail   towards   large   values.   The   holding   current,   Ihold,   had   an  
average  value  of  62.3  ±  7.9  pA  (ranging  from  -­100.0  to  195.0  pA).  This  indicates  that  the  
Vrest  was  typically  more  hyperpolarized  than  -­70  mV.  The  relevant  histogram  based  on  a  
bin  width  of  40  pA  is  presented  in  in  B.  
σn,  for  an  average  Rs  of  16  ±  1  MΩ,  ranged  from  0.66  to  1.22  pA,  with  an  average  value  
of  0.88  ±  0.02  pA.  With  a  bin  width  of  0.08  pA,  the  relevant  density  is  presented  in  C.  
Note  that  σn  in  each  cell  was  much  smaller  than  the  peak  of  the  unitary  EPSC  amplitude  
(E   and   F),   enabling   the   observation   of   EPSC   amplitudes   as   small   as   -­1.5   pA.   The  
average  peak-­to-­peak  latency  was  2.8  ±  0.1  ms  (ranging  from  1.4  to  4.8  ms;;  bin  width  
0.5  ms;;  D).  The  initial  EPSC  amplitude,  during  the  first  minute  of  recording,  was  -­30.2  ±  
3.6  pA  (ranging  from  -­5.4  to  -­145.1  pA;;  bin  width  10  pA;;  E).  Its  distribution  was  negatively  
skewed  (-­2.16;;  note  that  the  x  axis  in  E  is  reversed,  with  more  negative  values  indicating  
larger   amplitudes).   After   the   slow   depression   had   reached   a   steady   state,   the  
subsequent  stationary  EPSC  amplitudes  were  binned  at  7.5  pA,  with  the  density  shown  
in  F.  The  average  peak  EPSC  amplitude  during  this  stationary  period  was  -­14.2  ±  1.6  pA  
(ranging   from   -­1.4   to   -­63.7   pA).   This   indicates   that,   in   this   data   set   (including   the  
stationary   pairs),   the   EPSCs   on   average   depressed   by   48   ±   5%.   These   amplitudes  
remained  negatively  skewed  despite  the  depression  (skew  =  -­2.03).  The  density  for  the  
rise  times  is  presented  in  G.  The  average  value  was  1.7  ±  0.0  ms  (ranging  from  1.2  to  
2.5  ms;;  bin  width  0.2  ms).    The  average  half-­width  was  4.5  ±  0.1  ms  (ranging  from  3.0  to  
7.3  ms;;  bin  width  0.5  ms;;  H).  Both  distributions  are  positively  skewed  (1.15  and  0.86).  
Histograms  of  the  peak-­to-­peak  latencies,  rise  times,  and  half-­widths  also  showed  tails  
towards  larger  values.  
To  check  how  these  parameters  changed  from  the  first  to  the  second  EPSC,  their  values  
were  plotted  against  each  other   (n  =  38)   in  Fig.  4.4.7.  The  data   for   the  peak-­to-­peak  
latency  of   the  second  against   that  of   the   first  EPSCs   is   shown   in  A.  The  data  points  
grouped   around   the   line   of   identity   (dashed).   In   fact,   this   data   set   showed   a   highly  
significant  correlation  (pPr  <  10-­15),  whose  best  fit  was  no  different  to  the  line  of  identify  
(pPr  =  0.99;;  solid  line),  suggesting  that  the  latencies  after  both  stimuli  were  identical.  
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Figure  4.4.6.  Histograms  of  postsynaptic  properties  and  EPSCs.  
Histograms  of  Rin  (A),   Ihold  (B),  σn  (C),   initial  peak-­to-­peak  latency  (D),   initial  amplitude  (E),  
stationary  amplitude  (F),  rise  time  (G),  and  half-­width  (F).  
  
  
Figure  4.4.7.  Comparison  of  2nd  and  1st  EPSCs  during  paired-­pulses.  
Plots  of  the  peak-­to-­peak  latencies  (A),  rise  times  (B),  half-­widths  (C),  and  peak  amplitudes  
of  the  second  vs.  first  EPSCs  (D).  Solid  lines  represent  the  best  linear  fit  to  the  data.  Dashed  
line  represents  line  of  equality.  E.  Histogram  of  respective  PPR  values.  
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Likewise,  both  of   the  plots  of   the  EPSC  rise   times   (B)  and  half-­widths   (C),  were  also  
linearly  correlated  (both  pPr  <  10-­10)  and  no  different  from  the  line  of  identity  (pPr  >  0.12  in  
both  cases).  
I  then  plotted  the  peak  amplitudes  of  the  second  vs.  that  of  the  first  EPSCs.  The  data  are  
presented   in   D.   In   most   instances,   the   data   points   were   below   the   line   of   identity,  
indicating   that   in   most   cells   there   was   a   small   amount   of   short-­term   depression,  
consistent  with  the  average  value  for  PPR.  It  ranged  from  0.55  to  1.40,  with  an  average  
value  of  0.83  ±  0.03.  Again,  this  set  of  data  was  best  fit  with  a  line  (pPr  <  10-­15),  however,  
it  was  statistically  not  different  from  the  line  of  identity  suggesting  that  on  average  there  
was  no  systematic  change  in  PPR.  The  respective  histogram  of  the  values  of  PPR,  with  
a  bin  width  0.1,   is  shown   in  E.  With   the  peak  of   the  distribution  <  1.0,   the  majority  of  
pyramidal  cells  (n  =  30;;  79%)  showed  a  small  amount  of  short-­term  depression.  For  the  
remainder,  there  was  a  small  amount  of  facilitation.  
4.4.1.5.  Evidence  for  Release-­Independence  
The  concept  of  release-­dependence  states  that,  if  synaptic  vesicles  are  released  from  a  
finite   pool   of   vesicles   in   rapid   succession,   upon   a   second   stimulus,   the   pool   size   is  
reduced.  Consequently,  due  to  depletion,  the  amplitudes  of  the  subsequent  EPSCs  are  
smaller.   If   this   is   due   to   vesicle   depletion   alone,   subsequent   EPSCs   should   be   anti-­
correlated;;  i.e.  if  many  vesicles  were  released,  only  few  can  be  released  subsequently,  
and   vice   versa.   Therefore,   in   a   plot   of   the   second   vs.   the   first   EPSC   amplitudes  
(Fuhrmann  et  al.,  2004),  there  would  be  a  significant  anticorrelation.  I  tested  if  this  was  
the  case  in  the  6  pairs  with  stationary  EPSC  amplitudes.  
An  example   for   this   type  of  analysis   is   illustrated   in  Fig.  4.4.8.   In  A,   the  average  time  
course  is  shown  containing  the  first  and  second  EPSCs  from  the  300  repetitions.  The  
average  peak  amplitude  of  the  first  EPSC  was  -­12.4  ±  0.5  pA,  whilst  the  average  for  the  
second  one  was  -­9.4  ±  0.5  pA;;  i.e.  there  was  short-­term  depression  in  this  case  (PPR  =  
0.76  ±  0.05).  B  shows  the  plot  of  all  second  vs.  first  peak  amplitudes.  The  horizontal  and  
vertical  dashed  lines  are  drawn  to  indicate  zero  for  both  the  second  and  first  EPSCs.  The  
horizontal   and   vertical   solid   lines   indicated   the   respective   average   peak   amplitudes.  
When  the  extent  of  correlation  between  the  two  EPSCs  was  calculated,  pPr  was  0.93;;  i.e.  
there  was  no  significant  correlation  in  this  case.  This  is  consistent  with  the  idea  that  in  
this  case,  the  short-­term  depression  was  release-­independent.  
I  acknowledge  that,  strictly  speaking,  the  concept  of  release-­dependence  is  only  defined  
for  depressing  synapses  (Fuhrmann  et  al.,  2004).  However,  I  tried  to  extend  the  same  
reasoning  as  above  to  the  two  stationary  pairs  which  showed  facilitation.  Such  a  case  is  
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illustrated  in  C  and  D.  In  this  pair,  the  average  peak  amplitude  of  the  first  EPSC  was  -­5.8  
±  0.3  pA,  whilst  the  average  for  the  second  one  was  -­8.0  ±  0.3  pA,  resulting  in  a  PPR  of  
1.38  ±  0.09.  When  all  second  peak  amplitudes  were  plotted  against  the  first  ones  (D),  
again  no  linear  correlation  was  observed  (pPr  =  0.93).  
  
  
Figure  4.4.8.  Evidence  of  release-­independence.  
A.  Time  course  of  the  average  EPSCs  from  300  repetitions  using  a  paired-­pulse  with  an  
interval  of  50  ms.  B.  Plot  of  the  respective  peak  amplitudes  of  the  second  vs.  first  EPSCs.  
Dashed  lines  indicate  the  respective  failures.  The  horizontal  and  vertical  solid  lines  indicate  
the  average  peak  amplitudes  of  the  second  and  first  EPSCs,  respectively.  C.  Same  as  in  
A,  but  for  a  pair  with  short-­term  facilitation.  D.  Same  as  in  B,  but  for  the  case  shown  in  C.  
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Within  this  group  of  6  pairs,  for  the  4  pairs  with  depressing  synapses,  the  second  EPSC  
amplitudes  were  not  correlated  with  the  first  ones  (pPr  >  0.28).  In  other  words,  no  anti-­
correlation  was  observed  in  these  pairs.  Likewise,  for  the  two  facilitating  pairs,  there  was  
no  correlation  either  (pPr  >  0.93).  Therefore,  I  conclude  from  this  set  of  data  that  the  short-­
term   plasticity   is   not   affected   by   the   preceding   release,   hence,   is   mostly   release-­
independent.  
4.4.2.  Serotonergic  Depression  of  Evoked  Release  
In  this  section,  I  will  describe  the  impact  of  10  µM  5-­HT  on  evoked  glutamate  release,  
and  describe  the  changes  of  the  pre-­  and  postsynaptic  properties  upon  5-­HT  exposure.  
Much  of  the  data  will  focus  on  the  peak  EPSC  amplitude,  because  the  largest  and  most  
significant  change  was  observed  in  this  parameter.  Note  that  the  average  peak  EPSC  
amplitude  of  the  control  period  was  from  the  stationary  period  after  the  slow  depression  
had  reached  a  steady-­state  in  the  respective  pairs.  
4.4.2.1.  Large  EPSC  Depression  Caused  by  5-­HT  
In  the  presence  of  3  µM  gabazine  to  block  GABAA  receptors,  10  µM  5-­HT  was  added  to  
the   superfusate,   whilst   both   the   presynaptic   APs   and   the   postsynaptic   EPSCs   were  
recorded.  The  results  of  such  an  experiment  in  a  pair  which  had  a  stationary  amplitude  
throughout   the   control   period,   are   shown   in   Fig.   4.4.9.  During   the   25  minutes   of   the  
control  period  (blue),  the  same  paired-­pulse  stimulation  was  repeated  for  300  times  at  
0.5  Hz,   and   the   respective  EPSCs  were   recorded  postsynaptically.   The  average   first  
EPSC   amplitude   was   stationary   at   -­12.4   ±   0.5   pA   (A,   lower   trace   and   C).   After   the  
subsequent   addition   of   10   µM  5-­HT   (red)   and  waiting   for   five  minutes   until   the   5-­HT  
concentration  in  the  bath  had  stabilised,  the  first  EPSC  amplitude  depressed  by  57  ±  4%  
to  -­5.3  ±  0.4  pA  (pt  =  2·10-­26;;  lower  trace  in  B  and  C).  In  contrast  to  the  transient  increase  
in  mEPSC  frequency,  this  depression  was  fully  established  within  the  five  minutes  before  
the  resumption  and  then  persisted  for  the  remainder  of  the  recording.  The  depression  
was  characterized  by  more   failures  and  smaller  EPSCs  than  during  control.  Similarly,  
the  second  EPSC  also  depressed  by  63  ±  6%  from  -­9.4  ±  0.5  to  -­3.5  ±  0.5  pA.  During  
control,  PPR  was  0.69  ±  0.05  and  after  5-­HT,  it  remained  at  0.62  ±  0.09.  Consequently,  
PPR  was  not  significantly  altered  during  this  depression.  
Concurrently  with  the  EPSC  depression,  the  presynaptic  cell  showed  a  hyperpolarization  
by  7.3  mV  from  -­74.7  to  -­82.0  mV  (D,  left  traces).  Comparison  between  the  time  courses  
of  the  first  APs  in  control  vs.  that   in  5-­HT  done  by  alignment  the  two  traces  at  Vthr  (D,  
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Figure  4.4.9.  5-­HT  depressed  EPSC  amplitude.  
A.  Time  courses  of  the  two  APs  (upper  trace)  and  respective  EPSCs  (lower  trace).  B.  Same  
as   in  A,   except   after   5-­HT  application.  C.   Individual   peak  amplitudes  of   the   first  EPSC  
plotted  against  time  during  the  experiment.  Time  0  corresponds  to  when  10  µM  5-­HT  was  
added  to  the  superfusate.  D.  Superposition  of  the  time  courses  of  the  first  APs  during  both  
periods  without  (left)  or  with  alignment  for  the  same  Vthr  (right).  E.  Superposition  of  the  time  
courses   of   the   first   EPSCs   during   both   periods   (left),   and   after   peak-­scaling   for   the  
amplitude  during  control  (right).  
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I  also  checked   if  5-­HT  affected  Vrest  of   the  postsynaptic  cell.  To  estimate   this  value   in  
voltage-­clamp,  I  used  Ohm’s  law  and  multiplied  the  peak  change  in  Ihold  (31  pA)  with  Rin  
(125  MΩ).  This  provided  a  hyperpolarization  of  3.9  mV.  This  value  was  much  smaller  
than  that  of  the  presynaptic  cell.  The  average  time  courses  of  the  first  EPSC  were  also  
peak  scaled  and  aligned  (E).  It  revealed  a  small  difference  during  the  late  decay  phase,  
but  no  significant  change  in  either  the  rise  time  or  half-­width.  
In  Fig.  4.4.10,  I  show  a  5-­HT  mediated  depression  in  a  pair  which  had  a  slow  depression  
but  which  had  reached  a  steady  state  for  8  min  during  control.  During  this  period,  the  
average  amplitude  of  the  first  EPSC  was  -­28.3  ±  1.2  pA  (lower  trace  in  A  and  C).  After  
the  addition  of  5-­HT,  the  EPSC  depressed  by  38  ±  4%  to  -­17.8  ±  0.7  pA  (pt  <  8·10-­12;;  
lower   trace   in   B   and   C),   and   remained   stationary   throughout   the   remainder   of   the  
recording.  PPR  during  control  was  0.73  ±  0.03,  and  0.72  ±  0.04  after  5-­HT.  Hence,  the  
large  depression  in  the  first  EPSC  amplitude  was  not  accompanied  by  significant  change  
in  PPR.  
Again,  after  addition  of  5-­HT,  there  was  a  pronounced  hyperpolarization  by  8.4  mV  from  
-­69.1  to  -­77.5  mV  in  the  presynaptic  cell  (D,  left).  Likewise,  the  postsynaptic  cell  showed  
an   increase   in   Ihold,   which   peaked   by   70   pA,   corresponding   to   an   estimate   of   the  
hyperpolarization   by   5.0   mV.   The   two   time   courses   of   the   respective   first   APs   after  
alignment  for  the  same  Vthr   (D,  right)  did  not  show  any  significant  change,  nor  did  the  
EPSC   time   courses   (E).   Further   details   regarding   any   other   change   in   the   pre-­   and  
postsynaptic  properties  of  these  pyramidal  cells  will  be  provided  in  4.4.2.2  and  3.  
The  depression  by  10  µM  5-­HT  was  very  different   to   the   slow  depression  seen  after  
obtaining  the  whole-­cell  recording  condition.  The  τ  of  the  latter  was  10.8  ±  2.0  minutes  
(see  4.4.1.1),  whereas  the  depression  by  5-­HT  was  fully  established  <  8  min  (compare  
Figs.  4.4.1B  with  4.4.10C).  
Next,   I   asked   the   question   if   the   depression   by   5-­HT   in   pairs,  which   showed   a   slow  
depression,  was  different  to  that  in  pairs  without.  For  this  purpose,  I  pooled  the  18  pairs  
from   this   and   subsequent   data   sets   (4.4.2.4   and   4.4.4.1),   and   compared   the   5-­HT-­
induced  depression  in  pairs  without  (n  =  4;;  two  pairs  could  not  be  included  in  this  set  as  
these  had  Gβγ  binding  peptides  in  them)  with  that  in  pairs  with  a  slow  depression  (n  =  
14).  The  average  depression  by  5-­HT  in  the  former  group  was  53  ±  9%,  compared  to  47  
±  3%  in  the  latter  group.  There  was  no  significant  difference  (pt  =  0.66).  Consequently,  
the  data  from  the  two  groups  were  pooled.  This  comparison  indicates  that  the  depression  
caused  by  5-­HT  is  molecularly  very  different  to  of  the  slow  depression.  
  
   Impact  on  evoked  transmitter  release  
        187  
  
  
Figure  4.4.10.  5-­HT  depressed  EPSC  amplitude  despite  slow  depression.  
Same  colour  code  as  before.  The  same  figure  legend  as  in  Fig.  4.4.9  applies  here.  
  
In  Fig.  4.4.11,  the  values  for  all  8  pairs  exposed  to  10  µM  5-­HT  are  presented.  Each  pair  
showed  a  significant  depression  in  the  EPSC  amplitude.  On  average  (n  =  8),  the  peak  
amplitude  of  the  first  EPSC  depressed  from  -­10.7  ±  2.8  to  -­5.8  ±  1.8  pA  (ppt  =  0.002;;  A,  
black)  by  46  ±  4%  (B).  This  depression  was  not  accompanied  by  significant  change  in  
PPR  (0.70  ±  0.03  vs.  0.70  ±  0.04,  respectively;;  ppt  =  0.77;;  C).    
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Figure  4.4.11.  Depression  of  EPSC  amplitudes.  
Individual  EPSC  amplitudes  for  each  pair  during  control  and  after  5-­HT  shown  in  grey,  with  
the  respective  averages.  Paired  values  are  joined  by  a  line.  B.  Same  as  in  A  except  that  in  
this  case,  the  amplitudes  were  normalised  for  a  control  value  of  0.  Dashed  line  indicates  no  
depression.  C.  Plot  of  PPR  in  both  conditions  for  individual  experiments  and  the  population  
averages.  Dashed  line  indicates  no  change.  
  
4.4.2.2.  Presynaptic  Changes  
5-­HT  might  have  caused  changes  to  the  presynaptic  membrane  properties  and/or  AP,  
which  may  have   resulted   in   the  observed  depression.  Hence,   I   checked   the   relevant  
properties,  and  quantified  the  respective  changes.  
In  Fig.  4.4.12,  I  present  data  showing  the  typical  changes  caused  by  exposure  to  5-­HT.  
In  this  cell,  Rin  decreased  by  52  MΩ  from  234  to  182  MΩ,  consistent  with  an  opening  of  
a  considerable  conductance.  Similar  to  what  was  shown  in  Fig.  4.4.9,  Vrest  hyperpolarized  
by  3.6  mV  from  -­77.6  to  -­81.2  mV  (A),  suggesting  that  the  conductance  had  a  reversal  
potential  more  negative  than  Vrest.  
In  regard  to  the  AP,  the  values  of  the  first  during  control  and  after  5-­HT  were  as  follows:  
time  to  Vthr  was  3.3  vs.  3.6  ms,  Vthr  -­42.2  vs.  -­38.3  mV,  Vrel  35.4  vs.  43.0  mV,  H  66.6  vs.  
61.4  mV,  RT  0.6  vs.  0.6  ms,  and  W  1.0  vs.  1.1  ms.  Changes  to  the  AP  were  observed  
for  Vrel  and  H.  The  change  in  Vrel  was  expected  because  the  hyperpolarization  by  5-­HT  
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Figure  4.4.12.  Changes  to  Vrest  and  AP.  
A.   Time   courses   of   membrane   voltage   with   two   APs.   B.   Comparisons   of   the   relative  
difference  in  voltage  (Vrel)  for  the  first  AP.  C.  Superposition  of  the  first  APs  during  control  
and  after  5-­HT  after  adjusting  for  the  same  Vthr.  D.  Same  as  in  B,  but  for  the  second  AP.  
E.  Comparison  of  time  to  Vthr  for  the  second  AP.  F.  Same  as  in  C,  but  for  the  second  AP.  
  
made   the   voltage   change   to   reach  Vthr   larger   as   shown   in  B.  Although   there  was  no  
noticeable   change   in   the   time  course  of   the   fast   part   of   the  AP,  5-­HT  decreased   the  
amplitude  (H)  by  5.2  mV.  This  difference  is  clearly  detectable  when  the  two  traces  were  
superimposed  and  aligned  at  the  same  value  of  Vthr  (C).  
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The  respective  values  for  the  second  AP  were  as  follows:  time  to  Vthr  was  2.5  vs.  3.2  ms,  
Vthr  -­41.8  vs.  -­38.6  mV,  Vrel  35.9  vs.  42.7  mV,  H  66.0  vs.  61.8  mV,  RT  0.7  vs.  0.6  ms,  and  
W  1.1  vs.  1.2  ms.  For  this  second  AP,  in  addition  to  the  changes  in  Vrel  and  H,  time  to  
Vthr  became  longer  (E).  Again,  the  change  in  time  to  Vthr  was  most  likely  explained  by  the  
hyperpolarization.  Similar   to   the   first  one,   there  was  no  noticeable  change   in   the   time  
course  of  the  fast  part,  but  H  again  decreased  by  4.2  mV  (F).  This  was  likely  related  to  
the  observed  drop  in  Rin.  
Table  4.4.1.  Presynaptic  changes.  
     Control   5-­HT   Δ   ppt  
Basic  Properties  (n  =  39)           
Rin  [MΩ]   171  ±  11   138  ±  11   -­33  ±  13   0.013  *  
Vrest  [mV]   -­75.0  ±  0.8   -­77.1  ±  0.9   -­2.1  ±  0.9   0.023  *  
Properties  of  1st  AP  (n  =  34)               
Time  to  Vthr  [ms]   3.6  ±  0.1   3.6  ±  0.1   0.0  ±  0.1   0.58  
Vthr  [ms]   -­41.7  ±  1.1   -­40.9  ±  1.7   0.8  ±  1.0   0.43  
Vrel  [ms]   33.6  ±  1.3   35.7  ±  1.5   2.1  ±  0.8   0.014  *  
H  [mV]   71.7  ±  1.4   68.0  ±  1.5   -­3.7  ±  0.8   5·10-­5  **  
RT  [ms]   0.6   0.6   0.0  ±  0.0   0.41  
W  [ms]   0.9   0.9   -­0.0  ±  0.0   0.16  
Properties  of  2nd  AP  (n  =  23)           
Time  to  Vthr  [ms]   3.1  ±  0.1   3.5  ±  0.2   0.4  ±  0.1   0.002  **  
Vthr  [ms]   -­41.3  ±  1.2   -­41.6  ±  2.0   -­0.3  ±  1.2   0.82  
Vrel  [ms]   34.0  ±  1.6   36.3  ±  1.7   2.4  ±  0.8   0.010  **  
H  [mV]   71.6  ±  1.5   68.5  ±  1.5   -­3.1  ±  0.6   5·10-­5  **  
RT  [ms]   0.6   0.6   -­0.0  ±  0.0   0.56  
W  [ms]   1.0   0.9   -­0.1  ±  0.0   0.013  *  
  
Respective  parameters  during  control  and  after  5-­HT  (or  full  agonist)  addition,  together  with  
the   calculated   differences.   Values   for   RT   and  W   are   given   without   errors   as   those   were  
smaller  than  the  A/D  sampling  time.  Significances  were  based  on  paired  t-­tests.  Significant  
differences  are  highlighted  on  a  grey  background.  *  for  ppt  <  0.05  and  **  for  <  0.01.    
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Pooling  the  data  from  all  pairs  (n  =  39),  I  found  that  the  addition  of  5-­HT  or  relevant  full  
agonist  caused  significant  changes  which  are  given  in  Table  4.4.1.  For  the  first  AP,  these  
were  1)  Rin,  2)  Vrest,  3)  Vrel  and  4)  H.  For  the  second,  5)  time  to  Vthr,  6)  Vrel,  7)  H,  and  8)  
W.  Specifically,  Rin  of  the  presynaptic  cell  decreased  by  33  ±  13  from  171  ±  11  to  138  ±  
11  MΩ  (n  =  39;;  ppt  =  0.013).  Vrest  hyperpolarized  by  2.1  ±  0.9  from  -­75.0  ±  0.8  to  -­77.1  ±  
0.9  mV  (ppt  =  0.023).  This  value  was  very  likely  a  slight  underestimate  because  in  the  
pairs   exposed   to   the   5-­HT2R   agonist   α-­methyl-­5-­HT   (n   =   6),   the   agonist   caused   a  
depression  without  a  hyperpolarization  of  the  presynaptic  cell  (see  4.4.2.4  below).  
After  5-­HT  addition,  Vrel  of  the  first  AP  increased  on  average  by  2.1  ±  0.8  mV  from  33.6  
±  1.3  to  35.7  ±  1.5  mV  (n  =  34;;  ppt  =  0.014).  Likewise,  Vrel  of  the  second  AP  increased  by  
2.4  ±  0.8  from  34.0  ±  1.6  to  36.3  ±  1.7  mV  (ppt  =  0.010).  H  of  both  the  first  and  second  
AP  decreased  by  3.7  ±  0.8  mV  from  71.7  ±  1.4  to  68.0  ±  1.5  mV  (ppt  =  5·10-­5),  and  3.1  ±  
0.6  from  71.6  ±  1.5  to  68.5  ±  1.5  mV  (ppt  =  5·10-­5),  respectively.  Lastly,  W  of  the  second  
AP  decreased  by  0.1  from  1.0  to  0.9  ms  (ppt  =  0.013).  This  shortening  was  likely  related  
to  the  smaller  H  as  a  consequence  of  the  drop  in  Rin.  
Although  there  were  several  significant  changes  to  the  AP,  these  were  quite  small  and,  
therefore,   unlikely   the   explanation   for   the   depression   by   49   ±   3%   (see   4.4.2.3).   This  
conclusion  is  further  supported  by  a  set  of  experiments  to  be  presented  later,  in  which  
the  depression  could  be  fully  blocked,  while  both  decreases  in  H  and  W  remained  (see  
4.4.4.2  and  3).  
To  summarise,  5-­HT  caused  some  small  and  significant  changes  to  the  presynaptic  cell  
and  the  APs,  but  these  likely  had  minimal  impacts  on  the  depression.  
4.4.2.3.  Postsynaptic  Changes  
A   postsynaptic   depression   could   have   been   caused   if   for   example   the   membrane  
resistivity  was  lowered  at  synapses  which  escaped  the  imposed  space-­clamp  (Spruston  
et   al.,   1993;;   Williams   &   Mitchell,   2008).   To   rule   out   this   possibility,   I   checked   the  
membrane  and  EPSC  properties  of  the  respective  postsynaptic  cells.    
In   Fig.   4.4.13,   I   present   relevant   data   from   a   single   cell.   The   time   courses   of   the  
respective  membrane  voltages  and  currents  are  presented  in  A  for  the  first  and  in  B  the  
second  AP  and  EPSC  during  control  (top)  and  after  5-­HT  (bottom).  After  the  exposure  
to  5-­HT,  Rin  decreased  by  63  MΩ  from  135  to  72  MΩ,  again  indicating  the  opening  of  a  
slightly  larger  conductance.  At  the  same  time,  Ihold  increased  by  70  from  160  to  230  pA;;  
i.e.   the   cell   hyperpolarized.   In   keeping  with   the   finding   for   the   presynaptic   cell,   this  
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Figure  4.4.13.  Changes  to  EPSC  properties.  
A.  Comparison  of  the  peak-­to-­peak  latencies  of  first  APs  and  EPSCs  during  control  (top)  
and  in  5-­HT  (bottom).  Dashed  lines  are  given  to  facilitate  comparisons.  B.  Same  as  in  A,  
except  for  the  second  APs  and  EPSCs.  Superposition  of  the  average  time  courses  of  the  
first  (C)  and  second  (D)  EPSCs  before  and  after  addition  of  5-­HT.  E.  Same  as  C,  except  
for  peak  scaling  to  the  amplitude  during  control.  Both  D  and  F  are  similar  to  C  and  E,  except  
for  the  second  EPSCs.  
  
indicated  that   the  reversal  potential  of   this  conductance  was  more  negative  than  Vrest.  
Furthermore,  during  control,  σn  for  a  Rs  of  11  MΩ  was  0.7  pA.  After  5-­HT,  and  despite  
the  drop  in  Rin,  σn  for  a  Rs  of  10  MΩ  remained  0.7  pA.  
During  control,  the  average  peak  amplitude  of  the  first  EPSC  was  -­28.3  ±  1.2  pA  (A,  top).  
After  5-­HT  (A,  bottom),  the  EPSC  amplitude  depressed  by  38  ±  4%  to  -­17.8  ±  0.7  pA  (pt  
<   8·10-­12;;   C).   The   remaining   characteristics   of   the   first   EPSC   before   and   after   5-­HT  
addition  were  as  follows:  the  peak-­to-­peak  latencies  were  2.3  vs.  2.4  ms,  the  rise  times  
1.7  vs.  1.6  ms,  and  the  half-­widths  4.1  vs.  4.0  ms.  When  the  time  courses  of  the  average  
EPSCs   were   superimposed   without   (D)   and   after   peak   scaling   (E),   only   minimal  
differences   were   found   for   the   latter,   suggesting   that   the   time   courses   of   EPSCs  
remained  largely  unchanged.  Therefore,  the  only  significant  change  to  the  EPSC  was  its  
depression.  
A  similar  set  of  findings  was  made  for  the  second  EPSCs  (B,  D,  and  F).  Specifically,  the  
peak-­to-­peak  latencies  were  2.2  vs.  2.3  ms,  rise  times  1.6  vs.  1.5  ms,  the  half-­widths  3.9  
vs.  4.0  ms,  and  PPR  0.73  vs.  0.72.  No  significant  changes   to   the   time  courses  were  
found  either.  These  data  further  support  the  findings  that  there  were  minimal  changes  to  
the  second  EPSC  (F),  but  a  large  depression  (D)  with  no  significant  change  to  PPR  (ppt  
=  0.3).  
Pooling  the  data  from  all  pairs  (n  =  40),  I  found  that  5-­HT  or  the  full  agonist  caused  a  
large  decrease  in  Rin  in  all  postsynaptic  cells,  together  with  a  pronounced  depression  in  
the  EPSC  amplitude  (Table  4.4.2).  Specifically,  Rin  decreased  on  average  by  55  ±  17  
from  198  ±  17   to  143  ±  14  MΩ   (28  ±  9%;;  ppt   =  0.002).  The  decrease   in  Rin  was  not  
accompanied  by  any  significant  change  in  Ihold  (66.7  ±  8.2  vs.  69.0  ±  16.6  pA;;  ppt  =  0.83),  
suggesting  that  the  conductance(s)  in  this  case  had  a  (combined)  reversal  potential(s)  
close  to  the  holding  potential,  which  is  different  to  what  was  found  for  the  presynaptic  
cells.  
The  first  EPSC  amplitude  depressed  by  8.3  ±  1.5  from  -­16.4  ±  2.6  to  -­8.1  ±  1.3  pA  (49  ±  
3%,  n  =  30;;  ppt  =  4·10-­6).  I  averaged  the  PPR  from  all  possible  18  pairs,  and  found  that  
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the  PPR  remained  the  same,  i.e.  0.78  ±  0.05  vs.  0.79  ±  0.05  for  control  vs.  after  5-­HT  
(ppt  =  0.69).  These  data  showed   that   the  second  EPSC  amplitude  also  depressed  by  
51%  from  its  control  value.  The  peak  latencies  and  time  courses  of  both  EPSCs  were  
not  altered  by  5-­HT  (ppt  >  0.18),  indicating  that  the  depression  was  unlikely  caused  by  
any  change  to  the  kinetics  of  the  postsynaptic  AMPA  receptors.  
Table  4.4.2.  Postsynaptic  changes.    
     Control   5-­HT   Δ   ppt  
Basic  Properties  (n  =  40)           
Rs  [MΩ]   15  ±  1   16  ±  1   1  ±  1   0.13  
Rin  [MΩ]   198  ±  17   143  ±  14   -­55  ±  17   0.002**  
Ihold  [pA]   66.7  ±  8.2   69.0  ±  16.6   2.3  ±  10.6   0.83  
Properties  of  1st  EPSC  (n  =  30)               
σn  [pA]   0.9  ±  0.0   0.9  ±  0.0   0.0  ±  0.0   0.07  
Amplitude  [pA]   -­16.4  ±  2.6   -­8.1  ±  1.3   8.3  ±  1.5   4·10-­6**  
Peak  latency  [ms]   2.7  ±  0.1   2.9  ±  0.2   0.2  ±  0.1   0.18  
Rise  time  [ms]   1.7  ±  0.0   1.8  ±  0.1   0.1  ±  0.1   0.55  
Half-­width  [ms]   4.2  ±  0.2   4.3  ±  0.2   0.1  ±  0.2   0.70  
Properties  of  2nd  EPSC  (n  =  18)           
PPR   0.78  ±  0.05   0.79  ±  0.05   0.01  ±  0.02   0.69  
Peak  latency  [ms]   2.5  ±  0.2   2.4  ±  0.2   -­0.1  ±  0.2   0.63  
Rise  time  [ms]   1.6  ±  0.1   1.7  ±  0.1   0.1  ±  0.1   0.38  
Half-­width  [ms]   3.8  ±  0.2   4.0  ±  0.3   0.3  ±  0.2   0.23  
  
Relevant  parameters  during  control  and  after  5-­HT  (or  full  agonist  addition),  along  with  the  
estimated   differences.   Significances   were   determined   based   on   paired   t-­tests.   Significant  
differences  are  highlighted  on  a  grey  background.  *  for  ppt  <  0.05  and  **  for  <  0.01.  
  
In  the  two  sections  above  and  here,  I  have  provided  data  to  indicate  that  5-­HT  (or  the  
relevant   full   agonist)   altered   properties   of   both   the   pre-­   and   postsynaptic   cells.   One  
finding  worth  stressing  was  that  Rin  decreased  in  both  the  pre-­  and  the  postsynaptic  cells.  
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This  result  reminded  me  of  the  differences  found  for  responders  and  non-­responders  in  
Part  3  (see  3.4.3.3).  This  will  be  addressed  later  in  4.4.5.  
4.4.2.4.  Depression  Mediated  via  Activation  of  5-­HT2R  
In   this   section,   I   determined   the   identity   of   the   5-­HT   receptor(s)   mediating   this  
depression.  Given  that  the  reversal  potential  in  the  postsynaptic  cell  associated  with  the  
change  in  Rin  was  unlikely  solely  caused  by  GIRK  channels,  and  anticipating  a  possible  
similarity  with  the  findings  in  Part  3,  where  5-­HT2R  were  involved,  I  started  off  by  applying  
the  pan-­5-­HT2R  agonist  α-­methyl-­5-­HT.  
A   typical   such   recording   is   shown   in   Fig.   4.4.14.   The   time   courses   of   the   APs   and  
respective  EPSCs  are  shown  during   the  control  period   in  A  and  after  5-­HT   in  B.  The  
average   peak   amplitude   of   the   first   EPSC  was   -­11.8   ±   0.6   pA   (A,   bottom).  With   the  
resumption  of  the  recording  5  min  after  exposure  to  20  µM  α-­methyl-­5-­HT  (B,  bottom),  
the  first  EPSC  amplitude  had  depressed  by  52  ±  4%  to  -­5.7  ±  0.4  pA  (pt  =  5·10-­14).  In  C,  
the  individual  peak  amplitudes  of  the  first  EPSCs  are  presented,  showing  that  these  were  
stationary   during   the   control   period.   After   agonist   application   and   resumption   of   the  
recording  (t  >  5  min),  the  EPSC  remained  stationary,  but  had  depressed  within  5  min,  
which  persisted  for  the  remainder  of  the  recording.  Consistent  with  Figs.  A  and  B,  PPR  
during   control  was   0.65   ±   0.05,   and   after   α-­methyl-­5-­HT  0.68   ±   0.12,  which  was   not  
significantly  different  (pt  =  0.17).  
After   the   exposure   to   this   agonist,   the   presynaptic   cell   only   showed   a   small  
hyperpolarization  by  0.6  mV  from  -­73.0  to  -­73.6  mV  (D,  left).  The  comparison  between  
the   time   courses   of   the   first   AP,   after   alignment   at   the   same   threshold,   revealed   no  
significant  changes  to  the  early  part  of  the  AP  (D,  right).  
The  postsynaptic  cell  showed  a  small  increase  in  Ihold  by  15  pA,  which  corresponded  to  
a   slight   hyperpolarization   after   the   exposure   to   5-­HT.   Again,   when   the   average   time  
courses  of  the  first  EPSC  were  peak-­scaled  (E,  right),  no  significant  changes  were  found.          
In  all  6  pairs  studied,  α-­methyl-­5-­HT  depressed  the  peak  amplitude  of  all  first  EPSCs,  on  
average  by  49  ±  5  %  from  -­10.3  ±  2.5   to   -­5.3  ±  1.6  pA  (ppt  =  0.003;;  F  and  G,  black).  
Overall,  this  depression  was  not  accompanied  by  any  significant  change  in  PPR  (0.89  ±  
0.13  vs.  0.86  ±  0.11;;  ppt  =  0.65;;  H,  black).  
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Figure  4.4.14.  α-­Methyl-­5-­HT  mimicked  5-­HT  in  causing  EPSC  depression.  
A.  Time  courses  of  the  membrane  potential  with  two  APs  (upper  trace)  and  the  currents  
containing  the  respective  EPSCs  (lower  trace)  during  control.  B.  Same  as  in  A,  except  after  
addition  of  α-­methyl-­5-­HT.  C.  Individual  peak  amplitudes  of  the  first  EPSC  plotted  against  
time  during  the  recording.  20  µM  α-­methyl-­5-­HT  was  added  to  the  superfusion  at  t  =  0.  D.  
Superposition  of  the  first  APs  during  both  periods  without  (left)  and  with  (right)  aligning  for  
the  same  Vthr.  E.  Superposition  of   the  first  EPSCs  in  both  periods  (left),  and  after  peak-­
scaling  (right).  F.  Plot  of  individual  average  EPSC  amplitudes  during  control  and  after  α-­
methyl-­5-­HT  (AM5-­HT)  with  the  paired  values  joined  by  a  line.  Grey  circles  for  individual,  
and  the  black  for  the  average  of  these  data.  G.  Plot  of  the  depression  in  each  pair,  including  
the  respective  sample  average.  Dashed  line  indicates  no  depression.  H.  Plot  of  PPR  values  
for  each  experiment  in  both  conditions.  
  
Comparing  the  depression  by  5-­HT  to  that  by  α-­methyl-­5-­HT,  both  of  which  persisted  for  
the  remainder  of  the  recording,  there  was  no  significant  difference  (46  ±  4  vs.  49  ±  5%;;  
pt   =   0.57).   This   observation   suggests   that   α-­methyl-­5-­HT   is   a   full   agonist   at   these  
receptors.   In   addition,   as   with   5-­HT,   PPR   also   remained   unchanged   after   agonist  
addition.  However,  whilst  5-­HT  caused  a  significant  hyperpolarization  by  7.2  ±  2.6  mV  
from  -­75.2  ±  1.4  to  -­82.5  ±  2.3  in  the  presynaptic  cell  (ppt  =  0.027),  α-­methyl-­5-­HT  did  not  
cause  a  significant  hyperpolarization  (-­76.1  ±  1.6  vs.  -­71.4  ±  4.2  mV;;  ppt  =  0.38).  This  
difference  is  likely  explained  as  follows.  20  µM  α-­methyl-­5-­HT  activated  only  5-­HT2R.  In  
contrast,  5-­HT  also  activated  5-­HT1R,  which  then  caused  the  opening  of  GIRK  channels,  
resulting  in  the  hyperpolarization  observed  (Andrade  et  al.,  1986).  
Altogether,   the  data   from   this   set  of  experiments  showed   that  α-­methyl-­5-­HT   is  a   full  
agonist  at   these   receptors  and  mimicked   the  action  of  5-­HT  on   the  depression  of   the  
EPSC  amplitude  but  not  in  regard  to  the  hyperpolarization  in  the  presynaptic  cells.  This  
is  consistent  with  the  idea  that  the  depression  is  caused  by  5-­HT2R  but  the  presynaptic  
hyperpolarization  is  caused  by  5-­HT1R.  
4.4.3.  Comparison  with  Modulation  by  NA  
The  depression  observed  with  5-­HT  and  a  5-­HT2R  agonist  reminded  me  of  that  observed  
with  10  µM  NA  observed  earlier  in  this  laboratory.  Before  going  any  further,  I  will  present  
some  data  on  how  NA  modulated  excitatory  transmitter  release  in  these  cells.  In  4.4.3.1,  
I  present  data  for  the  noradrenergic  modulation  of  spontaneous  release,  and  point  out  
the  mechanism(s)   involved.   In   4.4.3.2,   I   present   data   on   how  NA  modulated   evoked  
release.  The  mechanism  involved  in  the  EPSC  depression  will  be  provided  in  4.4.3.3.  
Note  that  most  of  the  data  in  sections  4.4.3.1  and  4.4.3.2  was  acquired  by  Drs.  Julian  
Choy  and  Li  Li   (Choy,  2011),  when  working   in   the   laboratory.  However,   I   contributed  
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crucial  data  as  to  the  molecular  mechanism  in  4.4.3.3.  Some  of  these  data  will  appear  in  
joint  publications  (Choy  et  al.,  2017a;;  Choy  et  al.,  2017b).  
4.4.3.1.  Involvement  of  Store  Release  in  NA-­Mediated  mEPSC  Frequency  Increase  
Any  receptor   that   is  capable  of  activating  the  classical  Gq  cascade,  may  release  Ca2+  
from   stores   to  modulate   transmitter   release.  Some  potential   candidates,   such   as   the  
group  I  metabotropic  glutamate  receptors  (Simkus  &  Stricker,  2002a)  and  α1-­AR  were  
investigated  in  this  laboratory.  The  impact  of  α1-­AR  activation  on  spontaneous  release  is  
shown  in  Fig.  4.4.15.  In  A,  the  individual  mEPSC  frequencies  during  the  control  period  
(blue  bar)  and  after  addition  of  10  µM  NA  (red  bar)  are  presented.  The  average  mEPSC  
frequency  during  control  was  39  ±  1  Hz,  and  the  amplitude  -­13.0  ±  0.1  pA.  After  addition  
of  NA  at   t  =  0,  and   the   resumption  of   the   recording  after  another  5  min,   the  average  
mEPSC  frequency  increased  by  34  ±  3%  to  53  ±  1  Hz  (A,  D).  Minute  averages  of  the  
mEPSC  frequency  were  normalised  to  the  average  value  during  control,  and  are  shown  
in   B.   Note   that,   in   contrast   to   the   case   with   5-­HT,   the   mEPSC   frequency   increase  
persisted   for   the  whole  period  after  addition  of  NA.  The  mEPSC  amplitude   remained  
unchanged   (-­13.0   ±   0.1   pA;;  C),   not   significantly   different   from   control   (E).  When   the  
average   time   courses   of   mEPSCs   were   superimposed   (F)   there   was   no   significant  
change  by  NA.  
When  all  such  experiments  were  analysed  (n  =  49),  it  was  found  that  24  (49%)  pyramidal  
cells  showed  a  sustained  increase  in  the  mEPSC  frequency  as  described  above.  Like  in  
Part   3,   these   cells   were   referred   to   as   responders.   On   average,   NA   increased   the  
mEPSC  frequency  by  56  ±  7%   from  39  ±  2   to  59  ±  3  Hz   (ppt  <  10-­8;;  Fig.  G)   in   these  
responders.  This  increase  persisted  throughout  the  recording.  The  rest  did  not  show  any  
significant   increase  in  the  mEPSC  frequency  (non-­responders).  A  significantly  smaller  
mEPSC   frequency   during   the   control   period   was   observed   in   responders   than   non-­
responders  (39  ±  2  vs.  53  ±  4  Hz;;  pt  <  10-­3).  In  addition,  the  NA  and  agonists  caused  a  
significant  decrease  of  Rin  only  in  responders  (9  ±  7%  from  122  ±  8  to  103  ±  7  MΩ;;  ppt  =  
0.01).  
The  mechanisms  causing  the  increase  in  mEPSC  frequency  were  identified  as  follows  
(Choy  et  al.,  2017a).  1)  NA  acted  via  ɑ1-­ARs,  which  in  turn  2)  activated  PLCβ,  resulting  
in  3)  PIP2  hydrolysis  to  produce  IP3  and  DAG.  4)  The  former  bound  to  IP3R  on  presynaptic  
stores  to  cause  5)  Ca2+  release  from  stores,  which  then  6)  drove  vesicle  fusion,  observed  
as  an  increase  in  mEPSC  frequency.  
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Figure  4.4.15.  NA  increased  the  mEPSC  persistently.  
A.  Individual   instantaneous  mEPSC  frequencies   in  a  single  pyramidal  cell  shown  during  
control  (t  <  0  min),  and  after  addition  of  NA  (t  ≥  0  min).  B.  Minute  averages  of  the  data  in  A  
after  normalising  the  average  control  value  to  0%,  including  the  respective  error  bars  which  
were  smaller  than  the  diameter  of  the  dots.  Dashed  line  indicates  no  change.  C.  Same  as  
in  B,   but   for   the  mEPSC  amplitude.  D.   cPDFs  of   the   instantaneous   frequencies  during  
control  and  after  NA.  E.  Same  as  in  F,  but  for  the  mEPSC  amplitude.  F.  Superposition  of  
the  average  mEPSC  time  courses  during  control  and   in  NA.  G.  Minute  averages  of   the  
pooled  mEPSC  frequency  change  in  responders,  after  normalising  as  in  B.  
  
Consequently,   in   regard   to   spontaneous   transmitter   release,   both   NA   and   5-­HT   1)  
increased   the  mEPSC   frequency  without   affecting   its   amplitude.      2)   The   increase   in  
mEPSC  frequency  was  restricted  to  a  subset  of  pyramidal  cells  (responders).  3)  Both  
agonists   signalled   via   a   classical   Gq   cascade   to   increase   the  mEPSC   frequency   via  
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presynaptic   Ca2+   release   from   stores.   However,   in   contrast   to   NA,   the   increase   in  
mEPSC   frequency   by   5-­HT   was   transient,   but   become   maintained   after   PKC   was  
blocked.  The  impact  of  NA  on  evoked  transmitter  release,  and  how  it  compared  with  5-­
HT,  will  be  presented  next.  
4.4.3.2.  EPSCs  Depression  by  NA  
Different   from  what   was   expected   from   its   impact   on   spontaneous   release,   NA   also  
depressed  evoked  glutamate  release  in  this  layer.  
The  results  obtained  in  a  paired-­recording  after  exposure  to  10  µM  NA  is  illustrated  in  
Fig.  4.4.16.  In  A,  the  time  course  of  the  presynaptic  AP  (top)  with  the  evoked  average  
EPSC  (bottom)  during  control   is  presented.  The  average  peak  EPSC  amplitude  was  -­
47.2  ±  1.2  pA.  Addition  of  NA  depressed  the  EPSC  amplitude  by  71  ±  5%  to  -­13.7  ±  0.9  
pA  (B).  Individual  peak  amplitudes  during  control  and  after  NA  are  plotted  in  C.  It  shows  
that  NA  caused  a  persisting  depression  within  5  min  of  exposure.  The  time  courses  of  
the   respective  EPSCs   are   given   in  D,  with   the   traces   superimposed   (left)   and   peak-­
scaled  for  comparison  (right).  
Seven  such  experiments  are  presented  in  E,  where  the  paired  values  of  the  amplitudes  
in  control  and  NA  for  the  respective  pairs  are  joined  by  a  grey  line.  The  average  EPSC  
amplitude  during  control  was  -­24.0  ±  5.6  pA,  but  depressed  by  62  ±  7%  to  -­8.3  ±  2.0  pA  
(ppt  =  0.01)  after  addition  of  NA.  Even  though  this  depression  was  strictly  not  larger  than  
the  one  caused  by  5-­HT,  it  was  close  to  significant  (62  ±  7  vs.  49  ±  3%;;  pt  =  0.06).  
The  depression  by  NA  was  caused  by  ɑ1-­AR  activation  (Choy  et  al.,  2017b).  Specifically,  
application  of  the  ɑ1-­AR  agonist  cirazoline  (5  µM)  caused  a  constant  EPSC  depression  
by  54  ±  18%  from  -­8.2  ±  1.5  to  -­3.1  ±  0.3  pA  (n  =  4;;  ppt  <  0.05).  Compared  to  NA,  the  
extent  of  the  depression  caused  by  the  ɑ1-­AR  agonist  was  indistinguishable  (pt  =  0.40).  
This   depression   persisted   in   the   presence   of   ɑ2-­   and   β-­AR   blockers   yohimbine   and  
propranolol,  respectively  (1  µM  in  both  cases;;  n  =  5),  further  strengthening  the  idea  that  
ɑ1-­AR  caused  this  depression.  It   is  also  important  to  add  that   in  all  cases  tested  PPR  
was  not  significantly  altered  (ppt  =  0.37).  
Comparing  the   impacts  of  NA  on  transmitter  release  with  those  of  5-­HT,  the  following  
observations  can  be  made:  1)  Both,  NA  and  5-­HT  considerably  depressed   the  EPSC  
amplitude,  but  increased  spontaneous  transmitter  release.  2)  Both,  the  depression  and  
the  increase  in  m  EPSC  frequency  were  downstream  of  a  Gq-­linked  signalling  cascade.  
3)  In  both  cases,  despite  a  large  EPSC  depression,  on  average  PPR  was  not  altered.  
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Figure  4.4.16.  NA  depressed  the  evoked  EPSC  amplitude.  
Control  in  blue  and  exposure  to  NA  in  red.  A.  Time  courses  of  the  first  presynaptic  AP  and  
the  average  EPSC  during  control.  B.  Same  as  in  A,  but  in  the  presence  of  NA.  C.  Individual  
first   peak  EPSC  amplitudes  before  and  after   addition  of  NA  at   time  0  min.  D.  Overlaid  
average  EPSC  time  courses  before  and  after  NA  (left)  and  after  peak  scaling  for  the  control  
amplitude  (right).  E.  Pair-­wise  plot  of  different  experiments  for  the  first  EPSC  amplitudes  
during  control  and  after  addition  of  NA.  Data  from  the  same  experiment  are   joined  by  a  
line.  
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These  comparisons  suggested  that  the  activation  of  both  receptors  very  likely  employed  
the  same  or  very  similar  molecular  mechanisms  to  modulate  transmitter  release.  
4.4.3.3.  Presynaptic  Gβγ  Signalling  Causing  NA-­Induced  Depression  
Because  of  the  dissociation  of  the  increase  in  spontaneous,  but  the  depression  in  evoked  
release,  I  checked  at  which  step  downstream  of  α1-­AR  activation  the  signalling  diverged.  
This   line   of   investigation   was   started   at   the   first   step   in   this   cascade,   which   is   the  
activation  of  PLCβ.  
After  blocking  PLCβ  with  30  µM  edelfosine,  NA  still  depressed  the  EPSC  by  61  ±  11%  
(ppt  =  0.004;;  Choy  et  al.,  2017b),  suggesting  that  the  relevant  signalling  occurred  before  
this  step,  most  likely  at  the  level  of  the  G  protein.  Since  receptor  activation  produces  Gα  
and   Gβγ   from   the   trimeric   G   protein,   both   of   which   have   been   found   to   initiate  
downstream  signalling  (Betke  et  al.,  2012),  and  cognisant  of  the  fact  that  Gβγ  has  been  
found   to   directly   bind   to   the   SNARE   complex   and   inhibit   transmitter   release  
(Gerachshenko   et   al.,   2005),  we  hypothesised   that   the   latter  was   responsible   for   the  
depression.  
To   test   this   possibility,   I   performed   experiments   in   which   I   utilized   the   commercially  
available  synthetic  peptide  mSIRK,  which  scavenges  Gβγ  (Goubaeva  et  al.,  2003)  and  
therefore  blocks  its  action.  Different  from  previous  conditions,  in  which  pharmacological  
agents  were  added  to  the  superfusate,  in  this  case,  mSIRK  was  added  to  the  presynaptic  
patch  solution  and  allowed  to  diffuse  into  the  cell  after  break-­in.  Since  the  relevant  nerve  
terminals  were  on  average  91  ±  47  µm  away  from  the  soma,  and  due  to  its  dilution  by  
the   cell   volume,  we   chose   a   concentration   of   100   µM.   A   loading   time   of   at   least   20  
minutes   was   allowed   until   the   data   were   considered   for   analysis.   This   time   was  
sufficiently   long   given   the   relationship   between   molecular   weight   and   diffusion   rate  
(Pusch  &  Neher,  1988).  
After   loading   the   presynaptic   cell   with   mSIRK   for   at   least   20   minutes,   EPSCs   were  
evoked  in  the  postsynaptic  cell  again   in  response  to  the  normal  paired-­pulse  stimulus  
protocol.   Data   was   taken   before   (control)   and   after   addition   of   10   µM   NA   to   the  
superfusate.  Such  a  recording   is  presented   in  Fig.  4.4.17.   In   this  experiment,   the   first  
EPSC  had  an  average  peak  amplitude  of   -­3.8  ±  0.5  pA  during   the   control   period   (A,  
bottom   trace).  Subsequent   application  of  NA  prevented   the  depression  as   the  EPSC  
amplitude  remained  at   -­3.8  ±  0.3  pA  (pt  =  0.98;;  B,  bottom  trace).  The   individual  peak  
amplitudes  of  the  first  EPSC  are  plotted  in  C  for  the  control  period  and  after  exposure  to  
NA  showing  that  the  release  process  remained  stationary.  As  expected,  PPR  was  not  
altered  either  (0.89  ±  0.06  in  control  vs.  0.95  ±  0.08  in  NA;;  pt  =  0.14).  The  time  courses  
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of  the  first  AP  (D,  right  traces)  and  the  first  EPSC  (E,  right  traces)  in  control  vs.  after  NA  
showed  no  significant  change.  
In  7  pairs  studied,  the  peak  amplitude  of  the  first  EPSC  during  control  period  was  -­4.5  ±  
1.1  pA.  The  subsequent  application  of  NA  failed  to  cause  any  significant  depression,  as  
the  amplitude   remained  at   -­4.3  ±  1.2  pA   (ppt  =  0.55;;  F  and  G).  Neither  was   there  on  
average  a  significant  change  in  PPR  (0.78  ±  0.08  vs.  0.78  ±  0.10  for  control  vs.  NA;;  ppt  
=  0.98;;  H).  
These  results  strongly  suggest  that  NA  caused  the  large  presynaptic  EPSC  depression  
via  Gβγ  signalling  downstream  of  ɑ1-­AR  activation.  Because  of  the  similarities  between  
NA  and  5-­HT,  I  hypothesized  that  downstream  of  5-­HT2R  activation,  the  depression  is  
also  caused  via  Gβγ  signalling.  In  the  following  section,  I  will  provide  data  in  support  of  
this  idea.  
4.4.4.  Mechanism  of  EPSC  Depression  by  5-­HT  
As  indicated  above,  the  most  likely  mechanism  how  5-­HT  caused  the  EPSC  depression  
is  via  the  production  of  Gβγ  upon  receptor  activation.  The  following  section  addresses  
this  hypothesis  but  also  rules  out  the  alternative  possibility  that  it  may  have  been  caused  
by  activation  of  PKC.  In  4.4.4.1,  I  will  present  data  from  experiments  in  which  PKC  was  
blocked.  This  data  set  served  as  a  control,  to  rule  out  the  possibility  that  the  depression  
was   caused   by   the   production   of   DAG   downstream   of   PLCβ   and   the   subsequent  
activation  of  PKC  (see  also  Part  3).  In  4.4.4.2,  the  addition  of  the  Gβγ  scavenger  mSIRK  
to   the   presynaptic   recording   solution   in   the   patch   pipette   successfully   blocked   the  
depression  by  5-­HT.  In  4.4.4.3,  I  will  provide  additional  data  with  another  Gβγ-­binding  
peptide,  which  also  blocked  the  depression  observed.  In  4.4.4.4,  I  will  provide  data  to  
indicate   the  downstream   target(s)  of  Gβγ  by  comparing   the   recovery   from  short-­term  
depression  with  that  in  NA.  With  this  neuromodulator,  Gβγ  most  likely  bound  to  the  c-­
terminus  of  SNAP-­25.  In  4.4.4.5,  I  will  present  results  from  quantal  analyses  of  individual  
EPSCs  (Stricker  &  Redman,  1994;;  Stricker  et  al.,  1994;;  Stricker  et  al.,  1996b,  a)  and  
compare  these  with  similar  ones  with  NA,  where  a  significant  reduction  in  quantal  size  
was  observed,  consistent  with  Gβγ  binding  to  SNAP-­25.  
4.4.4.1.  PKC  Block  
Because  the  transient  mEPSC  frequency  increases  became  sustained  when  PKC  was  
blocked   (see   3.4.4.6),   I   checked   if   PKC  activation  was   involved   in   the   depression   of  
evoked  release.  
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Figure  4.4.17.  Depression  by  NA  was  blocked  by  mSIRK.  
The  same  figure   legend  as   for  Fig.  4.4.14  also  applies  here,  with   the  additions   that   red  
codes  for  NA,  and  green  indicates  the  presence  of  mSIRK  in  the  recording  pipette.  
  
Data  from  an  experiment  with  PKC  blocked  with  100  nM  Gö  6983,  and  GABAA  receptors  
with  3  µM  gabazine,  are  illustrated  in  Fig.  4.4.18.  In  A,  the  time  courses  of  the  respective  
APs  and  EPSCs  recorded  during  control  are  shown.  Control  experiments  for  the  action    
of  the  PKC  blocker  revealed  that  Gö  6983  itself  did  not  significantly  change  the  pre-­  and  
postsynaptic  properties  (n  =  4;;  ppt  ≥  0.23).  In  this  experiment,  during  control,  the  average  
first  EPSC  amplitude  was  -­5.7  ±  0.5  pA.  In  the  presence  of  Gö  6983  and  after  the  addition  
of  5-­HT  for  five  minutes  (B),  the  first  EPSC  amplitude  still  depressed  by  53  ±  7%  to  -­2.7  
±  0.3  pA  (pt  <  2·10-­7).  This  depression  was  largely  established  within  the  first  five  minutes  
in  5-­HT  and  persisted   for   the  remainder  of   the  recording  (C).  PPR   in   this  pair  did  not  
change  (0.77  ±  0.10  in  control  vs.  0.84  ±  0.32  in  5-­HT;;  pt  =  0.17).  
After   the   addition   of   5-­HT,   the  membrane   potential   in   the   presynaptic   cell   showed   a  
depolarization  by  4.6  from  -­76.5  to  -­71.9  mV  (D,  left  traces).  The  comparison  between  
the  two  AP  time  courses  after  aligning  for  Vthr  showed  no  significant  change  in  either  RT  
or  W.  However,  H  of  the  AP  was  reduced  by  3.6  from  66.0  to  62.4  mV.  
The  postsynaptic  cell  showed  a  decrease  in  Ihold  by  65  pA  from  55  to  -­10  pA.  At  a  Rin  of  
142  MΩ,  this  change  would  have  corresponded  to  a  depolarization  by  9.2  mV.  When  the  
time  courses  of  the  first  EPSC  were  aligned  and  peak-­scaled  (E,  right  traces),  no  change  
was  observed.  
This  set  of  experiments  consisted  of  four  pairs.  Because  in  two  out  of  four  presynaptic  
cells,  Vm  required  a  bias  current  to  keep  then  at  <-­70  mV,  I  am  unable  to  comment  on  
the  change  in  the  presynaptic  membrane  potential  following  5-­HT.  However,  I  am  able  
to  comment  on  that  in  the  postsynaptic  cell,  there  was  on  average  no  significant  change  
to  Ihold  (32.8  ±  33.2  vs.  31.5  ±  61.1  pA;;  ppt  =  0.98).  The  EPSC  time  courses  including  rise  
time  and  half-­width  remained  unaltered  (ppt  ≥  0.36).    
In  the  4  pairs  studied,  5-­HT  still  consistently  depressed  the  EPSC  amplitude  by  51  ±  9%  
from  -­13.9  ±  5.5  to  -­6.7  ±  3.1  pA  (ppt  =  0.04;;  F  and  G,  black)  despite  PKC  block.  This  
depression  was  also  accompanied  by  no  change  in  PPR  (0.80  ±  0.08  vs.  0.89  ±  0.04;;  ppt  
=   0.24;;   H   black).   The   extent   of   depression   with   or   without   PKC   inhibition   was  
indistinguishable  (51  ±  9  vs.  46  ±  4%;;  pt  =  0.57),  as  was  PPR.  Therefore,  I  conclude  that  
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Figure  4.4.18.  EPSC  depression  persists  despite  PKC  block.  
This  figure  is  made  similarly  to  that  shown  in  Fig.  4.4.14  and  therefore  the  legend  there  
applies  here,  with   the  exception   that   this   experiment  was  performed  with  PKC  blocked  
throughout.  
  
PKC  is  not  significantly  involved  in  causing  the  EPSC  depression.  Since  the  depression  
is   brought   about   by   receptor   signalling   proximal   to   PKC,   the   most   likely   candidate,  
therefore,  is  Gβγ.  
4.4.4.2.  Depression  Blocked  by  mSIRK  
Because  scavenging  Gβγ  by  mSIRK  blocked  the  depression  caused  by  NA  (see  4.4.3.3  
above),  I  tested  the  impact  of  this  peptide  on  the  depression.  100  µM  mSIRK  was  added  
to   only   the   patch   solution   of   the   presynaptic   cell.   As   above,   after   re-­patching   the  
presynaptic  cell  with  an  intracellular  solution  containing  mSIRK,  it  was  allowed  to  diffuse  
for  >  20  minutes  before  5-­HT  was  added  to  the  superfusion.    
When   I  compared   the  presynaptic  properties   immediately  after   re-­patching  with   those  
after  loading  mSIRK  for  >  20  minutes  (n  =  13),  I  found  that  for  the  first  AP,  significant  
changes  were  observed  in  regard  to  Vthr,  Vrel,  H,  RT,  and  W.  Specifically,  Vthr  depolarized  
by  6.5  ±  1.6  from  -­45.4  ±  1.3  to  -­38.9  ±  1.5  mV  (ppt  =  2·10-­3),  Vrel  increased  by  6.0  ±  1.9  
from  31.8  ±  1.9  to  37.8  ±  2.2  mV  (ppt  =  0.011),  H  decreased  by  7.2  ±  1.7  from  79.6  ±  2.0  
to  72.5  ±  2.4  mV  (ppt  =  2·10-­3),  RT  was  prolonged  by  0.1  from  0.5  to  0.6  ms  (ppt  =  7·10-­5)  
and  W  broadened  by  0.1  ms  from  0.9  to  1.0  ms  (ppt  =  9·10-­4).  Similar  changes  were  also  
observed  for  the  second  AP.  Vthr  depolarized  by  6.5  ±  1.5  from  -­45.1  ±  1.3  to  -­38.6  ±  1.5  
mV  (ppt  =  2·10-­3),  Vrel  increased  by  6.0  ±  1.9  from  32.1  ±  1.8  to  38.1  ±  2.2  mV  (ppt  =  0.01),  
H  decreased  by  7.1  ±  1.5  from  79.0  ±  1.8  to  71.9  ±  2.2  mV  (ppt  =  7·10-­4),  and  W  broadened  
by  0.1  ms  from  1.0  to  1.1  ms  (ppt  =  2·10-­4).    
Despite  the  changes  indicated  above,  Vrest  remained  the  same  (-­77.3  ±  1.5  vs.  -­77.0  ±  
1.2  mV;;  ppt  =  0.77).  Because  Rin  was  not  measured  20  minutes  after  loading,  I  am  unable  
to  present  direct  evidence  if  Rin  was  affected  by  mSIRK.  However,  since  the  change  in  
Rin  estimated  before  mSIRK  loading  and  after  addition  of  5-­HT  in  its  presence  was  not  
significantly  different  from  that  in  “plain”  experiments  (pt  =  0.68),  Rin  was  unlikely  affected  
by  mSIRK.  
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Figure  4.4.19.  Depression  was  blocked  with  mSIRK  in  the  presynaptic  solution.  
The  same  legend  as  in  Fig.  4.4.17  applies  here,  except  that  the  slices  were  exposed  to  10  
µM  5-­HT.  
  
How  5-­HT  affected  the  presynaptic  APs  and  the  postsynaptic  EPSCs  after  mSIRK  being  
loaded  to  the  presynaptic  cell   is  shown  in  Fig.  4.4.19.  Specifically,  after  20  minutes  of  
mSIRK  loading  of  the  presynaptic  cell,  the  time  courses  of  the  APs  and  average  EPSCs  
during  the  control  period  are  presented  in  A.  The  first  EPSC  had  an  average  amplitude  
of   -­15.2   ±   1.3   pA   (A,   bottom).   Subsequent   exposure   to   5-­HT   failed   to   cause   any  
significant  depression,  as  the  average  amplitude  remained  at  -­14.7  ±  0.8  pA  (pt  =  0.70;;  
B,  bottom).  The  individual  peak  amplitudes  of  the  EPSCs  before  and  after  5-­HT  addition  
are  presented  in  C  indicating  that  the  EPSC  remained  stationary  during  both  recording  
periods.  As  expected,  PPR  did  not  change  significantly  either  (0.83  ±  0.04  in  control  vs.  
0.77  ±  0.05  in  5-­HT;;  pt  =  0.09).    
Upon  exposure  to  5-­HT,  the  presynaptic  cell  depolarized  by  2.7  from  -­78.7  to  -­76.0  mV  
(D,  left).  The  comparison  between  the  two  time  courses  of  the  first  AP,  after  aligning  for  
the  Vthr  (D,  right),  revealed  no  change  in  RT  and  W,  but  a  small  decrease  in  H  by  1.6  
from  71.0  to  69.4  mV.  The  postsynaptic  cell  showed  an  increase  in  Ihold  by  53  pA,  which  
corresponded   to   a   hyperpolarization   by   5.3  mV   for   a  Rin   of   100  MΩ.  When   the   time  
courses  of  the  first  EPSC  were  aligned  and  peak-­scaled  (E,  right),  no  significant  change  
was  observed.  
After  exposure  to  5-­HT,  the  presynaptic  cells  did  not  show  any  significant  change  in  Vrest  
(-­75.9  ±  1.5  vs.  -­75.7  ±  1.3  mV;;  ppt  =  0.84).  With  the  exception  of  H,  other  properties  of  
the  AP  were  not  significantly  altered  either  (ppt  ≥  0.08).  On  average,  H  of  the  first  AP  still  
decreased  by  2.6  ±  0.5  from  73.0  ±  3.1  to  70.4  ±  2.9  mV  (ppt  =  0.003),  and  the  second  
by  2.5  ±  0.5  from  72.1  ±  2.9  to  69.6  ±  2.7  mV  (ppt  =  0.004).  Neither  Ihold  (64  ±  35  vs.  26  ±  
93  pA;;  ppt   =  0.57),   nor  any  other  property  of   the  postsynaptic   cells  were   significantly  
altered  by  5-­HT  (ppt  ≥  0.051).  
The   presence   of   mSIRK   in   the   presynaptic   patch   pipette   prevented   a   significant  
depression  in  5  out  6  pairs.  In  one  pair,  a  significant  depression  by  39  ±  4%  from  -­20.6  
±  1.1  to  -­12.6  ±  0.5  pA  remained  (pt  =  5·10-­9).  One  likely  explanation  for  this  observation  
was  that  the  larger  Rs  associated  with  this  presynaptic  cell  (~18  MΩ)  slowed  the  diffusion  
of   mSIRK   to   the   nerve   terminals.   However,   in   comparison   with   experiments   without  
mSIRK,  the  number  of  pairs  with  no  depression  increased  significantly  (0  out  of  7  vs.  5  
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On  average,  after  mSIRK  was  loaded  into  all  presynaptic  cells,  the  peak  amplitude  of  the  
first  EPSC  during  control  period  was  -­11.6  ±  3.8  pA.  The  subsequent  addition  of  5-­HT  
did  not  cause  any  significant  depression,  as  the  peak  amplitude  remained  at  -­10.2  ±  3.1  
pA  (pt  =  0.32;;  F  black).  In  addition,  no  significant  change  was  observed  for  PPR  either  
(0.93  ±  0.06  vs.  0.99  ±  0.07;;  pt  =  0.41;;  H  black).      
These  results   indicated   that  when  mSIRK  bound  Gβγ,   the  EPSC  depression  by  5-­HT  
was  largely  abolished.  However,  because  in  this  case  5-­HT  still   reduced  H  of   the  AP,  
without   any   depression   of   the   EPSC,   under   physiological   conditions   the   depression  
observed   is  not  due   to  a  smaller  AP.  Furthermore,  because  mSIRK  also  blocked   the  
presynaptic  hyperpolarization,  which  was  also  not  observed  when  the  5-­HT2R  agonist  
was  used  (see  4.4.2.4),  the  hyperpolarization  likely  occurred  via  the  activation  of  5-­HT1R,  
which  signalled  via  Gβγ  subunits  to  activate  GIRK  channels  (Lüscher  et  al.,  1997).    
4.4.4.3.  Depression  Also  Blocked  by  ct-­SNAP-­25    
Because   mSIRK   is   myristoylated   to   allow   for   membrane   penetration,   a   potential  
conjecture  could  be  that  its  action  was  not  restricted  to  the  presynaptic  nerve  terminals  
as   it   could   have   diffused   out   of   the   cell,   and   in   doing   so,   could   have   affected   nerve  
terminals  and  dendrites  nearby.  This  then  could  have  somehow  blocked  the  depression  
observed.  
To  rule  such  a  scenario  out,  I  performed  another  set  of  experiments,  this  time  using  a  
peptide  of  14  amino-­acids  corresponding  to  the  C-­terminal  of  SNAP-­25  (ct-­SNAP-­25),  to  
which  physiologically  Gβγ  binds  (Gerachshenko  et  al.,  2005).  Specifically,   the  peptide  
sequence   is  DEANQRATKMLGSG.  Again,   this  peptide  was  added   to   the  presynaptic  
solution  at  a  concentration  of  5.4  mM.  Otherwise,  these  experiments  were  conducted  in  
the  same  way  as  with  mSIRK.  However,  because  of  a  small  sample  size  (n  =  3),   the  
presentation  will  be  restricted  to  the  ability  of  ct-­SNAP-­25  to  block  the  depression.  
One  of  these  experiments  is  illustrated  in  Fig.  4.4.20.  The  time  courses  of  the  AP  and  
the  average  EPSC  during  the  control  period  are  presented  in  A.  The  first  EPSC  had  an  
average  peak  amplitude  of  -­14.1  ±  1.0  pA  (A,  bottom).  Subsequent  addition  of  5-­HT  did  
not   result   in  a  significant  depression  (-­12.6  ±  0.8  pA;;  pt  =  0.25;;  B,  bottom).   Individual  
peak  amplitudes  of  the  first  EPSCs  for  the  periods  before  and  after  5-­HT  are  shown  in  
C,  further  corroborating  that  there  was  no  significant  depression.  At  the  same  time,  PPR  
remained  unchanged  throughout  recording  (0.93  ±  0.04  in  control  vs.  0.95  ±  0.06  in  5-­
HT;;  pt  =  0.13).    
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The  presynaptic  cell,  loaded  with  ct-­SNAP-­25,  showed  a  depolarization  by  2.4  from  -­76.9  
to  -­74.5  mV  after  5-­HT  was  added  (D,  left).  After  aligning  the  two  time  courses  for  Vthr,  
the  comparison  of  the  first  APs  before  and  after  5-­HT  (D,  right)  revealed  no  change  in  
RT  and  W.  However,  H  showed  a  small  decrease  by  1.4  from  77.2  to  75.9  mV.  
Ihold  of  the  postsynaptic  cell  showed  a  very  small  increase  by  8  pA  at  a  Rin  of  109  MΩ,  
which  corresponded  to  a  hyperpolarization  by  0.9  mV.  When  the  time  courses  of  the  first  
EPSC  during  control  and  in  5-­HT  were  aligned  and  peak-­scaled  (E,  right),  no  significant  
change  was  observed.  
On  average,   the  peak  amplitude  of   the   first  EPSC  was   -­15.2  ±  3.0  pA  during  control.  
Subsequent  addition  of  5-­HT  did  not   cause  a  significant  depression   (G  black)  as   the  
EPSC  amplitude  remained  at  -­13.8  ±  2.5  pA  (ppt  =  0.11;;  F  black).  In  support,  PPR  in  this  
data  set  did  not  show  any  significant  change  either  (0.88  ±  0.11  vs.  0.91  ±  0.08;;  ppt  =  
0.44;;  H  black).  
Admittedly  based  on  a  small  sample  size,  these  experiments  still  strengthen  the  idea  that  
when  Gβγ  was  bound  to  ct-­SNAP-­25  instead  of  its  physiological  target,  the  depression  
by  5-­HT  was  largely  blocked.  Because  the  outcome  of  this  set  of  experiments  was  no  
different  from  that  with  mSIRK,  it  was  unlikely  that  mSIRK  significantly  affected  signalling  
outside  of  the  respective  nerve  terminals  to  prevent  the  depression.  
4.4.4.4.  No  Speed-­Up  of  the  Recovery  Rate  from  Depression  
After  confirming  that  5-­HT  caused  the  EPSC  depression  via  Gβγ  signalling,  insights  into  
the   respective   targets  were  sought.  Based  on  previous  studies,   there  are   two  known  
mechanisms  by  which  Gβγ  might  cause  the  observed  depression.  In  the  first  mechanism,  
Gβγ  binds  to  high  voltage-­activated  Ca2+  channels  to  limit  Ca2+  influx  (Ikeda,  1996).  In  
the  second,  it  directly  binds  to  SNAP-­25  of  the  SNARE  complex,  to  inhibit  subsequent  
membrane  fusion  (Blackmer  et  al.,  2005).  
In  the  latter  case,  Gβγ  competes  with  Ca2+/synaptotagmin  1  for  binding  to  the  SNARE  
complex   in   a  Ca2+-­dependent  way.  At   high  Ca2+   concentrations,  Gβγ   unbinds   from  
SNAP-­25  and  Ca2+/synaptotagmin  1  rebinds  to  cause  a  temporary  relief  from  depression  
(Yoon  et  al.,  2007),  seen  as  a  speed-­up  in  the  rate  of  recovery  from  depression.  When  
Gβγ  binds  to  the  distal  part  of  SNAP-­25,  it  reduces  the  quantal  amplitude  by  altering  the  
fusion  pore   (Photowala   et   al.,   2006;;  Schwartz   et   al.,   2007;;  Fang   et   al.,   2008).   It   has  
previously  been  shown  in  this  laboratory  that  this  mechanism  is  most  likely  responsible  
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Figure  4.4.20.  Depression  was  also  blocked  by  ct-­SNAP-­25.  
The  figure  legend  for  Fig.  4.4.19  also  applies  here,  with  the  exception  that  green  indicates  
the  presence  of  ct-­SNAP-­25  in  presynaptic  cell.  
  
for   the   depression   by   NA,   as   evidenced   by   a   speed-­up   in   the   recovery   rate   from  
depression  and  a  reduced  quantal  size,  both  implicating  the  critical  role  of  Gβγ  binding  
to  SNAP-­25  in  this  process  (Choy  et  al.,  2017b).  
A  protocol  was  designed  (see  4.3.2)  to  test  if  the  rate  of  recovery  from  depression  was  
accelerated  by  5-­HT.  For  this  purpose,  short-­term  depression  was  induced  by  a  burst  of  
20  APs  at  a  rate  of  50  Hz.  500  ms  later,  another  AP  was  evoked  to  gauge  the  rate  of  
recovery.  Such  a  set  of  stimuli  was  repeated  20  times  every  25  s  as  higher  rates  incurred  
a   powerful   depression.   From   these   repetitions,   an   average   time   course  was   formed.  
Based  on  this  time  course,  the  recovery  from  (short-­term)  depression  was  quantified  as  
R50,  as  described  in  Methods,  section  4.3.5.  A  value  of  R50  =  -­1  indicates  no  recovery,  0  
full  recovery  within  500  ms,  and  values  >  0  denote  that  the  recovery  EPSC  is  larger  than  
the  first  EPSC  in  the  train.  
Before  proceeding  further,  I  summarise  data  from  experiments  with  NA.  Exposure  to  10  
µM  NA  caused  a  significant   increase  in  R50  from  -­0.20  ±  0.06  during  control  to  0.51  ±  
0.29  (n  =  5;;  ppt  =  0.03;;  Choy  et  al.,  2017b).  This  result  was  consistent  with  the  idea  that,  
in  the  case  of  NA,  after  α1  receptor  activation  Gβγ  most  likely  bound  to  SNAP-­25.  If  5-­HT  
also  caused  the  depression  via  the  same  mechanism,  a  significant  increase  in  R50  would  
be  uncovered.  
Such  an  experiment  is  illustrated  in  Fig.  4.4.21.  During  the  control  period  (A),  the  average  
peak  amplitude  of  the  first  EPSC  was  -­40.4  ±  2.1  pA.  At  this  set  of  synapses,  after  20  
APs,   there  was   a   steady-­state   depression   by   57   ±   3%   to   -­17.3   ±   0.5   pA.   The   peak  
amplitude  of  the  recovery  EPSC  was  -­38.3  ±  1.9  pA,  resulting  in  a  value  for  R50  of  -­0.09  
±  0.12.  This   indicated  that  within  500  ms,   the  EPSC  recovered   just  about  back  to   the  
amplitude  of  the  first  EPSC  in  the  train.  After  exposure  to  5-­HT  (B),  the  first  EPSC  in  the  
burst  depressed  by  42  ±  5%  to  -­23.4  ±  1.6  pA,  consistent  with  my  previous  findings  (see  
4.4.2.1).   After   20   APs,   the   steady   state   amplitude   depressed   to   -­8.8   ±   0.8   pA.   The  
recovery  EPSC  amplitude  remained  slightly  smaller  than  the  first  EPSC  in  the  stimulus  
sequence,  i.e.  -­22.0  ±  2.0  pA  vs.  -­23.4  ±  1.6  pA,  respectively.  Consequently,  in  this  case  
R50  was  -­0.10  ±  0.18,  not  different  from  the  starting  value  (pt  =  0.50).  
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Figure  4.4.21.  5-­HT  did  not  speed-­up  recovery  from  depression.  
A.  Average  time  courses  of  the  presynaptic  APs  and  postsynaptic  EPSCs  elicited  by  20  
APs  at  50  Hz,   followed  by  eliciting  a  single  AP  with  a  500  ms  delay  and  measuring  the  
respective  EPSC.  The  black  line  indicates  the  amplitude  of  the  1st  EPSC,  the  grey  one  the  
amplitude  of  the  recovery  EPSC.  The  dashed  line  indicates  the  baseline  against  which  the  
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amplitudes  were  measured  B.  Same  as  in  A,  but  after  addition  of  5-­HT.  C.  Whisker  plot  of  
the  values  for  R50  during  control  period  (n  =  18)  and  in  5-­HT  (n  =  12).  D.  Pair-­wise  values  
of  R50  plotted  before  and  after  5-­HT  addition  with  the  values  in  the  respective  experiment  
joined  by  a  line.  The  black  values  represent  the  population  averages  with  the  respective  
errors.  
  
During  control,  in  18  pyramidal  pairs,  R50  ranged  from  -­0.62  ±  0.09  to  0.84  ±  0.80,  with  a  
median  value  of  0.05  ±  0.02  (C)  and  a  mean  of  0.07  ±  0.09.  I  was  able  to  extract  the  
values  of  R50  before  and  after  5-­HT  in  12  out  of  those  18  pairs  (D).  On  average,  R50  did  
not  significantly  change  with  5-­HT  (0.07  ±  0.12  vs.  0.59  ±  0.41;;  ppt  =  0.10).  
Because  5-­HT  did  not  alter  R50  significantly,  I  conclude  that  Gβγ  downstream  of  5-­HT2R  
activation  unlikely  binds  to  the  C-­terminus  of  SNAP-­25.  These  results  then  point  towards  
the  idea  that  in  the  case  of  5-­HT,  the  targets  of  Gβγ  may  likely  be  VDCC.  If  that  were  the  
case,  then  the  quantal  size  should  remain  unaltered,  in  contrast  to  what  was  found  in  the  
case  of  NA.  
4.4.4.5.  Quantal  Analysis  on  5-­HT-­Induced  EPSC  Depression  
To   further   explore   the  molecular   targets   through  which   the   depression  was   incurred,  
quantal   analysis   was   performed   on   a   subset   of   such   recordings.   This   was   done   in  
keeping  with  how  NA  affected  the  quantal  parameters  (Choy  et  al.,  2017b).  Specifically,  
in  that  data  set,  a  significant  drop  in  quantal  size  by  39  ±  5%  was  uncovered.  Because  
this  decrease  was  restricted  to  the  presynaptic  terminal,   this  observation  is  consistent  
with  Gβγ  binding  to  SNAP-­25,  in  competition  with  Ca2+,  to  most  likely  cause  fusion  pore  
limitation.  
For  this  purpose,  I  performed  a  density-­based  quantal  analysis.  To  be  included  in  this  
analysis,  a  data  set  should  have  had  at  least  about  100  –  300  stationary  EPSCs  evoked  
during   the   control   period,   and   about   an   equal   number   after   the   addition   of   5-­HT.  An  
example  of  such  data  set  is  given  in  Fig.  4.4.22.  Individual  peak  amplitudes  of  the  first  
EPSC  during  the  control  period  (solid  black)  and  after  5-­HT  exposure  (open)  are  shown  
in  A.  The  average  value  for  the  279  measured  EPSCs  during  control  period  was  -­12.0  ±  
0.5   pA,   with   a   coefficient   of   variation   (CV)   of   0.67.   The   respective   noise   standard  
deviation  (σn)  was  0.91  pA.  The  density  of  these  amplitudes,  formed  using  a  Gaussian  
kernel  of  0.27  pA,  is  illustrated  in  B  (solid  line).  After  the  addition  of  5-­HT,  the  average  
peak  EPSC  amplitude  was  -­5.1  ±  0.3  pA,  with  a  CV  of  0.95  and  σn  of  1.04  pA.  Using  a  
kernel  size  of  0.31  pA,  the  density  of  these  amplitudes  was  formed  and  is  shown  in  C  
(solid  line).    
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Figure  4.4.22.  Quantal  analysis  of  5-­HT  mediated  EPSC  depression.  
A.  Individual  peak  EPSC  amplitudes  during  the  control  period  (solid)  and  after  addition  of  
5-­HT  (open).  B.  Probability  density  of  the  EPSC  amplitudes  during  control  (solid  line)  and  
with  the  best  fit  (grey).  C.  Same  as  for  B,  but  after  exposure  to  5-­HT.  D.  Estimates  of  the  
amplitude  probabilities  and  quantal  amplitudes,  including  the  respective  error  bars  for  the  
best  model  during  control.  E.  Same  as  in  D,  but  for  the  best  model  in  the  presence  of  5-­
HT.  
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The  best  model  during  the  control  period  was  an  unconstrained  quantal  process  with  10  
modes   and   a   quantal   size   (Q)   of   -­3.0   ±   0.3   pA   (B,   grey   density).   Consequently,   the  
quantal  content  (m)  was  estimated  to  be  3.9  ±  0.5,  with  a  failure  rate  (P0)  of  0.10  ±  0.03.  
After  addition  of  5-­HT,  the  best  model  remained  an  unconstrained  quantal  process,  but  
this  time  only  with  6  modes  and  a  Q  of  -­3.5  ±  0.3  pA  (C,  grey  density).  Based  on  this  
value,  m   equalled  1.5  ±  0.1  and  P0  was  0.33  ±  0.04.  The   respective  amplitudes  and  
associated  probabilities,  together  with  the  respective  error  bars,  are  presented  in  Fig.  D  
for  the  control  and  E  for  the  period  with  5-­HT.  Note  how  the  error  bars  for  the  amplitudes  
become  larger  with  the  number  of  modes  due  to  the  accumulation  of  the  respective  error  
in  quantal  size.  A  comparison  between  Q  during  control  and  after  5-­HT  reveals  that  these  
values  were  indistinguishable  (pt  =  0.07).  
Because  there  was  no  difference  in  the  outcomes  when  5-­HT  (n  =  8)  or  the  agonist  α-­
methyl-­5-­HT  (n  =  6)  was  used,  the  data  sets  were  pooled.  From  these  14  data  sets,  6  
passed  the  unimodality  tests  (43%).  The  average  peak  EPSC  amplitude  during  control  
was  -­11.2  ±  2.3  pA,  based  on  an  average  sample  size  of  197  ±  36.  σn  was  0.94  ±  0.07  
pA   (kernel   size  0.30  ±  0.02  pA).  After   the  addition  of   5-­HT,   the  average  peak  EPSC  
amplitude  was  -­4.6  ±  0.9  pA  based  on  an  average  sample  size  of  212  ±  16.  σn  was  of  
0.89  ±  0.05  pA  (kernel  size  0.30  ±  0.02  pA).  These  numbers  correspond  to  an  average    
depression  in  peak  EPSC  amplitude  by  55  ±  7%,  which  was  not  different  from  that  in  the  
overall  sample  (pt  =  0.42).  
Similar  to  the  example  presented  above,  all  data  sets  were  well  fit  with  an  unconstrained  
quantal  model  without  variance.  The  average  value  of  Q  during  control  was  -­2.9  ±  0.1  
pA.  After  5-­HT,  Q   remained   the  same  (-­2.9  ±  0.2  pA;;  pt  =  0.65).  The  values   for  each  
experiment   are   presented   in   Fig.   4.4.23.   In   A,   the   dashed   line   indicates   the   line   of  
identity.  Note  that  all  data  points  group  around  it.  This  finding  is  in  contrast  to  that  with  
NA,  where  a  reduction  in  Q  by  39  ±  5%  was  uncovered  (Choy  et  al.,  2017b).  Based  on  
the  individual  values  of  Q,  the  average  value  of  m  was  estimated  to  be  3.8  ±  0.7  and  1.6  
±  0.3  during  control  and  after  5-­HT,  respectively.  This  is  shown  in  B,  where  the  respective  
values  are  plotted  with  the  line  of  identity  dashed.  In  fact,  there  is  a  significant  correlation  
between  m5-­HT  and  mC  when  the  offset  was  constrained  to  0  (B,  solid  line;;  slope  0.40  ±  
0.05,  r  =  0.77,  pPr  =  0.045).  When  the  depression  in  m  was  plotted  against  the  EPSC  
depression   (C),  all   data  points  grouped  around   the   line  of   identity,   indicating   that   the  
EPSC  depression  was  mostly  due  to  a  reduction  in  m.  Again,  this  is  different  to  what  was  
seen  with  NA,  suggesting  that  in  this  case,  Gβγ  did  not  primarily  bind  to  the  C-­terminal  
of  SNAP-­25.  
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Figure  4.4.23.  Reduction  in  quantal  content,  but  not  size.  
A.  Quantal  size  (Q)  after  addition  of  5-­HT  plotted  against  that  during  the  control  period  with  
their  respective  error  bars.  Line  of  identity  dashed.  B.  Same  as  in  A,  but  for  quantal  content  
(m).  C.  Depression  in  m  plotted  against  that  of  the  EPSC  amplitude.  D.  CV-­2  analysis  of  the  
same   data   set.   Both   values   normalised   to   the   control   condition.   Dashed   lines   indicate  
values  of  1  for  both  CV-­2  and  mean,  and  delineate  the  area  of  depression  between  values  
of  0  and  1.  The  solid  line  is  the  best  fit  to  the  data  set,  but  also  the  line  of  identify.  Values  
on  and  below  the  line  are  interpreted  as  due  to  a  change  in  release  probability.  
  
To  cross-­check  the  outcomes  of  the  density  based  estimation,  the  data  set  was  subject  
to  a  CV-­2  analysis   (Del  Castillo  &  Katz,  1954b;;  Bekkers  &  Stevens,  1990;;  Malinow  &  
Tsien,  1990).  This  is  illustrated  in  D.  In  its  classic  interpretation,  any  change  associated  
with  the  quantal  size  should  not  change  CV-­2,  but  affect  the  mean  (points  would  fall  into  
the  triangle  above  the  line  of  identity),  whereas  changes  in  release  probability  strongly  
affect  both  the  relative  CV-­2,  but  to  a  lesser  extent  the  relative  mean  (points  would  fall  
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into  the  line  of  identity  or  below).  In  the  case  of  the  depression  incurred  by  5-­HT,  all  6  
data  points  fell  near  or  onto  the  line  of  identity.  In  fact,  the  best  fit  to  this  data  was  the  
line  of  identity  (r  =  0.88;;  pPr  =  0.02).  This  finding  supports  the  conclusion  drawn  above  
that  most,  if  not  all  the  depression  is  due  to  a  change  in  release  probability.  
This  set  of  analyses  further  supported  the  idea  that  5-­HT  caused  the  EPSC  depression  
through  a  mechanism  different   to   that  of  NA,   i.e.  consequently,  most   likely  by   limiting  
Ca2+  influx  via  N-­  and/or  P/Q  Ca2+  channels  or  a  yet  to  be  discovered  mechanism.  
4.4.5.  Network  Specificity  of  Modulation  by  5-­HT    
In   this  section,   I  will   show   that   the  serotonergic  modulation  of  glutamate   release  was  
specific  within  the  network  of  layer  II  pyramidal  cells.  Specifically,  in  4.4.5.1,  I  will  provide  
analyses  and  comparisons   that   link   together   the  conceptions  of   responders  and  non-­
responders  as  defined  in  Part  3,  extending  it  to  include  the  pre-­  and  postsynaptic  cells.  
In   4.4.5.2,   I   will   present   further   evidence   that   in   the   postsynaptic   cells   which  
corresponded   to   responders,   together   with   the   depression   observed,   there   was   a  
concurrent   increase   in   spontaneous   glutamate   release   after   exposure   to   5-­HT.   This  
finding   further   strengthens   the   conclusion   drawn   in   4.4.5.1,   by   showing   that   the  
serotonergic  modulation  is  restricted  to  specific  synapses  in  the  network.  In  4.4.5.3,  I  will  
present  further  data  in  support  of  this  idea  by  experimentally  testing  in  paired  recordings  
the  conclusion  drawn  in  4.4.5.1  and  2.  
4.4.5.1.  Non-­Responders  Are  Mostly  Presynaptic,  Responders  Postsynaptic  
In   Part   3,   responders   were   functionally   defined   as   showing   an   increase   in   mEPSC  
frequency.  About  half  of  the  cells  were  captured  in  this  definition.  However,  in  this  part,  
depression  was  not   restricted   to  a  subset,  but  was  observed   in  all  postsynaptic  cells.  
This   result   raised   the   question   if   the   modulation   of   glutamate   release   by   5-­HT   was  
restricted  to  a  specific  set  of  synapses  that  preferentially  connected  onto  pyramidal  cells.  
Or   in   other   words,   only   very   specific   cells   that   form   connections   in   this   layer   were  
modulated  by  5-­HT,  hence,  form  a  specific  network.  
If  5-­HT  specifically  modulated  glutamate  release  at  synapses  that  linked  pyramidal  cells,  
the  responders  and  the  postsynaptic  cells  should  show  identical  changes  in  both  Rin  and  
Ihold  after  5-­HT  exposure.  Furthermore,  there  should  be  no  statistical  difference  between  
the  percentages  of  cells,  which  showed  a  net   inward  (-­ΔIhold)  or  a  net  outward  current  
(+ΔIhold).  Data  to  make  such  comparisons  are  presented  in  Table  4.4.3.  
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As  shown  in  Part  3,  after  exposure  to  5-­HT,  the  decrease  in  Rin  for  responders  was  -­56  
±  13  from  197  ±  15  to  141  ±  8  MΩ  (n  =  36;;  ppt  =  10-­4;;  Table  4.4.3).  Similarly,  the  reduction  
in  Rin  for  the  postsynaptic  cells  in  the  pairs  presented  in  this  part  was  also  -­55  ±  17  from  
198  ±  17  to  143  ±  14  MΩ  (n  =  40;;  ppt  =  0.002).  Under  the  null  hypothesis  (H0)  that  there  
was   no   difference   between   the   two   samples,   when   the   two   decreases   in   Rin   were  
compared,  H0  had  to  be  accepted  at  pt  =  0.97.  This  result  indicates  that,  on  a  statistical  
basis,  the  postsynaptic  pyramidal  cells  in  the  pairs  correspond  to  responders.    
Table  4.4.3.  Comparison  of  spontaneous  and  evoked  data  sets.  
  
The  significant  change  is  marked  with  a  grey  background  and  by  *  for  a  value  >  0.95.  
  
This  specificity  was  further  supported  by  the  following  analysis.  After  exposure  to  5-­HT  
or  the  full  agonist  α-­methyl-­5-­HT,  responders  in  Part  3  on  average  showed  no  significant  
change  in  Ihold  (78.9  ±  8.4  vs.  85.2  ±  12.6  pA,  n  =  25;;  ppt  =  0.43;;  Table  4.4.3).  In  this  part  
(4.4.2.3),  the  postsynaptic  cells  also  had  an  insignificant  change  in  Ihold  (66.7  ±  8.2  vs.  
69.0  ±  16.6  pA,  n  =  43;;  ppt  =  0.83).  Again,  when  these  two  values  were  compared,  there  
was  no  significance  (pt  =  0.76),  further  strengthening  the  idea  that  the  postsynaptic  cells  
in  the  pairs  correspond  to  responders.  
    Changes  by  5-­HT                                  Spontaneous            vs.            Evoked  
        Parameter     Non-­Responder  (n)   Presynaptic  (n)   Statistics  
          ΔRin  [MΩ]   -­30  ±  11   (67)   -­33  ±  13   (39)   pt  =  0.83  
          ΔIhold  [pA]   34.4  ±  4.2   (51)   -­        -­  
          ΔVm  [mV]   -­        -­3.4  ±  1.3   (21)   -­  
  -­ΔIhold  /  +ΔVm  [%]   6   (3)   19   (4)   =  0.09  
+ΔIhold  /    -­ΔVm  [%]   94   (48)   81   (17)  
     Responder  (n)   Postsynaptic  (n)       
          ΔRin  [MΩ]   -­56  ±  13   (36)   -­55  ±  17   (40)   pt  =  0.97*  
          ΔIhold  [pA]   6.3  ±  7.8   (25)   2.3  ±  10.6   (43)   pt  =  0.76  
        -­ΔIhold  [%]   40   (10)   42   (18)   =  0.88  
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Because   the  average  changes   in  holding  current   for  both  data  sets  were  made  up  of  
cells  showing  either  a  net  inward  or  outward  current,  a  further  refined  analysis  was  done  
by  counting  the  respective  numbers  of  cells  and  asking  if  based  on  a  χ2-­test,  there  was  
a  difference  in  the  make-­up.  As  presented  previously  in  Part  3,  10  out  of  25  responders  
showed  a  net  inward  and,  consequently,  15  had  a  net  outward  current  (Table  4.4.3).  An  
identical  set  of  numbers  was  found  in  Part  4  for  the  postsynaptic  cells.  18  out  of  43  cells  
showed  a  net  inward,  and  the  remaining  25  a  net  outward  current.  Based  on  a  χ2-­test,  
there   was   no   significant   difference   either   (   =   0.88),   further   strengthening   the  
conclusion  that  responders  are  the  postsynaptic  elements  in  the  layer  II  microcircuit.  This  
conclusion   implies   that   in   the   same   postsynaptic   pyramidal   cell,   besides   the   EPSC  
depression,   there   are   concurrent   changes   in   mEPSC   frequency.   Experimental   data  
supporting  this  conclusion  will  be  provided  in  the  next  section.  
If  responders  are  postsynaptic,  non-­responders  are  most  likely  presynaptic.  In  analogy  
to   the   analysis   above,   I   checked   the   possibility   if   non-­responders   were   indeed   the  
presynaptic  cells  within  the  network.  
On  average,  the  reduction  in  Rin  in  non-­responders  in  Part  3  was  -­30  ±  11  MΩ  (191  ±  10  
vs.  161  ±  7  MΩ,  n  =  67;;  ppt  =  0.003;;  Table  4.4.3).  For  comparison,  the  reduction  in  Rin  for  
the  presynaptic  cells  in  this  part  was  also  -­33  ±  13  MΩ  (171  ±  11  vs.  138  ±  11  MΩ,  n  =  
39;;  ppt  =  0.013).  When  comparing  these  reductions,  no  significant  difference  was  found  
(pt  =  0.83),  suggesting  that  the  idea  that  non-­responders  are  the  presynaptic  cells,  cannot  
be  rejected.  
Furthermore,   non-­responders   In   Part   3   showed   a   significant   increase   in   the   outward  
current  (+ΔIhold)  of  34.4  ±  4.2  pA  (75.4  ±  5.3  vs.  109.8  ±  7.4  pA,  n  =  51;;  ppt  =  0.001;;  Table  
4.4.3).   Because   the   presynaptic   cells   were   held   in   current-­clamp   to   evoke   action  
potentials,   a   direct   comparison  was  not   possible.  But   because  an  outward   current   in  
voltage-­clamp   corresponds   to   a   hyperpolarization   in   current-­clamp,   after   5-­HT   a  
hyperpolarization   (-­ΔVm)   was   expected   in   the   presynaptic   cells.   In   fact,   the   average  
change  in  membrane  potential  of  the  presynaptic  cells  was  indeed  -­3.4  ±  1.3  mV  (-­74.3  
±  1.2  vs.  -­77.7  ±  1.4  mV,  n  =  21;;  ppt  =  0.015).  This  further  strengthens  the  idea  that  the  
presynaptic  cells  correspond  to  non-­responders.  
In   addition,   I   compared   the   number   of   cells   showing   either   an   inward   current   or   a  
depolarization  (-­ΔIhold  /  +ΔVm)  vs.  outward  current  or  a  hyperpolarization  (+ΔIhold  /  -­ΔVm)  
in  both  data  sets.  As  shown  in  Part  3,  only  3  out  of  51  non-­responders  showed  an  inward  
(-­ΔIhold),  but  48  an  outward  current  (+ΔIhold;;  Table  4.4.3).  In  the  data  set  in  this  part,  4  out  
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Figure  4.4.24.  EPSC  depression  and  concomitant  increase  in  σwn.  
A.  Average  time  courses  of  the  first  (left)  and  second  (right)  EPSCs  during  control  and  after  
5-­HT.  B.  Superposition  of   the   respective  current   transients   to  a  voltage  step  of  0.5  mV  
reflecting  Rs  and  Rin.  C.  Raw  traces  of  three  evoked  trials  containing  the  two  EPSCs  before  
(left)  and  after  5-­HT  (right).  EPSC  onset   times  are   indicated  by  solid   lines.  The  dashed  
rectangles  indicate  the  time  windows  during  which  σwn  was  determined.  E.  Relative  EPSC  
amplitude  during  control  and  after  5-­HT  (left).  The  average  values  are  presented  in  black.  
Change  in  σwn  before  and  after  exposure  to  5-­HT.  F.  Same  as  in  E,  except  for  the  dataset,  
in  which  either  mSIRK  or  ct-­SNAP-­25  were  present.  
  
hyperpolarization   (-­ΔVm).   It   can   be   seen   that   in   both   sets,   most   cells   underwent   a  
hyperpolarization   after   5-­HT.      When   the   two   sets   were   compared   using   a   χ2-­test,   a  
significant  difference  was  hardly  uncovered  (   =  0.09),  further  supporting  the  idea  that  
non-­responders  are  the  presynaptic  cells  in  the  network.  
4.4.5.2.  Postsynaptic  Whole-­Cell  Noise  after  5-­HT  
To  find  further  evidence  in  support  of  the  conclusion  just  drawn,  the  standard  deviation  
of  the  whole-­cell  noise  (σwn)  in  the  postsynaptic  cells  before  and  after  exposure  to  5-­HT  
was  determined.  This  indirect  measure  was  chosen,  because  TTX  would  have  abolished  
AP  generation  and,  hence,  the  resulting  EPSC.  A  long  time  window  was  chosen,  over  
which   σwn   was   measured,   to   deliberately   include   spontaneous   EPSCs   (sEPSCs).  
Notably,  σwn   is   different   from  σnoise   in   3.4.1.2  and  part   4,   because   the   latter   excludes  
visible  spontaneous  glutamate  currents.  
Such  an  analysis  is  illustrated  in  Fig.  4.4.24.  In  A,  the  average  peak  amplitudes  of  the  
first  EPSC  (left  traces)  before  and  after  5-­HT  addition  are  shown.  During  control,  the  size  
of   the   first   EPSC   was   -­28.3   ±   1.2   pA.   The   addition   of   10   µM   5-­HT   depressed   the  
amplitude  by  38  ±  4%  to  -­17.8  ±  0.7  pA  (pt  <  8·10-­12).  As  mentioned  above  (4.4.2.1),  it  is  
critical  for  this  kind  of  comparison  that  Rs  did  not  change  by  more  than  10%  between  the  
two  conditions.  Specifically,   in   this  example,  Rs  of   the  postsynaptic  cell  during  control  
was  estimated  after  rounding  to  be  9  and  after  5-­HT  10  MΩ  (B),  not  significantly  altering  
the  current  decay  after  a  voltage  step  of  0.5  mV.    
Next,  I  determined  σwn  in  the  postsynaptic  cell.  In  C  and  D,  three  individual  traces  are  
presented  which  were  acquired  during  control  and  5-­HT,  respectively,  with  the  onsets  of  
the  first  and  second  EPSCs  indicated  by  solid  lines.  The  periods,  during  which  σwn  was  
measured,   are   indicated   by   dashed   rectangles.   Specifically,   30  ms   after   the   second  
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period  was  4.1  pA.  After  exposure  to  5-­HT,  it  increased  to  5.7  pA  consistent  with  the  idea  
that  spontaneous  release  increased.  Note  that  after  exposure  to  5-­HT,  at  the  same  time,  
a  large  depression  in  the  first  and  second  EPSCs  was  also  evident.  
In  a  set  of  36  experiments  where  this  type  of  analysis  could  be  done,  5-­HT  depressed  
the  average  peak  amplitude  of  the  first  EPSC  by  49  ±  3%  from  -­16.4  ±  2.6  to  -­8.1  ±  1.3  
pA  (ppt  =  4·10-­6;;  E,  left  set).  Consistent  with  the  idea  above,  this  depression  was  typically  
accompanied  by  a  significant  increase  in  σwn  by  28  ±  9%  from  3.5  ±  0.2  to  4.2  ±  0.3  pA  
(ppt  =  0.004;;  E,  right  set).  Together  these  results  support  the  idea  that  the  evoked  EPSC  
depression  and   increase   in  spontaneous  transmitter   release  occur  concurrently   in   the  
same  postsynaptic  cell.  
I  extended  the  same  analysis  also  to  the  pairs  loaded  either  with  mSIRK  or  ct-­SNAP-­25.  
In  these  cells,  5-­HT  failed  to  cause  any  significant  depression  of  the  EPSCs  (-­12.8  ±  2.7  
vs.  -­11.4  ±  2.2  pA;;  ppt  =  0.14;;  F,  left  set).  However,  σwn  still  increased  by  38  ±  16%  from  
2.5  ±  0.1  to  3.4  ±  0.5  pA  (ppt  =  0.026;;  F  right  set).  These  findings  make  one  important  
point,   namely   that   the   signalling   for   spontaneous   and   evoked   release   could   be  
dissociated  at  the  level  of  the  G  protein.  
4.4.5.3.  Testing  for  Network  Specificity  
To  directly  test  the  prediction  that  the  postsynaptic  cells  correspond  to  responders  and  
the   presynaptic   to   non-­responders,   I   performed   a   set   of   experiments   in   which   I   first  
obtained   a   connected   pair.   Having   determined   which   of   the   cells   was   pre-­   and  
postsynaptic  and  their  respective  membrane  properties,  among  them  Rin,  1  µM  TTX  was  
added  to  the  superfusate,  and  mEPSCs  were  recorded  before  and  after  the  addition  of  
5-­HT.  
A  recording  from  such  a  pair  with  unidirectional  connectivity  is  presented  in  Fig.  4.4.25.  
Specifically,   in  A,  a  schematic  of  the  respective  connection  is  drawn  together  with  the  
respective  time  courses  of  the  APs  (presynaptic)  and  the  EPSCs  (postsynaptic).  In  B  –  
F  the  data  from  the  presynaptic,  and  in  G  –  L  that  of  the  postsynaptic  cell  are  illustrated.  
First,  data  for  the  presynaptic  cell  will  be  presented  with  the  prediction  that  these  should  
be  consistent  with  the  properties  of  non-­responders.  In  this  cell,  the  mEPSC  frequency  
during  the  control  period  was  80  ±  4  Hz  (B0).  After  5-­HT  had  been  added,  there  was  no  
significant  increase  (81  ±  3  Hz;;  B1  –  3,  C,  D,  and  E).  The  respective  amplitudes  were  -­
5.6  ±  0.1  and  -­5.6  ±  0.1  pA  (B0  –  3  and  F),  with  an  average  rise  time  of  0.7  and  0.7  ms,  
and  half-­width  of  2.0  and  1.9  ms,  respectively.  There  was  no  significant  change  in  any  
of  these  properties.  In  contrast,  after  the  addition  of  5-­HT,  Rin  decreased  by  19  from  141  
   Impact  on  evoked  transmitter  release  
        225  
to   122   MΩ,   but   Ihold   increased   by   35.0   from   50.0   to   85.0   pA,   reflecting   a   small  
hyperpolarization  by  0.7  mV.  These  data  were  then  clearly  consistent  with  the  prediction  
that  the  presynaptic  cell  displayed  all  the  hallmarks  of  a  non-­responder.  
I  now  present  data   from   the  postsynaptic  cell  with   the  expectation   that   the  properties  
should  be  consistent  with  those  of  responders.  Specifically,  during  the  control  period,  the  
instantaneous  mEPSC   frequency  was   64   ±   2  Hz   (G0).   After   addition   of   5-­HT   to   the  
superfusate,  the  frequency  increased  initially  to  84  ±  4  Hz;;  i.e.  by  31  ±  7%  (G1,  H,  I,  and  
J).  The  frequency  then  gradually  decreased  to  65  ±  3  Hz,  which  was  not  different  from  
the  control  value  (G2).  Subsequently,  it  resurged  back  by  29  ±  9%  to  reach  another  peak  
at  83  ±  5  Hz  (G3  and  K).  Throughout,  the  mEPSC  amplitude  did  not  show  any  significant  
change,  as  it  remained  at  the  control  value  of  -­10.0  ±  0.1  pA  (L).  There  was  not  change  
in   the   average   time   courses   of   the  mEPSCs  during   control   and   after   5-­HT   (data   not  
shown),  with   the   average   rise   time  and  half-­width   also   remaining   at   0.6   and  1.8  ms,  
respectively.  After  5-­HT,  I  observed  a  decrease  in  Rin  by  34  from  124  to  90  MΩ,  which  
was  accompanied  by  a  small  increase  in  Ihold  by  18  pA  (106  vs.  124  pA).  In  comparison  
to  the  presynaptic  cell  above,  the  decrease  in  Rin  was  larger,  but  the  increase  in  Ihold  was  
smaller.  These  data  were  then  clearly  consistent  with  the  prediction  that  the  postsynaptic  
cell  displayed  all  the  hallmarks  of  a  responder.  
Overall,  I  was  able  to  perform  such  mEPSC  recordings  in  4  pairs,  each  of  which  showed  
connectivity   only   in   one   direction.   For   the   presynaptic   cells,   there  was   no   significant  
mEPSC   increase   in   any   of   the   cells.   In   addition,   they   had   all   the   hallmarks   of   non-­
responders,  namely  a  drop  in  Rin  on  average  by  21  ±  45  from  173  ±  34  to  152  ±  28  MΩ  
(ppt  =  0.34),  associated  with  an  outward  current  of  38.0  ±  1.3  pA  (ppt  =  4·10-­5).  When  
these   changes   in  Rin   and   Ihold  were   compared   to   those   of   non-­responders   (see   table  
4.4.3),   no   significant   differences   were   found   (pt   =   0.86   and   0.43,   respectively).  
Altogether,  these  findings  are  consistent  with  the  prediction.  
In  2  out  of   the  4  postsynaptic  cells,   there  were  transient  mEPSC  frequency  increases  
after   5-­HT   addition;;   i.e.   consistent   with   the   notion   of   responders.   If   the   8   cells   were  
considered  as  a  “random”  sample,  as  in  Part  3,  the  percentage  of  responders  in  these  
recordings  was  not  significantly  different  from  that  has  been  reported  earlier  (25  vs.  47%;;  
=  0.31).  After  exposure  to  5-­HT,  Rin  changed  on  average  by  60  ±  39  from  175  ±  40  
to  115  ±  2  MΩ  (ppt  =  0.11).  Even  though  the  respective  number  was  larger,  it  was  not  
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Figure  4.4.25.  Modulation  of  mEPSCs  in  a  pre-­  vs.  postsynaptic  cell.  
A.  Schematic  of  the  unidirectional  recording  configuration  with  the  average  time  courses  of  
the   presynaptic   voltage   and   postsynaptic   current   shown.   B.   Representative   traces   of  
mEPSCs  in  the  presynaptic  cell  during  control  (B0)  and  after  5-­HT  exposure  (B1  –  3)  at  
different   points   in   time   as   indicated   in   C   (top).   C.   Plot   of   the   instantaneous   mEPSC  
frequencies   during   the   recording.   D.  Minute   averages   of   the  mEPSC   frequencies.   The  
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dashed   line   indicates   the   average   value   during   control.   E.   cPDFs   of   the   mEPSC  
frequencies   during   control   and   at   time   point   1   indicated   in   C.   F.   cPDFs   of   mEPSC  
amplitudes  during   control   and  during   the   last   five  minutes  with   5-­HT.  G  –   I.   The   same  
legends  as  for  B  –  D  apply,  except  that  the  data  were  recorded  postsynaptically.  J  and  K.  
Comparisons  between  cPDFs  of  the  frequencies  during  control  and  after  5-­HT  at  the  time  
points  indicated  in  H  by  number  1  and  3,  respectively.  L.  cPDFs  of  amplitudes  in  control  
and  during  the  last  five  minutes  with  5-­HT.  
  
So  far,  the  data  presented  were  consistent  with  pre-­  corresponding  to  non-­responders,  
and   postsynaptic   cells   to   responders.   This   conception   would   preclude   reciprocal  
connectivity.  If  there  were  reciprocal  connectivity,  such  topologies  would  constitute  the  
exceptions  from  the  rule  established.  Therefore,  I  checked  if  there  were  reciprocal  pairs  
in  my  data  set  and  estimated,   if   the  observed  connectivity  was  different   from  random  
connectivity.  
Indeed,   in  my  data  set,   I   found  7   reciprocal  connections  out  of   the  56  pairs   recorded  
from,   which   corresponded   to   a   probability   of   one   in   eight   (0.13).   To   check   if   this  
probability  was  consistent  with  random  connectivity,   I  did   the  following  estimation.  My  
experience  tells  that  the  connectivity  between  pyramidal  cells  within  a  target  radius  of  20  
µM  is  about  0.25.  Given  that  random  connectivity  could  exist,  the  respective  probability  
would  be  0.252  =  0.06.  Based  on  a  χ2-­test,  there  was  no  significant  difference  between  
the   expected   and   the   observed   probability   ( =   0.16).   Hence,   this   observation   is  
consistent   with   random   reciprocal   connectivity.   Given   that   only   a   few   reciprocal  
connections   existed   in   the   data   set,   these   would   unlikely   have   swayed   the   rules  
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4.5.  Discussion  
In   this   part   of  my   thesis,   I   have   investigated  how  5-­HT  modulated  evoked  glutamate  
release   in   a   set   of   56   connected   cell   pairs.   These   pairs   were   post   hoc   verified  
histologically,  and  confirmed  to  be  pyramidal  cells  in  layer  II.    
The  most  surprising  finding  was  that,  despite  the  fact  that  10  µM  5-­HT  increased  the  rate  
of   spontaneous   transmitter   release   as   shown   in   Part   3,   the   same   concentration  
consistently  depressed  the  evoked  EPSC  amplitude  by  about  half   in  all  pairs  studied,  
except  one.  Consistent  with  Part  3,   though,   this  depression  was  also  mediated  by  5-­
HT2R  activation.  
Subsequent  analyses  revealed  that  5-­HT  had  some  “specificity”  to  its  action.  Specifically,  
the  postsynaptic  cells  of  connected  pairs  corresponded  to  what  was  described  earlier  as  
responders,  whereas   the  presynaptic   cells   belonged   to   the  group  of   non-­responders.  
This   network   specificity   was   further   supported   by   experimental   data   showing   that,  
consistent  with  Part  3,  the  membrane  current  noise  in  the  postsynaptic  cell,  as  a  proxy  
for  spontaneous  release,  increased  after  addition  of  5-­HT.  In  addition,  I  provided  direct  
evidence  for  this  specificity  by  showing  that,  after  having  obtained  a  cell  pair,  no  increase  
in  the  mEPSC  frequency  was  detectable  in  the  presynaptic,  but  only  in  the  postsynaptic  
cells.  
I  then  showed  that  this  depression  was  mostly  due  to  a  presynaptic  mechanism.  When  
either   the  Gβγ-­binding   peptide  mSIRK   or   ct-­SNAP-­25  was   added   to   the   presynaptic  
patch   solution,   the   depression   was   abolished,   suggesting   that   the   crucial   signalling  
molecule  downstream  of  receptor  activation  was  Gβγ.  I  propose  that  the  depression  seen  
in  this  case  was  most  likely  caused  by  Gβγ  binding  to  N-­  and/or  P/Q-­type  VDCC,  thereby  
limiting  the  Ca2+  influx  resulting  in  a  considerable  depression  of  the  EPSCs  (Ikeda  1996;;  
Trombley   1994).   This   mechanism   is   most   likely   different   to   the   one   seen   with   NA,  
whereby  direct  binding  of  Gβγ  to  the  SNARE  complex  caused  the  depression  (Yoon  et  
al.   2007).   Two   lines   of   evidence   for   this   idea   are   provided.   1)   In   contrast   to   the  
mechanism   seen   with   noradrenaline   (NA),   where   the   recovery   rate   from   short-­term  
depression  following  a  train  of  20  APs  at  50  Hz  was  much  accelerated,  5-­HT  failed  to  
speed  up  this  rate.  2)  Whilst  NA  consistently  reduced  the  quantal  size  in  accordance  with  
SNARE  inhibition,  the  quantal  size  in  5-­HT  remained  unaltered.  
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4.5.1.  Properties  of  Pyramidal  Cell  Pairs  in  Layer  II  
I  recorded  from  56  pairs  in  15  –  20  day-­old  rats  at  physiological  temperature.  Subsequent  
histological  verification  confirmed  that  the  location  of  pairs  was  in  the  layer  II,  with  few  
were  located  on  the  border  with  layer  III.  In  regard  to  Rin,  these  cells  were  not  different  
to  those  presented  in  Part  3  (184  ±  10  here  vs.  187  ±  6  MΩ  in  Part  3;;  pt  =  0.78).  
As   the   postsynaptic   cells   were   kept   in   voltage-­clamp,   the   AP   parameters   were  
determined  for  presynaptic  cells  only,  in  most  cases  in  the  presence  of  gabazine.  When  
comparisons  were  made  between  these  average  values  vs.  the  data  from  Part  3,  I  found  
that  there  was  no  difference  in  either  Vrest  (-­75.4  ±  0.5  vs.  -­76.6  ±  0.3  mV;;  pt  =  0.06)  or  H  
(73.8  ±  1.2  vs.  74.0  ±  0.4  mV;;  pt  =  0.90).  There  were  small  but  significant  differences  
found  for  Vthr  (-­43.2  ±  0.8  vs.  -­38.0  ±  0.3  mV;;  pt  =  9·10-­8)  and  W  (0.9  ±  0.0  vs.  1.0  ±  0.0  
ms;;  pt  =  2·10-­6),  which  may  have   likely  resulted   from  the  presence  of  gabazine   in   the  
ACSF   in   these  pairs.  This   is  because  of   the   fact   that   there   is   typically  a   tonic  GABAA  
conductance  present  in  these  cells  (Otis  et  al.,  1991).  Because  Vm  was  typically  more  
negative   than   the   chloride  equilibrium  potential   (ECl)   in   these   cells,   there  would  have  
been  a  depolarising  current  present  at   rest.  The  block  would  have   turned   this   inward  
current  off,  which  resulted  in  a  hyperpolarisation,  causing  the  small  effects  seen.  Note  
that  in  these  recordings,  I  did  not  correct  for  the  liquid  junction  potential.  
Consequently,  and  compared  to  the  data  presented  in  Part  3,  I  am  confident  that  I  was  
unlikely  dealing  with  a  biased  sample.  Therefore,  comparisons  with  other  reports  from  
this  laboratory  are  justified  (Choy,  2011;;  Choy  et  al.,  2017a;;  Choy  et  al.,  2017b).  
4.5.2.  5-­HT  Affects  AP  and  Postsynaptic  Properties  
The  depression  observed  could  have  been  caused  by  5-­HT  affecting  either  the  AP  or  the  
postsynaptic   (i.e.   dendritic)   membrane   properties.   I   was   able   to   rule   out   most   such  
considerations.  
4.5.2.1.  Modulation  of  AP  
Consistent  with  the  idea  put  forward  in  Part  3,  most  of  the  effect  of  5-­HT  on  the  AP  very  
likely  reflected  the  activation  of  5-­HT1AR  and  the  subsequent  activation  of  GIRK  channels  
by   Gβγ   (Andrade   &   Nicoll,   1987;;   Lüscher   et   al.,   1997).   Specifically,   this   most   likely  
caused  the  hyperpolarization  of  Vrest  by  about  2  mV.  5-­HT  also  reduced  the  amplitude  of  
the  APs.  Different  from  the  hyperpolarization  mentioned  above,  the  mechanism  for  this  
decrease  was  independent  of  presynaptic  Gβγ  signalling  because  it  persisted  when  Gβγ  
was  bound  by  mSIRK  and  ct-­SNAP-­25.  A  concern  might  be  that  this  decrease  in  H  might  
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have  been  responsible  for  the  EPSC  depression.  However,  as  H  was  also  reduced  in  
the   presence   of   mSIRK   and   ct-­SNAP-­25,   when   the   depression   was   abolished,   this  
possibility  is  very  unlikely.  
4.5.2.2.  Modulation  of  Dendritic  Properties  
I  observed  that  exposure  of  5-­HT  caused  a  small  reduction  in  Rin  in  non-­responders,  but  
a  large  one  in  responders.  Consequently,  owing  to  the  expression  of  distinct  5-­HTR  in  
the  two  groups  of  cells,  there  is  most  likely  a  differential  impact  on  synaptic  integration  
(Kia  et  al.,  1996;;  Cornea-­Hébert  et  al.,  1999).  This  would  mean  that  the  time  window  of  
integration  in  responders  is  significantly  shorter  than  that  in  non-­responders.  This  could  
further  be  accentuated  as  it  is  known  that  5-­HT2R  activation  also  inhibits  sodium  currents  
and  dendritic  excitability  via  a  PKC-­dependent  cascade  (Franceschetti  et  al.,  2000;;  Carr  
et  al.,  2002;;  Carlier  et  al.,  2006).  However,  nothing  is  known  if  this  mechanism  may  be  
differentially  expressed  in  the  two  subtypes  of  pyramidal  cells.  
Whilst   I   recorded   synaptic   currents   generated   at   synapses   most   likely   onto   basal  
dendrites   (Feldmeyer  et  al.,  2006),   I  admit   that   the   recorded  currents  were  subject   to  
space-­clamp   issues.  Therefore,   the  underlying  currents  at   these  synapses  were   likely  
much  faster  and  larger  (Spruston  et  al.,  1993;;  Williams  &  Mitchell,  2008).  Or  expressed  
differently,   the   EPSC   decay   times   most   likely   were   affected   by   the   membrane   time  
constant  as   is   the  case  of  EPSPs.  Given   that  Rin  decreased  considerably  upon  5-­HT  
exposure,  the  EPSC  amplitudes,  affected  by  the  escape  from  space-­clamp,  should  have  
become  smaller,  and  the  time  constant  shorter.  Consequently,  it  could  be  that  some  of  
the  depression  observed  might  have  been  due  to  the  decrease  in  Rin.  Whilst   I  cannot  
rule  out  a  small  contribution  of  this  factor  to  the  overall  depression,  I  think  that  such  a  
mechanism   was   unlikely   at   work   here.   My   main   argument   is   that   in   this   case,   a  
depressed  EPSC  should  have  been  associated  with  a  faster  decay  time,  something  not  
observed  in  this  data  set.  Likewise,  when  the  depression  was  blocked  presynaptically  by  
Gβγ-­binding  peptides,   the   time  courses  did  not  change  either,  strengthening   the   idea  
that  the  postsynaptic  effects  on  the  dendritic  membranes  were  likely  minimal.  However,  
given   the  considerable   reduction   in  Rin   in   responders,   it   remains  surprising   that  no  or  
minimal  changes  to  the  EPSC  time  courses  were  detectable.  This  may  well  be  linked  to  
the  co-­expression  of  “opposing”  receptors,  like  5-­HT1R  and  5-­HT2R  (Amargós-­Bosch  et  
al.,  2004)  and/or  the  differential  signalling  downstream  of  the  respective  receptors,  which  
may  result  in  “counter-­balancing”  the  effects  on  EPSCs.  
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4.5.3.  Network  Specificity  
The  most  intriguing  finding  in  this  part  is  that  non-­responders  were  congruent  with  the  
pre-­  and   responders  with   the  postsynaptic  cells.  This  was  surprising,  as  such  a  clear  
distinction  was  not  found  with  NA  (Choy  et  al.,  2017a;;  Choy  et  al.,  2017b)  in  the  same  
layer.  This  might  suggest  that  the  effect  of  5-­HT  on  the  network  made  up  of  these  cells  
is  likely  distinct  to  that  of  NA.  
This  observation  was  further  strengthened  by  the  following  additional  evidence.  First,  I  
provided  data  confirming  that,  after  addition  of  5-­HT  to  the  superfusate,  the  whole-­cell  
recording  noise  increased  in  postsynaptic  cells.  Whilst  this  was  an  indirect  proxy  for  the  
increase  in  the  sEPSC  frequency,  it  was  consistent  with  the  idea  put  forward.  More  direct  
support  was  gained  after  obtaining  a  paired  recording  and  then  measuring  mEPSCs  in  
pre-­   and   postsynaptic   cells,   respectively.   The   data   provided   was   consistent   with   the  
prediction  made;;  all  presynaptic  cells  were  consistent  with  non-­responders,  whereas  the  
postsynaptic  neurons  were  mostly  responders.  One  reason  that  most  but  not  necessarily  
all   postsynaptic   neurons   fitted   this   classification  was   likely   linked   to   the   strictness   of  
significance  level  set  for  the  KS  statistic,  which,  after  all,  was  rather  ad  hoc.  
It   is   important   to   restate   that   the  specificity  of  connectivity   is  not  absolute.  As  alluded  
above,   I   found   reciprocal   connectivity   in   7   out   of   56.   This   number   is   small   and  may  
contain  a  bias.  To  avoid  this,  the  data  from  all  pairs  in  layer  II  obtained  in  this  laboratory  
over  more  than  8  years  were  pooled.  In  a  total  set  of  306  pairs,  13  reciprocal  connections  
were  found;;   i.e.  the  rate  of  reciprocal  connectivity  was  4.3%,  smaller  than  the  value  in  
the  sample  here.  This  value   is  very  close   to   that  estimated   for  a   random  connectivity  
assuming   a   connectivity   rate   of   0.25.   This   suggests   that,   besides   the   specificity  
observed,  random  connectivity  coexisted.  This  random  connectivity  could  also  underlie  
the  observation,  that  no  depression  was  found  for  one  EPSC.  It  is  also  important  to  point  
out  that  these  few  reciprocal  connections  would  not  have  much  affected  the  conclusions  
reached  for  responders  and  non-­responders.  
A   further   discussion   and   a   consideration   of   potential   functional   implications   of   this  
network  specificity  will  be  discussed  below  (see  5.4).  
4.5.4.  Properties  of  EPSCs  
The  amplitudes  of   the  EPSCs  evoked  during   the   first  minute  of   recording  were   in   the  
range  from  -­5.4  to  -­145.1  pA,  with  an  average  of  -­30.2  ±  3.6  pA,  similar  to  that  presented  
in  Choy   et   al.   (2017b).  Because   these  data  were   recorded   in   voltage-­clamp,  a  direct  
comparison  with  a  similar  data  set  by  Feldmeyer  et  al.  (2006),  mostly  made  in  current  
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clamp,  is  problematic.  However,  their  average  EPSC  amplitude  in  the  small  sample  they  
recorded  in  voltage-­clamp  was  slightly  larger  but  not  significantly  different  (n  =  7;;  -­58  ±  
35  vs.-­30.2  ±  3.6  pA;;  pt  =  0.27).  
I  chose  voltage-­clamp  because  of  the  lower  noise  conditions  obtained  in  this  recording  
mode,  compared  to  that  with  current  clamp  amplifiers.  Note,  however,  that  I  do  not  claim  
that   the  EPSCs  were   voltage-­clamped,  as  most   of   them  would  have  been  subject   to  
space-­clamp  escape  (Spruston  et  al.,  1993;;  Williams  &  Mitchell,  2008)  and,  therefore,  
the  time  courses  would  have  been  subject  to  dendritic  filtering.  Because  of  that,  in  regard  
to  both  latency  and  amplitude,  the  values  were  comparable  to  Feldmeyer  et  al.  (2006).  
But  the  values  for  the  rise  times  were  much  slower  in  this  data  set.  This  is  most  likely  
due   to   the   fact   that,   in  order   to  keep   the  recording  noise   to  a  minimum  (important   for  
quantal  analysis,  see  later),  no  series  resistance  compensation  was  made.  I  do  not  think  
that  the  slightly  older  age  bracket  (17  –  23)  of  animals  in  Feldmeyer  et  al.  (2006)  was  a  
significant  contributing  factor  to  the  differences  reported.  
I  note  that  in  this  data  set,  EPSCs  were  evoked  using  a  paired-­pulse  stimulus  with  an  
interval  of  50  ms  repeated  every  5  s.  PPR  in  this  data  set  ranged  from  0.55  to  1.40,  with  
an  average  value  of  0.83  ±  0.3,  comparable  to  that   found  by  Feldmeyer  et  al.   (2006).  
Overall,  the  average  PPR  in  this  data  set  was  slightly  smaller  than  1;;  i.e.  it  was  biased  
towards  depression,  but  variable  over  a  considerable  range,  with  both  facilitation  as  well  
as  depression  seen  at  these  synapses.  
Classically,  the  interpretation  of  PPR  relies  on  the  release-­dependence  of  subsequent  
EPSCs.  Specifically,  an  anti-­correlation   is  expected  between   the  second  and   the   first  
EPSCs  if   the  depression   is  due  to  vesicle  depletion.  Such  correlations  were  found  for  
EPSCs  from  pairs  in  layers  IV  (Cowan  &  Stricker,  2004)  and  V  (Fuhrmann  et  al.,  2004).  
However,   in   this  data  set,   there  was  no  such  correlation;;   i.e.   transmitter   release  was  
mostly   release-­independent   consistent   with   the   findings   in   Choy   (2011).   The  
mechanisms  causing  release-­independence  remained  unclear.  
4.5.5.  5-­HT  Quickly  Depresses  the  EPSC  Amplitude  
In  contrast  to  Part  3,  where  5-­HT  caused  a  transient  increase  in  the  mEPSC  frequency,  
the  same  neuromodulator  caused  a  fast-­onset  and  large  depression  of  EPSCs  by  49  ±  
3%   in   the   recorded  pairs.  Consistent  with   the   ideas  by  Katz,  a  potentiation/facilitation  
would  have  been  expected.  
Ever  since   the   first   reports  of   the   functional   impact  of  5-­HT  on  neurons   in   the  central  
nervous  system,  it  was  recognised  that  it  depressed  the  excitability  of  some  nerve  cells  
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as  assayed  in  single  unit  recordings  (Krnjevic  &  Phillis,  1963;;  Wang  &  Aghajanian,  1977).  
This  is  consistent  with  the  data  presented  here.  It  is  also  consistent  with  studies  on  its  
impact  on  synapses  reporting  depressions   in  the  spinal  cord  of   lamprey  (Buchanan  &  
Grillner,   1991;;  Takahashi   et   al.,   2001)  and   rat   (Singer   et   al.,   1996),   in   the  brainstem  
(Umemiya  &  Berger,  1995),  the  raphe  nucleus  itself  (Lemos  et  al.,  2006),  at  the  reticulo-­
geniculate  synapse  (Chen  &  Regehr,  2003),  in  the  suprachiasmatic  nucleus  (Bramley  et  
al.,  2005),  amygdala  (Wang  &  Aghajanian,  1977),  hippocampus  (Segal,  1980),  cingulate  
(Tanaka  &  North,  1993),  entorhinal  (Schmitz  et  al.,  1998),  ventrolateral  orbital  (Huo  et  
al.,  2010),  and  human  prefrontal  cortex  (Komlosi  et  al.,  2012).  However,  it  is  at  odds  with  
several  reports  suggesting  a  facilitatory  contribution  to  the  EPSC  (Delaney  et  al.,  1991;;  
Hori  et  al.,  1996;;  Aghajanian  &  Marek,  1997;;  Hasuo  et  al.,  2002;;  Beique  et  al.,  2007;;  
Austgen  et  al.,  2012;;  Barre  et  al.,  2016).  It  needs  to  be  pointed  out  that  in  most  of  the  
studies  mentioned,  the  receptor  types  involved  were  not  well  characterised.  However,  
the  opposing  effects  seen  with  5-­HT  likely  suggest  that  its  action  is  specific  to  the  cells  
recorded  from  and  their  respective  location,  the  receptors  involved  (see  below),  and  the  
downstream   signalling   targets   implicated.   From   the   observations   made   here,   it   is  
therefore  most  likely  inappropriate  to  generalise  to  other  areas  of  the  brain.  
Because   this   synaptic   depression   was   evident   in   paired   recordings,   and   since   the  
presynaptic  stimulation  was  restricted  to  a  single  axon,  it  is  highly  unlikely  that  activity  
within   a   network   was   generated   via   second   order   cells,   to   the   extent   that   other  
presynaptic  mechanisms  would  have  to  be  taken  into  account.  I  base  this  statement  on  
the  fact  that,  after  stimulating  the  presynaptic  cell,  in  none  of  the  pairs  recorded  from,  an  
AP  was  ever  elicited.  
Without  5-­HT,  in  most  pairs  recorded  from,  a  slowly  evolving  depression  of  the  EPSC  
was  observed  during  the  control  period,  which  after  about  10  –  20  minutes  had  stabilised  
and   reached   a   constant   value.   The   reason(s)   for   this   depression   remain   unclear.  
Feldmeyer  et  al.  (2006)  mentioned  that  this  depression  was  avoided  by  stimulating  at  a  
rate  of  0.03  –  0.05  Hz.  I  was  unable  to  confirm  this,  as  a  depression  remained  even  at  
much  lower  stimulus  rates,  but  admittedly,  the  rate  of  depression  was  much  slowed  (Li  
et  al.,  2010).  An   interesting  clue  may  be  that  no  depression  was  seen  when  the  PKC  
inhibitor  Gö  6883  was  used   in  a   subset  of   experiments.  This  preliminary  observation  
awaits  further  experimental  verification,  but  may  suggest  that  a  critical  phosphorylation  
is  most   likely   involved,  which   then   leads   to   the  slow  depression.   I  don’t   think   that   the  
targets  of  this  phosphorylation  are  AMPA  receptors  (Lüscher  et  al.,  1999),  as  there  was  
no   evidence   that   the   quantal   size   (see   below),   nor   the   mEPSC   amplitude   (Part   3)  
changed  with  5-­HT.  In  addition,  it  is  unlikely  that  5-­HT2R  were  the  target  either,  as  the  
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size  of  the  depression  in  cells  with  and  without  the  slow  depression  was  the  same  and  
the  increase  in  sEPSC  frequency  also  remained  (see  below).  
It  is  important  to  stress  that  the  slow  depression  was  independent  of  that  produced  by  5-­
HT.  In  my  hands,  the  former  typically  set   in  over  a  time  of  10  –  20  minutes,  and  then  
persisted  for  the  entire  time  of  the  recording,  whereas  the  one  by  5-­HT  was  established  
within  3  –  5  minutes,  a   time  consistent  with  a  complete  solution  exchange  within   the  
chamber  used.  To  make  this  clear,  I  showed  that  even  in  pairs  which  had  undergone  the  
slow   depression,   5-­HT   still   produced   a   depression   together   with   an   increase   in   the  
sEPSC  frequency.  The  extent  of  this  depression  was  no  different  to  that  in  the  set  of  cells  
that  did  not  show  the  slow  depression;;  i.e.  the  two  were  independent  of  each  other.  Both  
points  suggest  that  the  molecular  mechanism  of  the  5-­HT-­mediated  depression  is  distinct  
from  that  of  the  slow  depression.  
It   is   also   unlikely,   that   the   EPSC   depression   was   caused   by   an   evolving   receptor  
desensitisation  (Roth  et  al.,  1995;;  Berg  et  al.,  2001).  Whilst  there  are  admittedly  slight  
differences  between  the  different  types  of  5-­HT2R,  at  10  µM  5-­HT,  desensitisation  occurs  
on   a   time   scale   of   several   minutes.   In   expression   systems,   after   about   5   minutes,  
desensitisation  is  ~90%.  Consequently,  a  significant,  but  not  a  full  desensitisation  may  
likely  have  occurred  during  the  time  of  wash-­in.  However,  an  increasing  depression  in  
the   early  minutes   should   have   been   seen   in   our   recordings,   something   that  was   not  
observed.  In  addition,  the  extent  of  desensitisation  at  10  µM  5-­HT  is  about  70%  (Berg  et  
al.,  2001),  much  larger  than  the  actual  depression  observed.  Furthermore,  the  block  of  
PKC  (see  also  below)  should  have  affected   the  extent  of  desensitisation   (Berg  et  al.,  
2001),  something  that  we  did  not  observe  either.  Whilst  I  cannot  exclude  a  contribution  
of  desensitisation  to  the  depression  observed,  I  am  convinced  that  at  best  it  was  small.  
4.5.6.  Involvement  of  5-­HT2R  
My  data  clearly  shows  that  the  depression  of  EPSCs  was  mimicked  by  the  pan-­5-­HT2R  
agonist  α-­methyl-­5-­HT.  This  conclusion  relies  on  the  fact  that  the  depression  evoked  by  
α-­methyl-­5-­HT  was  not  different  to  the  one  by  5-­HT  (pt  =  0.57).  This  finding  is  consistent  
with  previous  reports  (Singer  et  al.,  1996;;  Komlosi  et  al.,  2012;;  Nozaki  et  al.,  2016).  Given  
that   the   depression   by   α-­methyl-­5-­HT   accounted   for   the   full   depression,   and   at   the  
concentration  used,  does  not  activate  5-­HT1R,  it  is  unlikely  that  there  was  any  significant  
contribution  by  the  latter,  something  reported  in  other  preparations  (Schmitz  et  al.,  1998;;  
Nozaki   et   al.,   2016).   Due   to   time   constraints,   I   was   unable   to   further   dissect   the  
pharmacological  characteristics  of  the  receptors  involved,  but   it   is   likely  that  the  same  
receptors   involved   in  driving  spontaneous  are  also  causing   the  depression  of  evoked  
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release.  Therefore,  the  most  likely  candidate  is  5-­HT2CR,  but  admittedly,  5-­HT2AR  could  
also   participate,   as   both   receptors   have   been   found   to   be   associated   with   nerve  
terminals.  In  addition,  the  affinity  of  α-­methyl-­5-­HT  is  about  the  same  at  both  receptors  
(Di   Giovanni   &   De   Deurwaerdere,   2016).   This   idea   is   consistent   with   other   reports  
(Abramowski  et  al.,  1995;;  Willins  et  al.,  1997;;  Cornea-­Hébert  et  al.,  1999;;  Jansson  et  al.,  
2001).  
In  both  parts  I  have  mostly  added  10  µM  5-­HT  to  the  superfusate.  The  question  arises  if  
this  concentration  was  sufficient  to  activate  5-­HT2R  and  cause  the  depression  observed.  
The   affinity   of   5-­HT   at   5-­HT2AR   and   5-­HT2CR   as   assayed   in   binding   studies   using  
expression  systems   is  6  and  16  nM,   respectively   (Knight  et  al.,  2004).   It   is,  however,  
important  to  note  that  the  EC50  measured  in  situ  and  in  expression  systems  was  much  
higher,   namely  about  324  and  51  nM,   respectively   (Xu  &  Chuang,  1987;;  Berg   et   al.,  
2001).   Consequently,   10   µM   is   a   more   than   sufficient   concentration   for   receptor  
activation,  consistent  with  earlier  reports  also  using  a  similar  concentration  (Hasuo  et  al.,  
2002;;  Beique  et  al.,  2007).  However,  it  is  smaller  than  others  have  used  (Aghajanian  &  
Marek,  1999;;  Marek  &  Aghajanian,  1999).  
4.5.7.  Downstream  Signalling  
Downstream  of  G-­protein-­coupled  receptor  activation,  Gα  and  Gβγ  are  produced.  The  
classical  signalling  cascade  is  turned  on  by  either  of  these,  then  results  in  the  activation  
of  PLCβ  (Day  et  al.,  2002),  which  then  causes  the  formation  of  IP3  and  DAG  from  PIP2,  
with  IP3  causing  presynaptic  store  release.  Indeed,  these  steps  were  verified  in  Part  3  
for  miniature  transmitter  release.  
However,   similar   to   NA   (Choy   et   al.,   2017b),   the   depression   seen   with   5-­HT   was  
dependent   on   Gβγ.   When   either   mSIRK   (Goubaeva   et   al.,   2003)   or   ct-­SNAP-­25  
(Gutierrez   et   al.,   1997)   was   contained   in   the   presynaptic   pipette   solution,   the   EPSC  
depression   was   blocked,   suggesting   that   the   signalling   downstream   of   5-­HT2R   was  
independent  of  the  “classical”  cascade.  In  addition  to  the  report  mentioned  above,  Gβγ-­
dependent  EPSC  depressions  have  also  been  described  for  5-­HT1R  (Gerachshenko  et  
al.,  2005),  α2-­ARs  (Delaney  et  al.,  2007)  and  group  II  metabotropic  glutamate  receptors  
(Zhang  et  al.,  2011),  which,  with   the  exception  of  α1-­ARs  (Choy  et  al.,  2017b),  are  all  
coupled  to  Gi/o  proteins.  
We  chose  two  different  Gβγ-­binding  peptides  as  mSIRK  is  myristoylated  and,  therefore,  
membrane  permeant.  Consequently,  a  small  chance  existed  that  the  action  of  mSIRK  
was  not  restricted  to  the  patched  presynaptic  cell,  but  could  potentially  have  spread  to  
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nearby  terminals.  To  exclude  this  possibility,  ct-­SNAP-­25  was  chosen,  which  is  a  peptide  
that  contains  the  binding  region  of  Gβγ  to  SNAP-­25  and,  therefore,  should  also  bind  it.  I  
found   that   with   both   peptides,   the   5-­HT  mediated   depression  was   blocked.   After   re-­
patching   with   the   solution   containing   the   respective   peptide,   I   waited   for   at   least   20  
minutes  until  data  were  gathered;;  in  most  situations,  during  the  time  when  the  peptide  
diffused  from  the  tip  of  the  electrode  into  the  cell,  the  respective  control  measurements  
were  obtained.  Consequently,  within   this   time,   the  peptides  should  have  well   reached  
the  nerve  terminals  (Pusch  &  Neher,  1988).  I  would  like  to  point  out  that  I  am  not  claiming  
that  in  the  presence  of  both  peptides,  the  depression  was  fully  blocked,  as  I  admit  that  
some   small   depression   might   have   persisted   but   remained   undetectable   within   the  
statistical  comparison.  However,  even   if  a  small  amount  remained,   it  does  not  detract  
from  the  fact  that  both  peptides  were  able  to  block  most  of  the  depression.  
The   concentrations   used   in   the   patch   solution   in   both   cases   were   ≥   100   µM.   This  
concentration   is  higher   than   the  10  µM   typically  chosen   for  mSIRK   (Goubaeva  et  al.,  
2003).   I   chose   the   former   concentration   to   speed-­up   the   diffusion   into   the   nerve  
terminals,  and  to  be  sure  that  a  sufficiently  high  concentration  was  reached  in  the  cytosol  
to  efficiently  bind  most  Gβγ.  A  similar  concentration  was  used  by  Zhang  et  al.   (2011)    
when  mSIRK  was  extracellularly  puffed  onto  nerve  terminals.  
The  experiments  using  these  two  peptides  also  shed  some  light  on  the  idea  if  there  is  
tonic  Gβγ  production  in  these  nerve  terminals.  In  fact,  in  some  of  the  recordings,  it  did  
look  as  if  after  peptide  infusion,  the  EPSCs  slowly  grew  in  amplitude.  However,  this  was  
far  from  a  large  effect.  Consequently,  it  may  be  that  Gβγ  was  produced  in  the  absence  
of  respective  receptor  activation.  Indeed,  G-­protein  signalling  without  receptor  activation  
has  been  linked  to  activators  of  G-­protein  signalling  (AGS;;  Blumer  et  al.,  2007)  of  which  
there  are  three  different  groups  (I  –  III)  and  about  10  isoforms,  some  of  which  are  also  
known   as   G-­protein   signalling   modulators   (GPSM1   –   3).   In   fact,   AGS1   is   markedly  
expressed   in   prefrontal   cortex,   and   after   a   single   dose   of   amphetamine   upregulated  
within  3  hours  (Schwendt  &  McGinty,  2010).  In  addition,  AGS3  is  also  expressed  in  the  
prefrontal  cortex.  It  is  involved  in  cocaine  craving  (Bowers  et  al.,  2004),  and  upregulated  
after  trauma  to  the  brain  (Wang  et  al.,  2013).  It  is  commonly  believed  that  these  proteins  
are  likely  involved  in  the  fine  tuning  of  synapses  (Andreeva  et  al.,  2007;;  Crawford  et  al.,  
2011).  
I  would  also  like  to  point  out  that  the  depression  was  not  linked  to  PKC  activation  either,  
as   it   made   no   difference   to   the   EPSC   depression   if   PKC  was   blocked.   I   tested   this  
because  there  is  some  evidence  in  the  literature  that  PKC  activation  is  linked  to  5-­HT2AR  
internalisation  (Bhattacharyya  et  al.,  2002;;  Raote  et  al.,  2013).  As  a  consequence,  the  
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receptor  “sensitivity”  would  decrease  and  result  in  either  a  smaller  or  even  no  depression.  
However,   based   on   the   study   cited,   the   time   scale   of   this  mechanism   is   quite   slow.  
Endocytosis  was  stopped  in  a  ligand-­specific  manner  within  2.5  hours,  much  slower  than  
the  depression  observed  here.  
As  Gβγ  binding  prevented  the  depression,  the  important  point  is  what  the  physiological  
target(s)  downstream  of  5-­HT2R  activation  was/were.  So  far,  two  mechanisms  have  been  
identified   in  which  Gβγ  binds   to   specific  molecular   targets   that   can   inhibit   transmitter  
release.  The   first   target   is   the  high  voltage-­activated  Ca2+  channels   (Trombley,  1994;;  
Ikeda,  1996).  According  to  this  mechanism,  Gβγ-­binding  to  the  CaV2  family  of  channels  
(Tedford  &  Zamponi,  2006)  in  the  nerve  terminals  limits  Ca2+  influx,  and  as  less  becomes  
available  for  the  activation  of  the  release  complex,  a  depression  results.  Specifically,  the  
Gβγ-­binding  site  has  been  identified  to  be  located  on  the  I  –  II   linker  region  on  the  N-­
terminus  of  the  α1-­subunit  of  VGCC  (for  review  see  Tedford  &  Zamponi,  2006).  The  other  
target  is  SNAP-­25.  In  this  case  Gβγ  directly  binds  to  an  element  of  the  SNARE  complex,  
and  in  doing  so,  prevents  the  SNARE  zipping  to  limit  vesicle  fusion,  which  also  results  in  
depression  (Blackmer  et  al.,  2005;;  Gerachshenko  et  al.,  2005;;  Yoon  et  al.,  2007).  I  am  
not  aware  of  a  third  target  of  Gβγ,  which  resulted  in  a  depression  of  evoked  transmitter  
release.    
Unfortunately,  it  is  not  possible  to  comment  on  the  role  of  Gβγ  and  Gαq  in  the  activation  
of  PLCβ1  (Kim  et  al.,  1997).  Even  though  the  whole-­cell  current  noise,  indicative  of  an  
increased  rate  of  sEPSCs,  increased  in  my  experiments,  the  restricted  diffusion  of  the  
Gβγ-­binding  peptides  into  a  single  axon  unlikely  filled  a  sufficiently  large  number  of  nerve  
terminals   that  a   reduction   in   the  sEPSC   rate  became  detectable.   I  note   that   such  an  
experiment   would   be   possible   with   mSIRK   as   it   could   be   applied   to   all   presynaptic  
structures  via  the  superfusate.  However,   it  would  require  quite  a  considerable  amount  
(and  cost)  as   the   target  concentration   is  about  10  µM  at  a  molecular  weight  of  about  
2’000  Da.  
4.5.8.  Comparison  with  NA  
Some  experiments  where  I  have  used  NA  in  contrast   to  5-­HT  shed  some  light  on  the  
molecular  mechanism(s)  involved.  First,  it  is  important  to  point  out  that  like  5-­HT,  NA  also  
increased  the  mEPSC  frequency,  but  the  frequency  increase  persisted  for  the  remainder  
of  the  recording.  This  is  an  important  point  as  it  renders  the  possibility  very  unlikely  that  
the  transient  nature  of  the  mEPSC  frequency  increase  was  a  recording  artefact  (see  also  
Part  3  for  a  further  discussion).  In  addition,  10  µM  NA  also  caused  a  large  depression  of  
the  EPSC.  I  noted  that  the  depression  seen  with  NA  was  62  ±  7,  whereas  that  for  5-­HT  
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was  49  ±  3%.  The  comparison  was  very  close  to  be  significant  (pt  =  0.06),  suggesting  
that  the  mechanism  of  the  NA-­mediated  depression  may  not  be  identical  to  that  of  5-­HT.  
Second,   like  with  NA,   the  depression  was  established   largely  within   the   time  of  a   full  
solution  exchange  in  the  recording  chamber  (3  –  5  minutes).  Third,  whilst  NA  could  be  
displaced  by  competitive  antagonists,  and  ɑ1-­AR  agonists  could  be  washed-­out,  I  was  
not  able  to  satisfactorily  wash  5-­HT  out;;  i.e.  even  after  1  hour,  a  considerable  depression  
remained.  This  observation   is  most   likely   linked   to   the  much  higher  affinity  of  5-­HT2R  
compared  to  α1-­AR  (Xu  &  Chuang,  1987).  Consequently,  a  much  longer  unbinding  time  
would  be  expected.  This  was  also  observed  by  others  (Hori  et  al.,  1996).  Fourth,  when  
mSIRK  was  used   in   the  presynaptic   patch  pipette,   the  depression  was  also  blocked,  
suggesting   that   in   both   cases   Gβγ   is   the   crucial   signalling   molecule   downstream   of  
receptor  activation.  
In  addition,   it   is   important   to  point  out   that   in  contrast   to  NA,   the  changes   in  Rin  were  
much  more  striking.  In  particular,  in  non-­responders,  there  was  no  significant  drop  in  Rin  
with  NA,  but  one  with  5-­HT  (-­19  ±  8%),  whereas  in  responders,  the  drop  in  NA  was  much  
less  (-­9  ±  7  vs.  -­28  ±  9%).  This  indicates  that  in  these  cells,  5-­HT  has  a  much  larger  effect  
on  postsynaptic  membrane  conductances  than  NA.  This  observation  is  further  supported  
by  the  fact  that  Ihold  in  NA  did  not  change  significantly,  something  that  was  certainly  the  
case  with  5-­HT  for  non-­responders  but  much  less  so  in  responders.  
4.5.9.  Unaltered  Recovery  from  Depression    
Normally,  the  recovery  time  constant  from  short-­term  depression  is  in  the  range  of  about  
1  s  for  neocortical  nerve  terminals  (Markram  &  Tsodyks,  1996).  There  are  several  reports  
in  the  literature,  in  which  the  recovery  from  depression  was  accelerated  when  Ca2+  rose  
in  the  respective  nerve  terminals  (Dittman  &  Regehr,  1998;;  Wang  &  Kaczmarek,  1998;;  
Fuhrmann  et  al.,  2004).  The  point  of   the  experiment   in  4.4.4.4  was   to  gain  additional  
insight   into   the  molecular  mechanism  downstream  of   receptor  activation,  besides   that  
gained  by  quantal  analysis   (see  below).   In   the  case  of  Gβγ  binding   to  SNAP-­25,   the  
binding   to   SNARE   complex   is   in   competition   with   Ca2+/synaptotagmin   1,   in   a   Ca2+-­
dependent  way.  This  means  that  at  a  high  Ca2+  concentration,  as  after  a  burst  of  action  
potentials   at   50   Hz,   Gβγ   unbinds   from   SNAP-­25   causing   a   temporary   relief   from  
depression.  This  is  then  seen  as  a  speed-­up  of  the  recovery  from  depression  (Yoon  et  
al.,  2007).  At  the  same  time,  the  same  Gβγ  binding  to  SNAP-­25  also  causes  a  reduction  
in  the  quantal  size  (see  below).  
Consistent  with  this  idea,  in  the  case  of  NA,  after  a  burst  of  20  APs  at  50  Hz,  an  additional  
AP  elicited  after  500  ms  caused  an  EPSC,  which  was  much  larger  than  the  first  in  the  
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burst.  This  speed-­up  in  recovery  was  quantified  as  R50,  where  -­1  indicates  no  recovery  
within  the  500  ms,  0  full  recovery,  and  1  a  recovery,  which  is  larger  than  the  amplitude  
of  the  first  EPSC.  In  NA,  R50  was  on  average  0.51  ±  0.29,  clearly  indicating  an  increased  
recovery.  With  5-­HT,  however,  R50  was  on  average  0.07  ±  0.09,  not  different  from  zero.  
Whilst  the  change  in  R50  from  control  to  NA  was  significant  (ppt  =  0.03),  in  the  case  of  5-­
HT   it   was   not   (ppt   =   0.10).   These   data   then   suggest   that   in   the   case   of   5-­HT,   the  
mechanism  of  depression  unlikely  involves  the  binding  of  Gβγ  to  the  SNARE  complex.  
This  is  somewhat  surprising,  as  this  mechanism  was  identified  in  the  lamprey  spinal  cord  
where  5-­HT  was  acting  via  5-­HT1R  (Blackmer  et  al.,  2001;;  Blackmer  et  al.,  2005;;  Yoon  
et  al.,  2007;;  Gerachshenko  et  al.,  2009;;  Zurawski  et  al.,  2016).  
It  is  worth  pointing  out  that  this  idea  is  representative  of  most  data  points  in  this  data  set,  
except   one,   which   may   be   considered   an   outlier.   However,   looking   at   it   with   the  
mechanism  for  NA  in  mind,  there  was  clearly  a  speed-­up  in  recovery,  consistent  with  the  
idea  of  Gβγ  binding  to  SNAP-­25.  This  observation,  whilst  admittedly  taken  with  caution,  
may  suggest  that,   in  the  case  of  5-­HT,  the  mechanism  of  depression  could  potentially  
vary  downstream  of  receptor  activation  and,  for  example,  be  specific  to  particular  axons,  
or  reflect  the  proximity  of  the  Gβγ  producing  receptors  to  the  respective  target  (see  5.2  
for  more  on  this  point).  
4.5.10.  Quantal  Properties  of  EPSC  Depression  
The   point   of   quantal   analysis   was   to   further   provide   evidence   for   the   molecular  
mechanism   involved   in   the   depression   observed.   With   NA   in   the   superfusate,   a  
consistent   and   significant   reduction   in   the   quantal   size   by   39   ±   5%   was   observed,  
consistent  with  the  idea  that  Gβγ  interacted  at  the  C-­terminus  of  SNAP-­25  (Choy  et  al.,  
2017b).  In  support  of  this  idea  are  studies  which  also  showed  that  when  Gβγ  bound  to  
SNAP-­25,  the  quantal  size  decreased  (Photowala  et  al.,  2006).  In  addition,  when  this  C-­
terminus  region  was  mutated,  the  fusion  mode  was  altered  (Gil  et  al.,  2002;;  Fang  et  al.,  
2008).  
For  this  study,  I  successfully  performed  quantal  analyses  on  data  from  14  pairs,  of  which  
6  passed  the  stringent  unimodality  tests.  This  rate  is  comparable  to  what  was  observed  
in  other  cortical  areas  (Stricker  et  al.,  1996a,  b;;  Stricker  et  al.,  1999;;  Cowan  &  Stricker,  
2004;;  Choy  et  al.,  2017b).   In  addition,  σn   (1.2  ±  0.1  vs.  0.9  ±  0.1  pA;;  pt  =  0.15),  The  
average  EPSC  amplitude  (-­19.9  ±  0.7  vs.  -­11.2  ±  2.3  pA;;  pt  =  0.14),  the  quantal  size  (-­
3.9  ±  0.3  vs.  -­2.8  ±  0.1  pA;;  pt  =  0.10),  the  quantal  content  (4.8  ±  0.5  vs.  3.8  ±  0.7  pA;;  pt  
=  0.22)  and  the  failure  rate  (0.12  ±  0.03  vs.  0.15  ±  0.05;;  pt  =  0.32)  were  comparable  to  
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what  was  found  before  (Choy  et  al.,  2017b).  Insofar,  this  limited  data  set  was  not  different  
to  what  was  estimated  before.  
The   overall   finding   was   that   in   contrast   to   NA,   5-­HT   did   not   cause   any   reduction   in  
quantal  size,  with  the  other  quantal  parameters  indistinguishable  from  those  obtained  in  
a  previous  study  (Choy  et  al.,  2017b).  This  was  backed-­up  by  a  CV-­2  analysis,  which  also  
indicated   that   there  was  mostly   a   reduction   in   release   probability.  Conversely,   in   the  
context  with  5-­HT,  the  whole  depression  was  solely  due  to  a  decrease  in  quantal  content.  
In  addition,  based  on  a  χ2-­test,  the  outcomes  in  this  case  were  indeed  very  different  to  
what  was  observed  with  NA  (6:0  vs.  0:9;;     =  10-­4).  
This  outcome   is   consistent  with  a  presynaptic  mechanism  of  depression  as   the  Gβγ-­
binding  peptides  were  applied  to  the  presynaptic  axon  only.  In  addition,  despite  the  fact  
that   the   analysed   sample   was   quite   small,   the   findings   using   quantal   analysis   were  
uniformly  similar   in  all  cases.  Together  with   the   finding  above,   that   there  was  also  no  
speed-­up  in  recovery  from  depression,  these  data  suggest  that  despite  Gβγ  being  the  
signalling  molecule  downstream  of  5-­HT2R  activation,   the  molecular   target   is   unlikely  
SNAP-­25  but  VDCC.  
4.5.11.  Molecular  Mechanism  of  Depression  
In  contrast  to  the  data  obtained  with  NA,  and  despite  the  fact  that  in  both  cases  Gβγ  was  
the  relevant  signalling  molecule  downstream  of  5-­HT2R  activation,  I  conclude  that  5-­HT  
caused  the  depression  without  binding  to  SNAP-­25  (Blackmer  et  al.,  2001;;  Blackmer  et  
al.,  2005;;  Yoon  et  al.,  2007;;  Wells  et  al.,  2012;;  Zurawski  et  al.,  2016).   In   this  case,   I  
suggest   that  Gβγ  most   likely  binds   to  VDCC  of   the  CaV2   family   (Tedford  &  Zamponi,  
2006),   which   contain   the   P/Q-­   (2.1,   α1A),   N-­   (2.2,   α1B),   and   R-­types   (2.3,   α1E).   As   a  
consequence,  Ca2+  influx  into  the  nerve  terminals  is  inhibited.  However,  it  needs  to  be  
pointed  out  that  also  a  modulation  of  an  alternative  channel(s)  by  Gβγ  may  be  possible.  
Ca2+  current  inhibition  has  originally  been  described  in  dorsal  root  ganglion  cells  in  the  
chicken  (Dunlap  &  Fischbach,  1978).  Subsequently,  it  was  identified  for  a  number  of  G-­
protein-­coupled   receptors,  which   typically  signal  via  Gi/o,   like  µ-­opioid   (Bourinet  et  al.,  
1996),  α2-­adrenergic  (Herlitze  et  al.,  1996;;  Ikeda,  1996),  5-­HT1  (Penington  et  al.,  1991;;  
Foehring,  1996),  purinergic  (Currie  &  Fox,  1997),  dopaminergic  (Marchetti  et  al.,  1986;;  
Mirotznik  et  al.,  2000),  neuropeptide  Y  (Plummer  et  al.,  1991),  and  muscarinic  receptors  
(M1  and  M3;;  Bernheim  et  al.,  1991;;  but  also  M2  and  M4;;  Currie  &  Fox,  1997).  For  some  
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their  writing.  It  is  important  to  note  that  the  effect  of  current  inhibition  seems  to  be  larger  
for  N-­  than  for  P/Q-­type  channels  (Tedford  &  Zamponi,  2006).  
Two  conceptional  mechanisms  have  been  described  resulting  in  Ca2+  current  inhibition  
(for   review   see   Shapiro   &   Gamper,   2009).   In   fact,   the   two   can   co-­exist   to   potently  
modulate  Ca2+  channels  (Beech  et  al.,  1992).    One  of  them  is  acting  fast  (~  400  ms),  the  
other  slower  (~  30  s).  Because  both  times  are  shorter  than  the  exchange  time  of  5-­HT  in  
my  bath,  I  am  unable  to  distinguish  between  the  two.  The  first  was  originally  described  
by  Bean  (1989)  without  knowing  that  it  was  mediated  by  Gβγ.  He  noticed  that  the  current  
inhibition  was  voltage-­dependent.  He  correctly  identified  that  the  activation  curve  of  the  
Ca2+  channels  was  shifted  to  much  more  positive  voltages  without  actually  affecting  the  
maximal  flux.  He  suggested  that  the  channels  were  in  a  “willing”  mode  at  rest,  but  upon  
exposure  to  a  neuromodulator,  changed  into  a  “reluctant”  mode,  without  any  effect  on  
the   voltage-­dependence   of   inactivation   suggesting   that   the   switch   between   the   two  
modes  could  occur  fast.  This  model  implicated  that  the  G  protein  binding  to  the  channel  
was  voltage-­dependent.  Subsequent  work  confirmed  these  observations  and  found  that  
when  Gβγ  bound  to  N-­type  VDCC,  the  channels  switched  to  the  reluctant  mode  (Boland  
&  Bean,  1993).  In  addition,  the  inhibition  could  be  relieved  by  a  large  depolarization  to  
+100  mV  also  known  as  “pre-­pulse  facilitation”  (Bean,  1989).  (Brody  &  Yue,  2000)  used  
AP  waveforms  as  the  voltage-­protocols  and  showed  that  the  voltage-­dependent  unblock  
described  by  Bean  with   large  steps  also  occurs  with   these  more  physiological  stimuli.    
The  implication  is  that  the  modulation  is  effective  at  low  rates  of  stimuli  but  trains  of  APs  
can  reverse  it.  This  Ca2+  current  disinhibition  (Brody  &  Yue,  2000)  may  be  reminiscent  
of  the  Ca2+-­dependent  unbinding  of  Gβγ  from  SNAP-­25.  This  “facilitation”  was  dominant  
at  P/Q-­,  but  close  to  absent  at  N-­type  channels  (Rozov  et  al.,  2001).  This  is  consistent  
with  the  published  data  that  most  of  the  Ca2+  current  at  synapses  in  layer  II  is  made  up  
of  a  large  P/Q-­current  component  (Rozov  et  al.,  2001).  Given  that  when  20  APs  were  
evoked  at  50  Hz,  no  facilitaory  response  was  observed  suggests  that  this  mechanism  
may  not  be  operating  in  these  nerve  terminals.  
The  second  mechanism  consists  of  a  set  of  processes  all  linked  to  signalling  cascades  
around   PLC.   In   contrast   to   the   first,   the   action   on   VDCC   in   this   set   is   voltage-­
independent.  One  such  mechanism  was  first  characterised  for  M1  receptors  (Bernheim  
et  al.,  1991)  and   involved  a  Ca2+-­sensitive  step   in   the  signalling  cascade.   It  was   later  
found  that  it  was  linked  to  PLCδ  and  the  availability  of  PIP2  in  the  membrane  (Gamper  
et   al.,   2004)   with   a   reduction   resulting   in   a   current   inhibition.   Another   mechanism  
employs  signalling  downstream  of  of  PLCβ.  In  this  case,  DAG  lipase  forms  arachidonic  
acid  (Irvine,  1982)  from  DAG,  which  then  inhibits  Ca2+  channels  (Piomelli  et  al.,  1987).  
Because  of  the  involvement  of  several  enzymes  in  the  cascade,  it  is  not  surprising  that  
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this  set  of  mechanisms  can  take  tens  of  seconds  to  minutes  to  take  place.  Yet  another  
alternative  is  linked  to  the  fact  that  some  PLCβ  isoforms  can  be  activated  by  Gβγ  (see  
also  below),  but  the  required  concentrations  might  be  quite  high.  Downstream  signalling,  
via  for  example  the  DAG  lipase  path,  would  then  result  in  the  Ca2+  current  depression  
(Diversé-­Pierluissi  et  al.,  1995).  
In  future  experiments,  it  would  be  possible  to  evaluate  the  extent  of  the  involvement  of  
the   two   mechanisms.   One   could   block   PLC   isoforms   with   edelfosine   to   prevent  
downstream  signalling  associated  with  the  second  set  of  mechanisms.  Alternatively,  one  
could   attempt   to   perform   large   conditioning   voltage-­steps   to   +100   mV   for   several  
hundred  ms   followed  by  evoking  an  action  current  at   the  soma   to  evoked   transmitter  
release.  The  idea  here  is  that  it  may  be  possible  if  the  nerve  terminals  are  not  too  remote  
to  mimic  “pre-­pulse”  facilitation  (see  above).  
Based  on  my  dataset,  and  assuming  a  Ca2+  cooperativity  of  four  (Dodge  &  Rahamimoff,  
1967;;  Borst  &  Sakmann,  1996)  between  EPSC  and  the  Ca2+  current,  the  extent  of  the  
AP-­associated  Ca2+  current  depression  can  be  estimated  to  be  ~16  ±  1%.  This  extent  
should   be   detectable   when   doing   Ca2+   imaging   directly   from   single   nerve   terminals.  
Similar  measurements  have  been  made  (Chen  &  Regehr,  2003).  An  extension  of   this  
work  should  attempt  to  reveal  and  quantify  the  Ca2+  current  depression  associated  with  
a  single  action  potential.  
It   should   also   be   noted   that   whilst   the   Ca2+   current   depression   is   the   most   likely  
explanation   for   the  depression  observed,   I  cannot   rule  out   the  possibility   that  another  
mechanism  may  exist  which  depresses   transmitter   release  downstream  of  Gβγ.  One  
such   mechanism   may   act   via   K+   channels.   As   indicated   above,   the   family   of   GIRK  
channels  (KIR)  can  be  activated  by  Gβγ  (Logothetis  et  al.,  1987).  Synaptic  depression  
would   then  be   the   result   of   a   hyperpolarised  nerve   terminal,   in  which   the  Ca2+   influx  
becomes  limited.  However,  at   least   in  hippocampus,  there  is   little  evidence  that  GIRK  
channels   are   involved   and   cause   a   synaptic   depression   (Lüscher   et   al.,   1997).  
Alternative  K+  channels  include  Kv7.4  (Stott  et  al.,  2015)  and  TASK-­2  channels  (Añazco  
et   al.,   2013).   The   latter   are   of   the   family   of   two-­pore   potassium   channels,   which  
contribute   to   the   leak  conductance  and  pH  homeostasis.  These  channels  seem  to  be  
inhibited   by   Gβγ   (Lüscher   et   al.,   1997),   which   would   result   in   an   increase   in   input  
resistance  and  a  depolarisation  and  may   facilitate   transmitter   release   if   expressed   in  
nerve  terminals.  However,  the  expression  of  TASK-­2  channels  is  low  in  the  brain  (Gabriel  
et  al.,  2002),  which  makes  this  possibility  rather  unlikely.  
Channels  of  the  family  of  Kv7  (KCNQ)  channels  are  widely  expressed  in  the  brain  (for  
example  see  Schroeder  et  al.,  2000)  and  are  often  associated  with  the  M-­current  (Brown  
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&   Adams,   1980)   setting   the   excitability   in   nerve   cells.   These   channels   are   certainly  
expressed  in  myelinated  axons  in  layer  V  cells  (Battefeld  et  al.,  2014)  and  are  activated  
by  Gβγ  (Logothetis  et  al.,  1987;;  Stott  et  al.,  2015)  reducing  the  overall  excitability  and  
hyperpolarising  the  neuron.  Indeed,  some  are  expressed  on  nerve  terminals  (Huang  &  
Trussell,  2011).  When  blocked,   they   increase   the  postsynaptic  current  by  about  10  –  
20%   without   affecting   overall   the   time   course   of   short-­term   depression.   Conversely,  
when  activated,   they   should   slightly   reduce   the  amplitude  of   the  postsynaptic  EPSC,  
however,  unlikely  by  about  50%  as  in  reported  here.  Whilst  they  may  contribute  to  the  
depression,  they  are  unlikely  majorly  involved  here.  
4.5.12.  Alternative  Targets  of  Gβγ  
I   cannot   rule   out   alternative   targets   that   Gβγ   may   bind   to   and   modulate   transmitter  
release,  but  perhaps   to  a   lesser  extent.  As  mentioned  above,   relevant  proteins   in   the  
presynapse   also   include   phospholipase   A   (PLA)   and   PLCβ   isoforms.   In   the   case   of  
PLCβ,  Gβγ  binding  activates  it,  but  only  at  high  concentrations  (see  also  discussion  in  
3.5.8.1).  
Another  potential  target  is  the  plasma  membrane  Ca2+-­ATPase  (PMCA)  (Lotersztajn  et  
al.,   1992).   However,   it   is   unlikely   that   this   mechanism   is   significantly   at   work   here  
because  the  PMCA  provides  typically  a  continuous,  but  low  transport  capacity  (Fierro  et  
al.,  1998).  As  a  consequence,  the  increase  in  transport  activity  is  unlikely  to  significantly  
affect  the  Ca2+  concentration  in  nerve  terminals,  which  renders  this  possibility  unlikely.  
It  has  been  reported  that  IP3R  are  also  the  target  of  Gβγ  modulation.  Specifically,  Gβγ  is  
capable  of  activating  IP3R  on  stores  and  generate  Ca2+  oscillations  (Zeng  et  al.,  2003).  
Whilst  I  cannot  rule  a  small  contribution  out,  it  is  highly  unlikely  that  this  mechanism  is  
majorly  at  work  as  increased  release  from  intracellular  stores  would  augment  Ca2+  in  the  
nerve   terminal   and   facilitate   release,   which   is   not   consistent   with   the   depression  
observed.  
Gβγ  also  inhibits  phospho-­inositide  3-­kinase  (PI3K;;  Stephens  et  al.,  1994),  the  enzyme  
synthesising  phosphatidylinositol   (3,4,5)-­trisphosphate  (PIP3)   from   PIP2,   which   is   the  
substrate   of   PLCβ.   From   a   signalling   perspective,   inhibition   of   PI3K   may   lead   to  
accumulation  of  PIP2  and  in  doing  so  either  re-­direct  more  substrate  towards  PLCβ,  and  
increase  the  production  of  IP3  and  therefore,  Ca2+  release  from  stores.  In  addition,  the  
increase  in  membrane  PIP2  may  cause  a  Ca2+  current  facilitation.  This  was  not  observed.  
Therefore,  this  is  also  an  unlikely  mechanism.  
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Likewise,  adenylyl  cyclase  can  also  be  a  target  of  Gβγ,  however,  the  actions  are  different  
depending   on   the   isotype.   As   most   types   are   expressed   in   the   brain   (Sadana   &  
Dessauer,  2009),  the  picture  is  complex.  Whilst   isotypes  2,  4  –  7  and  9  are  activated,  
isotypes  1,  3,  8  are  inhibited  (Tang  &  Gilman,  1991).  The  result  would  be  either  an  in-­  or  
decrease   in   cAMP   and   associated   signalling.   As   cAMP   levels   modulate   synaptic  
plasticity  (Byrne  &  Kandel,  1996),  the  outcomes  are  not  necessarily  predictable.  I  cannot  
exclude  the  possibility  that  such  a  mechanism  may  partake  in  the  slow  mechanism  of  
Ca2+  current  inhibition.  
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5.  Overall  Discussion  and  Conclusions  
This  study  focussed  on  the  mechanisms  of  how  5-­HT  modulated  both  spontaneous  and  
evoked  transmitter  release.  The  outcomes  were  contrasted  to  similar  findings  made  in  
this  laboratory  for  NA  (Choy,  2011;;  Choy  et  al.,  2017a;;  Choy  et  al.,  2017b).  
5.1.  mEPSC  Frequency  Increase  vs.  EPSC  Depression  
In  Part  3,  I  reported  that  the  activation  of  5-­HT2CR  by  5-­HT  resulted  in  the  activation  of  a  
classical  Gq-­mediated  signalling  cascade,  causing  the  release  of  Ca2+  from  presynaptic  
Ca2+  stores,  which  was  seen  as  an  increase  in  mEPSC  frequency.  No  significant  change  
in  its  amplitude  was  observed.  However,  the  increase  in  mEPSC  frequency  was  transient  
within  the  first  5  minutes,  and  later  waned  and  waxed  again.  However,  when  PKC  was  
inhibited   using   Gö   6983,   the   mEPSC   frequency   increase   became   sustained   for   the  
duration  of  the  experiment,  suggesting  a  critical  phosphorylation  downstream  of  5-­HT2R  
activation.  
In  contrast,   in  Part  4,   I  observed   that   the  activation  of  5-­HT2R  depressed   the  evoked  
EPSCs  by  49  ±  3%,  however,  without  any  indication  of  waxing  and  waning.  These  two  
mutually  exclusive  observations   lend   further  support   to   the   idea   that   the  mechanisms  
resulting  in  the  transient  frequency  increase  are  most  likely  downstream  of  the  separation 
of the adaptor G-protein from its receptor and the subsequent dissociation of the Gα subunit 
from the Gβγ dimer.  
The  molecular  mechanisms  involved  in  both  instances,  as  presented  in  Parts  3  and  4,  
are  schematically  illustrated  in  Fig.  5.1.1.  The  case  for  evoked  release  is  shown  on  the  
left,  whilst  that  for  spontaneous  release  on  the  right.  The  explanation  can  be  found  in  the  
figure  legend.  
5.2.  Comparison  with  NA  
Similar  to  NA,  the  frequency  of  mEPSC  increased  due  to  store  release.  However,  with  
NA,  this  increase  persisted  throughout  the  recording  and  did  not  wax  and  wane.  Because  
both  NA  and  5-­HT  activated  signalling  via  the  Gq  protein,  the  two  outcomes  downstream  
of   the   same   G   protein   were   clearly   different.   It   remains   unclear   how   the   specificity  
downstream   of   Gq   activation   was   preserved   for   both   cascades.   It   may   well   be    
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Figure  5.1.1.  Modulation  of  spontaneous  and  evoked  glutamate  release.  
Mechanisms  involved  in  spontaneous  glutamate  release  (mEPSCs)  are  shown  on  the  right,  
whereas   those   for  evoked  are  on   the   left.  Arrows   indicate  activation  whereas  end  bars  
inhibition.  Right:  Upon   ligand  binding,  presynaptic  5-­HT2A/CR  are  activated  beyond  their  
constitutive   activity   and   initiate   the   classical   Gq-­mediated   signalling   cascade   by   firstly  
activating  PLCβ  (1),  which  then  hydrolyses  PIP2  to  produce  IP3  (2)  and  DAG.  The  IP3  binds  
to  IP3R  on  presynaptic  Ca2+  stores,  causing  store  release  (3).  This  Ca2+  binds  to  a  Ca2+  
sensor   likely  around  the  SNARE  complex  (grey),  causing   increased  release  of  vesicles,  
observed  as  an  increased  mEPSC  frequency.  The  other  product,  DAG  most  likely  activates  
PKC   to   phosphorylate   5-­HT2R   and   thereby   inhibiting   their   activity   (dashed   line).  
Alternatively,  and/or  additionally,  DAG  is  also  capable  of  activating  MAPK  and  its  various  
elements,  the  result  of  which  is  a  further  positive  feedback  onto  5-­HT2R  (dashed  line  with  
arrow).  MAPK  activity  itself  is  sensitive  to  PKC  block  (dashed).  Left:  In  the  case  of  evoked  
transmitter   release,  5-­HT  also  activates  presynaptic  5-­HT2A/CR.  Upon  activation,   the  Gq  
dissociates  into  Gα  and  Gβγ  subunits,  the  former  most  likely  activating  PLCβ  and  the  latter  
directly   or   indirectly   inhibiting   VDCC   (4).   This   inhibition   of   Ca2+   influx   curtails   evoked  
glutamate  release,  resulting  in  a  large  depression  in  the  EPSC  amplitude.  It  may  be  that  in  
some  cases,  Gβγ  can  bind   to  SNAP-­25   to   inhibit   transmitter   release  at   the   level  of   the  
SNARE  complex  (black,  dashed).  
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that   this   specificity   was   maintained   by   other   proteins   in   proximity   to   the   activated  
receptors;;  in  other  words,  it  may  well  be  that  the  local  biochemical  microdomains  around  
the   two   receptors   are   different   and,   consequently,   the   signalling   outcomes   become  
distinct  (see  also  below).  
Likewise,  evoked  transmitter  release  in  both  cases  was  depressed;;  notably  slightly  more  
for   NA   than   5-­HT.   Furthermore,   in   both   cases,   the   depression  was   sensitive   to  Gβγ  
binding  peptides.  However,  it  is  most  likely  that  the  targets  of  Gβγ  in  both  cases  are  very  
different.  With  NA,  the  most  likely  target  of  Gβγ  was  at  the  distal  end  of  SNAP-­25.  The  
evidence  for  this  stemmed  from  two  lines  of  evidence.  First,  the  increased  value  of  R50  
and  second,  the  reduction  in  quantal  size.  Both  of  these  observations  are  consistent  with  
a  target  on  the  distal  end  of  SNAP-­25.  However,  in  the  case  of  5-­HT,  the  target  was  most  
likely  different,  as  neither  R50  nor  the  quantal  size  changed.  Because  the  depression  was  
incurred  within  the  presynaptic  nerve  terminal,  where  the  peptides  were  applied  to,  the  
most  parsimonious  explanation  is  that  the  target  is  VDCCs.  As  noted  in  the  discussion  
in  Part  4,  I  did  observe  that  in  at  least  one  case,  R50  increased,  but  unfortunately,  this  
case  could  not  be  subjected  to  quantal  analysis.  Likewise,  even  in  the  case  with  NA,  a  
single  case  without  a  speed-­up   in   recovery  was  seen,  potentially   suggesting   that   the  
molecular  target  may  not  be  uniformly  identical  but  depend  on  local  factors  (proximity).  
The  fact  that  with  NA,  evoked  transmitter  release  depressed  but  spontaneous  increased,  
and   given   that   SNAP-­25   was   the   target,   suggested   that   there   were   at   least   two  
populations  of  vesicles  in  these  nerve  terminals,  as  depression  was  only  seen  for  evoked  
but  not  spontaneous  release  (Choy  et  al.,  2017a;;  Choy  et  al.,  2017b).  However,  in  the  
case  with  5-­HT  where   the   likely   target  was  VDCCs,   there   is  no  need  to  postulate   the  
existence  of  two  vesicle  pools,  unless  there  is  some  weight  given  to  the  observation,  that  
in  one  case  R50  increased.  This  is  simply  because  spontaneous  release  in  this  case  was  
independent  of  Ca2+  influx  via  VDCCs  (Katz  &  Miledi,  1963).  However,  this  conclusion  
does   not   rule   the   idea   of   two   pools   out   either   (see   two   differently   outlined   vesicle  
populations  in  Fig.  5.1.1).  
Given  that  it  is  very  likely  that  both  receptors  are  expressed  on  the  same  nerve  terminals  
(even   though   I   have   not   studied   this   aspect   directly),   an   interesting   question   arises,  
namely  why  in  the  case  of  5-­HT  the  target  is  the  VDCCs,  whereas  with  NA,  it  is  SNAP-­
25?   A   likely   explanation   is   that   there   is   a   difference   in   the   proximity   to   the   target.  
“Shielding”  by  (an)  adaptor  protein(s)  may  restrict   the  availability  of  a  potential   target.  
Another  possible  explanation   is   that  different  Gβγ  dimers  are  at  play.  A  similar  micro-­
organisation  was  found  for  the  case  with  5-­HT1R  and  GABABR  (Hamid  et  al.,  2014),  in  
which  the  signalling  downstream  of  receptor  activation  is  also  driven  by  Gβγ.  Specifically,  
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in  regard  to  the  molecular  micro-­organisation,  this  could  mean  that  in  the  case  of  5-­HT,  
VDCCs  and  5-­HT2R  are  very  much  closer,  whereas  α1-­AR  are  in  much  closer  proximity  
to  the  SNARE  complex.  This  is  something  that  may  be  resolved  by  the  FRET  interaction  
(Herrick-­Davis  et  al.,  2006)  between  the  receptor  and  the  target,  or  using  single-­molecule  
detection   microscopy   (for   an   idea   see   Saka   &   Rizzoli,   2012).   Alternatively,   there   is  
evidence  that  different  types  of  Gβ  and  Gγ  are  expressed  in  cortex,  which  may  give  rise  
to   the   formation   of   different   dimer   combinations   (Betke   et   al.,   2014).   Using   different  
purified  dimer  combinations  contained  in  the  presynaptic  patch  pipette  may  be  able  to  
clarify  this  idea.  
5.3.  Constitutive  5-­HT2R  Activity  
Another  feature  distinct  to  that  of  NA  was  that  there  is  evidence  of  constitutive  5-­HT2R  
activity  despite  having  severed  the  relevant  axons  during  slicing.  With  NA,  and  consistent  
with   an   earlier   report   from   this   laboratory   (Simkus   &   Stricker,   2002b,   a),   there   was  
evidence  that  only  PLCβ  was  tonically  active  in  both  instances,  a  fact  reported  by  others  
before  (Hardie  et  al.,  2004).  
The  evidence  for  constitutive  5-­HT2R  activity  was  obtained  in  a  set  of  experiments,  during  
which   5-­HT2A/CR   antagonists   were   utilised   while   recording   mEPSCs.   When   these  
antagonists  were  applied  to  the  superfusate,  an  increase  in  mEPSC  frequency  by  23  ±  
11%  was  observed  consistent  with  other  reports  (De  Deurwaerdere  et  al.,  2004;;  Austgen  
et  al.,  2012).  It  suggests  that  the  5-­HT2R/signalling  cascade  was  in  a  desensitised  state,  
which   was   relieved   when   exposed   to   the   antagonist.   This   then   resulted   in   a   higher  
mEPSC  frequency.  This  is  most  likely  the  mechanism  responsible  for  the  antidepressant  
activity  of  some  5-­HT2R  antagonists  (Di  Giovanni  &  De  Deurwaerdere,  2016).  
I  noted  that,  within  the  data  set  obtained  while  doing  paired  recordings,  no  evidence  for  
constitutive  activity  was  uncovered.  The  reason  for  this  lack  of  evidence  was  because  
so  far,  no  antagonists  were  used  in  this  context.  In  the  near  future,  it  would  be  important  
to  investigate  if  constitutive  activity  can  also  be  seen  when  doing  paired  recordings.  The  
prediction  would  be  that  upon  exposure  to  the  antagonists,  the  EPSCs  would  become  
larger  by  some  20  –  30%.  This  experiment   is   important,  as   it   remains  unknown   if   the  
increase  in  mEPSCs  is  downstream  of  the  same  subtype  of  5-­HT2R  as  that  of  the  EPSC  
depression.  
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5.4.  Specificity  within  Neocortical  Networks  
One  of  the  most  surprising  findings  in  this  study  was  that  a  simple  ad  hoc  classification  
based  on   the   impact  on   the  mEPSC   frequency,  as  presented   in  Part  3,  had  a  mirror  
image  in  Part  4,  where  I  found  that  non-­responders  were  typically  pre-­  and  responders  
postsynaptic  (Fig.  5.4.1).  This  idea  was  further  underpinned  by  the  fact  that,  statistically  
speaking,  the  null  hypothesis  in  the  case  of  the  presynaptic  cells  (i.e.  non-­responders)  
had  to  be  accepted  (pt  >  0.97);;  i.e.  it  is  with  very  high  confidence  that  presynaptic  cells  
belonged   to   the   class   of   non-­responders.   The   case   of   having   to   accept   the   null  
hypothesis   in   the   context   of   a   t-­test   is   rather   unusual   in   biology.   This   further   lends  
strength  to  this  classification.  In  hindsight,  it  is  also  interesting  to  point  out  that,  within  the  
confines  of  this  thesis,  the  significance  level  chosen  for  the  KS  statistic  was  very  likely  
appropriate.  
These  novel  results  are  consistent  with  two  earlier  studies,  which  found  that  the  effect  of  
5-­HT  was  largely  restricted  to  cortical  projection  neurons  (Dembrow  et  al.,  2010;;  Avesar  
&   Gulledge,   2012).   It   is   important   to   point   out   that   both   of   these   studies   assessed  
properties  that  mostly  reflected  those  of  the  postsynaptic  dendrite  (Dembrow  et  al.,  2010)  
and  its  excitability  (Avesar  &  Gulledge,  2012).  This  study,  though,  is  different  in  that  the  
specificity  was  related  to  the  expression  of  5-­HTR  on  notably  presynaptic  terminals  onto  
these   responders   (autoreceptors).   A   similar   finding  was   obtained   in   prefrontal   cortex  
(Beique  et  al.,  2007).  Whilst   I  cannot  exclude   the  possibility   that  most  of   these  nerve  
terminals  were  associated  with  pyramidal  cells  that  would  predominantly  project  outside  
of  the  cortex,  as  suggested  by  the  two  studies  cited,  it  is  unlikely  to  be  the  case  here  for  
the  following  three  reasons.  First,   I  did  find  reciprocal  connections  (7  out  of  56  pairs),  
which,  by  itself,  challenges  the  conception  of  specific  wiring  beyond  that  of  randomness  
(for  a  more  detailed  discussion  see  below).  Second,  given  that  the  sEPSC  rate  in  these  
cells   (52  ±  6  Hz),  and   its   increase  by  5-­HT   (28  ±  8  %)  was  sizeable,  a   considerable  
number  of  nerve  terminals  expressing  5-­HT2R  must  exist  in  this  layer,  which  is  unlikely  
made  up   from  axon   collaterals   of   projection  neurons  only.  And,   third,   using   immuno-­
histochemistry   (data   obtained   for   a   different   project   by   Le-­Thuy-­Van   Tran   in   the  
laboratory),   after   randomly   filling  pyramidal   cells   in   this   layer   for   this  part,  we  did  not  
observe  that  some  axons  were  devoid  of  5-­HT2R  expression  as  implicated  by  the  specific  
wiring  idea;;  i.e.  in  all  cells  imaged,  5-­HT2R  were  expressed  along  the  axon.    
All   three   considerations   suggest   that   the   presynaptic   nerve   terminals   when   making  
contact  to  a  responder  were  appropriately  “matched”  to  operate  as  a  single  entity  (Fig.    
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Figure  5.4.1.  Network  specificity  and  impact  on  glutamate  release.  
In   a   cell   pair   (typical   one-­way   connectivity),   non-­responders  are   very   likely   presynaptic  
(blue   for   control).   These   express   a   large   (axonal)   conductance   activated   by   5-­HT1R  
(orange),  and  send  axonal  projections  expressing  5-­HT2R  (red  dot)  to  form  synapses  with  
postsynaptic   cells.   These   are   the   responders,   which   also   express   a   larger   number   of  
dendritic   5-­HT2R   (filled   red   rectangle)   than   non-­responders.   At   such   a   connection,   in  
presynaptic  cells,  5-­HT  (red)  caused  an  insignificant   increase  in  mEPSC  frequency  with  
small   changes   to   the   AP,   together   with   a   large   hyperpolarization.   Conversely,   in  
postsynaptic   cells,   there   were   concomitant   transient   increases   in   mEPSC   frequency  
together  with  a  large  EPSC  depression,  associated  with  a  large  reduction  in  Rin,  but  a  small  
hyperpolarization.   Consequently,   signal   transmission   is   weakened   because   of   EPSC  
depression  on  an  increased  background  noise  caused  by  s/mEPSCs.  
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5.4.1);;   i.e.  both  the  pre-­  and  the  postsynaptic  cells  responded  simultaneously  to  5-­HT  
via   5-­HT2R.   The   idea   of  matching   pre-­   with   postsynaptic   properties   has   gained   little  
attention   in   the   literature   (Mohan   et   al.,   2013)   outside   the   conception   of   homeostatic  
plasticity   (Turrigiano   et   al.,   1998).   It   may   suggest   that   the   postsynaptic   element  
determines  the  presynaptic  characteristics  via  some  form  of  retrograde  message  (target  
specificity;;  see  also  Scanziani  et  al.,  1996;;  Reyes  et  al.,  1998;;  Mohrmann  et  al.,  1999;;  
Schinder  et  al.,  2000;;  Toth  &  McBain,  2000;;  Harney  &  Jones,  2002;;  Cowan  &  Stricker,  
2004;;  Dugue  et  al.,  2005;;  Koester  &  Johnston,  2005;;  Buchanan  et  al.,  2012;;  Rubio  et  al.,  
2014).  Except  in  the  case  of  synaptic  plasticity,  the  nature  of  this  retrograde  message  
remains  elusive,  but  likely  mediators  are  Eph  receptors  together  with  their  ephrin  ligands,  
and  cell  surface  proteins  like  N-­cadherin,  sidekicks,  flamingo,  SYG-­1  and  2  (Shen,  2004).    
The   fact   that,   based   on   immunohistochemistry   (see   above),   all   axons   labelled   with  
biocytin  also  expressed  5-­HT2R,  suggests  that  the  receptors  were  present  on  most  nerve  
terminals   in   layer  II.  However,   their   functional  state  differed;;   i.e.  onto  non-­responders,  
the  receptors  are  likely  silenced  (open  circles  on  nerve  terminals  in  Fig.  5.4.1)  or  non-­
responsive.  It  is  unclear  if  in  the  first  case,  the  respective  receptors  like  AMPAR  remained  
in  endosomal  vesicles,  ready  to  be  inserted  (Hayashi  et  al.,  2000),  or,  in  the  second  case  
the   receptors   were   in   the   membrane,   but   required   for   their   activation,   for   example,  
phosphorylation  (Sheffler  et  al.,  2006;;  Strachan  et  al.,  2009;;  Strachan  et  al.,  2010),  or  
another  post-­translational  modification,  which  rendered  them  unresponsive.  
5.5.  Systems  Impact  of  Serotonergic  Modulation  
These  data  suggest  that  in  specific  neocortical  networks,  increased  activity  in  the  raphe  
nuclei  could  cause  a  large  depression  of  sensory  input  and/or  local  recurrent  excitation,  
resulting  in  depressed  EPSCs,  and  consequently  reduced  firing.  Accordingly,  firing  may  
become  restricted  to  connections  with  initially  large  EPSCs  and  thereby,  “sharpening”  of  
the  respective  receptive  fields  may  occur  as  other  connections  “drop  out”  (Williams  et  
al.,  2002;;  Lottem  et  al.,  2016).  However,  at  the  same  time,  the  same  5-­HT  also  transiently  
increased  spontaneous  transmitter  release  via  store  activation,  which  was  seen  as  noise  
(Fig.  5.4.1).  Under  conditions  where  the  EPSC  is  depressed  on  an  increased  background  
“noise”,   spike   de-­correlations   may   occur,   which   have   been   reported   in   this   context  
(Favero  et  al.,  2012;;  Castro-­Alamancos  &  Gulati,  2014;;  Kapoor  et  al.,  2016).  
However,  I  am  unsure  about  the  impact  and  value  of  a  waxing  and  waning  background  
noise,   as   it   may   not   be   relevant   for   sensory   processing   (too   slow).   I   note   that   this  
observation  was  obtained  under  pharmacological  conditions,   i.e.  after  exposure   to  10  
µM  5-­HT.  This   concentration   is   likely   very  much  higher   than   that   under  physiological  
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conditions,  where,  using  microdialysis,   it  was  estimated   that  5-­HT   rose  by  a   factor  of  
about   two  to  ~15  nM  (Fujino  et  al.,  2002).  The  concentration  used   in  my  experiments  
may  have  forced  5-­HT2R  into  a  desensitised  and  altered  state,  which  may  have  caused  
the  waxing  and  waning.    
5.6.  Relevance  to  Disease  
The   5-­HT-­mediated   EPSC   depression   could   result   in   a   dampening   of   cortical  
“excitability”  when  predominantly  driven  by  synapses.  This  has   indeed  been   reported  
(Buchanan  et  al.,  2014).  Or  alternatively,  neocortical  excitability  increased  when  5-­HT2R  
were  knocked-­out  (Tecott  et  al.,  1995)  or  dysfunctional  (Bagdy  et  al.,  2007).  In  addition,  
5-­HT  has  been  found  to  reduce  the  incidence  of  absence  seizures  (Ohno  et  al.,  2010;;  
for  review  see  Guiard  &  Di  Giovanni,  2015).  In  fact,  it  has  been  known  for  60  years,  that  
the   antiepileptic   drug   phenytoin   augments   the   5-­HT   concentration   in   brain   tissue  
(Bonnycastle  et  al.,  1957).  Admittedly,  in  this  generalisation,  the  molecular  actions  are  
likely   highly   diverse,   with   both   direct   actions   on   glutamatergic   and   GABAergic  
transmission  reported  as  well  as  direct  effects  on  membrane  conductances  (Carr  et  al.,  
2002).  
With  epidemiological  data  suggesting  a  correlation  between  epilepsy  and  depression,  
and,  conversely,  depression  also   linked   to  some   forms  of  epilepsy   (Kanner,  2003;;  Di  
Giovanni   et   al.,   2016;;   Palacios   et   al.,   2017),   it   is  well   established   that   depression   is  
typically  linked  to  a  hypofunction  of  the  serotonergic  system  (Pytliak  et  al.,  2011;;  Lutz,  
2013;;   Olivier,   2015;;   Chagraoui   et   al.,   2016).   Therapeutically,   selective   serotonin   re-­
uptake  inhibitors  (SSRI)  are  among  the  drugs  used  to  treat  patients  suffering  from  this  
disease.  These  compounds  augment  the  5-­HT  concentration  in  brain  tissue  by  blocking  
the   respective   re-­uptake   into   glia   and   neurons.   It  may  well   be   that   one   of   the  major  
actions   in   this   regard   rests  upon   the  ability   of   5-­HT2R   to   transactivate,   i.e.  mimic   the  
action  of  some  neurotrophins  (Tsuchioka  et  al.,  2008;;  Kruk  et  al.,  2015).  
Furthermore,  it  has  been  reported  that  decreased  serotonergic  activity  is  a  key  player  in  
β-­amyloid   oligomer-­induced   depressive-­like   behaviour   in  mice,   a  model   of   Alzheimer  
disease  (Ledo  et  al.,  2016).   In  addition,   the  same  disease   is   linked  to   increased  Ca2+  
store  content  (Berridge,  2010),  which  may  well  alter  the  extent  of  the  transient  mEPSC  
frequency  increase,  but  more  importantly,  the  activation  of  the  β-­secretase  (Green  et  al.,  
2008;;   for   review   see   Green   &   LaFerla,   2008)   and   in   doing   so,   accelerate   the  
accumulation  and  toxicity  of  β-­amyloid  oligomers  in  the  extracellular  space.  A  detailed  
understanding  of  store  involvement  may  provide  crucial  insights  into  the  pathophysiology  
and  potential  drug  targets  in  Alzheimer  disease.  
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Beyond   the   classical   understanding   of   dimerization   of   5-­HT2R,   these   receptors   are  
involved  in  signalling  via  forming  heterodimers  beyond  the  same  class  of  receptors.  For  
example,   heterodimeric   receptors   are   involved   in   weight   control   (Tecott   et   al.,   1995;;  
Yadav  et  al.,  2009;;  Schellekens  et  al.,  2013;;  Schellekens  et  al.,  2015),  motor  function  
(Albizu  et  al.,  2011;;  Lukasiewicz  et  al.,  2011),  mood  disorder  (Kamal  et  al.,  2015),  and  
psychotic  disease  (Gonzalez-­Maeso  et  al.,  2008;;  Moreno  et  al.,  2012).  Consequently,  a  
vast   complexity   exists   in   association   with   5-­HT2R,   which   is   just   beginning   to   be  
recognized  and  their  clinical  implications  appreciated.  A  lot  more  knowledge  needs  to  be  
generated  until  a  full  picture  emerges  of  how  5-­HT  alters  various  properties  and  functions  
of  neocortical  microcircuits  (Douglas  &  Martin,  1991;;  Földy  et  al.,  2005;;  Grillner  et  al.,  
2005).
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